,Compound_ID,Uniprot_ID,Compound_Name,Standard_inchi_key,Max_Phase,Target_Pref_Name,Gene_Names,Target_Class,Wild_type_or_mutant,Mutation_information,PubMed_ID,End_Point_Standard_Type,End_Point_Standard_Relation,End_Point_Standard_Value,End_Point_Standard_Units,Endpoint_Mode_of_Action,Assay_Format,Assay_Type,Assay_Sub_Type,Inhibitor_Type,Detection_Technology,Compound_concentration_value,Compound_concentration_value_units,Substrate_type,Substrate_Type_Standard_Relation,Substrate_Type_Standard_Value,Substrate_Type_Standard_Units,Assay_cell_line,Assay_Description,Activity_Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation_Comments,Assay_ID,DTC_Tid,DTC_Activity_ID,DTC_Molregno,Record_ID,DTC_Document_ID,SMILES,base_rdkit_smiles
0,CHEMBL100045,P35368,,YLUGVAMRGOIDDQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,192.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1227191,DTCC00263329,258299,3366,CCC1=C(C(C(=C(N1)COC)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COC)N1
1,CHEMBL100052,P35368,,LXIPAAJKLDMQAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,49.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,506186,DTCC00267616,97011,3405,C1CN(CCC12CC3=CC=CC=C3C2=O)CCC4=CC=CC5=CC=CC=C54,O=C1c2ccccc2CC12CCN(CCc1cccc3ccccc13)CC2
2,CHEMBL100198,P35368,,IPEWCJVARRJXDP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,79.43,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,642295,DTCC00264117,562389,4573,CN(C)C(=O)C1=CC=CC=C1NCC2=NCCN2,CN(C)C(=O)c1ccccc1NCC1=NCCN1
3,CHEMBL100198,P35368,,IPEWCJVARRJXDP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,93.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,642296,DTCC00264117,562389,4573,CN(C)C(=O)C1=CC=CC=C1NCC2=NCCN2,CN(C)C(=O)c1ccccc1NCC1=NCCN1
4,CHEMBL100383,P35368,,VUZRSWNQYOEPCY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,633387,DTCC00264114,205141,4573,CCC(CC)OC(=O)C1=CC=CC=C1NCC2=NCCN2,CCC(CC)OC(=O)c1ccccc1NCC1=NCCN1
5,CHEMBL100434,P35368,,FXCQFMQQYXADPE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,9549.93,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1571179,DTCC00264434,108534,17389,CC(C)C1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,CC(C)c1ccc(N2CCN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC2)cc1
6,CHEMBL100481,P35368,,SKNPJRMJANYTMK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,4073.8,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1563840,DTCC00264809,173186,17389,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=C(C=C4)C(C)C)NC5=CC=CC=C52,Cc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(C(C)C)cc2)CC1
7,CHEMBL10085,P35368,MAZAPERTINE,ZKZFPRUSWCYSGT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18378462.0,KI,=,47.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic Alpha-1B receptor,,Recent advances in selective alpha1-adrenoreceptor antagonists as antihypertensive agents.,Bioorg. Med. Chem.,2008.0,16.0,9.0,"Jain KS, Bariwal JB, Kathiravan MK, Phoujdar MS, Sahne RS, Chauhan BS, Shah AK, Yadav MR",,530297.0,DTCT0023207,2394210,DTCC00137699,1017761,29385,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=CC=C3)C(=O)N4CCCCC4,CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1
8,CHEMBL100878,P35368,,KFOQZPZUMXHKTJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,53.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,503720,DTCC00267390,938517,3405,C1CN(CCC12C=CC3=CC=CC=C3O2)CCC4=CC=CC5=CC=CC=C54,C1=CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21
9,CHEMBL101322,P35368,,XKYLWRMBNQDHDM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,>,2000.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,485443,DTCC00267580,550831,3405,CS(=O)(=O)NC1=CC2=C(C=C1)OC3(CCN(CC3)CCC4=CC=CC=N4)CC2=O,CS(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3ccccn3)CC1)O2
10,CHEMBL101579,P35368,,QYNFZZOONQJAIB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,53.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,480882,DTCC00267579,193763,3405,CN1C=C(N=C1)S(=O)(=O)NC2=CC3=C(C=C2)OC4(CCN(CC4)CCC5=CC=CC6=CC=CC=C65)CC3=O,Cn1cnc(S(=O)(=O)Nc2ccc3c(c2)C(=O)CC2(CCN(CCc4cccc5ccccc45)CC2)O3)c1
11,CHEMBL101610,P35368,,KVIRFFFBTUTUIZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,24.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,347970,DTCC00267547,324169,3405,CC1=C(C(=NO1)C)S(=O)(=O)NC2=CC3=C(C=C2)OC4(CCN(CC4)CCC5=CC=CC6=CC=CC=C65)CC3=O,Cc1noc(C)c1S(=O)(=O)Nc1ccc2c(c1)C(=O)CC1(CCN(CCc3cccc4ccccc34)CC1)O2
12,CHEMBL101739,P35368,,MRGNBQGTIXPNTD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,55.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,479654,DTCC00267665,129262,3405,C1CC2(CCN(CC2)CCC3=CC=CC4=CC=CC=C43)OC5=CC=CC=C51,c1ccc2c(c1)CCC1(CCN(CCc3cccc4ccccc34)CC1)O2
13,CHEMBL101869,P35368,,CIBARXUQAXSAER-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,48.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,504942,DTCC00267815,2065829,3405,C1CN(CCC12CC(=O)C3=CC=CC=C3O2)CCC4=CC=CC5=CC=CC=C54,O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccccc21
14,CHEMBL10347,P35368,RAUWOLSCINE,BLGXFZZNTVWLAY-DIRVCLHFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,2270.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,932956,DTCC00137602,1144937,13230,COC(=O)[C@@H]1[C@H](CC[C@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21
15,CHEMBL10347,P35368,RAUWOLSCINE,BLGXFZZNTVWLAY-DIRVCLHFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,0.6,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from hamster clones.,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34313.0,DTCT0023207,754818,DTCC00137602,1144809,13167,COC(=O)[C@@H]1[C@H](CC[C@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21
16,CHEMBL10347,P35368,RAUWOLSCINE,BLGXFZZNTVWLAY-DIRVCLHFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,4.6,NM,,,,,,,,,,,,,,"The compound was tested for binding affinity against Alpha-1B adrenergic receptor, from human clones.",,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34464.0,DTCT0023207,754817,DTCC00137602,1144809,13167,COC(=O)[C@@H]1[C@H](CC[C@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21
17,CHEMBL104700,P35368,,SCDKHPSUXHBJDJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478100,DTCC00272114,931177,48255,C1CC2CCC1N2CC3=CN=CC=C3,c1cncc(CN2C3CCC2CC3)c1
18,CHEMBL1077168,P35368,,WNJWFQHRCYRXOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,58.88,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228652,DTCC00630971,1621931,38187,COC1=CC(=CC=C1)OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1
19,CHEMBL1078750,P35368,,FBYVWPPEENYVFP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228662,DTCC00631883,845820,38187,C1C(OC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=C(C=C4)C5=CC=CC=C5,c1ccc(-c2ccc(OCCNCC3COC(c4ccccc4)(c4ccccc4)O3)cc2)cc1
20,CHEMBL1078751,P35368,,YMKDCAYLGKAORC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228661,DTCC00631884,457195,38187,C1C(OC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC(=C4)C5=CC=CC=C5,c1ccc(-c2cccc(OCCNCC3COC(c4ccccc4)(c4ccccc4)O3)c2)cc1
21,CHEMBL1078772,P35368,,QTXPSJZUMKDMGD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228660,DTCC00631885,1298111,38187,C1C(OC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4C5=CC=CC=C5,c1ccc(-c2ccccc2OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1
22,CHEMBL1078773,P35368,,RBDSAWBTGMXGTK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,19.95,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228659,DTCC00631886,586998,38187,CC(C)OC1=CC=CC=C1OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,CC(C)Oc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1
23,CHEMBL1078953,P35368,,CLADBLWFXVASRD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,53.7,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228658,DTCC00631963,457197,38187,CCOC1=CC=CC=C1OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,CCOc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1
24,CHEMBL1078954,P35368,,IWORSPYCCXFFAN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,446.68,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228657,DTCC00631964,586999,38187,COC1=CC(=CC(=C1)OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4)OC,COc1cc(OC)cc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1
25,CHEMBL1079,P35368,TIZANIDINE,XFYDIVBRZNQMJC-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,-1.0,EC50,=,322.0,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15029410,DTCC00247641,2114304,70044,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,Clc1ccc2nsnc2c1NC1=NCCN1
26,CHEMBL1079065,P35368,,NTHBZKNEJJJYGF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,138.04,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228656,DTCC00631965,426195,38187,COC1=C(C=C(C=C1)OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4)OC,COc1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1OC
27,CHEMBL1079066,P35368,,JFRSZDORAGVQRA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,173.78,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228655,DTCC00631966,974491,38187,COC1=C(C(=CC=C1)OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4)OC,COc1cccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)c1OC
28,CHEMBL1079079,P35368,,WGIPGQAPFNVWIX-XXFZXMJFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19767206.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Displacement of [3H]Prazosin from alpha-1B adrenergic receptor at 10 uM by scintillation counting,,Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.,Bioorg. Med. Chem. Lett.,2009.0,19.0,21.0,"Donohue SR, Varnäs K, Jia Z, Gulyás B, Pike VW, Halldin C",,619800.0,DTCT0023207,3267832,DTCC00632772,857661,37697,COC1=CC=C(C=C1)C2=C(C(=NN2C3=CC=CC=C3[125I])C(=O)NN4CCCCC4)C#N,COc1ccc(-c2c(C#N)c(C(=O)NN3CCCCC3)nn2-c2ccccc2I)cc1
29,CHEMBL1082862,P35368,,ODHPQKBPZNUARX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,46.77,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228649,DTCC00631044,974480,38187,COC1=CC=CC=C1OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1
30,CHEMBL1083181,P35368,,NNVMIQMBTAAZFU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,63.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228648,DTCC00631045,1907262,38187,C1C(OC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4,c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1
31,CHEMBL1083182,P35368,,PEVLAFDVQRAQGN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,100.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228663,DTCC00631046,133307,38187,COC1=CC=CC=C1OCCNCC2CSC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)O1
32,CHEMBL1084132,P35368,,HVBAGGJDXDXSAY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20153647.0,KI,=,251.19,NM,,,,,,,,,,,,,,Activity at Alpha-1B adrenergic receptor,,"The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure.",Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Holmes IP, Blunt RJ, Lorthioir OE, Blowers SM, Gribble A, Payne AH, Stansfield IG, Wood M, Woollard PM, Reavill C, Howes CM, Micheli F, Di Fabio R, Donati D, Terreni S, Hamprecht D, Arista L, Worby A, Watson SP",,614258.0,DTCT0023207,3224936,DTCC00631001,663318,36246,C1CCNC(C1)CN2CCN(C2)C3=CC=CC=C3,c1ccc(N2CCN(CC3CCCCN3)C2)cc1
33,CHEMBL1084658,P35368,,GTSXERKGHGFELV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,239.88,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228650,DTCC00631043,1006942,38187,CC1=CC=CC=C1OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,Cc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1
34,CHEMBL1085672,P35368,,HVSRNYNPOUFDNJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20153647.0,KI,=,316.23,NM,,,,,,,,,,,,,,Activity at Alpha-1B adrenergic receptor,,"The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure.",Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Holmes IP, Blunt RJ, Lorthioir OE, Blowers SM, Gribble A, Payne AH, Stansfield IG, Wood M, Woollard PM, Reavill C, Howes CM, Micheli F, Di Fabio R, Donati D, Terreni S, Hamprecht D, Arista L, Worby A, Watson SP",,614258.0,DTCT0023207,3224935,DTCC00630996,177069,36246,C1CCNC(C1)CN2CCN(C2=O)C3=CC(=CC=C3)Cl,O=C1N(CC2CCCCN2)CCN1c1cccc(Cl)c1
35,CHEMBL1086156,P35368,,FGBDGNKVRNLYDB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,117.49,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228664,DTCC00630866,522723,38187,COC1=CC=CC=C1OCCNCC2CSC(S2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1ccccc1OCCNCC1CSC(c2ccccc2)(c2ccccc2)S1
36,CHEMBL1087942,P35368,,XRTCZMPGERZCKE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,75.86,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228654,DTCC00630969,1557031,38187,COC1=C(C(=CC=C1)OC)OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1
37,CHEMBL1088071,P35368,,OUDJOYYEESPOHX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,PKI,,,,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,Not Determined,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228653,DTCC00630970,716203,38187,COC1=CC=C(C=C1)OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1
38,CHEMBL1088072,P35368,,YKCXYNCLHSMBJV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,41.69,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228651,DTCC00630972,845805,38187,COC1=CC=CC=C1CCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1ccccc1CCCNCC1COC(c2ccccc2)(c2ccccc2)O1
39,CHEMBL1094208,P35368,"1-(2,3-DICHLOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)",SGKVPHOMCZNDPT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20427184.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic Alpha-1B receptor at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,10.0,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631276.0,DTCT0023207,3337663,DTCC00642251,1232809,38666,C1=CC(=C(C(=C1)Cl)Cl)C(C2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)(C(F)(F)F)O,OC(c1ccc2c(cnn2-c2ccc(F)cc2)c1)(c1cccc(Cl)c1Cl)C(F)(F)F
40,CHEMBL1094209,P35368,,HOMRLSWXGFQYGM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20427184.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic Alpha-1B receptor at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,10.0,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631276.0,DTCT0023207,3337659,DTCC00642252,1746259,38666,C1=CC(=CC=C1N2C3=C(C=C(C=C3)C(C4=CC(=NC=C4)Cl)(C(F)(F)F)O)C=N2)F,OC(c1ccnc(Cl)c1)(c1ccc2c(cnn2-c2ccc(F)cc2)c1)C(F)(F)F
41,CHEMBL1094231,P35368,"1-(3-CHLORO-4-FLUOROPHENYL)-2,2,2-TRIFLUORO-1-(1-(4-FLUOROPHENYL)-1H-INDAZOL-5-YL)ETHANOL (ENANTIOMERIC MIX)",DAXGWLCLIPNRDH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20427184.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic Alpha-1B receptor at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,10.0,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631276.0,DTCT0023207,3337660,DTCC00642205,133424,38666,C1=CC(=CC=C1N2C3=C(C=C(C=C3)C(C4=CC(=C(C=C4)F)Cl)(C(F)(F)F)O)C=N2)F,OC(c1ccc(F)c(Cl)c1)(c1ccc2c(cnn2-c2ccc(F)cc2)c1)C(F)(F)F
42,CHEMBL1094514,P35368,,FQPJRGDRIOAJCS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20427184.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic Alpha-1B receptor at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,10.0,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631276.0,DTCT0023207,3337662,DTCC00642303,683992,38666,CC1=C(C=CC(=C1)C(C2=CC3=C(C=C2)N(N=C3)C4=CC=C(C=C4)F)(C(F)(F)F)O)F,Cc1cc(C(O)(c2ccc3c(cnn3-c3ccc(F)cc3)c2)C(F)(F)F)ccc1F
43,CHEMBL1095274,P35368,,LFLUHLCPXQWQKW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19939513.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to adrenergic Alpha-1B receptor at 10 uM by radioligand displacement assay,Active,"8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,2010.0,45.0,2.0,"Ivachtchenko AV, Mitkin OD, Tkachenko SE, Okun IM, Kysil VM",,627780.0,DTCT0023207,3303533,DTCC00638646,1051183,38522,CN1CCC2=C(C1)C3=C(N2C)C=CC(=C3)S(=O)(=O)C4=CC=CC=C4.Cl,CN1CCc2c(c3cc(S(=O)(=O)c4ccccc4)ccc3n2C)C1
44,CHEMBL1096467,P35368,,DXRCWRDHBIVBIS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20427184.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic Alpha-1B receptor at 1 uM,,5-Functionalized indazoles as glucocorticoid receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,10.0,"Bai M, Carr G, Deorazio RJ, Friedrich TD, Dobritsa S, Fitzpatrick K, Guzzo PR, Kitchen DB, Lynch MA, Peace D, Sajad M, Usyatinsky A, Wolf MA",,631276.0,DTCT0023207,3337661,DTCC00642302,1746261,38666,C1=CC(=CC=C1N2C3=C(C=C(C=C3)C(C4=CC(=C(C=C4)F)C#N)(C(F)(F)F)O)C=N2)F,N#Cc1cc(C(O)(c2ccc3c(cnn3-c3ccc(F)cc3)c2)C(F)(F)F)ccc1F
45,CHEMBL1099284,P35368,,LEEDRVGVQYVFHX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19939513.0,ACTIVITY,=,37.0,%,,,,,,,,,,,,,,Binding affinity to adrenergic Alpha-1B receptor at 1 uM by radioligand displacement assay,,"8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,2010.0,45.0,2.0,"Ivachtchenko AV, Mitkin OD, Tkachenko SE, Okun IM, Kysil VM",,628588.0,DTCT0023207,3303522,DTCC00639104,1727244,38522,CN1CCC2=C(C1)C3=C(N2)C=CC(=C3)S(=O)(=O)NC4=CC(=CC=C4)F.Cl,CN1CCc2[nH]c3ccc(S(=O)(=O)Nc4cccc(F)c4)cc3c2C1
46,CHEMBL1112,P35368,ARIPIPRAZOLE,CEUORZQYGODEFX-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12784105.0,KI,=,34.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14756474,DTCC00106550,2110875,69826,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
47,CHEMBL1112,P35368,ARIPIPRAZOLE,CEUORZQYGODEFX-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,100.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329323.0,DTCT0023207,13582470,DTCC00106550,1580612,39761,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
48,CHEMBL111639,P35368,FLUOROCARAZOLOL,QHLGXPUIUKSADT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11512051.0,KI,=,677.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14736641,DTCC00281815,2106040,69642,CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O,CC(CF)NCC(O)COc1cccc2[nH]c3ccccc3c12
49,CHEMBL111639,P35368,FLUOROCARAZOLOL,QHLGXPUIUKSADT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11512051.0,KI,=,4600.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14736642,DTCC00281815,2106040,69642,CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O,CC(CF)NCC(O)COc1cccc2[nH]c3ccccc3c12
50,CHEMBL114012,P35368,,BDPXTGHWVMUJCT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10669560.0,LOG KI,,,,,,,,,,,,,,,,,Binding affinity towards alpha-1B adrenergic receptor; ND means no data.,Not Determined,"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).",J. Med. Chem.,2000.0,43.0,3.0,"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR",,32310.0,DTCT0023207,1106772,DTCC00290522,1208080,16008,CC1CCN(CC1)CCC2CCCCN2S(=O)(=O)C3=CC=CC4=CC=CC=C43,CC1CCN(CCC2CCCCN2S(=O)(=O)c2cccc3ccccc23)CC1
51,CHEMBL114054,P35368,,CPPOCROKOZZUJM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1173974,DTCC00107191,1435853,5253,C1=CC2=C(C=C(C=C2)O)C(=C1)NCC3=CN=CN3,Oc1ccc2cccc(NCc3cnc[nH]3)c2c1
52,CHEMBL114166,P35368,SK&F-104078,MBYSTKNEMJZSIK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,87.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,917679,DTCC01742473,1208198,13230,CC(=CCOC1=C2CCN(CCC2=C(C=C1)Cl)C)C,CC(C)=CCOc1ccc(Cl)c2c1CCN(C)CC2
53,CHEMBL114345,P35368,,JFQVHBZRRZBJFS-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12392747.0,KI,=,19.05,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.,Bioorg. Med. Chem. Lett.,2002.0,12.0,22.0,"Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR",,34624.0,DTCT0023207,1560672,DTCC00285662,1112493,5235,C1C[C@@H](N(C1)S(=O)(=O)C2=CC3=C(C=C2)C=CN3)CCN4CCC(CC4)C(=O)C5=CC=C(C=C5)F,O=C(c1ccc(F)cc1)C1CCN(CC[C@H]2CCCN2S(=O)(=O)c2ccc3cc[nH]c3c2)CC1
54,CHEMBL114669,P35368,,KJAQMQNRNCMXLV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1151631,DTCC00107192,756256,5253,C1CN=C(N1)CNC2=CC=CC3=C2C=C(C=C3)O,Oc1ccc2cccc(NCC3=NCCN3)c2c1
55,CHEMBL115262,P35368,,UBSGPBQBBCDFAL-HXUWFJFHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12392747.0,KI,=,43.65,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.,Bioorg. Med. Chem. Lett.,2002.0,12.0,22.0,"Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR",,34624.0,DTCT0023207,1565742,DTCC00285667,756212,5235,C1C[C@@H](N(C1)S(=O)(=O)C2=CC3=C(C=C2)C=CN3)CCN4CCC(CC4)N5C6=CC=CC=C6NC5=O,O=c1[nH]c2ccccc2n1C1CCN(CC[C@H]2CCCN2S(=O)(=O)c2ccc3cc[nH]c3c2)CC1
56,CHEMBL115977,P35368,,SZASDYKMOXPMCV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1150478,DTCC00290555,1786005,5253,C1=CC=C(C(=C1)C2=CC=NO2)OCC3=CN=CN3,c1ccc(-c2ccno2)c(OCc2cnc[nH]2)c1
57,CHEMBL116292,P35368,,UKCOOKOJJMPVCG-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12392747.0,KI,=,93.33,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.,Bioorg. Med. Chem. Lett.,2002.0,12.0,22.0,"Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR",,34624.0,DTCT0023207,1596904,DTCC00285624,237842,5235,C1C[C@@H](N(C1)S(=O)(=O)C2=CC3=C(C=C2)C=CN3)CCN4CCC(CC4)C(=O)C5=CC=C(C=C5)Cl,O=C(c1ccc(Cl)cc1)C1CCN(CC[C@H]2CCCN2S(=O)(=O)c2ccc3cc[nH]c3c2)CC1
58,CHEMBL116448,P35368,,JBIWUVRCMUOUNK-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10669560.0,LOG KI,,,,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor; ND means no data.,Not Determined,"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).",J. Med. Chem.,2000.0,43.0,3.0,"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR",,32308.0,DTCT0023207,1130373,DTCC00290938,108793,16008,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC(=CC=C3)Br,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(Br)c2)CC1
59,CHEMBL116700,P35368,,MKCFTZDMTGUFFC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1151615,DTCC00290580,1273638,5253,C1=CC=C(C=C1)C2=CC=CC=C2OCC3=CN=CN3,c1ccc(-c2ccccc2OCc2cnc[nH]2)cc1
60,CHEMBL116700,P35368,,MKCFTZDMTGUFFC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,IC50,=,5888.44,NM,,,,,,,,,,,,,,In vitro binding affinity against cloned human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32514.0,DTCT0023207,1151618,DTCC00290580,1273638,5253,C1=CC=C(C=C1)C2=CC=CC=C2OCC3=CN=CN3,c1ccc(-c2ccccc2OCc2cnc[nH]2)cc1
61,CHEMBL116843,P35368,,SIYVFOFBPDBXEI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1149376,DTCC00290571,820790,5253,CS(=O)(=O)C1=CC=CC=C1NCC2=CN=CN2,CS(=O)(=O)c1ccccc1NCc1cnc[nH]1
62,CHEMBL1169493,P35368,,IPBOROXXRHATRV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873568.0,KI,=,940.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor was evaluated by cloned receptor binding assay,,Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivity.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Patane MA, DiPardo RM, Price RP, Chang RS, Ransom RW, O'Malley SS, Di Salvo J, Bock MG",,33013.0,DTCT0023207,1122215,DTCC00656885,808681,2771,CCOC(=O)C1CN(CCC1C2=CC=CC=C2)CCCCN3C(=O)C4=C(S3(=O)=O)C=CC(=C4)Cl,CCOC(=O)C1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CCC1c1ccccc1
63,CHEMBL117094,P35368,,MCTRZCCYVQDHLM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1152723,DTCC00290572,1786004,5253,CS(=O)(=O)C1=CC=CC=C1NCC2=NCCN2,CS(=O)(=O)c1ccccc1NCC1=NCCN1
64,CHEMBL1171434,P35368,,XVOYSCVBGLVSOL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14738400,DTCC00655109,2106368,69159,C(C(C(=O)O)N)S(=O)(=O)O,NC(CS(=O)(=O)O)C(=O)O
65,CHEMBL117248,P35368,,YGIWTZGEYHABOR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,=,2.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1147991,DTCC00290548,982574,5253,CSC1=CC=CC=C1NCC2=NCCN2,CSc1ccccc1NCC1=NCCN1
66,CHEMBL117248,P35368,,YGIWTZGEYHABOR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,IC50,=,218.78,NM,,,,,,,,,,,,,,In vitro binding affinity against cloned human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32514.0,DTCT0023207,1147996,DTCC00290548,982574,5253,CSC1=CC=CC=C1NCC2=NCCN2,CSc1ccccc1NCC1=NCCN1
67,CHEMBL117248,P35368,,YGIWTZGEYHABOR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,MAX,=,105.0,%,,,,,,,,,,,,,,Activation of human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts as percent maximal effect relative to phenylephrine,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32512.0,DTCT0023207,1147992,DTCC00290548,982574,5253,CSC1=CC=CC=C1NCC2=NCCN2,CSc1ccccc1NCC1=NCCN1
68,CHEMBL117381,P35368,,HKSACLQULUKEGB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,977298,DTCC00290623,194674,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=CN=CO3,c1ccc(-c2cnco2)c(NCC2=NCCN2)c1
69,CHEMBL117381,P35368,,HKSACLQULUKEGB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,IC50,=,229.09,NM,,,,,,,,,,,,,,In vitro binding affinity against human Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34482.0,DTCT0023207,977301,DTCC00290623,194674,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=CN=CO3,c1ccc(-c2cnco2)c(NCC2=NCCN2)c1
70,CHEMBL117381,P35368,,HKSACLQULUKEGB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1169132,DTCC00290623,205408,5253,C1CN=C(N1)CNC2=CC=CC=C2C3=CN=CO3,c1ccc(-c2cnco2)c(NCC2=NCCN2)c1
71,CHEMBL117482,P35368,,DJYTZDSAQZPKOG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1153946,DTCC00290466,594876,5253,CCN(CC)C(=O)C1=CC=CC=C1NCC2=CN=CN2,CCN(CC)C(=O)c1ccccc1NCc1cnc[nH]1
72,CHEMBL117581,P35368,,GHCVLCQQNTYWFS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1140104,DTCC00291037,788441,5253,C1CCN(CC1)C2=CC=CC=C2NCC3=NCCN3,c1ccc(N2CCCCC2)c(NCC2=NCCN2)c1
73,CHEMBL117914,P35368,,RQXPJRXQQKFJSK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,858675,DTCC00291019,238326,5326,CCN(CC)C(=O)C1=CC=CC=C1OCC2=NCCN2,CCN(CC)C(=O)c1ccccc1OCC1=NCCN1
74,CHEMBL117914,P35368,,RQXPJRXQQKFJSK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,858676,DTCC00291019,238326,5326,CCN(CC)C(=O)C1=CC=CC=C1OCC2=NCCN2,CCN(CC)C(=O)c1ccccc1OCC1=NCCN1
75,CHEMBL117914,P35368,,RQXPJRXQQKFJSK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1154992,DTCC00291019,237903,5253,CCN(CC)C(=O)C1=CC=CC=C1OCC2=NCCN2,CCN(CC)C(=O)c1ccccc1OCC1=NCCN1
76,CHEMBL117914,P35368,,RQXPJRXQQKFJSK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,IC50,<,30199.52,NM,,,,,,,,,,,,,,In vitro binding affinity against cloned human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32514.0,DTCT0023207,1154995,DTCC00291019,237903,5253,CCN(CC)C(=O)C1=CC=CC=C1OCC2=NCCN2,CCN(CC)C(=O)c1ccccc1OCC1=NCCN1
77,CHEMBL118055,P35368,,HHQOMPROOBMQGY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,=,25.12,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1156324,DTCC00290832,368842,5253,CSC1=CC=CC=C1NCC2=CN=CN2,CSc1ccccc1NCc1cnc[nH]1
78,CHEMBL118055,P35368,,HHQOMPROOBMQGY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,IC50,=,891.25,NM,,,,,,,,,,,,,,In vitro binding affinity against cloned human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32514.0,DTCT0023207,1156329,DTCC00290832,368842,5253,CSC1=CC=CC=C1NCC2=CN=CN2,CSc1ccccc1NCc1cnc[nH]1
79,CHEMBL118055,P35368,,HHQOMPROOBMQGY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,MAX,=,78.0,%,,,,,,,,,,,,,,Activation of human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts as percent maximal effect relative to phenylephrine,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32512.0,DTCT0023207,1156325,DTCC00290832,368842,5253,CSC1=CC=CC=C1NCC2=CN=CN2,CSc1ccccc1NCc1cnc[nH]1
80,CHEMBL1182155,P35368,,GYSZUJHYXCZAKI-AWEZNQCLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,5.75,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756626,DTCC00661081,868334,53287,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1
81,CHEMBL11828,P35368,,UTACGRWSJNDCLR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,10000.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1181321,DTCC00140674,905325,3699,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CC(=O)CN3CCCCC3=O)O,CC(C)Oc1ccccc1N1CCN(CC(O)CC(=O)CN2CCCCC2=O)CC1
82,CHEMBL1189234,P35368,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11474393,DTCC00667938,1780157,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccccc1
83,CHEMBL1189234,P35368,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600216,DTCC00667938,1780916,55935,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccccc1
84,CHEMBL12062,P35368,RWJ-69736,STMYXSKGGILJBE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,10000.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1199828,DTCC00140595,1616722,3699,CC(C)OC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)CN3CCCCC3=O,CC(C)Oc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1
85,CHEMBL1209158,P35368,,GDTMZQXBYNLZHY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20620058.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha-1b receptor,,Smoothened antagonists for hair inhibition.,Bioorg. Med. Chem. Lett.,2010.0,20.0,16.0,"Li JJ, Shanmugasundaram V, Reddy S, Fleischer LL, Wang Z, Smith Y, Harter WG, Yue WS, Swaroop M, Li L, Ji CX, Dettling D, Osak B, Fitzgerald LR, Conradi R",,644070.0,DTCT0023207,3414602,DTCC00685994,1492899,39855,CC1=C(C=NN1C2=CC=CC=C2)CN3CC(C3)OC4=C(C=CC=C4F)OC,COc1cccc(F)c1OC1CN(Cc2cnn(-c3ccccc3)c2C)C1
86,CHEMBL12127,P35368,,KSRMLSMXMVIXSF-BQYQJAHWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,5316.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1199838,DTCC00103566,1292757,3699,CC(C)OC1=CC=CC=C1N2CCN(CC2)C/C=C/C(=O)CN3CCCCC3=O,CC(C)Oc1ccccc1N1CCN(C/C=C/C(=O)CN2CCCCC2=O)CC1
87,CHEMBL1215,P35368,PHENYLEPHRINE,SONNWYBIRXJNDC-VIFPVBQESA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,-1.0,EC50,=,10.0,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14971241,DTCC00314418,2114088,70044,CNC[C@@H](C1=CC(=CC=C1)O)O,CNC[C@H](O)c1cccc(O)c1
88,CHEMBL1215,P35368,PHENYLEPHRINE,SONNWYBIRXJNDC-VIFPVBQESA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,0.86,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14928660,DTCC00314418,2113757,70115,CNC[C@@H](C1=CC(=CC=C1)O)O,CNC[C@H](O)c1cccc(O)c1
89,CHEMBL1215,P35368,PHENYLEPHRINE,SONNWYBIRXJNDC-VIFPVBQESA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25813897.0,EC50,=,5.9,NM,,,,,,,,,,,,,,Agonist activity at alpha-1B adrenergic receptor (unknown origin) after 5 hrs by CCF4-AM staining-based cellular assay,,a-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.,Bioorg. Med. Chem.,2015.0,23.0,9.0,"Zareba P, Dudek M, Lustyk K, Siwek A, Starowicz G, Bednarski M, Nowinski L, Razny K, Sapa J, Malawska B, Kulig K",,1464291.0,DTCT0023207,14064361,DTCC00314418,1517084,61652,CNC[C@@H](C1=CC(=CC=C1)O)O,CNC[C@H](O)c1cccc(O)c1
90,CHEMBL12202,P35368,,NJIMRYVDUQIHPS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,2244.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1199833,DTCC00140784,1260398,3699,CC(C)OC1=CC=CC=C1N2CCN(CC2)CCOC(=O)CN3CCCCC3=O,CC(C)Oc1ccccc1N1CCN(CCOC(=O)CN2CCCCC2=O)CC1
91,CHEMBL1222552,P35368,,NSRMKMSTPLJNHM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20674357.0,KI,=,3.16,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human adrenergic Alpha-1B receptor assessed as intracellular calcium luminescence by cell based aequorin assay,,Novel imidazobenzazepine derivatives as dual H1/5-HT2A antagonists for the treatment of sleep disorders.,Bioorg. Med. Chem. Lett.,2010.0,20.0,17.0,"Gianotti M, Corti C, Delle Fratte S, Di Fabio R, Leslie CP, Pavone F, Piccoli L, Stasi L, Wigglesworth MJ",,651973.0,DTCT0023207,3460056,DTCC00691308,1939665,40377,C1CN(CCN1)C2=CC3=CC=CC=C3CN4C2=NC=C4,C1=C(N2CCNCC2)c2nccn2Cc2ccccc21
92,CHEMBL12264,P35368,SB-258719,AGVNHDNTFYHZNL-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9513592.0,KI,<,15848.93,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards adrenergic alpha-1B receptors,,"(R)-3,N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5-HT7 receptor antagonist.",J. Med. Chem.,1998.0,41.0,5.0,"Forbes IT, Dabbs S, Duckworth DM, Jennings AJ, King FD, Lovell PJ, Brown AM, Collin L, Hagan JJ, Middlemiss DN, Riley GJ, Thomas DR, Upton N",,217938.0,DTCT0023207,1304042,DTCC00141243,174112,15059,CC1CCN(CC1)CC[C@@H](C)N(C)S(=O)(=O)C2=CC=CC(=C2)C,Cc1cccc(S(=O)(=O)N(C)[C@H](C)CCN2CCC(C)CC2)c1
93,CHEMBL123012,P35368,,UJAZDXIAIGDQSX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,37.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,716686,DTCC00329656,1101446,15484,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)OC,CCC1=C(C(=O)OC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
94,CHEMBL123138,P35368,SK&F-105854,NYGANYRUZQPPGP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,783.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,931840,DTCC01742849,756376,13230,CN1CCC2=C(C=CC3=C2C(=C(O3)Br)C1)Cl,CN1CCc2c(Cl)ccc3oc(Br)c(c23)C1
95,CHEMBL1231795,P35368,,QOECJCJVIMVJGX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22975593.0,INHIBITION,>,64.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor at 1 uM,,ONCOEPIGENOMICS: MAKING HISTONE LYSINE METHYLATION COUNT.,EUR. J. MED. CHEM.,2012.0,56.0,,"DECARLO D, HADDEN MK",,861219.0,DTCT0023207,11409303,DTCC00694104,1623921,51316,CC(C)N1CCC(CC1)NC2=NC(=NC3=CC(=C(C=C32)OC)OCCCN4CCCC4)C5CCCCC5,COc1cc2c(NC3CCN(C(C)C)CC3)nc(C3CCCCC3)nc2cc1OCCCN1CCCC1
96,CHEMBL123349,P35368,SK&F-86466,RSRUDTPYRBLHEO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,485.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,932963,DTCC01742856,1339007,13230,CN1CCC2=C(CC1)C(=CC=C2)Cl,CN1CCc2cccc(Cl)c2CC1
97,CHEMBL123448,P35368,SK&F-106686,BAAUEDJUTZLMAN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,15.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,901037,DTCC01742848,270699,13230,CCC1=C2CN(CCC3=C(C=CC(=C32)S1)Cl)C,CCc1sc2ccc(Cl)c3c2c1CN(C)CC3
98,CHEMBL12364,P35368,,HJDROFKHSGSZLZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,10000.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1190956,DTCC00140794,937156,3699,C1CCN(C(=O)C1)CC(=O)NCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,O=C(CN1CCCCC1=O)NCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1
99,CHEMBL1241328,P35368,,QNNJWRQCDFPIQY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20681583.0,KI,=,758.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic Alpha-1B receptor,,Novel N-methylated 8-oxoisoguanines from Pacific sponges with diverse neuroactivities.,J. Med. Chem.,2010.0,53.0,16.0,"Sakurada T, Gill MB, Frausto S, Copits B, Noguchi K, Shimamoto K, Swanson GT, Sakai R",,659314.0,DTCT0023207,3469605,DTCC00695495,405967,40768,CN1C(=C2C(=NC1=O)N(C(=O)N2)C)N.Cl,Cn1c(N)c2[nH]c(=O)n(C)c2nc1=O
100,CHEMBL1241557,P35368,,MZMIENIIBMNHDS-OOWIMERYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,10.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464102,DTCC00695713,825092,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@@H]3CO[C@@](O3)(CN4C(=O)CC5(CCCC5)CC4=O)C6=CC=CC=C6,COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1
101,CHEMBL1242352,P35368,,XRKSDOUDYWUZPR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,6.76,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464090,DTCC00696483,2081895,40734,COC1=CC=CC=C1N2CCN(CC2)CC3OCC(O3)(C4=CC=CC=C4)C5=CC=CC=C5,COc1ccccc1N1CCN(CC2OCC(c3ccccc3)(c3ccccc3)O2)CC1
102,CHEMBL1242444,P35368,,AOZOBKDTJZCKJE-NVQXNPDNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,173.78,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464091,DTCC00696574,1310547,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@H]3CO[C@](O3)(CN4CCCC4=O)C5=CC=CC=C5,COc1ccccc1N1CCN(C[C@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1
103,CHEMBL1242445,P35368,,AOZOBKDTJZCKJE-GJZUVCINSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,70.79,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464092,DTCC00696575,1984592,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@@H]3CO[C@](O3)(CN4CCCC4=O)C5=CC=CC=C5,COc1ccccc1N1CCN(C[C@@H]2CO[C@](CN3CCCC3=O)(c3ccccc3)O2)CC1
104,CHEMBL1242541,P35368,,HCVFJHZVTICJEK-WNCULLNHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,128.82,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464093,DTCC00696672,825100,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@H]3CO[C@@](O3)(CN4CCCCC4=O)C5=CC=CC=C5,COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1
105,CHEMBL1242542,P35368,,HCVFJHZVTICJEK-YIXXDRMTSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,51.29,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464094,DTCC00696673,599000,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@@H]3CO[C@@](O3)(CN4CCCCC4=O)C5=CC=CC=C5,COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCC3=O)(c3ccccc3)O2)CC1
106,CHEMBL1242632,P35368,,HCKLMKILABOANU-RBJSKKJNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,72.44,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464095,DTCC00696763,890157,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@H]3CO[C@@](O3)(CN4CCCCCC4=O)C5=CC=CC=C5,COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1
107,CHEMBL1242633,P35368,,HCKLMKILABOANU-UFHPHHKVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,18.2,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464096,DTCC00696764,1790230,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@@H]3CO[C@@](O3)(CN4CCCCCC4=O)C5=CC=CC=C5,COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3CCCCCC3=O)(c3ccccc3)O2)CC1
108,CHEMBL1242724,P35368,,JCZSBAKXMUXIIN-HFZDXXHNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,85.11,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464097,DTCC00696853,1375694,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@H]3CO[C@@](O3)(CN4C(=O)CCC4=O)C5=CC=CC=C5,COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1
109,CHEMBL1242725,P35368,,JCZSBAKXMUXIIN-QFQXNSOFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,223.87,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464098,DTCC00696854,1212197,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@@H]3CO[C@@](O3)(CN4C(=O)CCC4=O)C5=CC=CC=C5,COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCC3=O)(c3ccccc3)O2)CC1
110,CHEMBL1242818,P35368,,YXYDEEZYQMLTIS-WXVAWEFUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,46.77,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464099,DTCC00696945,1277734,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@H]3CO[C@@](O3)(CN4C(=O)CCCC4=O)C5=CC=CC=C5,COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1
111,CHEMBL1242819,P35368,,YXYDEEZYQMLTIS-AJTFRIOCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,131.83,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464100,DTCC00696946,1504744,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@@H]3CO[C@@](O3)(CN4C(=O)CCCC4=O)C5=CC=CC=C5,COc1ccccc1N1CCN(C[C@@H]2CO[C@@](CN3C(=O)CCCC3=O)(c3ccccc3)O2)CC1
112,CHEMBL1242912,P35368,,MZMIENIIBMNHDS-VVFBEHOQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,9.33,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464101,DTCC00697035,922069,40734,COC1=CC=CC=C1N2CCN(CC2)C[C@H]3CO[C@@](O3)(CN4C(=O)CC5(CCCC5)CC4=O)C6=CC=CC=C6,COc1ccccc1N1CCN(C[C@H]2CO[C@@](CN3C(=O)CC4(CCCC4)CC3=O)(c3ccccc3)O2)CC1
113,CHEMBL1242923,P35368,,FLGSUSWMWSZVMP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20684563.0,KI,=,910.0,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010.0,53.0,17.0,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659613.0,DTCT0023207,3460962,DTCC00697046,1200707,40772,C1CN(CCC1NC(=O)CC2=CC=CC=C2)CCCN3C(=O)COC4=CC=CC=C43,O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1
114,CHEMBL1242950,P35368,AC-42,ANTKBACNWQHQJE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20684563.0,KI,=,65.0,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010.0,53.0,17.0,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659613.0,DTCT0023207,3460963,DTCC00032233,1972874,40772,CCCCC1CCN(CC1)CCCC(=O)C2=CC=CC=C2C,CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1
115,CHEMBL12501,P35368,,KEQNBNIXVZSUDE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,10000.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1180293,DTCC00140834,1066440,3699,COC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)CN3CCCCC3=O,COc1ccccc1N1CCN(CCCNC(=O)CN2CCCCC2=O)CC1
116,CHEMBL12529,P35368,,VRPBNMBLMZTHCA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,26310.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1186754,DTCC00140857,1616723,3699,CCOC(=O)C1CCC(=O)N1CC(=O)NCCN2CCN(CC2)C3=CC=CC=C3OC(C)C,CCOC(=O)C1CCC(=O)N1CC(=O)NCCN1CCN(c2ccccc2OC(C)C)CC1
117,CHEMBL125365,P35368,,UYZCRXKULSDXTA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12904082.0,KI,=,15.9,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]-prazosin binding to cloned human Alpha-1B adrenergic receptor in CHO cells (chinese hamster ovary cells),,New potential uroselective NO-donor alpha1-antagonists.,J. Med. Chem.,2003.0,46.0,17.0,"Boschi D, Tron GC, Di Stilo A, Fruttero R, Gasco A, Poggesi E, Motta G, Leonardi A",,34462.0,DTCT0023207,1265882,DTCC00301663,1404016,13339,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)NCCCN3CCN(CC3)C4=CC=CC=C4OCC5=NO[N+](=C5C(=O)N)[O-])C6=CC=CC=C6,Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C(N)=O)CC3)cccc2c1=O
118,CHEMBL1254582,P35368,,IHLSYSUPBGFXLU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,0.501,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496708,DTCC00698847,98039,40937,COC1=C(C(=CC=C1)OC)SCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1cccc(OC)c1SCCNCCOc1ccccc1OCc1ccccc1
119,CHEMBL1254659,P35368,,YFWWJPOZWVDALE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,6.92,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496709,DTCC00698925,1652015,40937,COC1=C(C(=CC=C1)OC)CCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1cccc(OC)c1CCCNCCOc1ccccc1OCc1ccccc1
120,CHEMBL1254660,P35368,,WGUPOYKGWRBZNW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496710,DTCC00698926,358577,40937,COC1=C(C(=CC=C1)OC)S(=O)CCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1cccc(OC)c1[S+]([O-])CCNCCOc1ccccc1OCc1ccccc1
121,CHEMBL1254742,P35368,,DZWBHIPIKLFYOT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,0.794,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496711,DTCC00699003,844201,40937,CCOC1=C(C(=CC=C1)OCC)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,CCOc1cccc(OCC)c1OCCNCCOc1ccccc1OCc1ccccc1
122,CHEMBL1254743,P35368,,LYVYZEAKTYROJI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,5.01,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496712,DTCC00699004,228492,40937,COC1=CC=CC(=C1OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3)[N+](=O)[O-],COc1cccc([N+](=O)[O-])c1OCCNCCOc1ccccc1OCc1ccccc1
123,CHEMBL1254828,P35368,,WPQSKLTVRIUFBU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,7.94,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496713,DTCC00126337,747412,40937,COC1=C(C(=CC=C1)Cl)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1
124,CHEMBL1254829,P35368,,WPQJHJUCAXKHKN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,5.01,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496714,DTCC00699086,1971476,40937,CC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1
125,CHEMBL1254914,P35368,,IZMYNAZDOKXFDK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,12.59,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496715,DTCC00699165,10933,40937,CCOC1=CC=CC=C1OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,CCOc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1
126,CHEMBL1254915,P35368,,PAEDPQXLBJMTGG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,19.95,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496716,DTCC00699166,1264904,40937,COC1=CC=CC=C1OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1ccccc1OCCNCCOc1ccccc1OCc1ccccc1
127,CHEMBL1255002,P35368,,PANUNJICXXHAIL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,79.43,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496717,DTCC00699249,1745895,40937,C1=CC=C(C=C1)COC2=CC=CC=C2OCCNCCOC3=C(C=CC=C3Cl)Cl,Clc1cccc(Cl)c1OCCNCCOc1ccccc1OCc1ccccc1
128,CHEMBL1255003,P35368,,BASQZMOJDHSJPS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,100.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496718,DTCC00699250,1907015,40937,CC1=C(C(=CC=C1)C)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,Cc1cccc(C)c1OCCNCCOc1ccccc1OCc1ccccc1
129,CHEMBL1255085,P35368,,ADSQCTGZHJXUFN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,100.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496719,DTCC00699331,1686399,40937,C1=CC=C(C=C1)COC2=CC=CC=C2OCCNCCOC3=C(C=CC=C3O)O,Oc1cccc(O)c1OCCNCCOc1ccccc1OCc1ccccc1
130,CHEMBL1255086,P35368,,MEUCRKVGHOJPJP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,100.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496720,DTCC00699332,1298204,40937,C1=CC=C(C=C1)COC2=CC=CC=C2OCCNCCOC3=CC=CC=C3,c1ccc(COc2ccccc2OCCNCCOc2ccccc2)cc1
131,CHEMBL1255582,P35368,FIPAMEZOLE,KXSUAWAUCNFBQJ-UHFFFAOYSA-N,2,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,2089.3,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531923,DTCC00699931,166024,41136,CCC1(CC2=C(C1)C=C(C=C2)F)C3=CN=CN3,CCC1(c2cnc[nH]2)Cc2ccc(F)cc2C1
132,CHEMBL1255616,P35368,,LQKQCQKZRUYZOI-SQWLQELKSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,8.91,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531910,DTCC00699352,1557218,41136,CCC[C@H]1C2=CC=CC=C2[C@@H]3[C@]1(C3)C4=CN=CN4,CCC[C@H]1c2ccccc2[C@H]2C[C@@]12c1cnc[nH]1
133,CHEMBL1255617,P35368,,FYLKUCQQWYKEOG-IUODEOHRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,14.79,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531909,DTCC00699353,1810708,41136,C1CC12C3=CC=CC=C3[C@@H]4[C@]2(C4)C5=CN=CN5,c1ccc2c(c1)[C@H]1C[C@@]1(c1cnc[nH]1)C21CC1
134,CHEMBL1255617,P35368,,FYLKUCQQWYKEOG-IUODEOHRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,18.2,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531908,DTCC00699353,1810711,41136,C1CC12C3=CC=CC=C3[C@@H]4[C@]2(C4)C5=CN=CN5,c1ccc2c(c1)[C@H]1C[C@@]1(c1cnc[nH]1)C21CC1
135,CHEMBL1255617,P35368,,FYLKUCQQWYKEOG-IUODEOHRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,97.72,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531907,DTCC00699353,1810764,41136,C1CC12C3=CC=CC=C3[C@@H]4[C@]2(C4)C5=CN=CN5,c1ccc2c(c1)[C@H]1C[C@@]1(c1cnc[nH]1)C21CC1
136,CHEMBL1255723,P35368,,ARHWJJBPLJIHQP-AEGPPILISA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,16.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531905,DTCC00126349,68986,41136,CC[C@H]1[C@H]2[C@@]1(CC3=CC=CC=C23)C4=CN=CN4,CC[C@H]1[C@@H]2c3ccccc3C[C@]12c1cnc[nH]1
137,CHEMBL1255724,P35368,,PRXCUMHAHRIDJF-CWRNSKLLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,3.55,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531904,DTCC00126350,1396089,41136,CCC[C@H]1[C@H]2[C@@]1(CC3=CC=CC=C23)C4=CN=CN4,CCC[C@H]1[C@@H]2c3ccccc3C[C@]12c1cnc[nH]1
138,CHEMBL1255770,P35368,,JWXMKFUDAOLJCY-DZGCQCFKSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,177.83,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531903,DTCC00699459,1939690,41136,CC1([C@H]2[C@@]1(CC3=CC=CC=C23)C4=CN=CN4)C,CC1(C)[C@@H]2c3ccccc3C[C@@]21c1cnc[nH]1
139,CHEMBL1255771,P35368,,DLWKVBPPVYZEML-ZIAGYGMSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,39.81,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531902,DTCC00699460,1168346,41136,C[C@]12C[C@]1(CC3=CC=CC=C23)C4=CN=CN4,C[C@]12C[C@@]1(c1cnc[nH]1)Cc1ccccc12
140,CHEMBL125585,P35368,,CTWGJCJJBKHITF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1374545,DTCC00300263,724463,17528,CC(C)NC1=C(C(=C(C=C1)C2=CC=CC=C2)CC(=O)NCC3=CC=C(C=C3)C(=N)N)O,CC(C)Nc1ccc(-c2ccccc2)c(CC(=O)NCc2ccc(C(=N)N)cc2)c1O
141,CHEMBL1256344,P35368,,AVGWWHGGUIZHBV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,1096.48,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534301,DTCC00699879,1212232,41150,CCOC(=O)C(C)N1C(=O)C(N(C1=O)CC(CN2CCN(CC2)C3=CC=CC=C3OC)O)(C4=CC=CC=C4)C5=CC=CC=C5,CCOC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O
142,CHEMBL1256378,P35368,,WYFCRYMMLDTJAM-CUOATXAZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,33.11,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531906,DTCC00699902,878581,41136,C[C@H]1[C@H]2[C@@]1(CC3=CC=CC=C23)C4=CN=CN4,C[C@H]1[C@@H]2c3ccccc3C[C@]12c1cnc[nH]1
143,CHEMBL1256414,P35368,,FIERHAFMRVRMDV-YPMHNXCESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,1.05,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531920,DTCC00699932,1654586,41136,C1[C@H]2[C@@]1(CC3=CC=CC=C23)C4=CN=CN4,c1ccc2c(c1)C[C@]1(c3cnc[nH]3)C[C@H]21
144,CHEMBL1256414,P35368,,FIERHAFMRVRMDV-YPMHNXCESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,1.32,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531922,DTCC00699932,1654584,41136,C1[C@H]2[C@@]1(CC3=CC=CC=C23)C4=CN=CN4,c1ccc2c(c1)C[C@]1(c3cnc[nH]3)C[C@H]21
145,CHEMBL1256414,P35368,,FIERHAFMRVRMDV-YPMHNXCESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,3.55,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531921,DTCC00699932,1654585,41136,C1[C@H]2[C@@]1(CC3=CC=CC=C23)C4=CN=CN4,c1ccc2c(c1)C[C@]1(c3cnc[nH]3)C[C@H]21
146,CHEMBL1256502,P35368,,HSSBMQXDKGERBI-MRVWCRGKSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,912.01,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531919,DTCC00700008,1072178,41136,CO[C@@H]1C2=CC=CC=C2[C@@H]3[C@]1(C3)C4=CN=CN4,CO[C@@H]1c2ccccc2[C@H]2C[C@]21c1cnc[nH]1
147,CHEMBL1256503,P35368,,HSSBMQXDKGERBI-KWCYVHTRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,63.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531917,DTCC00700009,1972905,41136,CO[C@H]1C2=CC=CC=C2[C@@H]3[C@]1(C3)C4=CN=CN4,CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1cnc[nH]1
148,CHEMBL1256503,P35368,,HSSBMQXDKGERBI-KWCYVHTRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,102.33,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531918,DTCC00700009,1972904,41136,CO[C@H]1C2=CC=CC=C2[C@@H]3[C@]1(C3)C4=CN=CN4,CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1cnc[nH]1
149,CHEMBL1256503,P35368,,HSSBMQXDKGERBI-KWCYVHTRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,1778.28,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531916,DTCC00700009,1972907,41136,CO[C@H]1C2=CC=CC=C2[C@@H]3[C@]1(C3)C4=CN=CN4,CO[C@H]1c2ccccc2[C@H]2C[C@@]12c1cnc[nH]1
150,CHEMBL1256565,P35368,,ASHFKBMVCDTQQO-VHDGCEQUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,39.81,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531915,DTCC00700061,393986,41136,CCO[C@H]1C2=CC=CC=C2[C@@H]3[C@]1(C3)C4=CN=CN4,CCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1cnc[nH]1
151,CHEMBL1256566,P35368,,IXRPDYSTGHYEBR-VNQPRFMTSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,11.48,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531914,DTCC00700062,328594,41136,CCCO[C@H]1C2=CC=CC=C2[C@@H]3[C@]1(C3)C4=CN=CN4,CCCO[C@H]1c2ccccc2[C@H]2C[C@@]12c1cnc[nH]1
152,CHEMBL1256608,P35368,,PNISAWOKGCKONH-VNQPRFMTSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,316.23,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531913,DTCC00700095,2005554,41136,CC(C)O[C@H]1C2=CC=CC=C2[C@@H]3[C@]1(C3)C4=CN=CN4,CC(C)O[C@H]1c2ccccc2[C@H]2C[C@@]12c1cnc[nH]1
153,CHEMBL1256609,P35368,,VDSXZDLUEYFJGH-MRCXROJRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,6.17,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531912,DTCC00700096,1875300,41136,C[C@H]1C2=CC=CC=C2[C@@H]3[C@]1(C3)C4=CN=CN4,C[C@H]1c2ccccc2[C@H]2C[C@@]12c1cnc[nH]1
154,CHEMBL1256610,P35368,,AKBJKOBHDJQWMB-GZBFAFLISA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,40.74,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531911,DTCC00700097,2070100,41136,CC[C@H]1C2=CC=CC=C2[C@@H]3[C@]1(C3)C4=CN=CN4,CC[C@H]1c2ccccc2[C@H]2C[C@@]12c1cnc[nH]1
155,CHEMBL125781,P35368,,UIFFGJRELUIVDZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,=,950.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1365437,DTCC00299856,1468517,17528,CC(C)NC1=C(C(=C(C=C1)C2=CC(=CC=C2)N)CC(=O)NCC3=CC=C(C=C3)C(=N)N)F,CC(C)Nc1ccc(-c2cccc(N)c2)c(CC(=O)NCc2ccc(C(=N)N)cc2)c1F
156,CHEMBL1257883,P35368,,ZTMOGXXMLUCQMX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,1819.7,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534302,DTCC00701074,599086,41150,CN1C(=O)C(N(C1=O)CC(CN2CCN(CC2)C3=CC=CC=C3F)O)(C4=CC=CC=C4)C5=CC=CC=C5,CN1C(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C(c2ccccc2)(c2ccccc2)C1=O
157,CHEMBL1258223,P35368,,WKWADEWWLCVVLF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20812727.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010.0,53.0,19.0,"Xu R, Hong J, Morse CL, Pike VW",,664937.0,DTCT0023207,3532950,DTCC00701398,1168405,41144,CCCCN1CCC(CC1)COC(=O)C2=CC(=C(C3=C2OCCO3)NC)Cl,CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1
158,CHEMBL1258228,P35368,,ZJFVRVHCJJOACM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,3630.78,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534305,DTCC00701403,373069,41150,COC(=O)CN1C(=O)C(N(C1=O)CC(CN2CCN(CC2)C3=CC=CC=C3)O)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C(c2ccccc2)(c2ccccc2)C1=O
159,CHEMBL1258344,P35368,,ROSFUYQZCZTAGG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,457.09,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534309,DTCC00701517,438129,41150,C1CN(CCN1CC(CN2C(=O)NC(=O)C2(C3=CC=CC=C3)C4=CC=CC=C4)O)C5=CC=CC=C5,O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1CC(O)CN1CCN(c2ccccc2)CC1
160,CHEMBL1258345,P35368,,HFWMUFQVQHUKDD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,53.7,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534310,DTCC00701518,1633924,41150,COC1=CC=CC=C1N2CCN(CC2)CC(CN3C(=O)NC(=O)C3(C4=CC=CC=C4)C5=CC=CC=C5)O,COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1
161,CHEMBL1258452,P35368,,DZZIAERGLDKTBT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20812727.0,KI,=,4228.0,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010.0,53.0,19.0,"Xu R, Hong J, Morse CL, Pike VW",,664937.0,DTCT0023207,3532995,DTCC00701623,716604,41144,CCCCN1CCC(CC1)COC(=O)C2=CC(=C(C=C2)N)OC,CCCCN1CCC(COC(=O)c2ccc(N)c(OC)c2)CC1
162,CHEMBL1258457,P35368,,KRYMKJFSDYDRHS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,45.71,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534311,DTCC00701628,1633925,41150,CCOC1=CC=CC=C1N2CCN(CC2)CC(CN3C(=O)NC(=O)C3(C4=CC=CC=C4)C5=CC=CC=C5)O,CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(=O)C2(c2ccccc2)c2ccccc2)CC1
163,CHEMBL1258614,P35368,,IUEKKZWRWOFGRT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20727749.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Alpha-1B adrenergic receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010.0,20.0,19.0,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664276.0,DTCT0023207,3527829,DTCC00701782,911256,41064,CCN(CC)C(=O)CC1=C2N=C(C=C(N2N=C1C3=CC=C(C=C3)OCC)C)C,CCOc1ccc(-c2nn3c(C)cc(C)nc3c2CC(=O)N(CC)CC)cc1
164,CHEMBL1258671,P35368,,WLHFUBIRAHRPHA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20812727.0,KI,=,9076.0,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010.0,53.0,19.0,"Xu R, Hong J, Morse CL, Pike VW",,664937.0,DTCT0023207,3533038,DTCC00701836,911257,41144,CCCCN1CCC(CC1)COC(=O)C2=CC(=C(C3=C2OCCO3)N)F,CCCCN1CCC(COC(=O)c2cc(F)c(N)c3c2OCCO3)CC1
165,CHEMBL1258722,P35368,,FZPKLZHGBRKKCP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20727749.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of Alpha-1B adrenergic receptor,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010.0,20.0,19.0,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664275.0,DTCT0023207,3527909,DTCC00701888,2038361,41064,CCCOC1=CC=C(C=C1)C2=NN3C(=CC(=NC3=C2CC(=O)N(CC)CC)C)C,CCCOc1ccc(-c2nn3c(C)cc(C)nc3c2CC(=O)N(CC)CC)cc1
166,CHEMBL1258723,P35368,,LHSWZGXDIPQNGE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20727749.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Alpha-1B adrenergic receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010.0,20.0,19.0,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664276.0,DTCT0023207,3527762,DTCC00701889,14439,41064,CCCCOC1=CC=C(C=C1)C2=NN3C(=CC(=NC3=C2CC(=O)N(CC)CC)C)C,CCCCOc1ccc(-c2nn3c(C)cc(C)nc3c2CC(=O)N(CC)CC)cc1
167,CHEMBL1258843,P35368,,VHENJOBTWCOIPN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20727749.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Alpha-1B adrenergic receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010.0,20.0,19.0,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664276.0,DTCT0023207,3527873,DTCC00702004,1265966,41064,CCN(CC)C(=O)CC1=C2N=C(C=C(N2N=C1C3=CC=C(C=C3)OCC#C)C)C,C#CCOc1ccc(-c2nn3c(C)cc(C)nc3c2CC(=O)N(CC)CC)cc1
168,CHEMBL125989,P35368,,QINUQIXOUYBPRY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12904082.0,KI,=,6.5,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]-prazosin binding to cloned human Alpha-1B adrenergic receptor in CHO cells (chinese hamster ovary cells),,New potential uroselective NO-donor alpha1-antagonists.,J. Med. Chem.,2003.0,46.0,17.0,"Boschi D, Tron GC, Di Stilo A, Fruttero R, Gasco A, Poggesi E, Motta G, Leonardi A",,34462.0,DTCT0023207,1248209,DTCC00301625,368997,13339,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)NCCCN3CCN(CC3)C4=CC=CC=C4OCC5=NO[N+](=C5C#N)[O-])C6=CC=CC=C6,Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C#N)CC3)cccc2c1=O
169,CHEMBL12603,P35368,RWJ-68157,XHBOWUOETHUEOP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,3536.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1190950,DTCC00140833,1292758,3699,CC(C)OC1=CC=CC=C1N2CCN(CC2)CCNC(=O)CN3CCCCCC3=O,CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCCC2=O)CC1
170,CHEMBL12624,P35368,SB-258741,YVWGGGGMRDLOGA-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10669560.0,KI,<,3162.28,NM,,,,,,,,,,,,,,Binding affinity towards alpha-1B adrenergic receptor,,"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).",J. Med. Chem.,2000.0,43.0,3.0,"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR",,32309.0,DTCT0023207,1115627,DTCC00141340,1500541,16008,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)C,Cc1cccc(S(=O)(=O)N2CCC[C@@H]2CCN2CCC(C)CC2)c1
171,CHEMBL12713,P35368,SERTINDOLE,GZKLJWGUPQBVJQ-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18378462.0,ACTIVITY,=,3.2,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor,,Recent advances in selective alpha1-adrenoreceptor antagonists as antihypertensive agents.,Bioorg. Med. Chem.,2008.0,16.0,9.0,"Jain KS, Bariwal JB, Kathiravan MK, Phoujdar MS, Sahne RS, Chauhan BS, Shah AK, Yadav MR",,530286.0,DTCT0023207,2394200,DTCC00141218,1535774,29385,C1CN(CCC1C2=CN(C3=C2C=C(C=C3)Cl)C4=CC=C(C=C4)F)CCN5CCNC5=O,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
172,CHEMBL128593,P35368,,ZFZUYTCCHMWWTD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11082457.0,KI,=,19.9526,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14743695,DTCC00311393,2108473,69438,C1CC2(CC3=CC=CC=C31)COC(=N2)N,NC1=NC2(CCc3ccccc3C2)CO1
173,CHEMBL1289626,P35368,WMS-1410,KKLZGWQBNXJWGZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20965739.0,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]-Prazosin from adrenergic Alpha-1B receptor at 1 to 3 uM,Not Active,"Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.",Bioorg. Med. Chem.,2010.0,18.0,22.0,"Tewes B, Frehland B, Schepmann D, Schmidtke KU, Winckler T, Wünsch B",,686661.0,DTCT0023207,3613299,DTCC00032749,40842,41994,C1CN(CC(C2=C1C=C(C=C2)O)O)CCCCC3=CC=CC=C3,Oc1ccc2c(c1)CCN(CCCCc1ccccc1)CC2O
174,CHEMBL132378,P35368,,STBHTUOPFMOXDX-LPWQTFTOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10514291.0,KI,<,1000.0,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned Alpha-1B adrenergic receptor,,WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.,J. Med. Chem.,1999.0,42.0,20.0,"Bolognesi ML, Budriesi R, Cavalli A, Chiarini A, Gotti R, Leonardi A, Minarini A, Poggesi E, Recanatini M, Rosini M, Tumiatti V, Melchiorre C",,34485.0,DTCT0023207,623712,DTCC00316266,336523,15434,C1C[C@@H]([C@H]([C@H]1NC[C@@H]2COC3=CC=CC=C3O2)O)OC4=CC=CC=C4,O[C@H]1[C@@H](NC[C@@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1
175,CHEMBL134,P35368,CLONIDINE,GJSURZIOUXUGAL-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,-1.0,EC50,=,83.0,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15016124,DTCC00155022,2114063,70044,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Clc1cccc(Cl)c1NC1=NCCN1
176,CHEMBL134,P35368,CLONIDINE,GJSURZIOUXUGAL-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11082457.0,KI,=,316.2278,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14740494,DTCC00155022,2104792,69438,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Clc1cccc(Cl)c1NC1=NCCN1
177,CHEMBL134,P35368,CLONIDINE,GJSURZIOUXUGAL-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,416869000000000.0,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor by the displacement of [3H]prazosin,,,Bioorg. Med. Chem. Lett.,1994.0,4.0,19.0,,,34607.0,DTCT0023207,1706627,DTCC00155022,29775,933,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Clc1cccc(Cl)c1NC1=NCCN1
178,CHEMBL134342,P35368,LIPOIC ACID,AGBQKNBQESQNJD-SSDOTTSWSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15633998.0,LOG KI,,,,,cell_based,,,,,,,,,,,CHO,Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1b expressed in CHO cells; Not tested,Not Determined,"Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.",J. Med. Chem.,2005.0,48.0,1.0,"Antonello A, Hrelia P, Leonardi A, Marucci G, Rosini M, Tarozzi A, Tumiatti V, Melchiorre C",,303920.0,DTCT0023207,1737940,DTCC00318217,1209140,19215,C1CSS[C@@H]1CCCCC(=O)O,O=C(O)CCCC[C@@H]1CCSS1
179,CHEMBL134428,P35368,,STBHTUOPFMOXDX-XNFNUYLZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10514291.0,KI,=,93.33,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned Alpha-1B adrenergic receptor,,WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.,J. Med. Chem.,1999.0,42.0,20.0,"Bolognesi ML, Budriesi R, Cavalli A, Chiarini A, Gotti R, Leonardi A, Minarini A, Poggesi E, Recanatini M, Rosini M, Tumiatti V, Melchiorre C",,34485.0,DTCT0023207,622605,DTCC00316242,950576,15434,C1C[C@H]([C@@H]([C@@H]1NC[C@@H]2COC3=CC=CC=C3O2)O)OC4=CC=CC=C4,O[C@@H]1[C@H](NC[C@@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1
180,CHEMBL134792,P35368,,MUVZWQIUHJRCSL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,=,1560.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1401962,DTCC00319783,1786357,17528,C1=CC=C(C=C1)CCNC2=C(C(=C(C=C2)F)CC(=O)NCC3=CC=C(C=C3)C(=N)N)F,N=C(N)c1ccc(CNC(=O)Cc2c(F)ccc(NCCc3ccccc3)c2F)cc1
181,CHEMBL135973,P35368,,STBHTUOPFMOXDX-LNKGRISISA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10514291.0,KI,=,46.77,NM,,,,,,,,,,,,,,Ability to displace [3H]prazosin from human cloned Alpha-1B adrenergic receptor,,WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.,J. Med. Chem.,1999.0,42.0,20.0,"Bolognesi ML, Budriesi R, Cavalli A, Chiarini A, Gotti R, Leonardi A, Minarini A, Poggesi E, Recanatini M, Rosini M, Tumiatti V, Melchiorre C",,33014.0,DTCT0023207,648106,DTCC00316349,1565194,15434,C1C[C@H]([C@@H]([C@@H]1NC[C@H]2COC3=CC=CC=C3O2)O)OC4=CC=CC=C4,O[C@@H]1[C@H](NC[C@H]2COc3ccccc3O2)CC[C@H]1Oc1ccccc1
182,CHEMBL135974,P35368,,STBHTUOPFMOXDX-FVCZOJIISA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10514291.0,KI,=,1819.7,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned Alpha-1B adrenergic receptor,,WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.,J. Med. Chem.,1999.0,42.0,20.0,"Bolognesi ML, Budriesi R, Cavalli A, Chiarini A, Gotti R, Leonardi A, Minarini A, Poggesi E, Recanatini M, Rosini M, Tumiatti V, Melchiorre C",,34485.0,DTCT0023207,619031,DTCC00316350,1818868,15434,C1C[C@@H]([C@H]([C@H]1NC[C@H]2COC3=CC=CC=C3O2)O)OC4=CC=CC=C4,O[C@H]1[C@@H](NC[C@H]2COc3ccccc3O2)CC[C@@H]1Oc1ccccc1
183,CHEMBL136098,P35368,,ODSRJIWRVVHLPN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1392087,DTCC00319493,1630036,17528,C1=CC=C(C=C1)CS(=O)(=O)NC2=C(C(=C(C=C2)F)CC(=O)NCC3=CC(=CC=C3)C(=N)N)F,N=C(N)c1cccc(CNC(=O)Cc2c(F)ccc(NS(=O)(=O)Cc3ccccc3)c2F)c1
184,CHEMBL136290,P35368,,CFISPWWFAULNRE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1390786,DTCC00319811,173749,17528,C1CNCCC1CNC(=O)CC2=C(C=CC(=C2F)NS(=O)(=O)CC3=CC=CC=C3)F,O=C(Cc1c(F)ccc(NS(=O)(=O)Cc2ccccc2)c1F)NCC1CCNCC1
185,CHEMBL136458,P35368,,XLJAXHKXAQXROY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9986714.0,KI,=,14.7,NM,,,,,,,,,,,,,,The binding affinity towards Alpha-1B adrenergic receptor in the COS cell line.,,"Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.",J. Med. Chem.,1999.0,42.0,3.0,"Leonardi A, Motta G, Boi C, Testa R, Poggesi E, De Benedetti PG, Menziani MC",,32304.0,DTCT0023207,1329194,DTCC00320168,886367,15565,CC(C)C1=C(C(=CC=C1)OC)OC(C)C(=O)N2CCN(CC2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)C(C)Oc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC
186,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,KI,=,191.0,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1B adrenergic receptor (n >= 2),,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34349.0,DTCT0023207,1442881,DTCC00142934,1423170,15108,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
187,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,158.49,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14741904,DTCC00142934,2107867,68596,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
188,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,398.11,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14741903,DTCC00142934,2107867,68596,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
189,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9822553.0,KI,=,64.57,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity at human cloned Alpha-1B adrenergic receptor in chinese hamster ovary cells by [3H]prazosin displacement.,,"Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.",J. Med. Chem.,1998.0,41.0,24.0,"Bolognesi ML, Budriesi R, Chiarini A, Poggesi E, Leonardi A, Melchiorre C",,34617.0,DTCT0023207,817932,DTCC00142934,1425069,14970,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
190,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10514291.0,KI,=,69.18,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned Alpha-1B adrenergic receptor,,WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.,J. Med. Chem.,1999.0,42.0,20.0,"Bolognesi ML, Budriesi R, Cavalli A, Chiarini A, Gotti R, Leonardi A, Minarini A, Poggesi E, Recanatini M, Rosini M, Tumiatti V, Melchiorre C",,34485.0,DTCT0023207,621340,DTCC00142934,1436137,15434,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
191,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11354357.0,KI,=,94.3,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor,,Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.,Bioorg. Med. Chem. Lett.,2001.0,11.0,9.0,"Carroll WA, Sippy KB, Esbenshade TA, Buckner SA, Hancock AA, Meyer MD",,34336.0,DTCT0023207,717438,DTCC00142934,1437828,4794,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
192,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11931617.0,KI,=,707.95,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,2002.0,45.0,8.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Gentili F, Marucci G, Carrieri A, Carotti A, Poggesi E, Leonardi A, Melchiorre C",,34488.0,DTCT0023207,1623046,DTCC00142934,1423488,17220,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
193,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12065700.0,KI,=,524.81,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14741898,DTCC00142934,2107869,69360,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
194,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,631.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34333.0,DTCT0023207,1597325,DTCC00142934,1435551,17389,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
195,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,ACTIVITY,=,0.1,,,,,,,,,,,,,,,Fraction involved in salt bridge interactions with Asp3:11 part of the alpha-1B adrenergic receptor,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34189.0,DTCT0023207,1101370,DTCC00142934,1434909,18073,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
196,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,168.2,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1101359,DTCC00142934,1434909,18073,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
197,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,PKB,=,6.55,,,,,,,,,,,,,,,Dissociation constant against guinea pig spleen alpha-1B adrenergic receptor in vitro was determined,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34192.0,DTCT0023207,1101364,DTCC00142934,1434909,18073,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
198,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,RATIO,=,210.25,,,,,,,,,,,,,,,Selectivity ratio towards alpha-1B adrenergic receptor compared with other receptors,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,226997.0,DTCT0023207,1101366,DTCC00142934,1434909,18073,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
199,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15828846.0,KI,=,191.0,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor,,"Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.",J. Med. Chem.,2005.0,48.0,8.0,"Konkel MJ, Wetzel JM, Cahir M, Craig DA, Noble SA, Gluchowski C",,302652.0,DTCT0023207,1825333,DTCC00142934,1425823,19681,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
200,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,707.95,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569133,DTCC00142934,1438347,31993,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
201,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,=,707.95,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228665,DTCC00142934,1428151,38187,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
202,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,707.95,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464103,DTCC00142934,1439969,40734,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
203,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,707.95,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608873,DTCC00142934,1429495,47207,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
204,CHEMBL13647,P35368,BMY-7378,AYYCFGDXLUPJAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,707.95,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756660,DTCC00142934,1450158,53287,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
205,CHEMBL136788,P35368,,LAMLVANAQCOTGS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1399454,DTCC00319787,821150,17528,C1=CC=C(C=C1)CS(=O)(=O)NC2=C(C(=C(C=C2)F)CC(=O)NCCCCCN=C(N)N)F,NC(N)=NCCCCCNC(=O)Cc1c(F)ccc(NS(=O)(=O)Cc2ccccc2)c1F
206,CHEMBL1371770,P35368,PIRIBEDIL,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,3,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11356907.0,KI,=,6165.95,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14744435,DTCC00778211,2108727,69742,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=NC=CC=N4,c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1
207,CHEMBL1371770,P35368,PIRIBEDIL,OQDPVLVUJFGPGQ-UHFFFAOYSA-N,3,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,6165.95,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14744434,DTCC00778211,2108726,69012,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=NC=CC=N4,c1cnc(N2CCN(Cc3ccc4c(c3)OCO4)CC2)nc1
208,CHEMBL137337,P35368,,NBDPWGFQTIQGHE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1389656,DTCC00319807,918057,17528,C1=CC=C(C=C1)CS(=O)(=O)NC2=C(C(=C(C=C2)F)CC(=O)NCCCN3C=CN=C3)F,O=C(Cc1c(F)ccc(NS(=O)(=O)Cc2ccccc2)c1F)NCCCn1ccnc1
209,CHEMBL13735,P35368,,HESSOZXPIKFUEI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11354357.0,KI,=,1.22,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor,,Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.,Bioorg. Med. Chem. Lett.,2001.0,11.0,9.0,"Carroll WA, Sippy KB, Esbenshade TA, Buckner SA, Hancock AA, Meyer MD",,34336.0,DTCT0023207,719748,DTCC00142967,1534884,4794,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(NC3=O)SC=C4,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sccc3c2=O)CC1
210,CHEMBL137444,P35368,,GXOLLDCZLSCRTK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,=,9500.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1369296,DTCC00319519,1436172,17528,COC1=C(C=CC(=C1CC(=O)NCC2=CC=C(C=C2)C(=N)N)C3=CC=CC=C3)NCCC4=CC=CC=C4,COc1c(NCCc2ccccc2)ccc(-c2ccccc2)c1CC(=O)NCc1ccc(C(=N)N)cc1
211,CHEMBL137483,P35368,,DLWCGMXCEMSQPE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,=,26900.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1394471,DTCC00319290,788794,17528,C1=CC=C(C=C1)CS(=O)(=O)NC2=C(C(=C(C=C2)F)CC(=O)NCC3=CC=C(C=C3)C(=N)N)F,N=C(N)c1ccc(CNC(=O)Cc2c(F)ccc(NS(=O)(=O)Cc3ccccc3)c2F)cc1
212,CHEMBL137487,P35368,,COQVFDLYAJKUNP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,=,10000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1371892,DTCC00319612,1404248,17528,C1=CC=C(C=C1)CNC2=C(C(=C(C=C2)C3=CC(=CC=C3)N)CC(=O)NCC4=CC=C(C=C4)C(=N)N)F,N=C(N)c1ccc(CNC(=O)Cc2c(-c3cccc(N)c3)ccc(NCc3ccccc3)c2F)cc1
213,CHEMBL13754,P35368,,MTWNRUIQFUUTJU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11354357.0,KI,=,3.7,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor,,Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.,Bioorg. Med. Chem. Lett.,2001.0,11.0,9.0,"Carroll WA, Sippy KB, Esbenshade TA, Buckner SA, Hancock AA, Meyer MD",,34336.0,DTCT0023207,709727,DTCC00142984,887950,4794,CC1=C(C2=C(S1)NC(=O)N(C2=O)CCN3CCN(CC3)C4=CC=CC=C4OC)C5=CC=CC=C5,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(C)c(-c4ccccc4)c3c2=O)CC1
214,CHEMBL137598,P35368,,WESSELXZMWZPLT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9986714.0,KI,=,0.46,NM,,,,,,,,,,,,,,The binding affinity towards Alpha-1B adrenergic receptor in the COS cell line.,,"Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.",J. Med. Chem.,1999.0,42.0,3.0,"Leonardi A, Motta G, Boi C, Testa R, Poggesi E, De Benedetti PG, Menziani MC",,32304.0,DTCT0023207,1327839,DTCC00319992,270955,15565,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(c4ccco4)CC3)nc(N)c2cc1OC
215,CHEMBL13789,P35368,,BPRZPBVOIULUSI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,896050,DTCC00143259,77015,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CC=C3,c1ccc(-c2ccccc2OCC2=NCCN2)cc1
216,CHEMBL13789,P35368,,BPRZPBVOIULUSI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,IC50,=,741.31,NM,,,,,,,,,,,,,,Binding affinity of compound towards human Alpha-1B adrenergic receptor expressed in rat fibroblast membranes,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34481.0,DTCT0023207,896056,DTCC00143259,77015,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CC=C3,c1ccc(-c2ccccc2OCC2=NCCN2)cc1
217,CHEMBL13789,P35368,,BPRZPBVOIULUSI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,896051,DTCC00143259,77015,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CC=C3,c1ccc(-c2ccccc2OCC2=NCCN2)cc1
218,CHEMBL13789,P35368,,BPRZPBVOIULUSI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1165359,DTCC00143259,76535,5253,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CC=C3,c1ccc(-c2ccccc2OCC2=NCCN2)cc1
219,CHEMBL13789,P35368,,BPRZPBVOIULUSI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,IC50,=,2398.83,NM,,,,,,,,,,,,,,In vitro binding affinity against cloned human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32514.0,DTCT0023207,1165362,DTCC00143259,76535,5253,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CC=C3,c1ccc(-c2ccccc2OCC2=NCCN2)cc1
220,CHEMBL137903,P35368,,OQDVCLJHYBLHNT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9986714.0,KI,=,1.57,NM,,,,,,,,,,,,,,The binding affinity towards Alpha-1B adrenergic receptor in the COS cell line.,,"Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.",J. Med. Chem.,1999.0,42.0,3.0,"Leonardi A, Motta G, Boi C, Testa R, Poggesi E, De Benedetti PG, Menziani MC",,32304.0,DTCT0023207,1356873,DTCC00319879,854089,15565,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)CC(C4=CC=CC=C4)C5=CC=CC=C5)N)OC,COc1cc2nc(N3CCN(C(=O)CC(c4ccccc4)c4ccccc4)CC3)nc(N)c2cc1OC
221,CHEMBL138109,P35368,,DFNUNBHMMOZMON-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11728188.0,KI,=,270.0,NM,,,,,,,,,,,,,,Binding affinity was determined on human cloned alpha-1B adrenergic receptor,,"trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.",J. Med. Chem.,2001.0,44.0,25.0,"Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R",,34339.0,DTCT0023207,1463308,DTCC00321929,854117,16537,COC1=CC=CC2=C(C=CC=C21)CCCNCCOC3=CC=CC=N3,COc1cccc2c(CCCNCCOc3ccccn3)cccc12
222,CHEMBL138119,P35368,,BMKZZNQBNUXUQB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,=,6800.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1398251,DTCC00319237,1597729,17528,C1=CC=C(C=C1)CCNC2=C(C(=C(C=C2)C3=CC=CC=C3)CC(=O)NCC4=CC=C(C=C4)C(=N)N)O,N=C(N)c1ccc(CNC(=O)Cc2c(-c3ccccc3)ccc(NCCc3ccccc3)c2O)cc1
223,CHEMBL13852,P35368,CIRAZOLINE,YAORIDZYZDUZCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,63.1,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,625746,DTCC00143000,1207793,4573,C1CC1C2=CC=CC=C2OCC3=NCCN3,c1ccc(C2CC2)c(OCC2=NCCN2)c1
224,CHEMBL13852,P35368,CIRAZOLINE,YAORIDZYZDUZCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,72.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,625747,DTCC00143000,1207793,4573,C1CC1C2=CC=CC=C2OCC3=NCCN3,c1ccc(C2CC2)c(OCC2=NCCN2)c1
225,CHEMBL13852,P35368,CIRAZOLINE,YAORIDZYZDUZCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,63.1,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,866170,DTCC00143000,1208543,5326,C1CC1C2=CC=CC=C2OCC3=NCCN3,c1ccc(C2CC2)c(OCC2=NCCN2)c1
226,CHEMBL13852,P35368,CIRAZOLINE,YAORIDZYZDUZCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,72.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,866171,DTCC00143000,1208543,5326,C1CC1C2=CC=CC=C2OCC3=NCCN3,c1ccc(C2CC2)c(OCC2=NCCN2)c1
227,CHEMBL13852,P35368,CIRAZOLINE,YAORIDZYZDUZCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,63.1,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1014688,DTCC00143000,1197500,5345,C1CC1C2=CC=CC=C2OCC3=NCCN3,c1ccc(C2CC2)c(OCC2=NCCN2)c1
228,CHEMBL13852,P35368,CIRAZOLINE,YAORIDZYZDUZCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,=,63.1,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1140098,DTCC00143000,1208081,5253,C1CC1C2=CC=CC=C2OCC3=NCCN3,c1ccc(C2CC2)c(OCC2=NCCN2)c1
229,CHEMBL13852,P35368,CIRAZOLINE,YAORIDZYZDUZCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,MAX,=,72.0,%,,,,,,,,,,,,,,Activation of human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts as percent maximal effect relative to phenylephrine,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32512.0,DTCT0023207,1140099,DTCC00143000,1208081,5253,C1CC1C2=CC=CC=C2OCC3=NCCN3,c1ccc(C2CC2)c(OCC2=NCCN2)c1
230,CHEMBL13856,P35368,A-123189,PANBMHHKBRMYAL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11354357.0,KI,=,9.09,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor,,Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.,Bioorg. Med. Chem. Lett.,2001.0,11.0,9.0,"Carroll WA, Sippy KB, Esbenshade TA, Buckner SA, Hancock AA, Meyer MD",,34336.0,DTCT0023207,728322,DTCC00142945,1631625,4794,CC1=CC(=CC=C1)C2=CSC3=C2C(=O)N(C(=O)N3)CCN4CCN(CC4)C5=CC=CC=C5OC,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3scc(-c4cccc(C)c4)c3c2=O)CC1
231,CHEMBL13903,P35368,,YCSBRVKGUOPSQB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11354357.0,KI,=,1.86,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor,,Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.,Bioorg. Med. Chem. Lett.,2001.0,11.0,9.0,"Carroll WA, Sippy KB, Esbenshade TA, Buckner SA, Hancock AA, Meyer MD",,34336.0,DTCT0023207,725753,DTCC00143030,1114416,4794,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(NC3=O)SC(=C4)C5=CC=CC=C5,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3sc(-c4ccccc4)cc3c2=O)CC1
232,CHEMBL139505,P35368,,XTICRBGKPDRHCR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11728188.0,KI,=,4.21,NM,,,,,,,,,,,,,,Binding affinity was determined on human cloned alpha-1B adrenergic receptor,,"trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.",J. Med. Chem.,2001.0,44.0,25.0,"Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R",,34339.0,DTCT0023207,1444933,DTCC00322167,1533295,16537,COC1=CC=CC2=C(C=CC=C21)CCCN3CCN(CC3)C4=CC=CC=N4,COc1cccc2c(CCCN3CCN(c4ccccn4)CC3)cccc12
233,CHEMBL140450,P35368,,MOVYLDZUBGRMTA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8917649.0,KI,=,18.62,NM,,tissue,,,,,,,,,,,,Compound was tested for binding affinity against human hippocampus Alpha-1B adrenergic receptor using radioligand ([3H]prazosin) binding assay,,"Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.",J. Med. Chem.,1996.0,39.0,23.0,"Giardinà D, Crucianelli M, Romanelli R, Leonardi A, Poggesi E, Melchiorre C",,34613.0,DTCT0023207,1425976,DTCC00326743,1662319,13894,C1CN(CCC1CC(CC=N)O)C2=CC=CC=C2OC3=CC=CC=C3,N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1
234,CHEMBL140450,P35368,,MOVYLDZUBGRMTA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8917649.0,KI,=,39.81,NM,,,,,,,,,,,,,,Compound was tested for binding affinity against cloned Alpha-1B adrenergic receptor from hamster smooth muscle using radioligand ([3H]prazosin) binding assay,,"Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.",J. Med. Chem.,1996.0,39.0,23.0,"Giardinà D, Crucianelli M, Romanelli R, Leonardi A, Poggesi E, Melchiorre C",,34317.0,DTCT0023207,1425973,DTCC00326743,1662319,13894,C1CN(CCC1CC(CC=N)O)C2=CC=CC=C2OC3=CC=CC=C3,N=CCC(O)CC1CCN(c2ccccc2Oc2ccccc2)CC1
235,CHEMBL141322,P35368,,UJELWGXJMXZTIC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,190.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,524968,DTCC00330649,304049,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
236,CHEMBL141322,P35368,,UJELWGXJMXZTIC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,480.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,523054,DTCC00330649,304047,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
237,CHEMBL141322,P35368,,UJELWGXJMXZTIC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,700.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,514786,DTCC00330649,304048,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
238,CHEMBL141444,P35368,,RUSCEAPEVNUTMN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,88.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,703096,DTCC00330472,324980,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=C(C=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F
239,CHEMBL141604,P35368,,JCTVCYAMDFKFLR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,400.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,522057,DTCC00330587,402160,15470,CC1=NC(=C(C(N1CCCCCN2CCC(CC2)(C#N)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC)COC,COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C(C)=N1
240,CHEMBL141821,P35368,,FDRLNNNWCSSRPY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,16.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1106819,DTCC00330163,971328,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3O)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3O)CC2)C1c1ccc(F)c(F)c1
241,CHEMBL141986,P35368,,ZWIHQOQCOUAKNQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,859807,DTCC00330030,434326,5326,CC1=C(N=CC=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1cccnc1-c1ccccc1OCC1=NCCN1
242,CHEMBL141986,P35368,,ZWIHQOQCOUAKNQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,859808,DTCC00330030,434326,5326,CC1=C(N=CC=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1cccnc1-c1ccccc1OCC1=NCCN1
243,CHEMBL14199,P35368,,MOYXTVNKHXOQKG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11354357.0,KI,=,15.8,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor,,Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.,Bioorg. Med. Chem. Lett.,2001.0,11.0,9.0,"Carroll WA, Sippy KB, Esbenshade TA, Buckner SA, Hancock AA, Meyer MD",,34336.0,DTCT0023207,701636,DTCC00142958,1725589,4794,COC1=CC=CC=C1N2CCN(CC2)CCCN3C(=O)C4=C(NC3=O)SC=C4C5=CC=CC=C5,COc1ccccc1N1CCN(CCCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1
244,CHEMBL14213,P35368,,BEJGRQHTUSMJBJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11354357.0,KI,=,4.47,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor,,Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.,Bioorg. Med. Chem. Lett.,2001.0,11.0,9.0,"Carroll WA, Sippy KB, Esbenshade TA, Buckner SA, Hancock AA, Meyer MD",,34336.0,DTCT0023207,725759,DTCC00142909,1884809,4794,CN1C2=C(C(=CS2)C3=CC=CC=C3)C(=O)N(C1=O)CCN4CCN(CC4)C5=CC=CC=C5OC,COc1ccccc1N1CCN(CCn2c(=O)c3c(-c4ccccc4)csc3n(C)c2=O)CC1
245,CHEMBL142236,P35368,,FXFOLWSUKNFCFK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,100.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1096085,DTCC00330578,1871794,15486,COCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=CC(=C(C=C4)F)F)C(=O)OC,COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1
246,CHEMBL142243,P35368,,HVNJSMJGJDSBBV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,440.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,772968,DTCC00329917,1080332,15485,CC1(CCN(CC1)CCCNC(=O)N2C(C(=C(NC2=O)COC)C(=O)OC)C3=CC(=C(C=C3)F)F)C4=CC=CC=C4,COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C(=O)N1
247,CHEMBL142251,P35368,,FOMUZVDWSAHVBW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,8.8,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1121594,DTCC00330162,1327510,15486,CCOC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)N3C(C(=C(NC3=O)C)C(=O)OC)C4=CC(=C(C=C4)F)F,CCOc1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)OC)C2c2ccc(F)c(F)c2)CC1
248,CHEMBL142307,P35368,,PKOIYURUOMCFSD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,17.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1096081,DTCC00330352,1262455,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=C(C=C3)Cl)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1
249,CHEMBL142310,P35368,,XETSZHAOODKPNL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,867620,DTCC00329585,1533382,5326,C1CN=C(N1)COC2=CC=CC=C2C3=NC=NC=C3,c1ccc(-c2ccncn2)c(OCC2=NCCN2)c1
250,CHEMBL142310,P35368,,XETSZHAOODKPNL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,867621,DTCC00329585,1533382,5326,C1CN=C(N1)COC2=CC=CC=C2C3=NC=NC=C3,c1ccc(-c2ccncn2)c(OCC2=NCCN2)c1
251,CHEMBL142383,P35368,,AXXIDQZJAQSNEN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,19.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,727450,DTCC00329315,1714768,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
252,CHEMBL142383,P35368,,AXXIDQZJAQSNEN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,28.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,722556,DTCC00329315,1714769,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
253,CHEMBL142383,P35368,,AXXIDQZJAQSNEN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,81.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,703069,DTCC00329315,1714766,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
254,CHEMBL142387,P35368,,YYCCOIONTNLQAS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,12.59,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,877918,DTCC00329290,595339,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=NS3,c1ccc(-c2ccns2)c(OCC2=NCCN2)c1
255,CHEMBL142387,P35368,,YYCCOIONTNLQAS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,56.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,877919,DTCC00329290,595339,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=NS3,c1ccc(-c2ccns2)c(OCC2=NCCN2)c1
256,CHEMBL142398,P35368,,RXBNQUXJGAHNLL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,15.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1097402,DTCC00330234,97780,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3Cl)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3Cl)CC2)C1c1ccc(F)c(F)c1
257,CHEMBL142606,P35368,,HXUMKMQRTFHLCC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,500.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,529752,DTCC00330586,1436305,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)C3=CC=CC=C3C(F)(F)F)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3C(F)(F)F)CC2)C1c1ccc(F)c(F)c1
258,CHEMBL142635,P35368,NAFTOPIDIL,HRRBJVNMSRJFHQ-UHFFFAOYSA-N,3,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,634.0,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27928,DTCC00328380,968757,65595,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1
259,CHEMBL142718,P35368,,AVZNXYFYVNZTRE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,720.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1103938,DTCC00330351,259148,15486,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=C(C=C(C=C4)F)F)C(=O)N,CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1
260,CHEMBL142719,P35368,,DCGSNFHTNRDXFG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,870.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,539172,DTCC00330784,821278,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=C(C=C(C=C4)F)F)C(=O)NC,CNC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F
261,CHEMBL142743,P35368,,LUKZCSDJGOLWJZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,27.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,716689,DTCC00330471,519502,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC5=NON=C5C=C4)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc2nonc2c1
262,CHEMBL142784,P35368,,JJNCVWTXKJXARP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,5.01,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,888032,DTCC00329402,1404372,5326,C1CN=C(N1)COC2=CC=CC=C2C3=COC=C3,c1ccc(-c2ccoc2)c(OCC2=NCCN2)c1
263,CHEMBL142784,P35368,,JJNCVWTXKJXARP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,111.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,888033,DTCC00329402,1404372,5326,C1CN=C(N1)COC2=CC=CC=C2C3=COC=C3,c1ccc(-c2ccoc2)c(OCC2=NCCN2)c1
264,CHEMBL142864,P35368,,SCBRBOJPMMAMHQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,875372,DTCC00329269,563083,5326,C1CN=C(N1)COC2=CC=CC=C2C3=NC=CN3,c1ccc(-c2ncc[nH]2)c(OCC2=NCCN2)c1
265,CHEMBL142864,P35368,,SCBRBOJPMMAMHQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,334951,DTCC00329269,563083,5326,C1CN=C(N1)COC2=CC=CC=C2C3=NC=CN3,c1ccc(-c2ncc[nH]2)c(OCC2=NCCN2)c1
266,CHEMBL142871,P35368,,WQQMEKYYFTXIEE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,19.95,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,859819,DTCC00329406,627834,5326,C1CN=C(N1)COC2=CC=CC=C2C3=NC=CS3,c1ccc(-c2nccs2)c(OCC2=NCCN2)c1
267,CHEMBL142871,P35368,,WQQMEKYYFTXIEE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,100.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,859820,DTCC00329406,627834,5326,C1CN=C(N1)COC2=CC=CC=C2C3=NC=CS3,c1ccc(-c2nccs2)c(OCC2=NCCN2)c1
268,CHEMBL142929,P35368,,JXDBPRQKWGFDFQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,130.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,807688,DTCC00330827,2013878,15485,COCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C#N)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC,COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1
269,CHEMBL142957,P35368,,XVBPXSHOAVVRID-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,15.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,722559,DTCC00329918,324979,15484,CCOC(=O)C1=C(NC(=O)N(C1C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC)C,CCOC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
270,CHEMBL142958,P35368,,OFXJYEGXFRBSGZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,863644,DTCC00329506,1786482,5326,CC1=CC=C(S1)C2=CC=CC=C2OCC3=NCCN3,Cc1ccc(-c2ccccc2OCC2=NCCN2)s1
271,CHEMBL142958,P35368,,OFXJYEGXFRBSGZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,863645,DTCC00329506,1786482,5326,CC1=CC=C(S1)C2=CC=CC=C2OCC3=NCCN3,Cc1ccc(-c2ccccc2OCC2=NCCN2)s1
272,CHEMBL142967,P35368,,OORBCPFAQRRXTM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,862334,DTCC00329449,77014,5326,CN1C(=CC=N1)C2=CC=CC=C2OCC3=NCCN3,Cn1nccc1-c1ccccc1OCC1=NCCN1
273,CHEMBL142967,P35368,,OORBCPFAQRRXTM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,862335,DTCC00329449,77014,5326,CN1C(=CC=N1)C2=CC=CC=C2OCC3=NCCN3,Cn1nccc1-c1ccccc1OCC1=NCCN1
274,CHEMBL142981,P35368,,VKJWHZVTJUKYAU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,140.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,784126,DTCC00330389,886466,15485,CC1=C(C(N(C(=O)N1)CCCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
275,CHEMBL142981,P35368,,VKJWHZVTJUKYAU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,140.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,524964,DTCC00330389,886473,15470,CC1=C(C(N(C(=O)N1)CCCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
276,CHEMBL143026,P35368,,FTEVEABUGCVYPW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,KI,=,8.91,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi,,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34611.0,DTCT0023207,1623068,DTCC00332133,1133606,17579,COC1=C(C=C2C(=C1)C(=C3CCC(CC3=N2)CNC(=O)C4=CC=C(C=C4)C(F)(F)F)N)OC,COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccc(C(F)(F)F)cc1)C3
277,CHEMBL143066,P35368,,YPRBAEIXVWNGTP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,50.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,715517,DTCC00329808,324981,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=CC=C4)Cl)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(Cl)c1
278,CHEMBL143558,P35368,,VVVAWPJJUKGKGT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,KI,=,39.81,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi,,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34611.0,DTCT0023207,1607716,DTCC00331852,1294968,17579,COC1=C(C(=CC=C1)OC)OCCNCC2CCC3=C(C4=CC(=C(C=C4N=C3C2)OC)OC)N,COc1cc2nc3c(c(N)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3
279,CHEMBL143562,P35368,,RKVMBHNDKVMNKU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,871560,DTCC00329382,724605,5326,CC1=C(OC=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1ccoc1-c1ccccc1OCC1=NCCN1
280,CHEMBL143562,P35368,,RKVMBHNDKVMNKU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,IC50,=,776.25,NM,,,,,,,,,,,,,,Binding affinity of compound towards human Alpha-1B adrenergic receptor expressed in rat fibroblast membranes,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34481.0,DTCT0023207,871565,DTCC00329382,724605,5326,CC1=C(OC=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1ccoc1-c1ccccc1OCC1=NCCN1
281,CHEMBL143562,P35368,,RKVMBHNDKVMNKU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,871561,DTCC00329382,724605,5326,CC1=C(OC=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1ccoc1-c1ccccc1OCC1=NCCN1
282,CHEMBL1437,P35368,NOREPINEPHRINE,SFLSHLFXELFNJZ-QMMMGPOBSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19857969.0,KI,=,20400.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human adrenergic Alpha-1B receptor expressed in CHO cell membrane,,Structural basis of the selectivity of the beta(2)-adrenergic receptor for fluorinated catecholamines.,Bioorg. Med. Chem.,2009.0,17.0,23.0,"Pooput C, Rosemond E, Karpiak J, Deflorian F, Vilar S, Costanzi S, Wess J, Kirk KL",,603939.0,DTCT0023207,3174206,DTCC00444460,947524,36739,C1=CC(=C(C=C1[C@H](CN)O)O)O,NC[C@H](O)c1ccc(O)c(O)c1
283,CHEMBL143766,P35368,,MAIIYZVIEWXUSC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,885615,DTCC00328970,31726,5326,CC1=NSC(=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1cc(-c2ccccc2OCC2=NCCN2)sn1
284,CHEMBL143766,P35368,,MAIIYZVIEWXUSC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,885616,DTCC00328970,31726,5326,CC1=NSC(=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1cc(-c2ccccc2OCC2=NCCN2)sn1
285,CHEMBL143801,P35368,,NDNJRVYHFSNFBJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,3.98,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,859813,DTCC00329427,821265,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CS3,c1csc(-c2ccccc2OCC2=NCCN2)c1
286,CHEMBL143801,P35368,,NDNJRVYHFSNFBJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,112.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,859814,DTCC00329427,821265,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CS3,c1csc(-c2ccccc2OCC2=NCCN2)c1
287,CHEMBL143940,P35368,,ZSBUPDFCHJYDDP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,27.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,711081,DTCC00329637,1489614,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
288,CHEMBL143973,P35368,,IJLWJFGTCGYKBI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,630.96,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,858681,DTCC00329587,1883295,5326,C1CN=C(N1)COC2=CC=CC=C2C3=NC=CN=C3,c1ccc(-c2cnccn2)c(OCC2=NCCN2)c1
289,CHEMBL143973,P35368,,IJLWJFGTCGYKBI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,46.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,858682,DTCC00329587,1883295,5326,C1CN=C(N1)COC2=CC=CC=C2C3=NC=CN=C3,c1ccc(-c2cnccn2)c(OCC2=NCCN2)c1
290,CHEMBL144286,P35368,,SGZPGIWGYCHZFH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,KI,=,12.3,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi,,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34609.0,DTCT0023207,1608924,DTCC00332162,1586155,17579,COC1=C(C=C2C(=C1)C(=C3CCC(CC3=N2)CNC(=O)C4=CC=CO4)N)OC,COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccco1)C3
291,CHEMBL144534,P35368,,LPTPYTCKPRTUIS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,310.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,537396,DTCC00331212,1080336,15470,CC1=C(C(N(C(=N1)COC)CCCCCN2CCC(CC2)(C#N)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC,COCC1=NC(C)=C(C(=O)OC)C(c2ccc(F)c(F)c2)N1CCCCCN1CCC(C#N)(c2ccccc2)CC1
292,CHEMBL144731,P35368,,BVILLZIQPZNAQJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,320.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,537392,DTCC00331265,77031,15470,CC1=C(C(N(C(=N1)C)CC2=CC=CC(=C2)CN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(Cc2cccc(CN3CCC(C(=O)OC)(c4ccccc4)CC3)c2)C1c1ccc(F)c(F)c1
293,CHEMBL144779,P35368,,VPMYQPYOAXNVFL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,KI,=,218.78,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi,,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34611.0,DTCT0023207,1631891,DTCC00331805,453939,17579,COC1=C(C(=CC=C1)OC)OCCNCC2CCC3=C(C2)NC4=CC(=C(C=C4C3=O)OC)OC,COc1cc2[nH]c3c(c(=O)c2cc1OC)CCC(CNCCOc1c(OC)cccc1OC)C3
294,CHEMBL144837,P35368,,IQHGWJHATVPELH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,LOG KI,,,,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi; ND=No data,Not Determined,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34612.0,DTCT0023207,1602673,DTCC00332220,2066627,17579,COC1=C(C=C2C(=C1)C(=C3CCCC(CC3=N2)CNC(=O)C4=CC=CO4)N)OC,COc1cc2nc3c(c(N)c2cc1OC)CCCC(CNC(=O)c1ccco1)C3
295,CHEMBL144925,P35368,,OAFCUWPULJWWTF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,340.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,704230,DTCC00329940,1807376,15484,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=C(C=C(C=C4)F)F)C(=O)N,CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
296,CHEMBL144925,P35368,,OAFCUWPULJWWTF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,220.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,810553,DTCC00329940,1819048,15485,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=C(C=C(C=C4)F)F)C(=O)N,CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
297,CHEMBL144933,P35368,,MMJIOQBMUWSARZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,30.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,779743,DTCC00330538,1339352,15485,COCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C#N)C3=CC=C(C=C3)F)C4=CC(=C(C=C4)F)F)C(=O)OC,COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)C(=O)N1
298,CHEMBL144938,P35368,,OYHBIUUZIRTADX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,1050.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,798059,DTCC00330215,1404381,15485,CC1=C(C(N(C(=O)N1)CC(=O)NCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(CC(=O)NCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
299,CHEMBL144956,P35368,,XUDKBTKAFPWCCT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,872888,DTCC00108179,369304,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=NC=C3,c1ccc(-c2ccncc2)c(OCC2=NCCN2)c1
300,CHEMBL144956,P35368,,XUDKBTKAFPWCCT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,872889,DTCC00108179,369304,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=NC=C3,c1ccc(-c2ccncc2)c(OCC2=NCCN2)c1
301,CHEMBL144965,P35368,,FUAZJQZXKXKCSP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,250.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,785511,DTCC00331058,854196,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
302,CHEMBL144989,P35368,,CHKOUYJMMIYLHA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,36.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,810556,DTCC00330335,271056,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
303,CHEMBL145001,P35368,,FCYFDSIYOJMHFF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,490.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,531629,DTCC00330619,1981070,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)(C#N)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
304,CHEMBL145072,P35368,,JHAYORQLJMSTOO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,130.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1114563,DTCC00330577,1871793,15486,COCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=CC(=C(C=C4F)F)F)C(=O)OC,COCC1=C(C(=O)OC)C(c2cc(F)c(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1
305,CHEMBL145122,P35368,,VOBJKTXVNRAUOO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,1300.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1130337,DTCC00330399,357604,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=C(C=C3)C(=O)C)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(C(C)=O)cc3)CC2)C1c1ccc(F)c(F)c1
306,CHEMBL145134,P35368,,GDBMQKGUAQWBLZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,730.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,774231,DTCC00330791,788906,15485,COCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C#N)C3=CC=CC=C3F)C4=CC(=C(C=C4)F)F)C(=O)OC,COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3F)CC2)C(=O)N1
307,CHEMBL145170,P35368,,MVUYRJDAYOGRLE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,400.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,793893,DTCC00329899,821273,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC3(CC2)C4=CC=CC=C4CO3)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCc2ccccc23)C1c1ccc(F)c(F)c1
308,CHEMBL145178,P35368,,IYHKQABMQSZQIQ-VUUJKMBOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,480.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,519973,DTCC00330782,1915514,15470,CC1=C(C(N(C(=N1)C)CCC[C@H](C)CN2CCC(CC2)(C#N)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
309,CHEMBL145190,P35368,,UIJPUNVNCOWEMQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,15.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1132984,DTCC00330959,971327,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C#N)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1
310,CHEMBL145190,P35368,,UIJPUNVNCOWEMQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,15.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1135469,DTCC00330959,971326,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C#N)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C#N)CC2)C1c1ccc(F)c(F)c1
311,CHEMBL145210,P35368,,NMJHFHBUIVGITI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,LOG KI,,,,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi; ND=No data,Not Determined,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34610.0,DTCT0023207,1605355,DTCC00332139,1521870,17579,COC1=C(C=C2C(=C1)C(=C3CCC(CC3=N2)CNC(=O)C4=CC=CC=C4)N)OC,COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccccc1)C3
312,CHEMBL145267,P35368,,QBCDWYYFGNYODX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,1600.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,727453,DTCC00329741,1871788,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)O,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1
313,CHEMBL145278,P35368,,XQPITIPYGHBCQW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,440.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,522053,DTCC00331290,756714,15470,CC1=C(C(N(C(=N1)C)CCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
314,CHEMBL145332,P35368,,MVTUYOJHINYPHS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,340.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,791083,DTCC00330663,950739,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C#N)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
315,CHEMBL145334,P35368,,USAJHRPHUPIVLS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,100.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,726051,DTCC00329947,648845,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)NC,CNC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
316,CHEMBL145338,P35368,,FANFEKCLDFPOHE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,25.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1127781,DTCC00330338,875043,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1
317,CHEMBL145353,P35368,,MFXXQERUKWXMIU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,410.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,534433,DTCC00330248,109272,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=C(C=C(C=C4)F)F)C(=O)N,COC(=O)C1(c2ccccc2)CCN(CCCCCN2C(C)=NC(C)=C(C(N)=O)C2c2ccc(F)cc2F)CC1
318,CHEMBL145394,P35368,,DMMNMIJPRNMLBQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,135.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1126542,DTCC00330336,1425054,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1
319,CHEMBL145394,P35368,,DMMNMIJPRNMLBQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,190.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1105395,DTCC00330336,1425053,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1
320,CHEMBL145411,P35368,,JICRZQUVMVWMQI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,250.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,540114,DTCC00330247,1533396,15470,CC1=CC=C(C=C1)C2(CCN(CC2)CCCCCN3C(C(=C(N=C3C)C)C(=O)OC)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5C,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1
321,CHEMBL145443,P35368,,IIGHIMZENWTPRU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,8.4,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1102441,DTCC00330219,616065,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC(=CC=C3)Cl)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(Cl)c3)CC2)C1c1ccc(F)c(F)c1
322,CHEMBL145459,P35368,,VNYMBUMHKREEFE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,36.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,772925,DTCC00330770,1915509,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
323,CHEMBL145525,P35368,,KTTHVCJSRNMDJY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,43.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1100115,DTCC00330813,65450,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC(=C3)C(F)(F)F)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)C1c1ccc(F)c(F)c1
324,CHEMBL145547,P35368,,JCWKQYAUPMXURC-LFUZPPSTSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,49.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1120011,DTCC00330339,875044,15486,C[C@H]1CN(CCN1CCCNC(=O)N2C(C(=C(NC2=O)C)C(=O)OC)C3=CC(=C(C=C3)F)F)C4=CC=CC=C4[N+](=O)[O-],COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@@H]2C)C1c1ccc(F)c(F)c1
325,CHEMBL145553,P35368,,IAPFEDPQSKFUSX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,3130.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,792530,DTCC00330360,1883308,15485,COCC1=C(C(N(C(=O)N1)C(=O)N2CCC(CC2)N3CCC(CC3)(C4=CC=CC=C4)C(=O)OC)C5=CC(=C(C(=C5)F)F)F)C(=O)OC,COCC1=C(C(=O)OC)C(c2cc(F)c(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1
326,CHEMBL145562,P35368,,VITDWMDDGMNHHH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,100.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,700859,DTCC00329948,1521831,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1
327,CHEMBL145571,P35368,,MWRJZYVRTRKJED-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,2820.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,810504,DTCC00331057,1948057,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC3(CC2)C4=CC=CC=C4C(=O)O3)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)c2ccccc23)C1c1ccc(F)c(F)c1
328,CHEMBL145574,P35368,,MGEPWLHHOOYNQU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,170.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1101230,DTCC00330413,939253,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=CC(=C(C=C4)F)F)C(=O)C,CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1
329,CHEMBL145587,P35368,,AOIKUDXNCODUKV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,67.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,522049,DTCC00330368,1113005,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCN(CC2)C3=CC=CC=C3OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1
330,CHEMBL145610,P35368,,QCNWWNZUDOKUHR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,78.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,723798,DTCC00329807,1197335,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1
331,CHEMBL145719,P35368,,DXKDPMJFFBCJSB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,860.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,784177,DTCC00330635,692290,15485,CC1=CC(=CC(=C1)C2(CCN(CC2)CCCNC(=O)N3C(C(=C(NC3=O)C)C(=O)OC)C4=CC(=C(C=C4)F)F)C5=CC(=CC(=C5)C)C)C,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3cc(C)cc(C)c3)(c3cc(C)cc(C)c3)CC2)C1c1ccc(F)c(F)c1
332,CHEMBL145746,P35368,,QMEPUSMYDLGAOV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,100.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,517840,DTCC00330698,1371962,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
333,CHEMBL145752,P35368,,QYNUTROASKYRGA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,139.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,715514,DTCC00329742,1229537,15484,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)NC,CCC1=C(C(=O)NC)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
334,CHEMBL145756,P35368,,VYEWPTHCXXZXSS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,510.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1112162,DTCC00330609,680774,15486,CC1=C(C=CC(=C1)OC)N2CCN(CC2)CCCNC(=O)N3C(C(=C(NC3=O)C)C(=O)OC)C4=CC(=C(C=C4)F)F,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3C)CC2)C1c1ccc(F)c(F)c1
335,CHEMBL145770,P35368,,WMJYLKOESTVKAR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,140.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,526873,DTCC00108199,304050,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)C3=CC=CC=C3OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1
336,CHEMBL145785,P35368,,QIOOWTWBRUIBKP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,KI,=,7.41,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi,,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34609.0,DTCT0023207,1623062,DTCC00332157,292434,17579,COC1=C(C=C2C(=C1)C(=C3CCC(CC3=N2)CNC(=O)C4=CC=CC=C4C(F)(F)F)N)OC,COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1ccccc1C(F)(F)F)C3
337,CHEMBL145793,P35368,,OOWAZNPOGJVTHK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,KI,=,295.12,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi,,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34611.0,DTCT0023207,1623075,DTCC00332044,1936126,17579,COC1=C(C=C2C(=C1)C(=O)C3=C(N2)CC(CC3)CNC(=O)C4=CC=CO4)OC,COc1cc2[nH]c3c(c(=O)c2cc1OC)CCC(CNC(=O)c1ccco1)C3
338,CHEMBL145843,P35368,,QORSFUXHRJFURF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,23.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1109431,DTCC00330303,777407,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3[N+](=O)[O-])C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])CC2)C1c1ccc(F)c(F)c1
339,CHEMBL145894,P35368,,ARVUOFMRSSPQPL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,80.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,804959,DTCC00330438,1754283,15485,CC1=CC=C(C=C1)C2(CCN(CC2)CCCNC(=O)N3C(C(=C(NC3=O)C)C(=O)OC)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5C,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(C)cc3)(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1
340,CHEMBL146109,P35368,,WXDGGVRRTFHCJF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,270.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,796715,DTCC00330960,1662375,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
341,CHEMBL146163,P35368,,LMLCPHRNHLEZIN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,48.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,720194,DTCC00330550,1714767,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)Cl)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(Cl)cc1
342,CHEMBL146654,P35368,,VRERDSWPFMZSEX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,18.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1096000,DTCC00330449,2001968,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)C1c1ccc(F)c(F)c1
343,CHEMBL146815,P35368,,WFTUNFKSJYIJPQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,1180.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1436730,DTCC00339113,31975,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)C,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1
344,CHEMBL146983,P35368,,KDLIJZLPUSNICY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,39500.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1442860,DTCC00338781,918290,15010,CCOC(=O)C1CCN(CC1)CCCNC(=O)C2=C(NC(=C(C2C3=CC=C(C=C3)[N+](=O)[O-])C(=O)NC)C)C,CCOC(=O)C1CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1
345,CHEMBL147077,P35368,,CAAOWRJNPRFDJE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,3660.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1434100,DTCC00338816,1694619,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)NC,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
346,CHEMBL147077,P35368,,CAAOWRJNPRFDJE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,4920.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1441686,DTCC00338816,1694623,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)NC,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
347,CHEMBL147077,P35368,,CAAOWRJNPRFDJE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,5170.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1441692,DTCC00338816,1694621,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)NC,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
348,CHEMBL148489,P35368,N-(3-PYRIDYLMETHYL)PYRROLIDINE,YFCWBKBNFCDPDF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478832,DTCC00339052,2026783,48255,C1CCN(C1)CC2=CN=CC=C2,c1cncc(CN2CCCC2)c1
349,CHEMBL148552,P35368,,SDLAGDZFGDPJLC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,720.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1420252,DTCC00339232,821383,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC5=C(C=C4)OCO5)C(=O)C,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc3c(c2)OCO3)CC1
350,CHEMBL1491,P35368,AMLODIPINE,HTIQEAQVCYTUBX-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,7943.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1243837,DTCC00112206,193707,3366,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl
351,CHEMBL149263,P35368,,RZKNQTFDVDQOIV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,3410.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1429026,DTCC00339231,498919,15010,CCOC(=O)C1(CCN(CC1)CCCNC(=O)C2=C(NC(=C(C2C3=CC4=C(C=C3)OCO4)C(=O)N)C)C)C5=CC=CC=C5,CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc3c(c2)OCO3)CC1
352,CHEMBL150161,P35368,,BETHXCLHMRGYBW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16621538.0,KI,=,41.7,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor by radioligand binding assay,,"Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol.",Bioorg. Med. Chem. Lett.,2006.0,16.0,12.0,"Ablordeppey SY, Lyles-Eggleston M, Bricker B, Zhang W, Zhu X, Goodman C, Roth BL",,361008.0,DTCT0023207,1937957,DTCC00335498,206917,20872,C1CN(CC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1
353,CHEMBL150161,P35368,,BETHXCLHMRGYBW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16621538.0,KI,=,102.4,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor by radioligand binding assay,,"Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol.",Bioorg. Med. Chem. Lett.,2006.0,16.0,12.0,"Ablordeppey SY, Lyles-Eggleston M, Bricker B, Zhang W, Zhu X, Goodman C, Roth BL",,361008.0,DTCT0023207,1937931,DTCC00335498,206916,20872,C1CN(CC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1
354,CHEMBL150696,P35368,,LEPCEIHDKKWUSM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,24400.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1431339,DTCC00339635,1241471,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)N(C)C)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)N(C)C)(c3ccccc3)CC2)=C(C)N1
355,CHEMBL150743,P35368,,QWRDGJNWAMEFDT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,39500.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1421536,DTCC00338758,627977,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCCCC2)C3=CC=C(C=C3)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCCCC2)=C(C)N1
356,CHEMBL151045,P35368,,ITROEMUZOALOMP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,1890.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1441677,DTCC00339320,336818,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)O)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(O)(c3ccccc3)CC2)=C(C)N1
357,CHEMBL1516176,P35368,,PDNJLMZEGXHSCU-VKHMYHEASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14743503,DTCC00912618,2108018,69159,C(CS(=O)O)[C@@H](C(=O)O)N,N[C@@H](CCS(=O)O)C(=O)O
358,CHEMBL151668,P35368,,YSNYWXWAQFVCJP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,29000.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1420249,DTCC00338940,2078258,15010,CC1=C(C(C(=C(N1)C)C(=O)O)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)O)C2c2ccc([N+](=O)[O-])cc2)CC1
359,CHEMBL151825,P35368,,CIMSZTVVTWKOJY-UUDCSCGESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,520.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1420246,DTCC00338941,1241472,15010,CC1=C(C(C(=C(N1)C)C(=O)OCCC#N)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCC#N)C2c2ccc([N+](=O)[O-])cc2)CC1
360,CHEMBL151878,P35368,,VRDGFJSTQSDKOA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,2720.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1441683,DTCC00338976,336817,15010,CCOC(=O)C1(CCN(CC1)CCCNC(=O)C2=C(NC(=C(C2C3=CC=C(C=C3)[N+](=O)[O-])C(=O)N)C)C)C4=CC=CC=C4,CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1
361,CHEMBL152154,P35368,,JIXBFNDMCXDDHF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1007107,DTCC00344971,227045,5345,CC1=NC(=CO1)C2=CC=CC=C2NCC3=NCCN3,Cc1nc(-c2ccccc2NCC2=NCCN2)co1
362,CHEMBL152155,P35368,,DCUZNLXOAOSQBG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,6.31,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,993933,DTCC00344973,1807547,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=CO3,c1coc(-c2ccccc2NCC2=NCCN2)c1
363,CHEMBL15245,P35368,YOHIMBINE,BLGXFZZNTVWLAY-SCYLSFHTSA-N,3,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,966.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,928226,DTCC00144859,76670,13230,COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21
364,CHEMBL15245,P35368,YOHIMBINE,BLGXFZZNTVWLAY-SCYLSFHTSA-N,3,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,1.1,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from hamster clones.,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34313.0,DTCT0023207,747322,DTCC00144859,76552,13167,COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21
365,CHEMBL15245,P35368,YOHIMBINE,BLGXFZZNTVWLAY-SCYLSFHTSA-N,3,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,7.2,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from human clone,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34465.0,DTCT0023207,747321,DTCC00144859,76552,13167,COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21
366,CHEMBL15245,P35368,YOHIMBINE,BLGXFZZNTVWLAY-SCYLSFHTSA-N,3,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10611634.0,KI,=,158.48,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14729353,DTCC00144859,2103457,69195,COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21
367,CHEMBL15245,P35368,YOHIMBINE,BLGXFZZNTVWLAY-SCYLSFHTSA-N,3,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12065700.0,KI,=,2398.83,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14729345,DTCC00144859,2103849,69360,COC(=O)[C@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21
368,CHEMBL152595,P35368,,BDPXTGHWVMUJCT-NRFANRHFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10669560.0,LOG KI,,,,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor; ND means no data.,Not Determined,"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).",J. Med. Chem.,2000.0,43.0,3.0,"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR",,32308.0,DTCT0023207,1114559,DTCC00343554,1850697,16008,CC1CCN(CC1)CC[C@@H]2CCCCN2S(=O)(=O)C3=CC=CC4=CC=CC=C43,CC1CCN(CC[C@@H]2CCCCN2S(=O)(=O)c2cccc3ccccc23)CC1
369,CHEMBL152693,P35368,,HCEHSLLRVKRKFF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,112.2,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1004671,DTCC00344867,325145,5345,CC1=C(SC=C1)C2=CC=CC=C2NCC3=NCCN3,Cc1ccsc1-c1ccccc1NCC1=NCCN1
370,CHEMBL152725,P35368,,XLGXOZAAAMQPIO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,46.77,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1003610,DTCC00108503,1554060,5345,CC1=CC=C(O1)C2=CC=CC=C2NCC3=NCCN3,Cc1ccc(-c2ccccc2NCC2=NCCN2)o1
371,CHEMBL1528238,P35368,,BKRGVLQUQGGVSM-RDTXWAMCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,16.6,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14755978,DTCC00923924,2110794,69012,CCN(CC)C(=O)N[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,CCN(CC)C(=O)N[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
372,CHEMBL154023,P35368,,KUBADPQAWRUMPM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,988899,DTCC00344994,1392840,5345,CC1=C(OC=N1)C2=CC=CC=C2NCC3=NCCN3,Cc1ncoc1-c1ccccc1NCC1=NCCN1
373,CHEMBL154023,P35368,,KUBADPQAWRUMPM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,IC50,=,323.59,NM,,,,,,,,,,,,,,In vitro binding affinity against human Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34482.0,DTCT0023207,988902,DTCC00344994,1392840,5345,CC1=C(OC=N1)C2=CC=CC=C2NCC3=NCCN3,Cc1ncoc1-c1ccccc1NCC1=NCCN1
374,CHEMBL154170,P35368,,RPXGGOSHABXVKK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,985358,DTCC00344768,1036437,5345,CC1=C(N=CC=C1)C2=CC=CC=C2NCC3=NCCN3,Cc1cccnc1-c1ccccc1NCC1=NCCN1
375,CHEMBL154274,P35368,,OCIBSJABYJIGGA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11140733.0,KI,>,1995.26,NM,,,,,,,,,,,,,,Compound was evaluated for binding affinity against Alpha-1B adrenergic receptor,,"Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).",Bioorg. Med. Chem. Lett.,2001.0,11.0,1.0,"Bromidge SM, Clarke SE, Gager T, Griffith K, Jeffrey P, Jennings AJ, Joiner GF, King FD, Lovell PJ, Moss SF, Newman H, Riley G, Rogers D, Routledge C, Serafinowska H, Smith DR",,32301.0,DTCT0023207,1491935,DTCC00344734,1229716,4218,COC1=C(C=C(C=C1)S(=O)(=O)NC2=C(C=CC(=C2)Br)Br)N3CCNCC3,COc1ccc(S(=O)(=O)Nc2cc(Br)ccc2Br)cc1N1CCNCC1
376,CHEMBL154298,P35368,,GXGVZZFPDOETFM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,30.2,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,979637,DTCC00344769,2035021,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=CC=N3,c1ccc(-c2ccccc2NCC2=NCCN2)nc1
377,CHEMBL154298,P35368,,GXGVZZFPDOETFM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,IC50,=,588.84,NM,,,,,,,,,,,,,,In vitro binding affinity against human Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34482.0,DTCT0023207,979641,DTCC00344769,2035021,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=CC=N3,c1ccc(-c2ccccc2NCC2=NCCN2)nc1
378,CHEMBL154346,P35368,,CDXFPRMENPXJMR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,986613,DTCC00345218,1904295,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=CON=C3,c1ccc(-c2cnoc2)c(NCC2=NCCN2)c1
379,CHEMBL155326,P35368,,PBLOKLHEMAJIKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,1.62,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,986606,DTCC00344992,1522013,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=NC=CO3,c1ccc(-c2ncco2)c(NCC2=NCCN2)c1
380,CHEMBL155326,P35368,,PBLOKLHEMAJIKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,IC50,=,446.68,NM,,,,,,,,,,,,,,In vitro binding affinity against human Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34482.0,DTCT0023207,986610,DTCC00344992,1522013,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=NC=CO3,c1ccc(-c2ncco2)c(NCC2=NCCN2)c1
381,CHEMBL155327,P35368,,LQBHYWDFUZWZET-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,3.72,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,992614,DTCC00344993,745487,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=NO3,c1ccc(-c2ccno2)c(NCC2=NCCN2)c1
382,CHEMBL155327,P35368,,LQBHYWDFUZWZET-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,IC50,=,131.83,NM,,,,,,,,,,,,,,In vitro binding affinity against human Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34482.0,DTCT0023207,992617,DTCC00344993,745487,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=NO3,c1ccc(-c2ccno2)c(NCC2=NCCN2)c1
383,CHEMBL155731,P35368,QUINELORANE,TUFADSGTJUOBEH-ZWNOBZJWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14739039,DTCC00347332,2106890,69012,CCCN1CCC[C@H]2[C@H]1CC3=CN=C(N=C3C2)N,CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@H]21
384,CHEMBL156661,P35368,,CMDSTJSCXRZEFV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,77.62,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1005848,DTCC00344798,1295108,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=NC=CC=N3,c1cnc(-c2ccccc2NCC2=NCCN2)nc1
385,CHEMBL156661,P35368,,CMDSTJSCXRZEFV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,IC50,=,2187.76,NM,,,,,,,,,,,,,,In vitro binding affinity against human Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34482.0,DTCT0023207,1005851,DTCC00344798,1295108,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=NC=CC=N3,c1cnc(-c2ccccc2NCC2=NCCN2)nc1
386,CHEMBL156893,P35368,,OAHLECZZVVVHND-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,999996,DTCC00344762,1197499,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=NC(=NC=C3)N,Nc1nccc(-c2ccccc2NCC2=NCCN2)n1
387,CHEMBL156950,P35368,,VNALJYKFTZMOJJ-LDADJPATSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,998713,DTCC00344890,1714893,5345,CC/C(=N\OC)/C1=CC=CC=C1NCC2=NCCN2,CC/C(=N\OC)c1ccccc1NCC1=NCCN1
388,CHEMBL157910,P35368,,ILTMQKYWOPLCSC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11140733.0,KI,>,3981.07,NM,,,,,,,,,,,,,,Compound was evaluated for binding affinity against Alpha-1B adrenergic receptor,,"Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).",Bioorg. Med. Chem. Lett.,2001.0,11.0,1.0,"Bromidge SM, Clarke SE, Gager T, Griffith K, Jeffrey P, Jennings AJ, Joiner GF, King FD, Lovell PJ, Moss SF, Newman H, Riley G, Rogers D, Routledge C, Serafinowska H, Smith DR",,32301.0,DTCT0023207,1490762,DTCC00345128,939443,4218,COC1=C(C=C(C=C1)S(=O)(=O)NC2=C(C(=CC(=C2)Cl)Cl)Cl)N3CCNCC3,COc1ccc(S(=O)(=O)Nc2cc(Cl)cc(Cl)c2Cl)cc1N1CCNCC1
389,CHEMBL158627,P35368,,WUACSCWYLJHDBV-HNNHSTSXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11266169.0,KI,<,5011.87,NM,,,,,,,,,,,,,,Evaluated for the binding affinity to alpha 1B receptor,,"Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor.",Bioorg. Med. Chem. Lett.,2001.0,11.0,5.0,"Austin NE, Avenell KY, Boyfield I, Branch CL, Hadley MS, Jeffrey P, Johnson CN, Macdonald GJ, Nash DJ, Riley GJ, Smith AB, Stemp G, Thewlis KM, Vong AK, Wood MD",,32311.0,DTCT0023207,728313,DTCC00353600,292662,4714,CS(=O)(=O)OC1=CC2=C(CN(C2)CCC3CCC(CC3)NC(=O)/C=C/C4=CC=C(C=C4)F)C=C1,CS(=O)(=O)Oc1ccc2c(c1)CN(CCC1CCC(NC(=O)/C=C/c3ccc(F)cc3)CC1)C2
390,CHEMBL1614664,P35368,PSEUDOHYPERICIN,YXBUQQDFTYOHQI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14739984,DTCC01003548,2107269,69275,CC1=CC(=C2C3=C4C5=C(C(=O)C=C(C5=C2O)O)C6=C7C4=C8C(=C13)C(=CC(=C8C(=C7C(=CC6=O)O)O)O)CO)O,Cc1cc(O)c2c(O)c3c(O)cc(=O)c4c5c(=O)cc(O)c6c(O)c7c(O)cc(CO)c8c1c2c(c34)c(c78)c65
391,CHEMBL1630938,P35368,,UZJCBXIOEQNDPF-MRXNPFEDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20934789.0,KI,=,1.91,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Synthesis and a1-adrenoceptor antagonist activity of tamsulosin analogues.,Eur. J. Med. Chem.,2010.0,45.0,12.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Poggesi E, Giardinà D",,693738.0,DTCT0023207,5008431,DTCC01016785,2023450,42213,C[C@H](CC1=CC(=C(C=C1)OC)S(=O)(=O)N)NCCOC2=CC=CC=C2OC(C)C,COc1ccc(C[C@@H](C)NCCOc2ccccc2OC(C)C)cc1S(N)(=O)=O
392,CHEMBL1630939,P35368,,ZGUOYAOEHJPFST-LJQANCHMSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20934789.0,KI,=,2.09,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Synthesis and a1-adrenoceptor antagonist activity of tamsulosin analogues.,Eur. J. Med. Chem.,2010.0,45.0,12.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Poggesi E, Giardinà D",,693738.0,DTCT0023207,5008430,DTCC01016786,215451,42213,C[C@H](CC1=CC(=C(C=C1)OC)S(=O)(=O)N)NCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1ccc(C[C@@H](C)NCCOc2ccccc2OCc2ccccc2)cc1S(N)(=O)=O
393,CHEMBL1630940,P35368,,CPWQIBJELMVKCH-CQSZACIVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20934789.0,KI,=,5.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Synthesis and a1-adrenoceptor antagonist activity of tamsulosin analogues.,Eur. J. Med. Chem.,2010.0,45.0,12.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Poggesi E, Giardinà D",,693738.0,DTCT0023207,5008429,DTCC01016787,1349004,42213,C[C@H](CC1=CC(=C(C=C1)OC)S(=O)(=O)N)NCCOC2=CC=CC=C2OCC(F)(F)F,COc1ccc(C[C@@H](C)NCCOc2ccccc2OCC(F)(F)F)cc1S(N)(=O)=O
394,CHEMBL1630941,P35368,,QXNTWXQFMCUIBK-BIENJYKASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20934789.0,KI,=,67.61,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Synthesis and a1-adrenoceptor antagonist activity of tamsulosin analogues.,Eur. J. Med. Chem.,2010.0,45.0,12.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Poggesi E, Giardinà D",,693738.0,DTCT0023207,5008428,DTCC01016788,572547,42213,C[C@H]1[C@H](OC2=CC=CC=C2O1)CN[C@H](C)CC3=CC(=C(C=C3)OC)S(=O)(=O)N,COc1ccc(C[C@@H](C)NC[C@H]2Oc3ccccc3O[C@H]2C)cc1S(N)(=O)=O
395,CHEMBL1630942,P35368,,QXNTWXQFMCUIBK-LPMFXHHGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20934789.0,KI,=,31.62,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Synthesis and a1-adrenoceptor antagonist activity of tamsulosin analogues.,Eur. J. Med. Chem.,2010.0,45.0,12.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Poggesi E, Giardinà D",,693738.0,DTCT0023207,5008427,DTCC01016789,1703807,42213,C[C@@H]1[C@@H](OC2=CC=CC=C2O1)CN[C@H](C)CC3=CC(=C(C=C3)OC)S(=O)(=O)N,COc1ccc(C[C@@H](C)NC[C@@H]2Oc3ccccc3O[C@@H]2C)cc1S(N)(=O)=O
396,CHEMBL1632158,P35368,,RNXYMZNGMNWKMC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21075638.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to Alpha-1B adrenergic receptor,,Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.,Bioorg. Med. Chem.,2010.0,18.0,24.0,"Brudeli B, Moltzau LR, Andressen KW, Krobert KA, Klaveness J, Levy FO",,697192.0,DTCT0023207,5017427,DTCC01017945,1445751,42157,COC(=O)CCCCCN1CCC(CC1)CNC(=O)C2=C3N(CCCO3)C4=CC=CC=C42,COC(=O)CCCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1
397,CHEMBL1632174,P35368,,ODMLUIATXKBXOW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21075638.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to Alpha-1B adrenergic receptor,,Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.,Bioorg. Med. Chem.,2010.0,18.0,24.0,"Brudeli B, Moltzau LR, Andressen KW, Krobert KA, Klaveness J, Levy FO",,697192.0,DTCT0023207,5017429,DTCC01017961,1185873,42157,C1CN2C3=CC=CC=C3C(=C2OC1)C(=O)NCC4CCN(CC4)CCCCCC(=O)O,O=C(O)CCCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1
398,CHEMBL1643899,P35368,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21146989.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Alpha-1B adrenergic receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700851.0,DTCT0023207,5036609,DTCC01020576,166198,42620,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC6=CC(=CC=C6)F,Fc1cccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)c1
399,CHEMBL1643899,P35368,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586607,DTCC01020576,168448,55935,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC6=CC(=CC=C6)F,Fc1cccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)c1
400,CHEMBL1643900,P35368,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21146989.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Alpha-1B adrenergic receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700851.0,DTCT0023207,5036644,DTCC01020577,942929,42620,C1C2C3CC4C2[C@@H](C5C1C3C45)NCCC6=CC(=CC=C6)F,Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1
401,CHEMBL1643900,P35368,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586604,DTCC01020577,945255,55935,C1C2C3CC4C2[C@@H](C5C1C3C45)NCCC6=CC(=CC=C6)F,Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1
402,CHEMBL1643901,P35368,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21146989.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Alpha-1B adrenergic receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700851.0,DTCT0023207,5036668,DTCC01020578,1460729,42620,CN(CC1=CC(=CC=C1)F)[C@H]2C3C4CC5C2C6C3CC4C56,CN(Cc1cccc(F)c1)[C@H]1C2C3CC4C5C3CC2C5C41
403,CHEMBL1643901,P35368,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586618,DTCC01020578,1463030,55935,CN(CC1=CC(=CC=C1)F)[C@H]2C3C4CC5C2C6C3CC4C56,CN(Cc1cccc(F)c1)[C@H]1C2C3CC4C5C3CC2C5C41
404,CHEMBL1643902,P35368,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21146989.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Alpha-1B adrenergic receptor at 10 uM,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700851.0,DTCT0023207,5036705,DTCC01020579,619871,42620,CN(CCC1=CC(=CC=C1)F)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CCc1cccc(F)c1)[C@H]1C2C3CC4C5C3CC2C5C41
405,CHEMBL1643902,P35368,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586614,DTCC01020579,622243,55935,CN(CCC1=CC(=CC=C1)F)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CCc1cccc(F)c1)[C@H]1C2C3CC4C5C3CC2C5C41
406,CHEMBL1651208,P35368,,DWTYHCYVKJONSP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23009245.0,INHIBITION,=,44.0,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human adrenergic alpha1b receptor at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012.0,55.0,22.0,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876215.0,DTCT0023207,11437773,DTCC01023515,317585,51586,C1CCC(C1)N2CC3=C(C2=O)C=CC(=C3)OCC4=CC(=CC=C4)C5=CC(=C(C=C5)Cl)C(=O)O,O=C(O)c1cc(-c2cccc(COc3ccc4c(c3)CN(C3CCCC3)C4=O)c2)ccc1Cl
407,CHEMBL1651219,P35368,,ZQBPXBADOJMCRU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23009245.0,INHIBITION,=,8.0,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human adrenergic alpha1b receptor at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012.0,55.0,22.0,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876215.0,DTCT0023207,11437724,DTCC01023526,1675972,51586,C1CCC(C1)N2C(=O)C3=C(S2)C=C(C=C3)OCC4=CC(=CC=C4)C5=CC(=C(C=C5)Cl)C(=O)O,O=C(O)c1cc(-c2cccc(COc3ccc4c(=O)n(C5CCCC5)sc4c3)c2)ccc1Cl
408,CHEMBL1668584,P35368,,YPVOSIDECMYMTD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21333408.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to Adrenergic Alpha-1B receptor at 10 uM by radioligand binding assay,Not Active,"2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,2011.0,46.0,4.0,"Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Mitkin OD, Tkachenko SE, Kysil VM, Okun I",,740254.0,DTCT0023207,5907274,DTCC01025412,943137,44130,CC1=CC(=NC2=C(C(=NN12)NC)S(=O)(=O)C3=CC=CC=C3)C,CNc1nn2c(C)cc(C)nc2c1S(=O)(=O)c1ccccc1
409,CHEMBL1672288,P35368,,LVXAMCKZCLWWTF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21207959.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic Alpha-1B receptor,,Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.,J. Med. Chem.,2011.0,54.0,3.0,"Siméon FG, Wendahl MT, Pike VW",,718863.0,DTCT0023207,5116564,DTCC01026954,798550,43561,C1=C(C=C(C=C1C#N)F)C#CC2=CSC(=N2)F,N#Cc1cc(F)cc(C#Cc2csc(F)n2)c1
410,CHEMBL1702607,P35368,,ADVPTQAUNPRNPO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14733095,DTCC01037443,2104825,69159,C(C(C(=O)O)N)S(=O)O,NC(CS(=O)O)C(=O)O
411,CHEMBL17151,P35368,,XAYQDNQPTLHHFC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,964846,DTCC00148507,1049346,6217,CC(C)N1C(=NC=N1)C2=CC=CC=C2NCC3=NCCN3,CC(C)n1ncnc1-c1ccccc1NCC1=NCCN1
412,CHEMBL17151,P35368,,XAYQDNQPTLHHFC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,964849,DTCC00148507,1049346,6217,CC(C)N1C(=NC=N1)C2=CC=CC=C2NCC3=NCCN3,CC(C)n1ncnc1-c1ccccc1NCC1=NCCN1
413,CHEMBL17221,P35368,,ITCCBDZCYYRNQI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,936282,DTCC00148436,500371,6217,CCN1C(=CC=N1)C2=CC=CC=C2NCC3=NCCN3,CCn1nccc1-c1ccccc1NCC1=NCCN1
414,CHEMBL17221,P35368,,ITCCBDZCYYRNQI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,936285,DTCC00148436,500371,6217,CCN1C(=CC=N1)C2=CC=CC=C2NCC3=NCCN3,CCn1nccc1-c1ccccc1NCC1=NCCN1
415,CHEMBL17491,P35368,,LLBMIYKGBZNMOP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,=,5.01,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,943941,DTCC00148580,919829,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=NC=NN3,c1ccc(-c2ncn[nH]2)c(NCC2=NCCN2)c1
416,CHEMBL17491,P35368,,LLBMIYKGBZNMOP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,100.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,943945,DTCC00148580,919829,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=NC=NN3,c1ccc(-c2ncn[nH]2)c(NCC2=NCCN2)c1
417,CHEMBL17492,P35368,,XSSNKDIFQCVNLK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,976124,DTCC00148439,952258,6217,CN1C=CC=C1C2=CC=CC=C2NCC3=NCCN3,Cn1cccc1-c1ccccc1NCC1=NCCN1
418,CHEMBL17492,P35368,,XSSNKDIFQCVNLK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,976127,DTCC00148439,952258,6217,CN1C=CC=C1C2=CC=CC=C2NCC3=NCCN3,Cn1cccc1-c1ccccc1NCC1=NCCN1
419,CHEMBL175934,P35368,,PUSDBRIZNFZIFK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15633998.0,KI,=,0.537,NM,,cell_based,,,,,,,,,,,CHO,Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1b expressed in CHO cells,,"Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.",J. Med. Chem.,2005.0,48.0,1.0,"Antonello A, Hrelia P, Leonardi A, Marucci G, Rosini M, Tarozzi A, Tumiatti V, Melchiorre C",,303918.0,DTCT0023207,1737816,DTCC00380523,1048385,19215,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCSS4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCSS4)CC3)nc(N)c2cc1OC
420,CHEMBL1765111,P35368,,BXUKKRHEMKVWOY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,31.62,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929143,DTCC01079679,166408,44212,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCN3CCCC(CC3)N4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCc2ccc(OCCCN3CCCCCC3)cc2)CC1
421,CHEMBL1765683,P35368,,ZVRXOXFSMYJETP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21428406.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to adrenergic Alpha-1B receptor at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011.0,54.0,8.0,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743830.0,DTCT0023207,5918951,DTCC01078226,652599,44302,CC1=C(N(N=C1C(=O)NC2(CCOCC2)C#N)C3=CC=CC=C3Br)C4=CC=C(C=C4)OC,COc1ccc(-c2c(C)c(C(=O)NC3(C#N)CCOCC3)nn2-c2ccccc2Br)cc1
422,CHEMBL1765684,P35368,,VCKIDQVWSDVZCZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21428406.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to adrenergic Alpha-1B receptor at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011.0,54.0,8.0,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743830.0,DTCT0023207,5918952,DTCC01078227,975211,44302,CC1=C(N(N=C1C(=O)NC2(CCCCC2)C#N)C3=CC=CC=C3Br)C4=CC=C(C=C4)OC,COc1ccc(-c2c(C)c(C(=O)NC3(C#N)CCCCC3)nn2-c2ccccc2Br)cc1
423,CHEMBL17657,P35368,,LXHKMUZCGIOORY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,5011.87,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,949104,DTCC00148476,1437870,6217,CC1=NC(=NN1)C2=CC=CC=C2NCC3=NCCN3,Cc1nc(-c2ccccc2NCC2=NCCN2)n[nH]1
424,CHEMBL17657,P35368,,LXHKMUZCGIOORY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,949107,DTCC00148476,1437870,6217,CC1=NC(=NN1)C2=CC=CC=C2NCC3=NCCN3,Cc1nc(-c2ccccc2NCC2=NCCN2)n[nH]1
425,CHEMBL1767134,P35368,,WRGOSJVRKURGMQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,199.53,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929127,DTCC01079653,879006,44212,CN(C)CCN1C(=O)C2=CC=CC=C2C(=N1)CC3=CC=C(C=C3)Cl,CN(C)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
426,CHEMBL1767135,P35368,,SAKVKDBLCRHLAV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,316.23,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929123,DTCC01079654,813625,44212,CN(C)CCCN1C(=O)C2=CC=CC=C2C(=N1)CC3=CC=C(C=C3)Cl,CN(C)CCCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
427,CHEMBL1767136,P35368,,WYRUGBCTQBZIHO-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,12.59,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929146,DTCC01079655,1746910,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
428,CHEMBL1767136,P35368,,WYRUGBCTQBZIHO-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,10.0,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345772,DTCC01079655,1747944,50693,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
429,CHEMBL1767137,P35368,,MBVVVQZOMZFVJF-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,158.49,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929130,DTCC01079656,1778940,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)OC,COc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1
430,CHEMBL1767138,P35368,,UJMUXUJLIHKBEA-MRXNPFEDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,398.11,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929122,DTCC01079657,263149,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)O,CN1CCC[C@@H]1Cn1nc(Cc2ccc(O)cc2)c2ccccc2c1=O
431,CHEMBL1767139,P35368,,URSKGEZFWCRYMD-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,>,1995.26,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929110,DTCC01079658,166406,44212,CCOC1=CC=C(C=C1)CC2=NN(C(=O)C3=CC=CC=C32)C[C@H]4CCCN4C,CCOc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1
432,CHEMBL1767140,P35368,,DCGYGKIBQOAKTB-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,79.43,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929136,DTCC01079659,361629,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)F,CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)cc2)c2ccccc2c1=O
433,CHEMBL1767141,P35368,,HTHMMDLGLVQHEM-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,15.85,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929144,DTCC01079660,1298867,44212,CC1=CC=C(C=C1)CC2=NN(C(=O)C3=CC=CC=C32)C[C@H]4CCCN4C,Cc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1
434,CHEMBL1767142,P35368,,DXZJJDOMGLPHDI-HXUWFJFHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,>,1995.26,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929111,DTCC01079661,911625,44212,CC(C)(C)C1=CC=C(C=C1)CC2=NN(C(=O)C3=CC=CC=C32)C[C@H]4CCCN4C,CN1CCC[C@@H]1Cn1nc(Cc2ccc(C(C)(C)C)cc2)c2ccccc2c1=O
435,CHEMBL1767143,P35368,,SHXAAVWRLZPGKQ-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,>,1995.26,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929112,DTCC01079662,1168808,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)C(=O)OC,COC(=O)c1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1
436,CHEMBL1767144,P35368,,AIQKTJZHRRQKTE-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,>,1995.26,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929113,DTCC01079663,1493446,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)C(=O)O,CN1CCC[C@@H]1Cn1nc(Cc2ccc(C(=O)O)cc2)c2ccccc2c1=O
437,CHEMBL1767145,P35368,,CJMVJEMHSLDPMO-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,398.11,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929121,DTCC01079664,1654939,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC(=CC=C4)F,CN1CCC[C@@H]1Cn1nc(Cc2cccc(F)c2)c2ccccc2c1=O
438,CHEMBL1767146,P35368,,YEFYNZHDZSJWCN-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,630.96,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929120,DTCC01079665,166407,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC(=CC=C4)Cl,CN1CCC[C@@H]1Cn1nc(Cc2cccc(Cl)c2)c2ccccc2c1=O
439,CHEMBL1767147,P35368,,JWDZDXFXHWMSGR-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,>,1995.26,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929114,DTCC01079666,394378,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC(=CC=C4)OC,COc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1
440,CHEMBL1767148,P35368,,YMFHXRKTKHBRIX-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,501.19,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929119,DTCC01079667,813626,44212,CC1=CC(=CC=C1)CC2=NN(C(=O)C3=CC=CC=C32)C[C@H]4CCCN4C,Cc1cccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)c1
441,CHEMBL1767149,P35368,,GFOPLENUCATIPC-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,316.23,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929124,DTCC01079668,457959,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC(=C(C=C4)F)F,CN1CCC[C@@H]1Cn1nc(Cc2ccc(F)c(F)c2)c2ccccc2c1=O
442,CHEMBL1767150,P35368,,YVEQOJSJKIAGFC-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,>,1995.26,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929115,DTCC01079669,1072579,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC(=C(C=C4)OC)OC,COc1ccc(Cc2nn(C[C@H]3CCCN3C)c(=O)c3ccccc23)cc1OC
443,CHEMBL1767151,P35368,,IGZMIXBCHNOMPG-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,>,1995.26,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929117,DTCC01079670,1493447,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4CCCCC4,CN1CCC[C@@H]1Cn1nc(CC2CCCCC2)c2ccccc2c1=O
444,CHEMBL1767152,P35368,,VHHWNRROUCRXSK-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,199.53,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929128,DTCC01079671,426927,44212,CN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CCC4=CC=CC=C4,CN1CCC[C@@H]1Cn1nc(CCc2ccccc2)c2ccccc2c1=O
445,CHEMBL1767153,P35368,,ZAIFESHMEUUZQE-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,1000.0,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929118,DTCC01079672,491220,44212,CCCCCC1=NN(C(=O)C2=CC=CC=C21)C[C@H]3CCCN3C,CCCCCc1nn(C[C@H]2CCCN2C)c(=O)c2ccccc12
446,CHEMBL1767154,P35368,,WYRUGBCTQBZIHO-KRWDZBQOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,19.95,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929145,DTCC01079673,1778941,44212,CN1CCC[C@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,CN1CCC[C@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
447,CHEMBL1767155,P35368,,OIZYYUJMNZAXNN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,79.43,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929135,DTCC01079674,587715,44212,CN1CCC(C1)CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,CN1CCC(Cn2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1
448,CHEMBL1767156,P35368,,FRUMSZUUBXPHHF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,6.31,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929147,DTCC01079675,943156,44212,CN1CCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,CN1CCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1
449,CHEMBL1767157,P35368,,HNLNXYUSMGCHFW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,316.23,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929126,DTCC01079676,1875684,44212,CN1CCCC1CCN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,CN1CCCC1CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
450,CHEMBL1767158,P35368,,OEYDBWKMXFZENQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,158.49,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929129,DTCC01079677,1396635,44212,CN1CCCCC(C1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,CN1CCCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)C1
451,CHEMBL1767159,P35368,,QYAXGGUCDQSHIT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,125.89,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929132,DTCC01079678,361630,44212,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CN3CCCC(CC3)N4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(Cc2ccc(OCCCN3CCCCCC3)cc2)CC1
452,CHEMBL1767160,P35368,,REXVRCXDIWIKGL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,79.43,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929137,DTCC01079680,328992,44212,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCN3CCCC(CC3)N4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCc2ccc(OCCCN3CCCCCC3)cc2)CC1
453,CHEMBL1767161,P35368,,QLOCEFPHCAKSLE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,100.0,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929134,DTCC01079681,1493448,44212,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCN3CCCC(CC3)N4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C1CCCN(CCCCc2ccc(OCCCN3CCCCCC3)cc2)CC1
454,CHEMBL1767162,P35368,,UUYDLXMNWLLYQV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,316.23,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929125,DTCC01079682,620104,44212,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCNCCN3C(=O)C4=CC=CC=C4C(=N3)CC5=CC=C(C=C5)Cl,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1CCNCCCCc1ccc(OCCCN2CCCCCC2)cc1
455,CHEMBL1767163,P35368,,QQERDUJEEYWVED-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,>,1995.26,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929116,DTCC01079683,1007709,44212,CN(CCCCC1=CC=C(C=C1)OCCCN2CCCCCC2)CCN3C(=O)C4=CC=CC=C4C(=N3)CC5=CC=C(C=C5)Cl,CN(CCCCc1ccc(OCCCN2CCCCCC2)cc1)CCn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
456,CHEMBL1767164,P35368,,YANGEESWIGIKOP-UUWRZZSWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,31.62,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929142,DTCC01079684,1654940,44212,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCN3CCC[C@@H]3CN4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1
457,CHEMBL1767164,P35368,,YANGEESWIGIKOP-UUWRZZSWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,31.62,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345767,DTCC01079684,1656024,50693,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCN3CCC[C@@H]3CN4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1
458,CHEMBL1767165,P35368,,AWKFJGDSZGEFRY-UUWRZZSWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,50.12,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929139,DTCC01079685,813627,44212,COC1=CC=C(C=C1)CC2=NN(C(=O)C3=CC=CC=C32)C[C@H]4CCCN4CCCCC5=CC=C(C=C5)OCCCN6CCCCCC6,COc1ccc(Cc2nn(C[C@H]3CCCN3CCCCc3ccc(OCCCN4CCCCCC4)cc3)c(=O)c3ccccc23)cc1
459,CHEMBL1767166,P35368,,IMKMPTLRTHMERW-MGBGTMOVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,125.89,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929131,DTCC01079686,1007710,44212,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCN3CCC[C@@H]3CN4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)O,O=c1c2ccccc2c(Cc2ccc(O)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1
460,CHEMBL1767167,P35368,,GQWSXILTLUTBAJ-PGUFJCEWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,50.12,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929141,DTCC01079687,879007,44212,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCCN3CCC[C@@H]3CN4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCCc1ccc(OCCCN2CCCCCC2)cc1
461,CHEMBL1767168,P35368,,YANGEESWIGIKOP-UMSFTDKQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,39.81,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929140,DTCC01079688,1875686,44212,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCN3CCC[C@H]3CN4C(=O)C5=CC=CC=C5C(=N4)CC6=CC=C(C=C6)Cl,O=c1c2ccccc2c(Cc2ccc(Cl)cc2)nn1C[C@@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1
462,CHEMBL1774991,P35368,,YTOGOMGUCNEXIR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21520940.0,KI,=,185.0,NM,,,,,,,,,,,,,,Inhibition of adrenergic Alpha-1B receptor,,"Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT(1A) Receptor.",J. Med. Chem.,2011.0,54.0,10.0,"Al Hussainy R, Verbeek J, van der Born D, Braker AH, Leysen JE, Knol RJ, Booij J, Herscheid JK",,747462.0,DTCT0023207,5942739,DTCC01083260,1575851,44583,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C45C6C7C4C8C5C6C78I,COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52I)c2ccccn2)CC1
463,CHEMBL1774995,P35368,,IUEHDTRLKKNLDW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21520940.0,KI,=,25.0,NM,,,,,,,,,,,,,,Inhibition of adrenergic Alpha-1B receptor,,"Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT(1A) Receptor.",J. Med. Chem.,2011.0,54.0,10.0,"Al Hussainy R, Verbeek J, van der Born D, Braker AH, Leysen JE, Knol RJ, Booij J, Herscheid JK",,747462.0,DTCT0023207,5942738,DTCC01083264,1252166,44583,C1CN(CCN1CCN(C2=CC=CC=N2)C(=O)C34C5C6C3C7C4C5C67I)C8=CC=CC=C8O,O=C(N(CCN1CCN(c2ccccc2O)CC1)c1ccccn1)C12C3C4C1C1C2C3C41I
464,CHEMBL17764,P35368,,WPXZJENXASTONP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,963658,DTCC00148842,1437869,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=NC=NN3CC(F)(F)F,FC(F)(F)Cn1ncnc1-c1ccccc1NCC1=NCCN1
465,CHEMBL17764,P35368,,WPXZJENXASTONP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,963661,DTCC00148842,1437869,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=NC=NN3CC(F)(F)F,FC(F)(F)Cn1ncnc1-c1ccccc1NCC1=NCCN1
466,CHEMBL17776,P35368,,INARLERZKDBYDJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,=,316.23,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,954468,DTCC00149115,2015438,6217,CCCN1C(=NC=N1)C2=CC=CC=C2NCC3=NCCN3,CCCn1ncnc1-c1ccccc1NCC1=NCCN1
467,CHEMBL17776,P35368,,INARLERZKDBYDJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,74.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,954472,DTCC00149115,2015438,6217,CCCN1C(=NC=N1)C2=CC=CC=C2NCC3=NCCN3,CCCn1ncnc1-c1ccccc1NCC1=NCCN1
468,CHEMBL1779058,P35368,,HJKLOGARPBXZTP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11474325,DTCC01084658,232067,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCCC(=O)C7=CC=C(C=C7)F)O,O=C(CCCN1C2C3C4CC5C6C4C2C6C1(O)C53)c1ccc(F)cc1
469,CHEMBL1779059,P35368,,QCBXRMVDVAHCPR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11474302,DTCC01084659,1365536,51935,COC1=C(C=C(C=C1)CCN2C3C4C5CC6C4C2(C7C6C5C73)O)OCCC8=CC=CC=C8,COc1ccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1OCCc1ccccc1
470,CHEMBL1779060,P35368,,ZOAKYUHDXICZSY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11474277,DTCC01084660,1719581,51935,CC1=CC(=C(C=C1)OC)C(=O)NCCN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1ccc(C)cc1C(=O)NCCN1C2C3C4CC5C6C4C2C6C1(O)C53
471,CHEMBL17819,P35368,,QHTWLQHVCYOHJB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,5011.87,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,971502,DTCC00148843,1177867,6217,CC1=NN(C(=N1)C2=CC=CC=C2NCC3=NCCN3)C,Cc1nc(-c2ccccc2NCC2=NCCN2)n(C)n1
472,CHEMBL17819,P35368,,QHTWLQHVCYOHJB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,971505,DTCC00148843,1177867,6217,CC1=NN(C(=N1)C2=CC=CC=C2NCC3=NCCN3)C,Cc1nc(-c2ccccc2NCC2=NCCN2)n(C)n1
473,CHEMBL17851,P35368,,QBNMURIWVMBLCJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,976109,DTCC00148873,1242984,6217,CN1C(=CC=N1)C2=CC=CC=C2NCC3=NCCN3,Cn1nccc1-c1ccccc1NCC1=NCCN1
474,CHEMBL17851,P35368,,QBNMURIWVMBLCJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,IC50,=,398.11,NM,,cell_based,,,,,,,,,,,,"Inhibitory concentration against radioligand binding to human Alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34484.0,DTCT0023207,976115,DTCC00148873,1242984,6217,CN1C(=CC=N1)C2=CC=CC=C2NCC3=NCCN3,Cn1nccc1-c1ccccc1NCC1=NCCN1
475,CHEMBL17851,P35368,,QBNMURIWVMBLCJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,976112,DTCC00148873,1242984,6217,CN1C(=CC=N1)C2=CC=CC=C2NCC3=NCCN3,Cn1nccc1-c1ccccc1NCC1=NCCN1
476,CHEMBL17856,P35368,,QBZZRVBTXBSWLN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,=,50.12,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,971508,DTCC00149119,370871,6217,CN1C=CC(=N1)C2=CC=CC=C2NCC3=NCCN3,Cn1ccc(-c2ccccc2NCC2=NCCN2)n1
477,CHEMBL17856,P35368,,QBZZRVBTXBSWLN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,33.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,971511,DTCC00149119,370871,6217,CN1C=CC(=N1)C2=CC=CC=C2NCC3=NCCN3,Cn1ccc(-c2ccccc2NCC2=NCCN2)n1
478,CHEMBL178673,P35368,,WLZJELZXDHZVLY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15633998.0,KI,=,0.309,NM,,cell_based,,,,,,,,,,,CHO,Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1b expressed in CHO cells,,"Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.",J. Med. Chem.,2005.0,48.0,1.0,"Antonello A, Hrelia P, Leonardi A, Marucci G, Rosini M, Tarozzi A, Tumiatti V, Melchiorre C",,303918.0,DTCT0023207,1737807,DTCC00380466,1916069,19215,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)CC4CCSS4)N)OC,COc1cc2nc(N3CCN(C(=O)CC4CCSS4)CC3)nc(N)c2cc1OC
479,CHEMBL1788231,P35368,,BDPXTGHWVMUJCT-OAQYLSRUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10669560.0,KI,<,1000.0,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).",J. Med. Chem.,2000.0,43.0,3.0,"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR",,32307.0,DTCT0023207,1118632,DTCC01088712,368839,16008,CC1CCN(CC1)CC[C@H]2CCCCN2S(=O)(=O)C3=CC=CC4=CC=CC=C43,CC1CCN(CC[C@H]2CCCCN2S(=O)(=O)c2cccc3ccccc23)CC1
480,CHEMBL178923,P35368,,TZIDXYRBHBHFBV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15633998.0,KI,=,1.26,NM,,cell_based,,,,,,,,,,,CHO,Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1b expressed in CHO cells,,"Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.",J. Med. Chem.,2005.0,48.0,1.0,"Antonello A, Hrelia P, Leonardi A, Marucci G, Rosini M, Tarozzi A, Tumiatti V, Melchiorre C",,303918.0,DTCT0023207,1737687,DTCC00380448,1883867,19215,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)CCCCC4CCSS4)N)OC,COc1cc2nc(N3CCN(C(=O)CCCCC4CCSS4)CC3)nc(N)c2cc1OC
481,CHEMBL1789975,P35368,,UMVYPFAJDLQOIO-IWHLBADBSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,1900.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,642337,DTCC01089574,690963,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@@H]2CC[C@@H](C2)N3CCC(CC3)(C#N)C4=CC=CC=C4)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1
482,CHEMBL179334,P35368,(-)-SNAP-5089,BBOBQBOYMRDFSY-GADTUSCJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7752182.0,KI,=,180.0,NM,,,,,,,,,,,,,,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,,Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.,J. Med. Chem.,1995.0,38.0,10.0,"Wetzel JM, Miao SW, Forray C, Borden LA, Branchek TA, Gluchowski C",,34326.0,DTCT0023207,1016089,DTCC00000755,884833,12993,CC1=C([C@H](C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1ccc([N+](=O)[O-])cc1
483,CHEMBL1796028,P35368,,LBMXVPSFRAYJDL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,7413.1,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001120,DTCC01091859,1704818,44951,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC(CC3=O)C4=CC=CC=C4,COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccccc3)CC2=O)CC1
484,CHEMBL1796029,P35368,,BNIMVTLJBJEXOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,2238.72,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001123,DTCC01091860,314597,44951,C1CN(CCN1CCN2C(=O)CC(CC2=O)C3=CC=CC=C3)C4=CC=CC=C4Cl,O=C1CC(c2ccccc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1
485,CHEMBL1796030,P35368,,LVTVPXIZHDLZMO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,112.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001126,DTCC01091861,1025948,44951,COC1=CC=CC=C1N2CCN(CC2)CCCN3C(=O)CC(CC3=O)C4=CC=CC=C4,COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1
486,CHEMBL1796031,P35368,,ODTONMYKXOZWKB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,112.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001129,DTCC01091862,541521,44951,C1CN(CCN1CCCN2C(=O)CC(CC2=O)C3=CC=CC=C3)C4=CC=CC=C4Cl,O=C1CC(c2ccccc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1
487,CHEMBL1796032,P35368,,YDXRRAQRFWEWFK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,331.13,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001132,DTCC01091863,119861,44951,COC1=C(C=C(C=C1)Cl)N2CCN(CC2)CCCN3C(=O)CC(CC3=O)C4=CC=CC=C4,COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(c3ccccc3)CC2=O)CC1
488,CHEMBL1796033,P35368,,PYDSDQAAKUFXEU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human adrenergic Alpha-1B receptor expressed in HEK293 cells assessed as [3H]inositol phosphate formation at 10 uM by scintillation counting,Not Active,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753975.0,DTCT0023207,6001203,DTCC01091864,1640796,44951,COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)CC(CC3=O)C4=CC=CC=C4,COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1
489,CHEMBL1796033,P35368,,PYDSDQAAKUFXEU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,3.98,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity against human cloned adrenergic Alpha-1B receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753885.0,DTCT0023207,6001194,DTCC01091864,1640796,44951,COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)CC(CC3=O)C4=CC=CC=C4,COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1
490,CHEMBL1796033,P35368,,PYDSDQAAKUFXEU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,23.99,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001135,DTCC01091864,1640796,44951,COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)CC(CC3=O)C4=CC=CC=C4,COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1
491,CHEMBL1796034,P35368,,LCQWPVVMQXWHCZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,30.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001138,DTCC01091865,2056561,44951,C1CN(CCN1CCCCN2C(=O)CC(CC2=O)C3=CC=CC=C3)C4=CC=CC=C4Cl,O=C1CC(c2ccccc2)CC(=O)N1CCCCN1CCN(c2ccccc2Cl)CC1
492,CHEMBL1796035,P35368,,XJQMGRBHCYQSND-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,107.15,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001141,DTCC01091866,993520,44951,COC1=C(C=C(C=C1)Cl)N2CCN(CC2)CCCCN3C(=O)CC(CC3=O)C4=CC=CC=C4,COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1
493,CHEMBL1796036,P35368,,PGGAKENNUWLOBA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,97.72,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001144,DTCC01091867,702910,44951,COC1=CC=CC=C1N2CCN(CC2)CCCCCN3C(=O)CC(CC3=O)C4=CC=CC=C4,COc1ccccc1N1CCN(CCCCCN2C(=O)CC(c3ccccc3)CC2=O)CC1
494,CHEMBL1796037,P35368,,MMECQTDYKMGZFE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,112.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001147,DTCC01091868,2024541,44951,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC(CC3=O)C4=CC=C(C=C4)Cl,COc1ccccc1N1CCN(CCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1
495,CHEMBL1796038,P35368,,OCLXFGLODKGRRE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001150,DTCC01091869,1479275,44951,C1CN(CCN1CCN2C(=O)CC(CC2=O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl,O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1
496,CHEMBL1796039,P35368,,NJFRMDBEAVUKJH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,125.89,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001153,DTCC01091870,605883,44951,COC1=CC=CC=C1N2CCN(CC2)CCCN3C(=O)CC(CC3=O)C4=CC=C(C=C4)Cl,COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1
497,CHEMBL1796040,P35368,,MYXXXOJPIMPYFF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,134.9,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001156,DTCC01091871,1991700,44951,C1CN(CCN1CCCN2C(=O)CC(CC2=O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl,O=C1CC(c2ccc(Cl)cc2)CC(=O)N1CCCN1CCN(c2ccccc2Cl)CC1
498,CHEMBL1796041,P35368,,QVYDXRNGKJCBFU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,245.47,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001159,DTCC01091872,1673078,44951,COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)CC(CC3=O)C4=CC=C(C=C4)Cl,COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc(Cl)cc3)CC2=O)CC1
499,CHEMBL1796042,P35368,,AJUJJQYPOFVICO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,128.82,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001162,DTCC01091873,1829631,44951,COC1=CC=CC=C1N2CCN(CC2)CCCN3C(=O)CC(CC3=O)C4=CC=C(C=C4)[N+](=O)[O-],COc1ccccc1N1CCN(CCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1
500,CHEMBL1796043,P35368,,NPGBHHBYDAPGFD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,208.93,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001165,DTCC01091874,1186966,44951,COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)CC(CC3=O)C4=CC=C(C=C4)[N+](=O)[O-],COc1ccccc1N1CCN(CCCCN2C(=O)CC(c3ccc([N+](=O)[O-])cc3)CC2=O)CC1
501,CHEMBL1796044,P35368,,NBBAMPGWOJEMGG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,128.82,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001168,DTCC01091875,1733003,44951,CC1(CC(=O)N(C(=O)C1)CCCN2CCN(CC2)C3=CC=CC=C3OC)C4=CC=CC=C4,COc1ccccc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1
502,CHEMBL1796045,P35368,,KCBGUGDNPBJJQV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,194.98,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001171,DTCC01091876,1154547,44951,CC1(CC(=O)N(C(=O)C1)CCCN2CCN(CC2)C3=C(C=CC(=C3)Cl)OC)C4=CC=CC=C4,COc1ccc(Cl)cc1N1CCN(CCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1
503,CHEMBL1796046,P35368,,KBIGYGRLFLGJAZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human adrenergic Alpha-1B receptor expressed in HEK293 cells assessed as [3H]inositol phosphate formation at 10 uM by scintillation counting,Not Active,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753975.0,DTCT0023207,6001204,DTCC01091877,541522,44951,CC1(CC(=O)N(C(=O)C1)CCCCN2CCN(CC2)C3=CC=CC=C3OC)C4=CC=CC=C4,COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1
504,CHEMBL1796046,P35368,,KBIGYGRLFLGJAZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,7.94,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity against human cloned adrenergic Alpha-1B receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753885.0,DTCT0023207,6001195,DTCC01091877,541522,44951,CC1(CC(=O)N(C(=O)C1)CCCCN2CCN(CC2)C3=CC=CC=C3OC)C4=CC=CC=C4,COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1
505,CHEMBL1796046,P35368,,KBIGYGRLFLGJAZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,56.23,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001174,DTCC01091877,541522,44951,CC1(CC(=O)N(C(=O)C1)CCCCN2CCN(CC2)C3=CC=CC=C3OC)C4=CC=CC=C4,COc1ccccc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1
506,CHEMBL1796047,P35368,,SMDCOYCKERWTAT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,151.36,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001177,DTCC01091878,443592,44951,CC1(CC(=O)N(C(=O)C1)CCCCN2CCN(CC2)C3=C(C=CC(=C3)Cl)OC)C4=CC=CC=C4,COc1ccc(Cl)cc1N1CCN(CCCCN2C(=O)CC(C)(c3ccccc3)CC2=O)CC1
507,CHEMBL1796048,P35368,,RTQLJFPZJBGGOG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,5011.87,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001180,DTCC01091879,832019,44951,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCC5=CC=CC=C54)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1
508,CHEMBL1796049,P35368,,DIHJKGKNVGCNHJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,234.42,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001183,DTCC01091880,1284829,44951,COC1=CC=CC=C1N2CCN(CC2)CCCN3C(=O)CC4(CCC5=CC=CC=C54)CC3=O,COc1ccccc1N1CCN(CCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1
509,CHEMBL1796050,P35368,,CFQKUDNKFVYAOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,HEK293,Antagonist activity at human adrenergic Alpha-1B receptor expressed in HEK293 cells assessed as [3H]inositol phosphate formation at 10 uM by scintillation counting,Not Active,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753975.0,DTCT0023207,6001205,DTCC01091881,1991701,44951,COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)CC4(CCC5=CC=CC=C54)CC3=O,COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1
510,CHEMBL1796050,P35368,,CFQKUDNKFVYAOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,19.95,NM,,cell_based,,,,,,,,,,,HEK293,Antagonist activity against human cloned adrenergic Alpha-1B receptor expressed in HEK293 cells assessed as inhibition of norepinephrine-induced [3H]inositol phosphate hydrolysis by scintillation counting,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753885.0,DTCT0023207,6001196,DTCC01091881,1991701,44951,COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)CC4(CCC5=CC=CC=C54)CC3=O,COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1
511,CHEMBL1796050,P35368,,CFQKUDNKFVYAOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,72.44,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001186,DTCC01091881,1991701,44951,COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)CC4(CCC5=CC=CC=C54)CC3=O,COc1ccccc1N1CCN(CCCCN2C(=O)CC3(CCc4ccccc43)CC2=O)CC1
512,CHEMBL179743,P35368,,WDWPULBPXBZDDC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15633998.0,KI,=,0.6759999999999999,NM,,cell_based,,,,,,,,,,,CHO,Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1b expressed in CHO cells,,"Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.",J. Med. Chem.,2005.0,48.0,1.0,"Antonello A, Hrelia P, Leonardi A, Marucci G, Rosini M, Tarozzi A, Tumiatti V, Melchiorre C",,303918.0,DTCT0023207,1737824,DTCC00380555,1080956,19215,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C4=CC(=O)C5=CC=CC=C5C4=O)N)OC,COc1cc2nc(N3CCN(C4=CC(=O)c5ccccc5C4=O)CC3)nc(N)c2cc1OC
513,CHEMBL180561,P35368,SNAP-5150,RJEWWPFKTYWTSS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,331.13,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,713656,DTCC00000759,873238,14595,CC1=C(C(C(=C(N1)C)C(=O)NCCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
514,CHEMBL180561,P35368,SNAP-5150,RJEWWPFKTYWTSS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,367.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1219883,DTCC00000759,874246,3366,CC1=C(C(C(=C(N1)C)C(=O)NCCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
515,CHEMBL1806874,P35368,,JCKSBFDVTFRZJP-JFGZAKSSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21591752.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Antagonist activity at adrenergic Alpha-1B receptor expressed in CHO cells assessed as inhibition of adrenaline-induced intracellular calcium after 3 to 5 mins by Fluo-4/AM assay,,"Identification of N-propylnoraporphin-11-yl 5-(1,2-dithiolan-3-yl)pentanoate as a new anti-Parkinson's agent possessing a dopamine D2 and serotonin 5-HT1A dual-agonist profile.",J. Med. Chem.,2011.0,54.0,13.0,"Zhang H, Ye N, Zhou S, Guo L, Zheng L, Liu Z, Gao B, Zhen X, Zhang A",,758566.0,DTCT0023207,6033642,DTCC01096952,1590353,45238,CCCN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=CC=C4)OC(=O)CCCCC5CCSS5,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CCCCC2CCSS2)c1-3
516,CHEMBL18069,P35368,,PQDQNUQTCBVXHM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,=,39.81,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,950348,DTCC00103779,790477,6217,CN1C(=NC=N1)C2=CC=CC=C2NCC3=NCCN3,Cn1ncnc1-c1ccccc1NCC1=NCCN1
517,CHEMBL18069,P35368,,PQDQNUQTCBVXHM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,93.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,950352,DTCC00103779,790477,6217,CN1C(=NC=N1)C2=CC=CC=C2NCC3=NCCN3,Cn1ncnc1-c1ccccc1NCC1=NCCN1
518,CHEMBL1808424,P35368,,PQQHOBXFKJXQAU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21724392.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1b receptor at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,15.0,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759479.0,DTCT0023207,6029646,DTCC01098485,216595,45305,CN1CC(=C(C1)Cl)C2=CN(C3=CC=CC=C32)S(=O)(=O)C4=CC=CC=C4,CN1CC(Cl)=C(c2cn(S(=O)(=O)c3ccccc3)c3ccccc23)C1
519,CHEMBL1808425,P35368,,IISCUUOMDCMADJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21724392.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1b receptor at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,15.0,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759479.0,DTCT0023207,6029657,DTCC01098486,735258,45305,CN1CC(=C(C1)Cl)C2=CN(C3=CC=CC=C32)S(=O)(=O)C4=CC=C(C=C4)Br,CN1CC(Cl)=C(c2cn(S(=O)(=O)c3ccc(Br)cc3)c3ccccc23)C1
520,CHEMBL1808426,P35368,,BSUNLXLBVQPAFJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21724392.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1b receptor at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,15.0,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759479.0,DTCT0023207,6029669,DTCC01098487,1187041,45305,CN1CC(=C(C1)Cl)C2=CN(C3=CC=CC=C32)S(=O)(=O)C4=CC=C(C=C4)F,CN1CC(Cl)=C(c2cn(S(=O)(=O)c3ccc(F)cc3)c3ccccc23)C1
521,CHEMBL1808432,P35368,,FEJYXUSNDZMQOV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21724392.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1b receptor at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,15.0,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759479.0,DTCT0023207,6029680,DTCC01098493,735260,45305,CN1CC(=C(C1)Cl)C2=CN(C3=C2C=C(C=C3)OC)S(=O)(=O)C4=CC=CC=C4,COc1ccc2c(c1)c(C1=C(Cl)CN(C)C1)cn2S(=O)(=O)c1ccccc1
522,CHEMBL1808433,P35368,,JEZVWAQXXDFILV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21724392.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1b receptor at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,15.0,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759479.0,DTCT0023207,6029691,DTCC01098494,1091327,45305,CN1CC(=C(C1)Cl)C2=CN(C3=C2C=C(C=C3)OC)S(=O)(=O)C4=CC=CC=C4Br,COc1ccc2c(c1)c(C1=C(Cl)CN(C)C1)cn2S(=O)(=O)c1ccccc1Br
523,CHEMBL1808437,P35368,,BZMIEAZWZMSACC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21724392.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1b receptor at 0.5 uM,,Rigidized 1-aryl sulfonyl tryptamines: synthesis and pharmacological evaluation as 5-HT6 receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,15.0,"Nirogi R, Dwarampudi A, Kambhampati R, Bhatta V, Kota L, Shinde A, Badange R, Jayarajan P, Bhyrapuneni G, Dubey PK",,759479.0,DTCT0023207,6029702,DTCC01098498,1991784,45305,CN1CC(=C(C1)Cl)C2=CN(C3=C2C=C(C=C3)OC)S(=O)(=O)C4=CC=C(C=C4)OC,COc1ccc(S(=O)(=O)n2cc(C3=C(Cl)CN(C)C3)c3cc(OC)ccc32)cc1
524,CHEMBL180932,P35368,(-)-SNAP-5399,FLMJQBHJNDEDJH-XIFFEERXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,323.59,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,695311,DTCC00000751,1066648,14595,CCC1=C([C@@H](C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)[C@H](c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1
525,CHEMBL1824777,P35368,,ZHHLHBNBIKLLJG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21788137.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of alpha-1B adrenergic receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767121.0,DTCT0023207,6074414,DTCC01106515,961498,45468,C1C2CC3CC1CC(C2)(N3CC4=CC=CC=C4)O.Cl,OC12CC3CC(CC(C3)N1Cc1ccccc1)C2
526,CHEMBL1824778,P35368,,LPAMOYXJLQSGRI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21788137.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of alpha-1B adrenergic receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767121.0,DTCT0023207,6074413,DTCC01106516,1058448,45468,C1C2CC3CC1CC(C2)(N3CC4=CC(=CC=C4)F)O.Cl,OC12CC3CC(CC(C3)N1Cc1cccc(F)c1)C2
527,CHEMBL1824784,P35368,,HXOMGUPFBWZKBK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21788137.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of alpha-1B adrenergic receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767121.0,DTCT0023207,6074412,DTCC01106522,638709,45468,C1C2CC3CC1CC(C2)N3CC4=CC=CC=C4.Cl,c1ccc(CN2C3CC4CC(C3)CC2C4)cc1
528,CHEMBL1824785,P35368,,ZILQWXOKQUVSTI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21788137.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of alpha-1B adrenergic receptor at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767121.0,DTCT0023207,6074411,DTCC01106523,1640941,45468,C1C2CC3CC1CC(C2)N3CC4=CC(=CC=C4)F.Cl,Fc1cccc(CN2C3CC4CC(C3)CC2C4)c1
529,CHEMBL18256,P35368,,AXBPYZBFXDVVMS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,=,39.81,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,955803,DTCC00149087,1308370,6217,CN1C=CN=C1C2=CC=CC=C2NCC3=NCCN3,Cn1ccnc1-c1ccccc1NCC1=NCCN1
530,CHEMBL18256,P35368,,AXBPYZBFXDVVMS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,104.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,955806,DTCC00149087,1308370,6217,CN1C=CN=C1C2=CC=CC=C2NCC3=NCCN3,Cn1ccnc1-c1ccccc1NCC1=NCCN1
531,CHEMBL18303,P35368,,APTMFOIALVJASZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,950355,DTCC00149122,790476,6217,CC(C)N1C(=CC=N1)C2=CC=CC=C2NCC3=NCCN3,CC(C)n1nccc1-c1ccccc1NCC1=NCCN1
532,CHEMBL18303,P35368,,APTMFOIALVJASZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,950358,DTCC00149122,790476,6217,CC(C)N1C(=CC=N1)C2=CC=CC=C2NCC3=NCCN3,CC(C)n1nccc1-c1ccccc1NCC1=NCCN1
533,CHEMBL1835609,P35368,,UBQRACCCHXXOJB-ZOWNYOTGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21905669.0,INHIBITION,=,-0.4,%,,,,,,,,,,,,,,Binding affinity to Alpha-1B adrenergic receptor at 10 uM by radioligand displacement assay,,Discovery of Isoxazole Analogues of Sazetidine-A as Selective a4ß2-Nicotinic Acetylcholine Receptor Partial Agonists for the Treatment of Depression.,J. Med. Chem.,2011.0,54.0,20.0,"Liu J, Yu LF, Eaton JB, Caldarone B, Cavino K, Ruiz C, Terry M, Fedolak A, Wang D, Ghavami A, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,772192.0,DTCT0023207,6125224,DTCC01111063,1285033,46123,C1CN[C@@H]1COC2=CN=CC(=C2)C3=CC(=NO3)CCCO.Cl,OCCCc1cc(-c2cncc(OC[C@@H]3CCN3)c2)on1
534,CHEMBL184238,P35368,URB597,ROFVXGGUISEHAM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16352709.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14740656,DTCC00000860,2107472,69711,C1CCC(CC1)NC(=O)OC2=CC=CC(=C2)C3=CC(=CC=C3)C(=O)N,NC(=O)c1cccc(-c2cccc(OC(=O)NC3CCCCC3)c2)c1
535,CHEMBL18436,P35368,,NKCHSAFUOLWUFI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,=,199.53,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,962387,DTCC00149327,305622,6217,CCCCN1C(=NC=N1)C2=CC=CC=C2NCC3=NCCN3,CCCCn1ncnc1-c1ccccc1NCC1=NCCN1
536,CHEMBL18436,P35368,,NKCHSAFUOLWUFI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,83.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,962391,DTCC00149327,305622,6217,CCCCN1C(=NC=N1)C2=CC=CC=C2NCC3=NCCN3,CCCCn1ncnc1-c1ccccc1NCC1=NCCN1
537,CHEMBL187928,P35368,,LYHQJHWJMJJLAD-GDHRODDYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16002289.0,KI,=,316.23,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity towards human alpha-1B-adrenergic receptor expressed in CHO cells using the radioligand [3H]prazosin,,Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.,Bioorg. Med. Chem. Lett.,2005.0,15.0,18.0,"Corbett DF, Heightman TD, Moss SF, Bromidge SM, Coggon SA, Longley MJ, Roa AM, Williams JA, Thomas DR",,304055.0,DTCT0023207,1797944,DTCC00394677,2046794,18666,C1=CC=C(C=C1)CCNCC2=CC=C(C=C2)C3=CC=C(C=C3)CN(CC4=CN=CC=C4)C(=O)/C=C/C5=CC=CC=C5.C(=O)(C(F)(F)F)O,O=C(/C=C/c1ccccc1)N(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)Cc1cccnc1
538,CHEMBL188486,P35368,,YGSBPGMQWWXFLI-GDHRODDYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16002289.0,KI,=,199.53,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity towards human alpha-1B-adrenergic receptor expressed in CHO cells using the radioligand [3H]prazosin,,Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.,Bioorg. Med. Chem. Lett.,2005.0,15.0,18.0,"Corbett DF, Heightman TD, Moss SF, Bromidge SM, Coggon SA, Longley MJ, Roa AM, Williams JA, Thomas DR",,304055.0,DTCT0023207,1800004,DTCC00394676,1048527,18666,CN(C)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)CNCCC3=CC=CC=C3)C(=O)/C=C/C4=CC=CC=C4.C(=O)(C(F)(F)F)O,CN(C)CCN(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)C(=O)/C=C/c1ccccc1
539,CHEMBL18972,P35368,GLEMANSERIN,AXNGJCOYCMDPQG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15999145.0,KI,=,1579.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14741911,DTCC00150824,2107870,69464,C1CN(CCC1C(C2=CC=CC=C2)O)CCC3=CC=CC=C3,OC(c1ccccc1)C1CCN(CCc2ccccc2)CC1
540,CHEMBL1898147,P35368,,KORNTPPJEAJQIU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,60.26,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14744898,DTCC01147332,2108408,69012,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2c3cccc4[nH]cc(c34)CC21
541,CHEMBL1910139,P35368,,PJPXYNKEROPCAD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22000209.0,KI,=,176.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]prazosin from Alpha-1B receptor expressed in HEK293 EBNA cells by radioligand binding assay,,"Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor.",Eur. J. Med. Chem.,2011.0,46.0,12.0,"Al Hussainy R, Verbeek J, van der Born D, Booij J, Herscheid JK",,774871.0,DTCT0023207,7512870,DTCC01157639,943640,46334,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C45C6C7C4C8C5C6C78CF,COc1ccccc1N1CCN(CCN(C(=O)C23C4C5C2C2C3C4C52CF)c2ccccn2)CC1
542,CHEMBL1910140,P35368,,WAEVDDXBNJUJNE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22000209.0,KI,=,110.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]prazosin from Alpha-1B receptor expressed in HEK293 EBNA cells by radioligand binding assay,,"Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor.",Eur. J. Med. Chem.,2011.0,46.0,12.0,"Al Hussainy R, Verbeek J, van der Born D, Booij J, Herscheid JK",,774871.0,DTCT0023207,7512871,DTCC01157640,1201574,46334,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C45CCC(CC4)(CC5)CF,COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)CC3)c2ccccn2)CC1
543,CHEMBL1910141,P35368,,PSWXVBZJWHEKPU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22000209.0,KI,=,38.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]prazosin from Alpha-1B receptor expressed in HEK293 EBNA cells by radioligand binding assay,,"Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor.",Eur. J. Med. Chem.,2011.0,46.0,12.0,"Al Hussainy R, Verbeek J, van der Born D, Booij J, Herscheid JK",,774871.0,DTCT0023207,7512872,DTCC01157641,1040635,46334,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C45CCC(C4)(CC5)CF,COc1ccccc1N1CCN(CCN(C(=O)C23CCC(CF)(CC2)C3)c2ccccn2)CC1
544,CHEMBL191460,P35368,,GQTXLMGFFOLOLU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16002289.0,KI,=,316.23,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity towards human alpha-1B-adrenergic receptor expressed in CHO cells using the radioligand [3H]prazosin,,Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.,Bioorg. Med. Chem. Lett.,2005.0,15.0,18.0,"Corbett DF, Heightman TD, Moss SF, Bromidge SM, Coggon SA, Longley MJ, Roa AM, Williams JA, Thomas DR",,304055.0,DTCT0023207,1798884,DTCC00394780,822034,18666,CN(C)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)CNCCC3=CC=CC=C3)C(=O)CCC4CCCC4.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O,CN(C)CCN(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)C(=O)CCC1CCCC1
545,CHEMBL192099,P35368,,RZWIBVNDYKVOQZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15828846.0,KI,=,1400.0,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor,,"Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.",J. Med. Chem.,2005.0,48.0,8.0,"Konkel MJ, Wetzel JM, Cahir M, Craig DA, Noble SA, Gluchowski C",,302652.0,DTCT0023207,1825477,DTCC00399541,1393489,19681,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC(=C(C=C4)F)F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)c(F)c2)CC1
546,CHEMBL19215,P35368,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20451398.0,ACTIVITY,=,123.0,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned adrenergic Alpha-1B receptor,,Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.,Bioorg. Med. Chem.,2010.0,18.0,22.0,"Hooker JM, Kim SW, Reibel AT, Alexoff D, Xu Y, Shea C",,681156.0,DTCT0023207,3578672,DTCC00150357,296043,41784,CN1C[C@@H](C[C@H]2[C@H]1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
547,CHEMBL193620,P35368,,AUQZROKGNYIFMG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15828846.0,KI,=,380.0,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor,,"Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.",J. Med. Chem.,2005.0,48.0,8.0,"Konkel MJ, Wetzel JM, Cahir M, Craig DA, Noble SA, Gluchowski C",,302652.0,DTCT0023207,1825490,DTCC00399829,1808159,19681,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC(=C(C=C4F)F)F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)c(F)cc2F)CC1
548,CHEMBL19376,P35368,,FACJCZHMOYUSSW-ZDUSSCGKSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,IC50,=,31.0,NM,,,,,,,,,,,,,,Compound was tested for the tissue binding affinity using [125I]- HEAT as radioligand to the human aorta Alpha-1B adrenergic receptor subtype.,,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34324.0,DTCT0023207,1416855,DTCC00151034,322875,15108,CC(C)(C)NC(=O)[C@@H]1CN(CCN1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC
549,CHEMBL19376,P35368,,FACJCZHMOYUSSW-ZDUSSCGKSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,KI,=,25.0,NM,,,,,,,,,,,,,,Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1B adrenergic receptor,,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34346.0,DTCT0023207,1416849,DTCC00151034,322875,15108,CC(C)(C)NC(=O)[C@@H]1CN(CCN1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,COc1cc2nc(N3CCN[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC
550,CHEMBL1946777,P35368,,RSSNMZIACDGNCO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,6.76,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608861,DTCC01174663,1429494,47207,COC1=CC=CC=C1N2CCN(CC2)CC3COC(O3)(C4=CC=CC=C4)C5=CC=CC=C5.C(=O)(C(=O)O)O,COc1ccccc1N1CCN(CC2COC(c3ccccc3)(c3ccccc3)O2)CC1
551,CHEMBL1946778,P35368,,NAPWALZTNSJDEL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,123.03,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608862,DTCC01174664,1267077,47207,C1CC(OC1CNCCOC2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O,c1ccc(OCCNCC2CCC(c3ccccc3)(c3ccccc3)O2)cc1
552,CHEMBL1946779,P35368,,KLARVYJBBKSBKO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,39.81,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608863,DTCC01174665,1234179,47207,COC1=CC=CC=C1OCCNCC2CCC(O2)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O,COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)O1
553,CHEMBL1946780,P35368,,DHKGWHVLDBGHID-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,8.91,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608864,DTCC01174666,943793,47207,COC1=CC=CC=C1N2CCN(CC2)CC3CCC(O3)(C4=CC=CC=C4)C5=CC=CC=C5.C(=O)(C(=O)O)O,COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)O2)CC1
554,CHEMBL1946781,P35368,,CFZKQWGVQRAOPG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608865,DTCC01174667,749969,47207,C1CC(C(=O)C1CNCCOC2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O,O=C1C(CNCCOc2ccccc2)CCC1(c1ccccc1)c1ccccc1
555,CHEMBL1946782,P35368,,FBIXRCIDRBFTIL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608866,DTCC01174668,2006663,47207,COC1=CC=CC=C1OCCNCC2CCC(C2=O)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O,COc1ccccc1OCCNCC1CCC(c2ccccc2)(c2ccccc2)C1=O
556,CHEMBL1946783,P35368,,APRDDCAAWFCTQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,141.25,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608867,DTCC01174669,1332210,47207,COC1=CC=CC=C1N2CCN(CC2)CC3CCC(C3=O)(C4=CC=CC=C4)C5=CC=CC=C5.C(=O)(C(=O)O)O,COc1ccccc1N1CCN(CC2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1
557,CHEMBL1946784,P35368,,VYYYSJHLVDYGHH-XSHMPXIGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608868,DTCC01174670,458633,47207,C1CC([C@@H]([C@@H]1CNCCOC2=CC=CC=C2)O)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O,O[C@@H]1[C@H](CNCCOc2ccccc2)CCC1(c1ccccc1)c1ccccc1
558,CHEMBL1946785,P35368,,VYYYSJHLVDYGHH-UPWLLONGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,288.4,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608869,DTCC01174671,2006664,47207,C1CC([C@@H]([C@H]1CNCCOC2=CC=CC=C2)O)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O,O[C@@H]1[C@@H](CNCCOc2ccccc2)CCC1(c1ccccc1)c1ccccc1
559,CHEMBL1946786,P35368,,HWGQQBMGHLWCIW-JEHHVLJISA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,74.13,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608870,DTCC01174672,329679,47207,COC1=CC=CC=C1OCCNC[C@H]2CCC([C@@H]2O)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O,COc1ccccc1OCCNC[C@H]1CCC(c2ccccc2)(c2ccccc2)[C@@H]1O
560,CHEMBL1946787,P35368,,PZKOLFCLELHKMC-OIVRKFCVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,165.96,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608871,DTCC01174673,1779530,47207,COC1=CC=CC=C1N2CCN(CC2)C[C@H]3CCC([C@H]3O)(C4=CC=CC=C4)C5=CC=CC=C5.C(=O)(C(=O)O)O,COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@H]2O)CC1
561,CHEMBL1946788,P35368,,PZKOLFCLELHKMC-UIWKITTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,245.47,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608872,DTCC01174674,1719002,47207,COC1=CC=CC=C1N2CCN(CC2)C[C@H]3CCC([C@@H]3O)(C4=CC=CC=C4)C5=CC=CC=C5.C(=O)(C(=O)O)O,COc1ccccc1N1CCN(C[C@H]2CCC(c3ccccc3)(c3ccccc3)[C@@H]2O)CC1
562,CHEMBL19476,P35368,L-765314,CGWOIDCAGBKOQL-FQEVSTJZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,IC50,=,8.8,NM,,,,,,,,,,,,,,Compound was tested for the tissue binding affinity using [125I]- HEAT as radioligand to the human aorta Alpha-1B adrenergic receptor subtype.,,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34324.0,DTCT0023207,1426585,DTCC00151066,1227464,15108,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C(=O)OCC2=CC=CC=C2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC
563,CHEMBL19476,P35368,L-765314,CGWOIDCAGBKOQL-FQEVSTJZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,IC50,=,5800.0,NM,,,,,,,,,,,,,,Compound was tested for the tissue binding affinity using [125I]- HEAT as radioligand to the human aorta Alpha-1B adrenergic receptor,,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34322.0,DTCT0023207,1426586,DTCC00151066,1227464,15108,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C(=O)OCC2=CC=CC=C2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC
564,CHEMBL19476,P35368,L-765314,CGWOIDCAGBKOQL-FQEVSTJZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,KI,=,2.0,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1B adrenergic receptor,,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34348.0,DTCT0023207,1426579,DTCC00151066,1227464,15108,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C(=O)OCC2=CC=CC=C2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)OCc4ccccc4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC
565,CHEMBL194849,P35368,,ONSCHPQYHGOIQX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16153828.0,KI,=,843.0,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity towards human alpha-1B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,,Bioisosteric phentolamine analogs as potent alpha-adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2005.0,15.0,21.0,"Hong SS, Bavadekar SA, Lee SI, Patil PN, Lalchandani SG, Feller DR, Miller DD",,320869.0,DTCT0023207,1859059,DTCC00407393,983908,19790,CC1=CC=C(C=C1)N(C2=CC(=CC=C2)O)NC3=NCCN3,Cc1ccc(N(NC2=NCCN2)c2cccc(O)c2)cc1
566,CHEMBL196817,P35368,,ZWJVFWQBNXKWES-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,0.39799999999999996,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870357,DTCC00409582,1274969,20070,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC=C(C=C3)[N+](=O)[O-],COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc([N+](=O)[O-])cc1
567,CHEMBL197442,P35368,,ORFCLRGEMAZVIP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,0.794,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870358,DTCC00409574,1819958,20070,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC(=CC=C3)[N+](=O)[O-],COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc([N+](=O)[O-])c1
568,CHEMBL19826,P35368,,XSHSZTXMXLVUME-INIZCTEOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,IC50,=,3.2,NM,,,,,,,,,,,,,,Compound was tested for the tissue binding affinity using [125I]- HEAT as radioligand to the human aorta Alpha-1B adrenergic receptor subtype,,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34323.0,DTCT0023207,1424203,DTCC00151371,840551,15108,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C(=O)C2=CC=CO2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC
569,CHEMBL19826,P35368,,XSHSZTXMXLVUME-INIZCTEOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,IC50,=,2600.0,NM,,,,,,,,,,,,,,Compound was tested for the tissue binding affinity using [125I]- HEAT as radioligand to the human aorta Alpha-1B adrenergic receptor subtype,,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34323.0,DTCT0023207,1424204,DTCC00151371,840551,15108,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C(=O)C2=CC=CO2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC
570,CHEMBL19826,P35368,,XSHSZTXMXLVUME-INIZCTEOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,KI,=,3.5,NM,,,,,,,,,,,,,,Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1B adrenergic receptor,,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34346.0,DTCT0023207,1424197,DTCC00151371,840551,15108,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C(=O)C2=CC=CO2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H](C(=O)NC(C)(C)C)C3)nc(N)c2cc1OC
571,CHEMBL198431,P35368,,KBOJVHFVCIFMSG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,6.31,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870356,DTCC00409479,951622,20070,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3OC,COc1ccccc1COc1ccccc1OCCNCCOc1c(OC)cccc1OC
572,CHEMBL198860,P35368,,UTHFWPXVKNBLGT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,0.158,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870364,DTCC00409062,983931,20070,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC(=CC=C3)Cl,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(Cl)c1
573,CHEMBL199077,P35368,,OIZQXQPFKPCWLD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,LOG KI,,,,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,Not Determined,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870352,DTCC00409423,531804,20070,CC(C)OC1=CC=C(C=C1)COC2=CC=CC=C2OCCNCCOC3=C(C=CC=C3OC)OC,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(OC(C)C)cc1
574,CHEMBL199080,P35368,,OYHGPJOLAUFAHT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,0.251,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870361,DTCC00409472,1242294,20070,CC1=CC(=CC=C1)COC2=CC=CC=C2OCCNCCOC3=C(C=CC=C3OC)OC,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1cccc(C)c1
575,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,0.32,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from hamster clones.,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34313.0,DTCT0023207,749923,DTCC00132268,1144808,13167,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
576,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,0.32,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from human clone,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34465.0,DTCT0023207,749922,DTCC00132268,1144808,13167,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
577,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7752182.0,KI,=,0.21,NM,,,,,,,,,,,,,,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,,Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.,J. Med. Chem.,1995.0,38.0,10.0,"Wetzel JM, Miao SW, Forray C, Borden LA, Branchek TA, Gluchowski C",,34326.0,DTCT0023207,1036880,DTCC00132268,1143603,12993,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
578,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8917649.0,KI,=,0.457,NM,,,,,,,,,,,,,,Compound was tested for binding affinity against cloned Alpha-1B adrenergic receptor from hamster smooth muscle using radioligand ([3H]prazosin) binding assay,,"Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.",J. Med. Chem.,1996.0,39.0,23.0,"Giardinà D, Crucianelli M, Romanelli R, Leonardi A, Poggesi E, Melchiorre C",,34317.0,DTCT0023207,1423533,DTCC00132268,1145240,13894,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
579,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,0.251,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,712608,DTCC00132268,1131654,14595,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
580,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,KI,=,0.21,NM,,,,,,,,,,,,,,Compound was tested for binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1B adrenergic receptor,,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34346.0,DTCT0023207,1409515,DTCC00132268,1131556,15108,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
581,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,0.16,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14758379,DTCC00132268,2111252,68596,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
582,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9822553.0,KI,=,0.40700000000000003,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity at human cloned Alpha-1B adrenergic receptor in chinese hamster ovary cells by [3H]prazosin displacement.,,"Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.",J. Med. Chem.,1998.0,41.0,24.0,"Bolognesi ML, Budriesi R, Chiarini A, Poggesi E, Leonardi A, Melchiorre C",,34617.0,DTCT0023207,825363,DTCC00132268,1133589,14970,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
583,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,0.55,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1429029,DTCC00132268,1145396,15010,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
584,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9888842.0,KI,=,0.28,NM,,cell_based,,,,,,,,,,,CHO,The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1B adrenergic receptor in CHO cells,,Novel adrenoceptor antagonists with a tricyclic pyrrolodipyridazine skeleton.,J. Med. Chem.,1999.0,42.0,1.0,"Barlocco D, Cignarella G, Montesano F, Leonardi A, Mella M, Toma L",,34467.0,DTCT0023207,1407882,DTCC00132268,1132037,15156,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
585,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,0.55,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1B adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,34329.0,DTCT0023207,1224650,DTCC00132268,1132741,3366,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
586,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,0.6,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,798024,DTCC00132268,1145289,15485,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
587,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10611634.0,KI,=,0.06,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14758446,DTCC00132268,2111249,69195,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
588,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,0.42,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1531846,DTCC00132268,1144237,16317,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
589,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12065700.0,KI,=,0.62,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14758447,DTCC00132268,2111251,69360,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
590,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,KI,=,0.40700000000000003,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi,,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34609.0,DTCT0023207,1607710,DTCC00132268,1133604,17579,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
591,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15633998.0,KI,=,0.40700000000000003,NM,,cell_based,,,,,,,,,,,CHO,Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1b expressed in CHO cells,,"Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.",J. Med. Chem.,2005.0,48.0,1.0,"Antonello A, Hrelia P, Leonardi A, Marucci G, Rosini M, Tarozzi A, Tumiatti V, Melchiorre C",,303918.0,DTCT0023207,1737680,DTCC00132268,1145904,19215,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
592,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16420037.0,KI,=,0.25,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14758380,DTCC00132268,2111250,68752,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
593,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24365159.0,KI,=,1.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from adrenergic alpha1B receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283839.0,DTCT0023207,12984053,DTCC00132268,1158871,56928,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
594,CHEMBL2,P35368,PRAZOSIN,IENZQIKPVFGBNW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24365159.0,KI,=,7.94,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from adrenergic alpha1B receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283839.0,DTCT0023207,12984018,DTCC00132268,1158871,56928,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC
595,CHEMBL200136,P35368,,XJDCBRPORGPJTQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,2.51,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870359,DTCC00409652,174746,20070,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3[N+](=O)[O-],COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1[N+](=O)[O-]
596,CHEMBL200366,P35368,,HSFCJJXHMJXZAX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,0.251,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870360,DTCC00409651,887323,20070,CC1=CC=C(C=C1)COC2=CC=CC=C2OCCNCCOC3=C(C=CC=C3OC)OC,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(C)cc1
597,CHEMBL200446,P35368,CLOPENPHENDIOXAN,RUMAWEVINCSBHA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,1.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870363,DTCC00409135,403072,20070,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC=C(C=C3)Cl,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccc(Cl)cc1
598,CHEMBL200580,P35368,,VFBXMTYMQDPWHB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,0.39799999999999996,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870354,DTCC00409416,1852039,20070,COC1=CC=C(C=C1)COC2=CC=CC=C2OCCNCCOC3=C(C=CC=C3OC)OC,COc1ccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)cc1
599,CHEMBL200777,P35368,,WPZACLGKYATVLS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,LOG KI,,,,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,Not Determined,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870353,DTCC00409417,1242295,20070,CCOC1=CC=C(C=C1)COC2=CC=CC=C2OCCNCCOC3=C(C=CC=C3OC)OC,CCOc1ccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)cc1
600,CHEMBL200839,P35368,,SNEXCDCPPGPIOK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,0.562,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870365,DTCC00409045,951621,20070,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3Cl,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1Cl
601,CHEMBL2024087,P35368,,FQIJPHXWIONJLF-JKOKRWQUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22171543.0,INHIBITION,=,-4.5,%,,,,,,,,,,,,,,Displacement of [3H]Prazosin from alpha1B adrenergic receptor at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012.0,55.0,2.0,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815934.0,DTCT0023207,10457804,DTCC01232472,1365032,48063,C1CN[C@@H]1COC2=CN=CC(=C2)[C@H]3C[C@@H]3CCO,OCC[C@H]1C[C@@H]1c1cncc(OC[C@@H]2CCN2)c1
602,CHEMBL2024089,P35368,,HGSHFGWWOPXUPH-WHOFXGATSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22171543.0,INHIBITION,=,14.1,%,,,,,,,,,,,,,,Displacement of [3H]Prazosin from alpha1B adrenergic receptor at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012.0,55.0,2.0,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815934.0,DTCT0023207,10457805,DTCC01232474,102538,48063,CNC(=O)OCC[C@H]1C[C@@H]1C2=CC(=CN=C2)OC[C@@H]3CCN3,CNC(=O)OCC[C@H]1C[C@@H]1c1cncc(OC[C@@H]2CCN2)c1
603,CHEMBL2024094,P35368,,NMIIKXFGCKOYRV-WHOFXGATSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22171543.0,INHIBITION,=,8.6,%,,,,,,,,,,,,,,Displacement of [3H]Prazosin from alpha1B adrenergic receptor at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012.0,55.0,2.0,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815934.0,DTCT0023207,10457806,DTCC01232479,1008460,48063,COCC[C@H]1C[C@@H]1C2=CC(=CN=C2)OC[C@@H]3CCN3,COCC[C@H]1C[C@@H]1c1cncc(OC[C@@H]2CCN2)c1
604,CHEMBL2030622,P35368,,ITUMTGGIBOPIJQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10477964,DTCC01235111,1610661,48255,C1CC2CCC1N2CC3=CC=CC=C3,c1ccc(CN2C3CCC2CC3)cc1
605,CHEMBL2030623,P35368,,HJOLMLNXMCFYQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478011,DTCC01235112,382111,48255,C1CC2CCC1N2CC3=CC(=CC=C3)F,Fc1cccc(CN2C3CCC2CC3)c1
606,CHEMBL2030624,P35368,,MFKYGKXYJBKSQN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478053,DTCC01235113,218663,48255,COC1=C(C=C(C=C1)CN2C3CCC2CC3)OC,COc1ccc(CN2C3CCC2CC3)cc1OC
607,CHEMBL2030625,P35368,,JVHYCBRRZUMPEJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818119.0,DTCT0023207,10478154,DTCC01235114,53054,48255,C1CCC(CC1)CN2C3CCC2CC3,C1CCC(CN2C3CCC2CC3)CC1
608,CHEMBL2030626,P35368,,TWUZJTIHFYRNSV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478193,DTCC01235115,1735130,48255,C1CC2CCC1N2CC34C5C6C3C7C6C5C47,C1CC2CCC1N2CC12C3C4C5C3C1C5C42
609,CHEMBL2030627,P35368,,JJTSIVODPMDGBG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478242,DTCC01235116,1417143,48255,C1CC2CCC1N2CCC3=CC=CC=C3,c1ccc(CCN2C3CCC2CC3)cc1
610,CHEMBL2030628,P35368,,URNOPSHFIGOPOJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478583,DTCC01235117,1221331,48255,C1CC2CCC1N2CCC3=CC(=CC=C3)F,Fc1cccc(CCN2C3CCC2CC3)c1
611,CHEMBL2030629,P35368,,SRRZEMVAQOSBLB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478630,DTCC01235118,963513,48255,C1CC2CCC1N2CCC3=CC=CC=N3,c1ccc(CCN2C3CCC2CC3)nc1
612,CHEMBL2030630,P35368,,LCBQDWKMNGEPLD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478677,DTCC01235119,1961153,48255,C1CC2CCC1N2CCCC3=CC(=CC=C3)F,Fc1cccc(CCCN2C3CCC2CC3)c1
613,CHEMBL2030631,P35368,N-BENZYLPYRROLIDINE,CWEGCQIIDCZZED-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478702,DTCC00041635,1993939,48255,C1CCN(C1)CC2=CC=CC=C2,c1ccc(CN2CCCC2)cc1
614,CHEMBL2030632,P35368,N-(3-FLUOROBENZYL)PYRROLIDINE,PRKCBGIXZFUCEF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478749,DTCC00041636,1417144,48255,C1CCN(C1)CC2=CC(=CC=C2)F,Fc1cccc(CN2CCCC2)c1
615,CHEMBL2030633,P35368,"N-(3,4-DIMETHOXYBENZYL)PYRROLIDINE",MIZXZRHARATZMK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10478786,DTCC00041637,801620,48255,COC1=C(C=C(C=C1)CN2CCCC2)OC,COc1ccc(CN2CCCC2)cc1OC
616,CHEMBL2030634,P35368,N-(CYCLOHEXYLMETHYL)PYRROLIDINE,ADGIWWYGVBZYMC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818119.0,DTCT0023207,10478868,DTCC00041638,769521,48255,C1CCC(CC1)CN2CCCC2,C1CCC(CN2CCCC2)CC1
617,CHEMBL2030635,P35368,N-(2-PHENYLETHYL)PYRROLIDINE,KLUCWWVQVUXBSE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10479224,DTCC00041639,995674,48255,C1CCN(C1)CCC2=CC=CC=C2,c1ccc(CCN2CCCC2)cc1
618,CHEMBL2030636,P35368,,PXBKRGXXBYALIH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10479268,DTCC00129963,1156787,48255,C1CCN(C1)CCC2=CC(=CC=C2)F,Fc1cccc(CCN2CCCC2)c1
619,CHEMBL2030637,P35368,,VBKWQJLSFFFYLC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10479352,DTCC00129964,834331,48255,C1CCN(C1)CCCC2=CC(=CC=C2)F,Fc1cccc(CCCN2CCCC2)c1
620,CHEMBL2031737,P35368,,GPZMWOXSIRVXQW-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22313227.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant alpha1B adrenergic receptor,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012.0,55.0,5.0,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818815.0,DTCT0023207,10474260,DTCC01236182,1106160,48153,C[C@@H]1CCCN1CCC2=CC3=C(O2)C=CC(=C3)C(=O)C4=CC=C(C=C4)[N+](=O)[O-],C[C@@H]1CCCN1CCc1cc2cc(C(=O)c3ccc([N+](=O)[O-])cc3)ccc2o1
621,CHEMBL2051956,P35368,DEXNIGULDIPINE,SVJMLYUFVDMUHP-MGBGTMOVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7752182.0,KI,=,56.0,NM,,,,,,,,,,,,,,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,,Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.,J. Med. Chem.,1995.0,38.0,10.0,"Wetzel JM, Miao SW, Forray C, Borden LA, Branchek TA, Gluchowski C",,34326.0,DTCT0023207,1029740,DTCC01244224,1046185,12993,CC1=C([C@H](C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@@H]1c1cccc([N+](=O)[O-])c1
622,CHEMBL2051956,P35368,DEXNIGULDIPINE,SVJMLYUFVDMUHP-MGBGTMOVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,25.12,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,697571,DTCC01244224,1034393,14595,CC1=C([C@H](C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@@H]1c1cccc([N+](=O)[O-])c1
623,CHEMBL2051956,P35368,DEXNIGULDIPINE,SVJMLYUFVDMUHP-MGBGTMOVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,54.95,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,713662,DTCC01244224,1034395,14595,CC1=C([C@H](C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@@H]1c1cccc([N+](=O)[O-])c1
624,CHEMBL210578,P35368,,CXQUOFVDYCOSEZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16621538.0,KI,=,42.7,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor by radioligand binding assay,,"Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidol.",Bioorg. Med. Chem. Lett.,2006.0,16.0,12.0,"Ablordeppey SY, Lyles-Eggleston M, Bricker B, Zhang W, Zhu X, Goodman C, Roth BL",,361008.0,DTCT0023207,1937956,DTCC00423474,564074,20872,C1CC2CC(CC1N2CCCC(=O)C3=CC=C(C=C3)F)(C4=CC=C(C=C4)Cl)O,O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1
625,CHEMBL2111563,P35368,,DTYAFBJXWWLRMA-MWTRTKDXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11133073.0,KI,=,74.0,NM,,,,,,,,,,,,,,Tested for binding affinity against recombinant human Alpha-1B adrenergic receptor using [125I]HEAT in competition binding assay,,Determination of the relative and absolute stereochemistry of a potent and alpha1A-selective adrenoceptor antagonist.,Bioorg. Med. Chem. Lett.,2000.0,10.0,24.0,"Lagu B, Wetzel JM, Forray C, Patane MA, Bock MG",,34463.0,DTCT0023207,675792,DTCC01263961,1693641,4034,C[C@@H]1[C@H](N(C(=O)O1)C(=O)NCCCN2CCC(CC2)C3=CC=C(C=C3)F)C4=CC(=C(C=C4)F)F,C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1
626,CHEMBL2112365,P35368,,DTYAFBJXWWLRMA-HJPURHCSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11133073.0,KI,=,76.0,NM,,,,,,,,,,,,,,Tested for binding affinity against recombinant human Alpha-1B adrenergic receptor using [125I]HEAT in competition binding assay,,Determination of the relative and absolute stereochemistry of a potent and alpha1A-selective adrenoceptor antagonist.,Bioorg. Med. Chem. Lett.,2000.0,10.0,24.0,"Lagu B, Wetzel JM, Forray C, Patane MA, Bock MG",,34463.0,DTCT0023207,690891,DTCC01264706,1914602,4034,C[C@H]1[C@H](N(C(=O)O1)C(=O)NCCCN2CCC(CC2)C3=CC=C(C=C3)F)C4=CC(=C(C=C4)F)F,C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H]1c1ccc(F)c(F)c1
627,CHEMBL2112774,P35368,,QEJVHQDLWUVNET-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11728188.0,KI,=,332.0,NM,,,,,,,,,,,,,,Binding affinity was determined on human cloned alpha-1B adrenergic receptor,,"trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.",J. Med. Chem.,2001.0,44.0,25.0,"Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R",,34339.0,DTCT0023207,1452348,DTCC01265099,402051,16537,COC1=CC=CC(=C1)C2CCC(CC2)NCCOC3=CC=CC=N3,COc1cccc(C2CCC(NCCOc3ccccn3)CC2)c1
628,CHEMBL2112778,P35368,,SHEZXZSIBXLQMP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11728188.0,KI,=,53.1,NM,,,,,,,,,,,,,,Binding affinity was determined on human cloned alpha-1B adrenergic receptor,,"trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.",J. Med. Chem.,2001.0,44.0,25.0,"Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R",,34339.0,DTCT0023207,1462109,DTCC01265103,530825,16537,COC1=CC=CC(=C1)C2CCC(CC2)N3CCN(CC3)C4=CC=CC=N4,COc1cccc(C2CCC(N3CCN(c4ccccn4)CC3)CC2)c1
629,CHEMBL2112779,P35368,,ZNFGZJGKELODLV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11728188.0,KI,=,43.3,NM,,,,,,,,,,,,,,Binding affinity was determined on human cloned alpha-1B adrenergic receptor,,"trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.",J. Med. Chem.,2001.0,44.0,25.0,"Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R",,34339.0,DTCT0023207,1458218,DTCC01265104,982957,16537,COC1=CC=CC(=C1)C2CCC(CC2)N3CCN(CC3)C4=CC=CC=C4OC,COc1cccc(C2CCC(N3CCN(c4ccccc4OC)CC3)CC2)c1
630,CHEMBL2112853,P35368,,NAEUHVGJYGSIJV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,KI,=,12.59,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi,,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34611.0,DTCT0023207,1636830,DTCC01265173,65480,17579,COC1=C(C=C2C(=C1)C(=C3CCC(CC3=N2)CNC(=O)C4=CC(=CC=C4)C(F)(F)F)N)OC.Cl,COc1cc2nc3c(c(N)c2cc1OC)CCC(CNC(=O)c1cccc(C(F)(F)F)c1)C3
631,CHEMBL2114249,P35368,,DTYAFBJXWWLRMA-WAIKUNEKSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11133073.0,KI,=,48.0,NM,,,,,,,,,,,,,,Tested for binding affinity against recombinant human Alpha-1B adrenergic receptor using [125I]HEAT in competition binding assay,,Determination of the relative and absolute stereochemistry of a potent and alpha1A-selective adrenoceptor antagonist.,Bioorg. Med. Chem. Lett.,2000.0,10.0,24.0,"Lagu B, Wetzel JM, Forray C, Patane MA, Bock MG",,34463.0,DTCT0023207,684669,DTCC01266215,1112159,4034,C[C@@H]1[C@@H](N(C(=O)O1)C(=O)NCCCN2CCC(CC2)C3=CC=C(C=C3)F)C4=CC(=C(C=C4)F)F,C[C@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1
632,CHEMBL2115086,P35368,,CAEZRWQRXPFXAO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,1.63,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1249328,DTCC01266561,485914,16272,COC1=CC=CC2=C1CCC3C2CN(C3)CCN4C(=O)C5=C(C=CS5)NC4=O,COc1cccc2c1CCC1CN(CCn3c(=O)[nH]c4ccsc4c3=O)CC21
633,CHEMBL214506,P35368,,ZHJBQCNJMQLLPC-VEIFNGETSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,549.54,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993365,DTCC00435690,163720,21490,COC1=C(C=CC(=C1)C2=CC=CC=C2)OCCNC[C@@H]3COC4=CC=CC=C4O3.Cl,COc1cc(-c2ccccc2)ccc1OCCNC[C@@H]1COc2ccccc2O1
634,CHEMBL214552,P35368,,JHHAAVCPJVMVLF-VEIFNGETSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,61.66,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993367,DTCC00110722,972461,21490,COC1=C(C=C(C=C1)C2=CC=CC=C2)OCCNC[C@@H]3COC4=CC=CC=C4O3.Cl,COc1ccc(-c2ccccc2)cc1OCCNC[C@@H]1COc2ccccc2O1
635,CHEMBL2146484,P35368,,SXNOWQCFHNZUIX-MRXNPFEDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,158.49,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345693,DTCC01282850,1365328,50693,CN1CCC[C@@H]1CN2C(=O)C3=C(C=CC=N3)C(=N2)CC4=CC=C(C=C4)Cl,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O
636,CHEMBL2146801,P35368,,REXDQAIKTDDWAC-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,10.0,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345692,DTCC01282844,1844612,50693,COCCN1CCC[C@@H]1CN2C(=O)C3=C(C=NC=C3)C(=N2)CC4=CC=C(C=C4)Cl,COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O
637,CHEMBL2146802,P35368,,YZAHEHXQIMZHAJ-HXUWFJFHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,15.85,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345773,DTCC01282845,675086,50693,CCCCN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
638,CHEMBL2146803,P35368,,KMFDXNUGIFDFHQ-LJQANCHMSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,12.59,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345774,DTCC01282846,1073688,50693,COCCN1CCC[C@@H]1CN2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccccc2c1=O
639,CHEMBL2146804,P35368,,RZBPSXCZVILRNE-MRXNPFEDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,125.89,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345775,DTCC01282847,944214,50693,CN1CCC[C@@H]1CN2C(=O)C3=C(C=CN=C3)C(=N2)CC4=CC=C(C=C4)Cl,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ccncc2c1=O
640,CHEMBL2146805,P35368,,HRSYZRFBUGIVHN-MRXNPFEDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,25.12,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345776,DTCC01282848,2007140,50693,CN1CCC[C@@H]1CN2C(=O)C3=C(C=NC=C3)C(=N2)CC4=CC=C(C=C4)Cl,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O
641,CHEMBL2146806,P35368,,VFIDGXZRONKQBZ-LJQANCHMSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,7.94,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345691,DTCC01282849,1267489,50693,CCCCN1CCC[C@@H]1CN2C(=O)C3=C(C=NC=C3)C(=N2)CC4=CC=C(C=C4)Cl,CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cnccc2c1=O
642,CHEMBL2146807,P35368,,UXQVMDVKHFQOEU-LJQANCHMSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,100.0,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345694,DTCC01282851,880097,50693,CCCCN1CCC[C@@H]1CN2C(=O)C3=C(C=CC=N3)C(=N2)CC4=CC=C(C=C4)Cl,CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O
643,CHEMBL2146808,P35368,,YLWRKTVVIPNRDE-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,316.23,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345695,DTCC01282852,1365329,50693,COCCN1CCC[C@@H]1CN2C(=O)C3=C(C=CC=N3)C(=N2)CC4=CC=C(C=C4)Cl,COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2cccnc2c1=O
644,CHEMBL2146809,P35368,,OUEZWZJJIKBFFV-MRXNPFEDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,50.12,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345696,DTCC01282853,588839,50693,CN1CCC[C@@H]1CN2C(=O)C3=C(C(=N2)CC4=CC=C(C=C4)Cl)N=CC=C3,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O
645,CHEMBL2146810,P35368,,FNEORDYLRZOEEP-LJQANCHMSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,19.95,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345697,DTCC01282854,750366,50693,CCCCN1CCC[C@@H]1CN2C(=O)C3=C(C(=N2)CC4=CC=C(C=C4)Cl)N=CC=C3,CCCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O
646,CHEMBL2146811,P35368,,SAMYTBZVLLYSKN-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,39.81,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345764,DTCC01282855,976344,50693,COCCN1CCC[C@@H]1CN2C(=O)C3=C(C(=N2)CC4=CC=C(C=C4)Cl)N=CC=C3,COCCN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2ncccc2c1=O
647,CHEMBL2146812,P35368,,DGZLHXBKGBELTQ-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,251.19,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345765,DTCC01282856,264280,50693,CN1CCC[C@@H]1CN2C(=O)C3=NC=CN=C3C(=N2)CC4=CC=C(C=C4)Cl,CN1CCC[C@@H]1Cn1nc(Cc2ccc(Cl)cc2)c2nccnc2c1=O
648,CHEMBL2146813,P35368,,CIAWHNGOFJZBCL-MGBGTMOVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,39.81,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345766,DTCC01282857,1169883,50693,C1CCCN(CC1)CCCOC2=CC=C(C=C2)CCCCN3CCC[C@@H]3CN4C(=O)C5=C(C=NC=C5)C(=N4)CC6=CC=C(C=C6)Cl,O=c1c2ccncc2c(Cc2ccc(Cl)cc2)nn1C[C@H]1CCCN1CCCCc1ccc(OCCCN2CCCCCC2)cc1
649,CHEMBL214694,P35368,,JHHAAVCPJVMVLF-BDQAORGHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,10.96,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993368,DTCC00435583,195623,21490,COC1=C(C=C(C=C1)C2=CC=CC=C2)OCCNC[C@H]3COC4=CC=CC=C4O3.Cl,COc1ccc(-c2ccccc2)cc1OCCNC[C@H]1COc2ccccc2O1
650,CHEMBL214762,P35368,,ZHJBQCNJMQLLPC-BDQAORGHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,186.21,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993366,DTCC00435597,1872929,21490,COC1=C(C=CC(=C1)C2=CC=CC=C2)OCCNC[C@H]3COC4=CC=CC=C4O3.Cl,COc1cc(-c2ccccc2)ccc1OCCNC[C@H]1COc2ccccc2O1
651,CHEMBL214952,P35368,,AFUDWLGGLABPSJ-FSRHSHDFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,151.36,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993369,DTCC00435673,1134713,21490,COC1=CC=CC(=C1OCCNC[C@@H]2COC3=CC=CC=C3O2)C4=CC=CC=C4.Cl,COc1cccc(-c2ccccc2)c1OCCNC[C@@H]1COc2ccccc2O1
652,CHEMBL214986,P35368,,KAHMEWANVDFFCQ-PFEQFJNWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,72.44,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993379,DTCC00110721,1619920,21490,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=CC=CC=C3O2.Cl,COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1
653,CHEMBL214986,P35368,,KAHMEWANVDFFCQ-PFEQFJNWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,72.44,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365924,DTCC00110721,1643588,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=CC=CC=C3O2.Cl,COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1
654,CHEMBL215151,P35368,,AFUDWLGGLABPSJ-FYZYNONXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,17.78,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993370,DTCC00435570,521938,21490,COC1=CC=CC(=C1OCCNC[C@H]2COC3=CC=CC=C3O2)C4=CC=CC=C4.Cl,COc1cccc(-c2ccccc2)c1OCCNC[C@H]1COc2ccccc2O1
655,CHEMBL215188,P35368,,FVVZSOKZMFBYMX-FERBBOLQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,891.25,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993378,DTCC00435689,195622,21490,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=CC4=CC=CC=C4C=C3O2.Cl,COc1cccc(OC)c1OCCNC[C@H]1COc2cc3ccccc3cc2O1
656,CHEMBL2153551,P35368,,IECDJRLGTAPRLT-ZOWNYOTGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,30.9,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365925,DTCC01286452,1417850,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=CC=CC(=C3O2)O.Cl,COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(O)c2O1
657,CHEMBL2153552,P35368,,IECDJRLGTAPRLT-BTQNPOSSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,398.11,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365926,DTCC01286453,770187,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=CC=CC(=C3O2)O.Cl,COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(O)c2O1
658,CHEMBL2153553,P35368,,SVIGTXXLLPDUPU-UQKRIMTDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,2.75,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365928,DTCC01286454,1352911,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=C(O2)C(=CC=C3)OC.Cl,COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(OC)c2O1
659,CHEMBL2153554,P35368,,SVIGTXXLLPDUPU-PFEQFJNWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,79.43,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365929,DTCC01286455,996372,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=C(O2)C(=CC=C3)OC.Cl,COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(OC)c2O1
660,CHEMBL2153555,P35368,,SRZQASDTTLSGGK-ZOWNYOTGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,2.19,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365930,DTCC01286456,1222040,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=C(O2)C(=CC=C3)Cl.Cl,COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(Cl)c2O1
661,CHEMBL2153556,P35368,,SRZQASDTTLSGGK-BTQNPOSSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,33.88,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365931,DTCC01286457,1287685,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=C(O2)C(=CC=C3)Cl.Cl,COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(Cl)c2O1
662,CHEMBL2153557,P35368,,GUKQFCSRQQWTQO-ZOWNYOTGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,2.4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365932,DTCC01286458,350258,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=C(O2)C(=CC=C3)F.Cl,COc1cccc(OC)c1OCCNC[C@H]1COc2cccc(F)c2O1
663,CHEMBL2153558,P35368,,GUKQFCSRQQWTQO-BTQNPOSSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,102.33,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365933,DTCC01286459,2027510,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=C(O2)C(=CC=C3)F.Cl,COc1cccc(OC)c1OCCNC[C@@H]1COc2cccc(F)c2O1
664,CHEMBL2153559,P35368,,DJRYYCRQDCUSHQ-UQKRIMTDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,446.68,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365934,DTCC01286460,122746,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=C(O2)C=CC=C3OC.Cl,COc1cccc(OC)c1OCCNC[C@H]1COc2c(OC)cccc2O1
665,CHEMBL2153560,P35368,,DJRYYCRQDCUSHQ-PFEQFJNWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,645.65,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365935,DTCC01286461,1449681,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=C(O2)C=CC=C3OC.Cl,COc1cccc(OC)c1OCCNC[C@@H]1COc2c(OC)cccc2O1
666,CHEMBL21536,P35368,XANOMELINE,JOLJIIDDOBNFHW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9884068.0,KI,=,1584.89,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14737842,DTCC00154255,2106436,69657,CCCCCCOC1=NSN=C1C2=CCCN(C2)C,CCCCCCOc1nsnc1C1=CCCN(C)C1
667,CHEMBL215421,P35368,,KAHMEWANVDFFCQ-UQKRIMTDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,5.75,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1990828,DTCC00435672,227996,21490,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=CC=CC=C3O2.Cl,COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1
668,CHEMBL215421,P35368,,KAHMEWANVDFFCQ-UQKRIMTDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23124215.0,KI,=,5.75,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned alpha1B adrenoceptor expressed in CHO cell membranes after 30 mins by liquid scintillation counter,,"Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective a(1B)-adrenoceptor antagonist.",Eur. J. Med. Chem.,2012.0,58.0,,"Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, Chiodini G, Bolchi C, Chiarini A, Micucci M, Valoti E",,854041.0,DTCT0023207,11365923,DTCC00435672,251765,50858,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=CC=CC=C3O2.Cl,COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1
669,CHEMBL215421,P35368,,KAHMEWANVDFFCQ-UQKRIMTDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23902232.0,KI,=,5.75,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human alpha-1B adrenoreceptor expressed in CHO cells after 30 mins,,"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective a1D-adrenoceptor antagonist.",J. Med. Chem.,2013.0,56.0,16.0,"Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, Chiodini G, Gobbi M, Laurino P, Micucci M, Straniero V, Valoti E",,978686.0,DTCT0023207,12543797,DTCC00435672,232854,55571,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=CC=CC=C3O2.Cl,COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1
670,CHEMBL215857,P35368,,KHWJVDNWRQSROE-GMUIIQOCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,398.11,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993373,DTCC00435717,1744166,21490,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=C(O2)C=C4CCCCC4=C3.Cl,COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3
671,CHEMBL2164350,P35368,,QJFWBEXGRNKZIY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22738628.0,KI,=,1051.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor by radioligand binding assay,,Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.,Bioorg. Med. Chem. Lett.,2012.0,22.0,14.0,"Mangin F, Dilly S, Joly B, Scuvée-Moreau J, Evans J, Setola V, Roth BL, Liégeois JF",,859962.0,DTCT0023207,11399030,DTCC01289819,19400,49664,C1CCC(CC1)C(=O)N(CCN2CCN(CC2)C3=CC=CC=C3)C4=CC=CC=N4,O=C(C1CCCCC1)N(CCN1CCN(c2ccccc2)CC1)c1ccccn1
672,CHEMBL2164354,P35368,,YUOLKUGHNOWKJF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22738628.0,KI,=,296.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor by radioligand binding assay,,Moderate chemical modifications of WAY-100635 improve the selectivity for 5-HT1A versus D4 receptors.,Bioorg. Med. Chem. Lett.,2012.0,22.0,14.0,"Mangin F, Dilly S, Joly B, Scuvée-Moreau J, Evans J, Setola V, Roth BL, Liégeois JF",,859962.0,DTCT0023207,11399023,DTCC01289823,1494590,49664,C1CCC(CC1)C(=O)N(CCN2CCC(=CC2)C3=CC=CC=C3)C4=CC=CC=N4,O=C(C1CCCCC1)N(CCN1CC=C(c2ccccc2)CC1)c1ccccn1
673,CHEMBL2165447,P35368,,KZONDTNPVHWVKU-NSHDSACASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,EFFICACY,=,18.1,%,,,,,,,,,,,,,,Displacement of [3H]prazosin from alpha 1B adrenergic receptor at 10 uM after 1 hr by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012.0,3.0,12.0,,,880439.0,DTCT0023207,11471992,DTCC01290805,912917,51811,C1CN[C@@H]1COC2=NOC(=C2)COC3=CC=CC=C3,c1ccc(OCc2cc(OC[C@@H]3CCN3)no2)cc1
674,CHEMBL2165524,P35368,,BPDIPISJQZBBJL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23036955.0,INHIBITION,=,4.22,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor at 1 uM,,"N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists.",Bioorg. Med. Chem. Lett.,2012.0,22.0,22.0,"Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK",,861077.0,DTCT0023207,11388927,DTCC01290868,1365426,51305,CN(C)C1CCC2=C(C1)C3=C(N2S(=O)(=O)C4=CC=CC=C4)C=CC(=C3)Br,CN(C)C1CCc2c(c3cc(Br)ccc3n2S(=O)(=O)c2ccccc2)C1
675,CHEMBL2165524,P35368,,BPDIPISJQZBBJL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23036955.0,INHIBITION,=,16.19,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor at 10 uM,,"N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists.",Bioorg. Med. Chem. Lett.,2012.0,22.0,22.0,"Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK",,861078.0,DTCT0023207,11388923,DTCC01290868,1365426,51305,CN(C)C1CCC2=C(C1)C3=C(N2S(=O)(=O)C4=CC=CC=C4)C=CC(=C3)Br,CN(C)C1CCc2c(c3cc(Br)ccc3n2S(=O)(=O)c2ccccc2)C1
676,CHEMBL2165527,P35368,,WJGHDFLJHZUCKM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23036955.0,INHIBITION,=,5.21,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor at 1 uM,,"N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists.",Bioorg. Med. Chem. Lett.,2012.0,22.0,22.0,"Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK",,861077.0,DTCT0023207,11388926,DTCC01290871,1267605,51305,CN(C)C1CCC2=C(C1)C3=C(N2S(=O)(=O)C4=CC=CC=C4)C=CC(=C3)OC,COc1ccc2c(c1)c1c(n2S(=O)(=O)c2ccccc2)CCC(N(C)C)C1
677,CHEMBL2165527,P35368,,WJGHDFLJHZUCKM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23036955.0,INHIBITION,=,5.26,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor at 10 uM,,"N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists.",Bioorg. Med. Chem. Lett.,2012.0,22.0,22.0,"Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK",,861078.0,DTCT0023207,11388922,DTCC01290871,1267605,51305,CN(C)C1CCC2=C(C1)C3=C(N2S(=O)(=O)C4=CC=CC=C4)C=CC(=C3)OC,COc1ccc2c(c1)c1c(n2S(=O)(=O)c2ccccc2)CCC(N(C)C)C1
678,CHEMBL2165538,P35368,,SRCUGVUYMUSXIR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23036955.0,INHIBITION,=,4.24,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor at 1 uM,,"N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists.",Bioorg. Med. Chem. Lett.,2012.0,22.0,22.0,"Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK",,861077.0,DTCT0023207,11388925,DTCC01290882,814857,51305,CN(C)C1CCC2=C(C1)C3=CC=CC=C3N2S(=O)(=O)C4=CC(=CC=C4)Cl,CN(C)C1CCc2c(c3ccccc3n2S(=O)(=O)c2cccc(Cl)c2)C1
679,CHEMBL2165538,P35368,,SRCUGVUYMUSXIR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23036955.0,INHIBITION,=,7.92,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor at 10 uM,,"N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists.",Bioorg. Med. Chem. Lett.,2012.0,22.0,22.0,"Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK",,861078.0,DTCT0023207,11388921,DTCC01290882,814857,51305,CN(C)C1CCC2=C(C1)C3=CC=CC=C3N2S(=O)(=O)C4=CC(=CC=C4)Cl,CN(C)C1CCc2c(c3ccccc3n2S(=O)(=O)c2cccc(Cl)c2)C1
680,CHEMBL2165541,P35368,,XNHXAWXVLOOHSD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23036955.0,INHIBITION,=,5.26,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor at 1 uM,,"N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists.",Bioorg. Med. Chem. Lett.,2012.0,22.0,22.0,"Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK",,861077.0,DTCT0023207,11388924,DTCC01290885,2007239,51305,CN(C)C1CCC2=C(C1)C3=CC=CC=C3N2S(=O)(=O)C4=CC=CC(=C4)C(F)(F)F,CN(C)C1CCc2c(c3ccccc3n2S(=O)(=O)c2cccc(C(F)(F)F)c2)C1
681,CHEMBL2165541,P35368,,XNHXAWXVLOOHSD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23036955.0,INHIBITION,=,8.72,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor at 10 uM,,"N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT6 receptor antagonists.",Bioorg. Med. Chem. Lett.,2012.0,22.0,22.0,"Nirogi RV, Konda JB, Kambhampati R, Shinde A, Bandyala TR, Gudla P, Kandukuri KK, Jayarajan P, Kandikere V, Dubey PK",,861078.0,DTCT0023207,11388920,DTCC01290885,2007239,51305,CN(C)C1CCC2=C(C1)C3=CC=CC=C3N2S(=O)(=O)C4=CC=CC(=C4)C(F)(F)F,CN(C)C1CCc2c(c3ccccc3n2S(=O)(=O)c2cccc(C(F)(F)F)c2)C1
682,CHEMBL217143,P35368,,KGWXTAUOHMLWSB-UNTBIKODSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,48.98,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993371,DTCC00110715,1393816,21490,COC1=C(C2=C(CCCC2)C=C1)OCCNC[C@@H]3COC4=CC=CC=C4O3.Cl,COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)CCCC2
683,CHEMBL2172192,P35368,,CHVVPMVMKPMDFR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22664127.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor at 1 uM by radioligand displacement assay,Not Active,"Antagonists of 5-HT(6) receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship.",Bioorg. Med. Chem. Lett.,2012.0,22.0,13.0,"Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Vorobiev AA, Okun I",,863369.0,DTCT0023207,11412225,DTCC01293389,576450,51365,CNC1=NN2C=C3CN(CCC3=NC2=C1S(=O)(=O)C4=CC=CC=C4)C,CNc1nn2cc3c(nc2c1S(=O)(=O)c1ccccc1)CCN(C)C3
684,CHEMBL217469,P35368,,JQLOQIYDEYNBTQ-LMOVPXPDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993376,DTCC00435711,1970520,21490,COC1=C(C2=CC=CC=C2C=C1)OCCNC[C@H]3COC4=CC=CC=C4O3.Cl,COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1
685,CHEMBL217469,P35368,,JQLOQIYDEYNBTQ-LMOVPXPDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23902232.0,KI,=,15.85,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human alpha-1B adrenoreceptor expressed in CHO cells after 30 mins,,"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective a1D-adrenoceptor antagonist.",J. Med. Chem.,2013.0,56.0,16.0,"Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, Chiodini G, Gobbi M, Laurino P, Micucci M, Straniero V, Valoti E",,978686.0,DTCT0023207,12543796,DTCC00435711,1975291,55571,COC1=C(C2=CC=CC=C2C=C1)OCCNC[C@H]3COC4=CC=CC=C4O3.Cl,COc1ccc2ccccc2c1OCCNC[C@H]1COc2ccccc2O1
686,CHEMBL2179217,P35368,,ZPUAIXYROPYWKA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23006002.0,KI,=,955.4,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012.0,55.0,21.0,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875719.0,DTCT0023207,11435588,DTCC01295975,641546,51583,CC1=CN(C2=C1C=C(C=C2)Cl)S(=O)(=O)C3=CC(=C(C=C3)OC)NC4CCN(CC4)C,COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)ccc32)cc1NC1CCN(C)CC1
687,CHEMBL2179222,P35368,,XRDVQWJPAZZLKN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23006002.0,KI,=,3791.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012.0,55.0,21.0,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875719.0,DTCT0023207,11435587,DTCC01295978,1028954,51583,CC1=CN(C2=C1C=C(C=N2)Cl)S(=O)(=O)C3=CC(=C(C=C3)OC)NC4CCN(CC4)C,COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)cnc32)cc1NC1CCN(C)CC1
688,CHEMBL218079,P35368,,KHWJVDNWRQSROE-FERBBOLQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,575.44,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993374,DTCC00435531,1263543,21490,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=C(O2)C=C4CCCCC4=C3.Cl,COc1cccc(OC)c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3
689,CHEMBL218732,P35368,,BXAUNYRCMJYSAD-ZMBIFBSDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,549.54,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993363,DTCC00435701,98866,21490,COC1=C(C2=CC=CC=C2C=C1)OCCNC[C@@H]3COC4=C(O3)C=C5CCCCC5=C4.Cl,COc1ccc2ccccc2c1OCCNC[C@@H]1COc2cc3c(cc2O1)CCCC3
690,CHEMBL219718,P35368,,CLMAYMICDQACRV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,19054.61,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017517,DTCC00441511,1393872,21852,C1CN(CCN1CCN2C(=O)C3=C(C4=CC=CC=C4S3)NC2=O)C5=CC(=C(C=C5)Cl)Cl,O=c1[nH]c2c(sc3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1
691,CHEMBL219719,P35368,,ZOJCSVHWXFCTBG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,602.56,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017516,DTCC00441512,260319,21852,CN1C2=CC=CC=C2C3=C1C(=O)N(C(=O)N3C)CCN4CCN(CC4)C5=CC(=C(C=C5)Cl)Cl,Cn1c(=O)n(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)c(=O)c2c1c1ccccc1n2C
692,CHEMBL220221,P35368,,KRIXMAGTZZHFLF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,17.38,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017513,DTCC00441523,66708,21852,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=CC=C4OC)SC5=CC=CC=C52,COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1
693,CHEMBL220221,P35368,,KRIXMAGTZZHFLF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,17.38,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793039,DTCC00441523,92583,59712,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=CC=C4OC)SC5=CC=CC=C52,COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1
694,CHEMBL2203551,P35368,,JUWUZLUBIRHYMM-LBPRGKRZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,EFFICACY,=,27.8,%,,,,,,,,,,,,,,Displacement of [3H]prazosin from alpha 1B adrenergic receptor at 10 uM after 1 hr by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012.0,3.0,12.0,,,880439.0,DTCT0023207,11471979,DTCC01298943,621402,51811,C1C[C@H](NC1)COC2=NOC(=C2)COC3=CC=CC=C3,c1ccc(OCc2cc(OC[C@@H]3CCCN3)no2)cc1
695,CHEMBL2203713,P35368,,BLZNLOLTHDUEOL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22840695.0,IC50,=,1800.0,NM,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,,"Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.",Eur. J. Med. Chem.,2012.0,55.0,,"Annedi SC, Maddaford SP, Ramnauth J, Renton P, Rybak T, Silverman S, Rakhit S, Mladenova G, Dove P, Andrews JS, Zhang D, Porreca F",,882990.0,DTCT0023207,11458182,DTCC00131535,738126,51915,C1CNCCC1N2CCC3=C2C=CC(=C3)N=C(C4=CC=CS4)N,NC(=Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1
696,CHEMBL220515,P35368,,AMDQVJAWEJXJFN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,4.47,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017515,DTCC00441516,1069895,21852,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)OC)NC5=CC=CC=C52,COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c([nH]c4ccccc43)c2=O)CC1
697,CHEMBL2205811,P35368,,ZKOQRCXMSDAJIR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472840,DTCC01301027,1267730,51935,COC1=CC=CC(=C1)CCN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1cccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)c1
698,CHEMBL2205812,P35368,,TWMXGXSGGIIQDM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472820,DTCC01301028,556858,51935,COC1=CC=C(C=C1)CCN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1ccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1
699,CHEMBL2205813,P35368,,FOTUXOOYRRRHFQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884056.0,DTCT0023207,11474504,DTCC01301029,1688236,51935,COC1=CC=CC(=C1OC)CCN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1cccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)c1OC
700,CHEMBL2205814,P35368,,KULMFBVVFDTVNX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472793,DTCC01301030,1623988,51935,COC1=C(C=C(C=C1)CCN2C3C4C5CC6C4C2(C7C6C5C73)O)OC,COc1ccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1OC
701,CHEMBL2205815,P35368,,MYZBXDLMEOAPIJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472783,DTCC01301031,1876967,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC8=C(C=C7)OCO8)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1ccc2c(c1)OCO2
702,CHEMBL2205816,P35368,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472754,DTCC01301032,880294,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC=CC=N7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1ccccn1
703,CHEMBL2205816,P35368,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600212,DTCC01301032,881049,55935,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC=CC=N7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1ccccn1
704,CHEMBL2205817,P35368,,GFQHCUYWLHSGJR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884056.0,DTCT0023207,11471538,DTCC01301033,912942,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CN=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1cccnc1
705,CHEMBL2205818,P35368,,VTLZIWJSKWWYHL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472733,DTCC01301034,1106585,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC=NC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1ccncc1
706,CHEMBL2205819,P35368,,GOYQRMVWIWPDFU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11477211,DTCC01301035,1170086,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCCC7=CC=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCCc1ccccc1
707,CHEMBL2205820,P35368,,HDZWTAJVYGVJEQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11425865,DTCC01301036,1559073,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCCC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCCc1cccc(F)c1
708,CHEMBL2205820,P35368,,HDZWTAJVYGVJEQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600211,DTCC01301036,1559919,55935,C1C2C3C4C1C5C2C6C3C4C5(N6CCCC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCCc1cccc(F)c1
709,CHEMBL2205821,P35368,,DHQYUPWRESNGBC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11429906,DTCC01301037,362894,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCCCC7=CC=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCCCc1ccccc1
710,CHEMBL2205822,P35368,,CUIQKJJPRAKRJM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11467276,DTCC01301038,1844780,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCCCC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCCCc1cccc(F)c1
711,CHEMBL2205823,P35368,,WWXCWTRLUXMAHX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,=,536.0,NM,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11474252,DTCC01301039,1780156,51935,COC1=CC=CC=C1CN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1ccccc1CN1C2C3C4CC5C6C4C2C6C1(O)C53
712,CHEMBL2205824,P35368,,LIKZWSUAMNZHAE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884056.0,DTCT0023207,11475943,DTCC01301040,1688238,51935,COC1=CC=CC(=C1)CN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1cccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)c1
713,CHEMBL2205825,P35368,,GYKFQDQFKGGVKD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11474233,DTCC01301041,750568,51935,COC1=CC=C(C=C1)CN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1ccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1
714,CHEMBL2205826,P35368,,TVDFWGUKMIRJAD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11474219,DTCC01301042,750569,51935,COC1=CC(=C(C=C1)CN2C3C4C5CC6C4C2(C7C6C5C73)O)OC,COc1ccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)c(OC)c1
715,CHEMBL2205827,P35368,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,=,2766.0,NM,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11473017,DTCC01301043,1812524,51935,COC1=C(C=C(C=C1)CN2C3C4C5CC6C4C2(C7C6C5C73)O)OC,COc1ccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1OC
716,CHEMBL2205827,P35368,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,=,2766.0,NM,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12601193,DTCC01301043,1813367,55935,COC1=C(C=C(C=C1)CN2C3C4C5CC6C4C2(C7C6C5C73)O)OC,COc1ccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1OC
717,CHEMBL2205828,P35368,,QUMVESOWCHBEEV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11454226,DTCC01301044,1234798,51935,COC1=CC(=CC(=C1)CN2C3C4C5CC6C4C2(C7C6C5C73)O)OC,COc1cc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc(OC)c1
718,CHEMBL2205829,P35368,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884056.0,DTCT0023207,11475870,DTCC01301045,330310,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC8=C(C=C7)OCO8)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccc2c(c1)OCO2
719,CHEMBL2205829,P35368,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586608,DTCC01301045,331095,55935,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC8=C(C=C7)OCO8)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccc2c(c1)OCO2
720,CHEMBL2205830,P35368,,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472974,DTCC01301046,1494712,51935,COC1=CC(=CC(=C1OC)OC)CN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1cc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc(OC)c1OC
721,CHEMBL2205830,P35368,,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600210,DTCC01301046,1495531,55935,COC1=CC(=CC(=C1OC)OC)CN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1cc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc(OC)c1OC
722,CHEMBL2205831,P35368,,RRBNCHNWWUXYEM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472944,DTCC01301047,556859,51935,C1CCC(CC1)CN2C3C4C5CC6C4C2(C7C6C5C73)O,OC12C3C4CC5C6C4C1C6C(C53)N2CC1CCCCC1
723,CHEMBL2205831,P35368,,RRBNCHNWWUXYEM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600209,DTCC01301047,557648,55935,C1CCC(CC1)CN2C3C4C5CC6C4C2(C7C6C5C73)O,OC12C3C4CC5C6C4C1C6C(C53)N2CC1CCCCC1
724,CHEMBL2205832,P35368,,ZUHLFYHHSNMSRE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884056.0,DTCT0023207,11475838,DTCC01301048,589038,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC=CC=N7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccccn1
725,CHEMBL2205833,P35368,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884056.0,DTCT0023207,11475803,DTCC01301049,2039955,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CN=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1cccnc1
726,CHEMBL2205833,P35368,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586609,DTCC01301049,2040747,55935,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CN=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1cccnc1
727,CHEMBL2205834,P35368,,QFMGHZDEZHDVJJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472917,DTCC01301050,167654,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC=NC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccncc1
728,CHEMBL2205835,P35368,,FPHVMMXTLGSYHV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472888,DTCC01301051,1623989,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1ccccc1
729,CHEMBL2205835,P35368,,FPHVMMXTLGSYHV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600214,DTCC01301051,1624817,55935,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1ccccc1
730,CHEMBL2205836,P35368,,PSBBAGWMKGXQRW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,=,3490.0,NM,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11472859,DTCC01301052,1041425,51935,COC1=CC=CC=C1CCN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53
731,CHEMBL220717,P35368,,IZXNMSMOJJZRBE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,83.18,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017514,DTCC00441517,1361481,21852,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC(=C(C=C4)Cl)Cl)NC5=CC=CC=C52,Cc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1
732,CHEMBL2207376,P35368,,MJYQMQCVUXOIFY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23141912.0,INHIBITION,=,0.78,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886901.0,DTCT0023207,11493451,DTCC01302559,750581,52134,CN1CCN(CC1)CC2=C3C(=CC=C2)N(C=C3Cl)S(=O)(=O)C4=CC(=CC=C4)Cl,CN1CCN(Cc2cccc3c2c(Cl)cn3S(=O)(=O)c2cccc(Cl)c2)CC1
733,CHEMBL2207382,P35368,,MBFLODNVCSXSKE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23141912.0,INHIBITION,=,2.17,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886901.0,DTCT0023207,11493450,DTCC01302565,1041441,52134,CN1CCN(CC1)CC2=C3C(=CC=C2)N(C=C3Br)S(=O)(=O)C4=CC=CC=C4,CN1CCN(Cc2cccc3c2c(Br)cn3S(=O)(=O)c2ccccc2)CC1
734,CHEMBL2207386,P35368,,AGKMPGSBLMAGAX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23141912.0,INHIBITION,=,2.26,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886901.0,DTCT0023207,11493454,DTCC01302569,718295,52134,CN1CCN(CC1)CC2=C3C=CN(C3=CC=C2)S(=O)(=O)C4=CC=CC=C4Br,CN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2Br)CC1
735,CHEMBL2207388,P35368,,CULSPSVPJXBZMJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23141912.0,INHIBITION,=,0.99,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886901.0,DTCT0023207,11493452,DTCC01302571,814971,52134,CN1CCN(CC1)CC2=C3C=CN(C3=CC=C2)S(=O)(=O)C4=CC=CC=C4,CN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
736,CHEMBL220781,P35368,,NFPVLBNNIZXLMJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,8.91,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017521,DTCC00441484,584993,21852,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5S4)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1
737,CHEMBL220781,P35368,,NFPVLBNNIZXLMJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,8.91,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793038,DTCC00441484,610890,59712,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5S4)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1
738,CHEMBL222896,P35368,,LGOXMVBGBCZVNL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,17.38,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017512,DTCC00441527,552823,21852,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)OC)SC5=CC=CC=C52,COc1ccc(Cl)cc1N1CCN(CCn2c(C)nc3c(sc4ccccc43)c2=O)CC1
739,CHEMBL223289,P35368,,CQVOUGAYKKUSBQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,91.2,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017518,DTCC00441505,1134784,21852,COC1=C(C=C(C=C1)Cl)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5S4)NC3=O,COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccccc43)c2=O)CC1
740,CHEMBL2234448,P35368,,PQIXPACOBOVXFY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,125.89,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951047,DTCC01309294,1075775,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCCCC4,COc1ccccc1N1CCN(CC2COC3(CCCCC3)O2)CC1
741,CHEMBL223842,P35368,,WYMHFMJVMHNEJU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,LOG KI,,,,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,Not Determined,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017533,DTCC00441504,1523009,21852,C1CN(CCN1CCN2C(=O)C3=C(C4=CC=CC=C4N3)NC2=O)C5=CC(=C(C=C5)Cl)Cl,O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1
742,CHEMBL2261604,P35368,(+)-CYCLAZOSIN,XBRXTUGRUXGBPX-IRXDYDNUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,0.135,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from Homo sapiens (human) alpha1B adrenergic receptor,,,Med Chem Res,2004.0,13.0,3.0,,,911271.0,DTCT0023207,11592808,DTCC01317681,459449,35124,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@@H]3CCCC4)C(=O)C5=CC=CO5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC
743,CHEMBL2261604,P35368,(+)-CYCLAZOSIN,XBRXTUGRUXGBPX-IRXDYDNUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,0.6920000000000001,NM,,,,,,,,,,,,,,Binding affinity to alpha1B adrenoreceptor (unknown origin) by radioligand binding assay,,,Med Chem Res,2004.0,13.0,3.0,,,911259.0,DTCT0023207,11592752,DTCC01317681,459449,35124,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@@H]3CCCC4)C(=O)C5=CC=CO5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC
744,CHEMBL2261605,P35368,,FRGDMYZRAPGDCP-MOGJOVFKSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,0.309,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from Homo sapiens (human) alpha1B adrenergic receptor,,,Med Chem Res,2004.0,13.0,3.0,,,911271.0,DTCT0023207,11592807,DTCC01317682,264661,35124,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@@H]3CCCC4)C(=O)C5=CC=C(O5)Br)N)OC.Cl,COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC
745,CHEMBL2261606,P35368,,LHQZAGFDSDUQIS-APTPAJQOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,0.871,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from Homo sapiens (human) alpha1B adrenergic receptor,,,Med Chem Res,2004.0,13.0,3.0,,,911271.0,DTCT0023207,11592806,DTCC01317683,1106730,35124,CC1=CC=C(O1)C(=O)N2CCN([C@@H]3[C@@H]2CCCC3)C4=NC5=CC(=C(C=C5C(=N4)N)OC)OC.Cl,COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC
746,CHEMBL2261607,P35368,,JYZGMCKAPNYCEI-QJHJCNPRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,0.871,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from Homo sapiens (human) alpha1B adrenergic receptor,,,Med Chem Res,2004.0,13.0,3.0,,,911271.0,DTCT0023207,11592805,DTCC01317684,70826,35124,COC1=CC=C(O1)C(=O)N2CCN([C@@H]3[C@@H]2CCCC3)C4=NC5=CC(=C(C=C5C(=N4)N)OC)OC.Cl,COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@H]3CCCC[C@@H]32)o1
747,CHEMBL2261608,P35368,,OPWUDKHNJTZQCL-APTPAJQOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,1.38,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from Homo sapiens (human) alpha1B adrenergic receptor,,,Med Chem Res,2004.0,13.0,3.0,,,911271.0,DTCT0023207,11592804,DTCC01317685,1941738,35124,CC(=O)C1=CC=C(O1)C(=O)N2CCN([C@@H]3[C@@H]2CCCC3)C4=NC5=CC(=C(C=C5C(=N4)N)OC)OC.Cl,COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC
748,CHEMBL226335,P35368,RUTIN,IKGXIBQEEMLURG-NVPNHPEKSA-N,2,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14750361,DTCC00448737,2109891,69275,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
749,CHEMBL228278,P35368,,JFRXSPVSGNWHOD-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,133.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104181,DTCC00454828,1437645,22924,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OC5CC5)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC
750,CHEMBL228278,P35368,,JFRXSPVSGNWHOD-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,133.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195238,DTCC00454828,1442397,23970,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OC5CC5)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC
751,CHEMBL228279,P35368,,CQABPCACTMBCQC-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,305.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104179,DTCC00454830,1373284,22924,COC1=C(C=C(C=C1)Cl)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OC5CC5,COc1ccc(Cl)cc1S(=O)(=O)NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1
752,CHEMBL228280,P35368,,LVDRNYWTLKUNNT-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,107.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104178,DTCC00454831,1695829,22924,C1CC(CCC1NS(=O)(=O)C2=C(C=CC(=C2)Cl)F)N3CCC(CC3)C4=CC=CC=C4OC5CC5,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F
753,CHEMBL228332,P35368,,LVDRNYWTLKUNNT-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,337.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104177,DTCC00454832,887789,22924,C1CC(CCC1NS(=O)(=O)C2=C(C=CC(=C2)Cl)F)N3CCC(CC3)C4=CC=CC=C4OC5CC5,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F
754,CHEMBL228333,P35368,,ZIIYCNPQTIYWFF-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,340.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104175,DTCC00454834,1373285,22924,C1CC(CCC1NS(=O)(=O)C2=CC3=C(C=C2)OCO3)N4CCC(CC4)C5=CC=CC=C5OC6CC6,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2
755,CHEMBL228334,P35368,,USIWFTPEBGPOSA-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,123.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104174,DTCC00454835,1534710,22924,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
756,CHEMBL228334,P35368,,USIWFTPEBGPOSA-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,123.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195230,DTCC00454835,1539450,23970,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
757,CHEMBL228389,P35368,,USIWFTPEBGPOSA-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,368.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104173,DTCC00454836,1016663,22924,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
758,CHEMBL228389,P35368,,USIWFTPEBGPOSA-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,368.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195229,DTCC00454836,1021471,23970,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
759,CHEMBL228390,P35368,,PPAIEDLGYFCKEB-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,91.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104171,DTCC00454838,2015222,22924,C1CC(CCC1NS(=O)(=O)C2=CC3=C(C=C2)OCCO3)N4CCC(CC4)C5=CC=CC=C5OCC(F)(F)F,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2
760,CHEMBL228445,P35368,,HNTIGZIKHBPAFD-BGYRXZFFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,181.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104168,DTCC00454843,564387,22924,C1CC(CCC1NS(=O)(=O)C2=C(C=CC(=C2)Cl)F)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F
761,CHEMBL228494,P35368,,HNTIGZIKHBPAFD-MXVIHJGJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,787.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104167,DTCC00454844,564388,22924,C1CC(CCC1NS(=O)(=O)C2=C(C=CC(=C2)Cl)F)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F
762,CHEMBL228496,P35368,,RVPGPLCUKORXKA-BGYRXZFFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,261.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104166,DTCC00454846,305396,22924,C1CC(CCC1NS(=O)(=O)C2=CC=CC(=C2)OC(F)F)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1
763,CHEMBL228553,P35368,,RVPGPLCUKORXKA-MXVIHJGJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,355.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104165,DTCC00454847,2047424,22924,C1CC(CCC1NS(=O)(=O)C2=CC=CC(=C2)OC(F)F)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1
764,CHEMBL228554,P35368,,GAFGMUJBSNDSHX-MXVIHJGJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,302.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104163,DTCC00454849,1502371,22924,C1CC(CCC1NS(=O)(=O)C2=CC=C(C=C2)OC(F)F)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1
765,CHEMBL228606,P35368,,NZOIFXLLVJGITJ-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,4403.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104161,DTCC00111482,693627,22924,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCCF)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC
766,CHEMBL228606,P35368,,NZOIFXLLVJGITJ-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,4403.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195235,DTCC00111482,698472,23970,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCCF)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC
767,CHEMBL228607,P35368,,QLLKZBYEHJGRHK-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,681.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104159,DTCC00111484,1437646,22924,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCC(F)F)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC
768,CHEMBL228607,P35368,,QLLKZBYEHJGRHK-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,681.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195233,DTCC00111484,1442398,23970,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCC(F)F)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC
769,CHEMBL228608,P35368,,FEQSGCAJKJDTEE-ZRZAMGCNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,690.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104158,DTCC00111485,693628,22924,CC(C)OC1=C(C=CC(=C1)F)C2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC
770,CHEMBL228658,P35368,,FEQSGCAJKJDTEE-YHBQERECSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,639.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104157,DTCC00111486,1209855,22924,CC(C)OC1=C(C=CC(=C1)F)C2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC
771,CHEMBL228659,P35368,,AEJCTJSNUNXYQL-ZRZAMGCNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,299.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104156,DTCC00454852,370660,22924,CC(C)OC1=C(C=C(C=C1)F)C2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC
772,CHEMBL229084,P35368,,NHRXMVNDSUMAIN-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,1385.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104183,DTCC00454826,1146636,22924,CC(C)OC1=CC=CC=C1C2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)F)F,CC(C)Oc1ccccc1C1CCN(C2CCC(NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1
773,CHEMBL229085,P35368,,JFRXSPVSGNWHOD-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,141.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104182,DTCC00454827,338040,22924,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OC5CC5)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC
774,CHEMBL229085,P35368,,JFRXSPVSGNWHOD-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,141.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195239,DTCC00454827,342911,23970,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OC5CC5)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC
775,CHEMBL229429,P35368,,WTLBLIGPXACYET-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17571866.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from adrenergic alpha-1B receptor,,Synthesis and simple 18F-labeling of 3-fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile as a high affinity radioligand for imaging monkey brain metabotropic glutamate subtype-5 receptors with positron emission tomography.,J. Med. Chem.,2007.0,50.0,14.0,"Siméon FG, Brown AK, Zoghbi SS, Patterson VM, Innis RB, Pike VW",,439677.0,DTCT0023207,2110777,DTCC00452403,403579,22982,C1=C(C=C(C=C1C#N)F)C#CC2=CSC(=N2)CF,N#Cc1cc(F)cc(C#Cc2csc(CF)n2)c1
776,CHEMBL230951,P35368,L-HOMOCYSTEATE,VBOQYPQEPHKASR-VKHMYHEASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14730834,DTCC00002972,2104237,69159,C(CS(=O)(=O)O)[C@@H](C(=O)O)N,N[C@@H](CCS(=O)(=O)O)C(=O)O
777,CHEMBL2312225,P35368,,MFUWMPKHVOQTMZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,323.59,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756655,DTCC01335680,1094669,53287,COC1=C(C(=CC=C1)OC)OCCNCC2COCC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1
778,CHEMBL2312226,P35368,,MFUWMPKHVOQTMZ-QHCPKHFHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,1659.59,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756665,DTCC01335681,1832928,53287,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COCC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1cccc(OC)c1OCCNC[C@H]1COCC(c2ccccc2)(c2ccccc2)O1
779,CHEMBL2312227,P35368,,HIASEHRDTBGCHW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,56.23,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756643,DTCC01335682,738492,53287,COC1=CC=CC=C1OCCNCC2COCC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1
780,CHEMBL2312536,P35368,,HIASEHRDTBGCHW-QHCPKHFHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,416.87,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756658,DTCC01335989,706204,53287,COC1=CC=CC=C1OCCNC[C@H]2COCC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1ccccc1OCCNC[C@H]1COCC(c2ccccc2)(c2ccccc2)O1
781,CHEMBL2312537,P35368,,ZCYQPTKLMLTYQD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,120.23,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756648,DTCC01335990,770715,53287,C1C(OC(CO1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4,c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1
782,CHEMBL2312538,P35368,,ZCYQPTKLMLTYQD-DEOSSOPVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,169.82,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756651,DTCC01335991,1386042,53287,C1[C@@H](OC(CO1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4,c1ccc(OCCNC[C@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1
783,CHEMBL232592,P35368,,HEEKUWDLPPDKMK-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,201.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166116,DTCC00464301,1151461,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC=C4[N+](=O)[O-],CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1
784,CHEMBL232593,P35368,,HEEKUWDLPPDKMK-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,236.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166115,DTCC00464302,1021362,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC=C4[N+](=O)[O-],CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1
785,CHEMBL232607,P35368,,KCWSSYYCEGZXTI-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,169.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166070,DTCC00464390,1378092,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CN=C4)OC,COc1ccncc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
786,CHEMBL232609,P35368,,LASDMXNHWPCZMK-KDURUIRLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,125.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166068,DTCC00464392,827489,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(N=C4)Cl)Br,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1
787,CHEMBL232779,P35368,,IMBDRGLQGCAYLF-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,108.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166114,DTCC00464307,1668505,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC(=C4)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cccc(F)c3)CC2)CC1
788,CHEMBL232780,P35368,,IMBDRGLQGCAYLF-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,545.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166113,DTCC00464308,1603894,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC(=C4)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cccc(F)c3)CC2)CC1
789,CHEMBL233407,P35368,,JOQJONDKZULBPP-BGYRXZFFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,120.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166084,DTCC00464375,1760268,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C(=CC=C4)Cl)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1
790,CHEMBL233410,P35368,,DGLBBHYIYLVQGF-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,101.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166082,DTCC00464380,1151463,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=C(C=C4)Cl)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1
791,CHEMBL233416,P35368,,ZDNRYSVLOMAJEZ-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,334.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166111,DTCC00464312,147845,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC(=C4)C(F)(F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1
792,CHEMBL2335706,P35368,MARISTACHONE A,VGUIDVOAJKITDB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23268694.0,INHIBITION,,,,,,,,,,,,,,,,,Displacement of [3H]prazosin from alpha1B receptor (unknown origin) at 10 uM,Not Active,Unprecedented Polyketides from a Marine Sponge-Associated Stachylidium sp.,J. Nat. Prod.,2013.0,76.0,3.0,"Almeida C, Eguereva E, Kehraus S, König GM",,942207.0,DTCT0023207,11820889,DTCC01349130,964975,53803,CC1=C(C=C(C(=C1OC)COC)C(C)O)O,COCc1c(C(C)O)cc(O)c(C)c1OC
793,CHEMBL233582,P35368,,DGLBBHYIYLVQGF-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,243.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166081,DTCC00464381,244417,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=C(C=C4)Cl)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1
794,CHEMBL233584,P35368,,HBVMKSZWZCERSH-ZRZAMGCNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,364.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166077,DTCC00464383,408408,23441,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCN(CC3)C4=CC=CC=C4OCC5CC5)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OCC4CC4)CC3)CC2)cc1OC
795,CHEMBL233592,P35368,,ZDNRYSVLOMAJEZ-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,222.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166112,DTCC00464311,115293,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC(=C4)C(F)(F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1
796,CHEMBL233623,P35368,,CHYHMJYTWVQCFW-YHBQERECSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,218.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166099,DTCC00464332,1728484,23441,CC1=CC(=C(C=C1)OC)S(=O)(=O)NC2CCC(CC2)N3CCN(CC3)C4=CC=CC=C4OC(C)C,COc1ccc(C)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
797,CHEMBL233790,P35368,,LASDMXNHWPCZMK-WGSAOQKQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,279.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166067,DTCC00464393,342808,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(N=C4)Cl)Br,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1
798,CHEMBL233814,P35368,,SHLHJQDYUNFBDK-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,162.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166098,DTCC00464335,989160,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)F)OC,COc1ccc(F)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
799,CHEMBL233816,P35368,,XRCQNHQVZIQOBE-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,78.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166096,DTCC00464338,1151462,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
800,CHEMBL233816,P35368,,XRCQNHQVZIQOBE-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,399.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166079,DTCC00464338,1151464,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
801,CHEMBL233849,P35368,,MDOKTLACQIDXQG-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,42.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166094,DTCC00464349,569222,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)Br)OC,COc1ccc(Br)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
802,CHEMBL234194,P35368,,AOESATFDEMWHLJ-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,424.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166101,DTCC00464329,698374,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)OC)OC,COc1ccc(OC)c(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1
803,CHEMBL234231,P35368,,VXZHIQQSDIJVSS-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,473.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166092,DTCC00464353,1182359,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)C(F)(F)F)OC,COc1ccc(C(F)(F)F)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
804,CHEMBL234232,P35368,,VXZHIQQSDIJVSS-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,258.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166091,DTCC00464356,408407,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)C(F)(F)F)OC,COc1ccc(C(F)(F)F)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
805,CHEMBL234422,P35368,,FFXLCCZAXLBJFW-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,173.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166089,DTCC00464361,179911,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)[N+](=O)[O-])OC,COc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
806,CHEMBL234423,P35368,,PNMMHGYXIWNCEE-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,167.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166088,DTCC00464365,472214,23441,CC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCN(CC3)C4=CC=CC=C4OC(C)C)Cl,Cc1ccc(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl
807,CHEMBL234474,P35368,,HQURDNFFLCLLLC-ZRZAMGCNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,601.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166076,DTCC00464384,1921433,23441,COC1=C(C=C(C=C1)Cl)S(=O)(=O)NC2CCC(CC2)N3CCN(CC3)C4=CC=CC=C4OCC5CC5,COc1ccc(Cl)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OCC3CC3)CC2)CC1
808,CHEMBL234476,P35368,,BQRCXSWHZYCROY-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,952.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166075,DTCC00464385,1728485,23441,C1CC1COC2=CC=CC=C2N3CCN(CC3)C4CCC(CC4)NS(=O)(=O)C5=C(C=CC(=C5)Cl)F,O=S(=O)(NC1CCC(N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1cc(Cl)ccc1F
809,CHEMBL234607,P35368,,XRCQNHQVZIQOBE-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,250.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166095,DTCC00464340,1603895,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
810,CHEMBL234609,P35368,,PNMMHGYXIWNCEE-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,193.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166087,DTCC00464366,1312917,23441,CC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCN(CC3)C4=CC=CC=C4OC(C)C)Cl,Cc1ccc(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl
811,CHEMBL234649,P35368,,OCDNDDLEORDHLQ-PSWAGMNNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,82.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166074,DTCC00464386,1378091,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)CC4=CC=CC=C4,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)Cc3ccccc3)CC2)CC1
812,CHEMBL234650,P35368,,OCDNDDLEORDHLQ-RQNOJGIXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,200.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166073,DTCC00464387,2019954,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)CC4=CC=CC=C4,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)Cc3ccccc3)CC2)CC1
813,CHEMBL234669,P35368,,BXGCCZDRUAOMRC-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,487.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166122,DTCC00464296,1442285,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC=C4,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccccc3)CC2)CC1
814,CHEMBL234679,P35368,,PAUUPYPPPJQSIG-ZRZAMGCNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,217.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166121,DTCC00464297,43165,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC=C4C#N,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccccc3C#N)CC2)CC1
815,CHEMBL234680,P35368,,PAUUPYPPPJQSIG-YHBQERECSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,31.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166120,DTCC00464298,1792759,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC=C4C#N,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccccc3C#N)CC2)CC1
816,CHEMBL234681,P35368,,MMNXGMKPQQFESW-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,385.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166118,DTCC00464300,1312915,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC=C4F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccccc3F)CC2)CC1
817,CHEMBL234854,P35368,,XOZBPBSXMJMBOL-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,400.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166072,DTCC00464388,1571324,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CN=CC=C4,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cccnc3)CC2)CC1
818,CHEMBL234874,P35368,,VZKPTHAFKKTYRC-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,150.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166110,DTCC00464313,1474779,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=C(C=C4)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)CC1
819,CHEMBL236617,P35368,,UHPXZGGJCMUMGZ-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,195.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166108,DTCC00464317,924488,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=C(C=C4)S(=O)(=O)C,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1
820,CHEMBL236618,P35368,,UHPXZGGJCMUMGZ-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,392.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166107,DTCC00464318,2084294,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=C(C=C4)S(=O)(=O)C,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1
821,CHEMBL236621,P35368,,YJXYZPLPRPNAPZ-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,126.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166103,DTCC00464326,1312916,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC
822,CHEMBL236621,P35368,,YJXYZPLPRPNAPZ-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,126.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195244,DTCC00464326,1313025,23970,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC
823,CHEMBL236830,P35368,,STAISUAHBRKLLH-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,174.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166106,DTCC00464320,1086591,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=C(C=C4)OC(F)(F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1
824,CHEMBL236832,P35368,,AOESATFDEMWHLJ-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,153.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166102,DTCC00464327,1760267,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)OC)OC,COc1ccc(OC)c(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1
825,CHEMBL2381116,P35368,,KLJVDMAOKMSBQX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23535330.0,INHIBITION,=,21.8,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha-1B receptor (unknown origin) at 1 ug/mL relative to control,,Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors.,Bioorg. Med. Chem. Lett.,2013.0,23.0,9.0,"Huang X, Cheng CC, Fischmann TO, Duca JS, Richards M, Tadikonda PK, Reddy PA, Zhao L, Arshad Siddiqui M, Parry D, Davis N, Seghezzi W, Wiswell D, Shipps GW",,959504.0,DTCT0023207,12441012,DTCC01374670,318350,54512,COC1=CC2=C(CN(C2=O)C3=NC(=CS3)C(=O)NC4=C(C=CN=C4)N5CCNCC5)C=C1,COc1ccc2c(c1)C(=O)N(c1nc(C(=O)Nc3cnccc3N3CCNCC3)cs1)C2
826,CHEMBL238401,P35368,,LVRHAAKFXRNPFH-RQNOJGIXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,109.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195242,DTCC00111808,1119200,23970,CCN(C1CCC(CC1)N2CCN(CC2)C3=CC=CC=C3OC(C)C)S(=O)(=O)C4=CC(=C(C=C4)OC)OC,CCN(C1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1
827,CHEMBL238402,P35368,,KBDQCTAMVLZQJL-MXVIHJGJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,39.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195231,DTCC00466780,634112,23970,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCN(CC3)C4=CC=CC=C4OCC(F)(F)F)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
828,CHEMBL238456,P35368,,HLBPILNTTPELKS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214257,DTCC00473103,99263,24162,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)C#N.C(=O)O,CC(C)N1CCC(Oc2ccc(N3CCN(C(=O)c4ccc(C#N)cc4)CC3=O)cc2)CC1
829,CHEMBL238503,P35368,,NQEWRKQNDSWJNM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214280,DTCC00473048,1135118,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=NC=C4.C(=O)O,O=C(c1ccncc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1
830,CHEMBL238504,P35368,,QUXZAXNZEZALDL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214279,DTCC00473049,488850,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=C5N=CC=CN5N=C4.C(=O)O,O=C(c1cnn2cccnc12)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1
831,CHEMBL238870,P35368,,DTTUPIQCRQKVGO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214272,DTCC00473079,1873318,24162,C1CCCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F.C(=O)O,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCCCC3)cc2)C(=O)C1
832,CHEMBL238871,P35368,,MMRPNJJCBOGWTP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214270,DTCC00473081,1361775,24162,C1CCCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC(=CC(=C4)F)F.C(=O)O,O=C(c1cc(F)cc(F)c1)N1CCN(c2ccc(OCCCN3CCCCCC3)cc2)C(=O)C1
833,CHEMBL238872,P35368,,FOCPBTUUAJZSNL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214269,DTCC00473082,1102918,24162,C1CCCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=C(C=C(C=C4)F)F.C(=O)O,O=C(c1ccc(F)cc1F)N1CCN(c2ccc(OCCCN3CCCCCC3)cc2)C(=O)C1
834,CHEMBL239080,P35368,,CXJWCTREHRSRNG-VEIFNGETSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,794.33,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214267,DTCC00473089,778878,24162,C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)C#N.C(=O)O,C[C@@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(C#N)cc3)CC2=O)cc1
835,CHEMBL239081,P35368,,JQJNQYUMEBRJKC-GMUIIQOCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,1584.89,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214266,DTCC00473091,1873319,24162,C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC(=CC(=C4)F)F.C(=O)O,C[C@@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3cc(F)cc(F)c3)CC2=O)cc1
836,CHEMBL239099,P35368,,IBEQZETWFPHMMF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,794.33,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214250,DTCC00473108,1937632,24162,C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=CC=C(C=C5)C#N.C(=O)O,N#Cc1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1
837,CHEMBL239101,P35368,,HTCLEEXSMMUUES-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,794.33,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214248,DTCC00473111,1684753,24162,C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=CC(=CC(=C5)F)F.C(=O)O,O=C(c1cc(F)cc(F)c1)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1
838,CHEMBL2391541,P35368,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23602445.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Prazosin from human recombinant adrenergic alpha1B receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,964972.0,DTCT0023207,12464767,DTCC01379235,1386484,54821,COC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12
839,CHEMBL2391541,P35368,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26739781.0,KI,<,10000.0,NM,,,,,,,,,,,,,,Binding affinity to alpha-1B adrenergic receptor (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016.0,26.0,3.0,"Cozzi NV, Daley PF.",,1550144.0,DTCT0023207,61521,DTCC01379235,1369782,65871,COC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12
840,CHEMBL239299,P35368,,VPAXWNMEGKLSOJ-GMUIIQOCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,794.33,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214264,DTCC00473092,293908,24162,C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=C(C=C(C=C4)F)F.C(=O)O,C[C@@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(F)cc3F)CC2=O)cc1
841,CHEMBL239300,P35368,,JHRLWHBYMHILPR-FYZYNONXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214263,DTCC00473095,1329060,24162,C[C@H]1CCCN1CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F.C(=O)O,C[C@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(F)cc3)CC2=O)cc1
842,CHEMBL239321,P35368,,VDZPNNUVDOABNY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214247,DTCC00473115,1652527,24162,C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=C(C=C(C=C5)F)F.C(=O)O,O=C(c1ccc(F)cc1F)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1
843,CHEMBL239510,P35368,,CXJWCTREHRSRNG-BDQAORGHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214262,DTCC00473096,1329061,24162,C[C@H]1CCCN1CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)C#N.C(=O)O,C[C@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(C#N)cc3)CC2=O)cc1
844,CHEMBL239724,P35368,,VPAXWNMEGKLSOJ-FERBBOLQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214260,DTCC00473100,67021,24162,C[C@H]1CCCN1CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=C(C=C(C=C4)F)F.C(=O)O,C[C@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(F)cc3F)CC2=O)cc1
845,CHEMBL2397268,P35368,,JAKRIQWSQWQJHM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23627311.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 5 uM by psychoactive drug screening programme assay,,Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.,J. Med. Chem.,2013.0,56.0,13.0,"Santangelo Freel RM, Ogden KK, Strong KL, Khatri A, Chepiga KM, Jensen HS, Traynelis SF, Liotta DC",,968914.0,DTCT0023207,12483485,DTCC01381880,1353904,54936,COC1=CC=C(C=C1)OCC2C3=C(CCN2C(=O)C4=CC(=CC=C4)Br)C=C(C=C3)OCC5=CC=CC=C5,COc1ccc(OCC2c3ccc(OCc4ccccc4)cc3CCN2C(=O)c2cccc(Br)c2)cc1
846,CHEMBL239744,P35368,,WSXMMXMXSWZQOD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214245,DTCC00473119,585290,24162,C1CCC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=CC=C(C=C5)Cl.C(=O)O,O=C(c1ccc(Cl)cc1)N1CCN(c2ccc(OC3CCN(C4CCCC4)CC3)cc2)C(=O)C1
847,CHEMBL239806,P35368,,GAQHMLXJZZLREV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,1940.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,811931,DTCC00330962,1915506,15485,CC1=C(C(N(C(=O)N1)C(=O)N2CCC(CC2)N3CCC(CC3)(C4=CC=CC=C4)C(=O)OC)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C1c1ccc(F)c(F)c1
848,CHEMBL239963,P35368,,HWSMMNKRBIFEDV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214244,DTCC00473123,1716130,24162,C1CCC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=CC=C(C=C5)F.C(=O)O,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OC3CCN(C4CCCC4)CC3)cc2)C(=O)C1
849,CHEMBL239964,P35368,,BTGWCFVBMYAJIJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214243,DTCC00473124,67022,24162,C1CCC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=CC=C(C=C5)C#N.C(=O)O,N#Cc1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCCC5)CC4)cc3)C(=O)C2)cc1
850,CHEMBL239975,P35368,,GXILWBIQFGWJQN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214287,DTCC00473039,1037730,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1
851,CHEMBL240141,P35368,,XSOFCOCSPTUCJQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214275,DTCC00473053,844084,24162,C1CCN(C1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)C#N.C(=O)O,N#Cc1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCC4)cc3)C(=O)C2)cc1
852,CHEMBL240178,P35368,,BPDXEOHDRPKAKE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214242,DTCC00473126,1491101,24162,CS(=O)(=O)C1=CC=C(C=C1)C(=O)N2CCN(C(=O)C2)C3=CC=C(C=C3)OC4CCN(CC4)C5CCCC5.C(=O)O,CS(=O)(=O)c1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCCC5)CC4)cc3)C(=O)C2)cc1
853,CHEMBL240185,P35368,,RAGNKICHAZGMOB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,2511.89,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214286,DTCC00473040,1037731,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F.C(=O)O,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1
854,CHEMBL240187,P35368,,JGPLBVWXJOJNGO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214284,DTCC00473042,1231057,24162,CS(=O)(=O)C1=CC=C(C=C1)C(=O)N2CCN(C(=O)C2)C3=CC=C(C=C3)OCCCN4CCCCC4,CS(=O)(=O)c1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCC4)cc3)C(=O)C2)cc1
855,CHEMBL240352,P35368,,DYKCULOUGOBIOM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214273,DTCC00473055,1102917,24162,C1CCN(C1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=C(C=C(C=C4)F)F,O=C(c1ccc(F)cc1F)N1CCN(c2ccc(OCCCN3CCCC3)cc2)C(=O)C1
856,CHEMBL240393,P35368,,DIQMIXLXBUWZKA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214283,DTCC00473044,1905615,24162,CS(=O)(=O)C1=CC=CC(=C1)C(=O)N2CCN(C(=O)C2)C3=CC=C(C=C3)OCCCN4CCCCC4.C(=O)O,CS(=O)(=O)c1cccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCC4)cc3)C(=O)C2)c1
857,CHEMBL240394,P35368,,ZOCDSDXGMIDSSE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214282,DTCC00473045,1652526,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC(=CC(=C4)F)F.C(=O)O,O=C(c1cc(F)cc(F)c1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1
858,CHEMBL240395,P35368,,JWVDVKRDYUKSCG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214393,DTCC00473047,940803,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)C(=O)N5CCC5.C(=O)O,O=C(c1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCC4)cc3)C(=O)C2)cc1)N1CCC1
859,CHEMBL240565,P35368,,QGFBWPZGQZAHLL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214241,DTCC00473128,359090,24162,CS(=O)(=O)C1=CC=CC(=C1)C(=O)N2CCN(C(=O)C2)C3=CC=C(C=C3)OC4CCN(CC4)C5CCCC5.C(=O)O,CS(=O)(=O)c1cccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCCC5)CC4)cc3)C(=O)C2)c1
860,CHEMBL240567,P35368,,ALWGROOEKGXBRR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214240,DTCC00473132,391827,24162,C1CCC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=CC(=CC(=C5)F)F.C(=O)O,O=C(c1cc(F)cc(F)c1)N1CCN(c2ccc(OC3CCN(C4CCCC4)CC3)cc2)C(=O)C1
861,CHEMBL240773,P35368,QUINPIROLE,FTSUPYGMFAPCFZ-ZWNOBZJWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14757184,DTCC00473134,2104029,69012,CCCN1CCC[C@H]2[C@H]1CC3=C(C2)NN=C3,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
862,CHEMBL2413153,P35368,,SXCVVYUSUGUSMW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23816046.0,KI,=,26.8,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor (unknown origin),,"Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.",Bioorg. Med. Chem.,2013.0,21.0,17.0,"Majo VJ, Milak MS, Prabhakaran J, Mali P, Savenkova L, Simpson NR, Mann JJ, Parsey RV, Kumar JS",,977150.0,DTCT0023207,12541939,DTCC01388347,1527733,55433,CN1C(=O)C=NN(C1=O)CCCCN2CCN(CC2)C3=CC=CC=C3OCCF,Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O
863,CHEMBL2413154,P35368,,MEKSQRMXWZHFIP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23816046.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor (unknown origin),,"Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.",Bioorg. Med. Chem.,2013.0,21.0,17.0,"Majo VJ, Milak MS, Prabhakaran J, Mali P, Savenkova L, Simpson NR, Mann JJ, Parsey RV, Kumar JS",,977150.0,DTCT0023207,12541938,DTCC01388348,1430770,55433,CN1C(=O)C=NN(C1=O)CCCCN2CCN(CC2)C3=CC=CC=C3OC,COc1ccccc1N1CCN(CCCCn2ncc(=O)n(C)c2=O)CC1
864,CHEMBL2419765,P35368,,UOWWWPYFAPQMPE-HNNXBMFYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23902232.0,KI,=,489.78,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human alpha-1B adrenoreceptor expressed in CHO cells after 30 mins,,"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective a1D-adrenoceptor antagonist.",J. Med. Chem.,2013.0,56.0,16.0,"Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, Chiodini G, Gobbi M, Laurino P, Micucci M, Straniero V, Valoti E",,978686.0,DTCT0023207,12543791,DTCC01392456,1009715,55571,COC1=C(C2=C(C=C1)C=CN2)OCCNC[C@H]3COC4=CC=CC=C4O3,COc1ccc2cc[nH]c2c1OCCNC[C@H]1COc2ccccc2O1
865,CHEMBL2419766,P35368,,UOWWWPYFAPQMPE-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23902232.0,KI,=,1905.46,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human alpha-1B adrenoreceptor expressed in CHO cells after 30 mins,,"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective a1D-adrenoceptor antagonist.",J. Med. Chem.,2013.0,56.0,16.0,"Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, Chiodini G, Gobbi M, Laurino P, Micucci M, Straniero V, Valoti E",,978686.0,DTCT0023207,12543790,DTCC01392457,298425,55571,COC1=C(C2=C(C=C1)C=CN2)OCCNC[C@@H]3COC4=CC=CC=C4O3,COc1ccc2cc[nH]c2c1OCCNC[C@@H]1COc2ccccc2O1
866,CHEMBL2419769,P35368,,HLAXELILYCMGLF-RSAXXLAASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23902232.0,KI,=,28.84,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human alpha-1B adrenoreceptor expressed in CHO cells after 30 mins,,"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective a1D-adrenoceptor antagonist.",J. Med. Chem.,2013.0,56.0,16.0,"Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, Chiodini G, Gobbi M, Laurino P, Micucci M, Straniero V, Valoti E",,978686.0,DTCT0023207,12543795,DTCC01392458,1780863,55571,COC1=C(C2=C(C=C1)C=CO2)OCCNC[C@H]3COC4=CC=CC=C4O3.Cl,COc1ccc2ccoc2c1OCCNC[C@H]1COc2ccccc2O1
867,CHEMBL2419770,P35368,,HLAXELILYCMGLF-XFULWGLBSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23902232.0,KI,=,125.89,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human alpha-1B adrenoreceptor expressed in CHO cells after 30 mins,,"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective a1D-adrenoceptor antagonist.",J. Med. Chem.,2013.0,56.0,16.0,"Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, Chiodini G, Gobbi M, Laurino P, Micucci M, Straniero V, Valoti E",,978686.0,DTCT0023207,12543794,DTCC01392459,1780864,55571,COC1=C(C2=C(C=C1)C=CO2)OCCNC[C@@H]3COC4=CC=CC=C4O3.Cl,COc1ccc2ccoc2c1OCCNC[C@@H]1COc2ccccc2O1
868,CHEMBL2419771,P35368,,RYWXHEQNEXECJD-RSAXXLAASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23902232.0,KI,=,21.88,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human alpha-1B adrenoreceptor expressed in CHO cells after 30 mins,,"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective a1D-adrenoceptor antagonist.",J. Med. Chem.,2013.0,56.0,16.0,"Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, Chiodini G, Gobbi M, Laurino P, Micucci M, Straniero V, Valoti E",,978686.0,DTCT0023207,12543793,DTCC01392460,848614,55571,COC1=C(C2=C(CCO2)C=C1)OCCNC[C@H]3COC4=CC=CC=C4O3.Cl,COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)OCC2
869,CHEMBL2419772,P35368,,RYWXHEQNEXECJD-XFULWGLBSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23902232.0,KI,=,162.18,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human alpha-1B adrenoreceptor expressed in CHO cells after 30 mins,,"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective a1D-adrenoceptor antagonist.",J. Med. Chem.,2013.0,56.0,16.0,"Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, Chiodini G, Gobbi M, Laurino P, Micucci M, Straniero V, Valoti E",,978686.0,DTCT0023207,12543792,DTCC01392461,1592149,55571,COC1=C(C2=C(CCO2)C=C1)OCCNC[C@@H]3COC4=CC=CC=C4O3.Cl,COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)OCC2
870,CHEMBL242507,P35368,,FZQMRWTUMFXQNY-ZWKOTPCHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17276073.0,KI,=,0.871,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic alpha-1b receptor expressed in CHO cells,,Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.,Bioorg. Med. Chem.,2007.0,15.0,6.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Leonardi A, Poggesi E, Giardinà D",,442028.0,DTCT0023207,2146165,DTCC00460421,1426405,23212,CC1=CC=C(O1)C(=O)N2CCN([C@H]3[C@@H]2CCCC3)C4=NC5=CC(=C(C=C5C(=N4)N)OC)OC,COc1cc2nc(N3CCN(C(=O)c4ccc(C)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
871,CHEMBL242508,P35368,,YPZGDVOCTNSNRN-DLBZAZTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17276073.0,KI,=,0.871,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic alpha-1b receptor expressed in CHO cells,,Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.,Bioorg. Med. Chem.,2007.0,15.0,6.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Leonardi A, Poggesi E, Giardinà D",,442028.0,DTCT0023207,2146164,DTCC00460422,1134964,23212,COC1=CC=C(O1)C(=O)N2CCN([C@H]3[C@@H]2CCCC3)C4=NC5=CC(=C(C=C5C(=N4)N)OC)OC,COc1ccc(C(=O)N2CCN(c3nc(N)c4cc(OC)c(OC)cc4n3)[C@@H]3CCCC[C@@H]32)o1
872,CHEMBL242723,P35368,,HDPKXGPZKXRUAV-ZWKOTPCHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17276073.0,KI,=,1.38,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic alpha-1b receptor expressed in CHO cells,,Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.,Bioorg. Med. Chem.,2007.0,15.0,6.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Leonardi A, Poggesi E, Giardinà D",,442028.0,DTCT0023207,2146163,DTCC00460423,66883,23212,CC(=O)C1=CC=C(O1)C(=O)N2CCN([C@H]3[C@@H]2CCCC3)C4=NC5=CC(=C(C=C5C(=N4)N)OC)OC,COc1cc2nc(N3CCN(C(=O)c4ccc(C(C)=O)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
873,CHEMBL242724,P35368,,UIAXVFLURTXSJC-DLBZAZTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17276073.0,KI,=,0.24,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic alpha-1b receptor expressed in CHO cells,,Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.,Bioorg. Med. Chem.,2007.0,15.0,6.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Leonardi A, Poggesi E, Giardinà D",,442028.0,DTCT0023207,2146162,DTCC00460424,876409,23212,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5=CC=CS5)N)OC,COc1cc2nc(N3CCN(C(=O)c4cccs4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
874,CHEMBL242725,P35368,,WORVXKSIJZQWMH-RBUKOAKNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17276073.0,KI,=,5.89,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic alpha-1b receptor expressed in CHO cells,,Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.,Bioorg. Med. Chem.,2007.0,15.0,6.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Leonardi A, Poggesi E, Giardinà D",,442028.0,DTCT0023207,2146160,DTCC00460426,682068,23212,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5=CC=CC=N5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccccn4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
875,CHEMBL242934,P35368,,LHLZWQUFUNHDHT-VQTJNVASSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17276073.0,KI,=,0.49,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic alpha-1b receptor expressed in CHO cells,,Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.,Bioorg. Med. Chem.,2007.0,15.0,6.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Leonardi A, Poggesi E, Giardinà D",,442028.0,DTCT0023207,2146159,DTCC00460427,746692,23212,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5=CC=CC=C5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccccc4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
876,CHEMBL2429890,P35368,,VGYQUDBPYFLBLJ-PTCVETCVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586602,DTCC01398005,1268545,55935,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC6=CC7=C(C=C6)OCO7,c1cc2c(cc1CN[C@H]1C3C4CC5C6C4CC3C6C51)OCO2
877,CHEMBL2431120,P35368,,SWEOAXMICIJCQC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,ACTIVITY,=,63.0,%,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor (unknown origin) at 10 uM relative to control,,,ACS Med. Chem. Lett.,2013.0,4.0,9.0,,,986226.0,DTCT0023207,12587429,DTCC01397077,771298,55848,COC1=CC=CC=C1N2CCN(CC2)C3=NC(=NC4=CC(=C(C=C43)OC)OC)C5CC5,COc1cc2nc(C3CC3)nc(N3CCN(c4ccccc4OC)CC3)c2cc1OC
878,CHEMBL2432038,P35368,,OKCSFONJDXUZOU-CAUKCHDASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586601,DTCC01398006,913793,55935,C1CCC(CC1)CN[C@H]2C3C4CC5C2C6C3CC4C56,C1CCC(CN[C@H]2C3C4CC5C6C4CC3C6C52)CC1
879,CHEMBL2432039,P35368,,CHZUEGVOEFMIJH-ZKRSMWHSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586600,DTCC01398007,1845582,55935,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC67C8C9C6C1C9C8C71,C1C2C3CC4C2C2C1C3[C@H](NCC13C5C6C7C5C1C7C63)C42
880,CHEMBL2432040,P35368,,MPBJQDFYALBXED-CAUKCHDASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586627,DTCC01398008,1139742,55935,CN(CC1=CC=CC=C1)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(Cc1ccccc1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
881,CHEMBL2432041,P35368,,MSTPNDDVMWUDFF-CAUKCHDASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586626,DTCC01398009,71453,55935,CN(CC1=CC(=CC=C1)F)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(Cc1cccc(F)c1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
882,CHEMBL2432042,P35368,,LNTMHZZRTAQEJQ-CPVTZQMHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586625,DTCC01398010,589816,55935,CN(CC1=CC(=C(C=C1)OC)OC)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,COc1ccc(CN(C)[C@H]2C3C4CC5C3C(=O)C3C5C4C32)cc1OC
883,CHEMBL2432043,P35368,,LKFSLMWAVKMONG-KPCGFGSOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586624,DTCC01398011,2040745,55935,CN(CC1=CN=CC=C1)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(Cc1cccnc1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
884,CHEMBL2432044,P35368,,IDXFKHDXIHNWAI-RAOGCBAWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586623,DTCC01398012,2040746,55935,CN(CCC1=CC=CC=C1)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(CCc1ccccc1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
885,CHEMBL2432045,P35368,,ZWCQZHOWEDKJBN-CAUKCHDASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,=,6196.0,NM,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600208,DTCC01398013,1657028,55935,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC6=CC=CC=C6,c1ccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc1
886,CHEMBL2432046,P35368,,KNBHNNRMMAKKFI-SEDVZXITSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586606,DTCC01398014,1009784,55935,COC1=C(C=C(C=C1)CN[C@H]2C3C4CC5C2C6C3CC4C56)OC,COc1ccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc1OC
887,CHEMBL2432047,P35368,,CNPQMMDLXZBMLB-KPCGFGSOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600207,DTCC01398015,1268546,55935,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC6=CN=CC=C6,c1cncc(CN[C@H]2C3C4CC5C6C4CC3C6C52)c1
888,CHEMBL2432048,P35368,,KBAKPEFQDPCCTP-RAOGCBAWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586605,DTCC01398016,1495532,55935,C1C2C3CC4C2[C@@H](C5C1C3C45)NCCC6=CC=CC=C6,c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)cc1
889,CHEMBL2432049,P35368,,DUZKXKAAUHDBQA-CAUKCHDASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,=,3442.0,NM,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600206,DTCC01398017,298486,55935,C1C2C3CC4C2[C@@H](C5C1C3C45)NCCC6=CC=CC=N6,c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1
890,CHEMBL2432050,P35368,,SJWCMFMHVZULSJ-DKSPCFMDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600205,DTCC01398018,881050,55935,C1C2C3CC4C2[C@@H](C5C1C3C45)NCCCC6=CC(=CC=C6)F,Fc1cccc(CCCN[C@H]2C3C4CC5C6C4CC3C6C52)c1
891,CHEMBL2432051,P35368,,CPLYGLAQLNAQOI-SEDVZXITSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586603,DTCC01398019,71454,55935,COC1=CC(=CC(=C1OC)OC)CN[C@H]2C3C4CC5C2C6C3CC4C56,COc1cc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc(OC)c1OC
892,CHEMBL2432052,P35368,,SGFPDDMJMPKKTB-RAOGCBAWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586622,DTCC01398020,783458,55935,CN(CCC1=CC(=CC=C1)F)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(CCc1cccc(F)c1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
893,CHEMBL2432053,P35368,,DEOOAAFCKARVDM-CAUKCHDASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586621,DTCC01398021,751332,55935,CN(CCC1=CC=CC=N1)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(CCc1ccccn1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
894,CHEMBL2432054,P35368,,QQUOSDRKLSIRED-DKSPCFMDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586620,DTCC01398022,945256,55935,CN(CCCC1=CC(=CC=C1)F)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(CCCc1cccc(F)c1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
895,CHEMBL2432055,P35368,,VNGQWOKKSKAESQ-RAOGCBAWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586619,DTCC01398023,2040748,55935,CN(CC1=CC=CC=C1)[C@H]2C3C4CC5C2C6C3CC4C56,CN(Cc1ccccc1)[C@H]1C2C3CC4C5C3CC2C5C41
896,CHEMBL2432056,P35368,,JHFKLSFCMAHSDK-LLOIJXFCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586617,DTCC01398024,103846,55935,CN(CC1=CC(=C(C=C1)OC)OC)[C@H]2C3C4CC5C2C6C3CC4C56,COc1ccc(CN(C)[C@H]2C3C4CC5C6C4CC3C6C52)cc1OC
897,CHEMBL2432057,P35368,,QHQJBDOHEUWLBB-CAUKCHDASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586616,DTCC01398025,71455,55935,CN(CC1=CN=CC=C1)[C@H]2C3C4CC5C2C6C3CC4C56,CN(Cc1cccnc1)[C@H]1C2C3CC4C5C3CC2C5C41
898,CHEMBL2432058,P35368,,MJOVYQVAQIHDSE-DKSPCFMDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586615,DTCC01398026,2008169,55935,CN(CCC1=CC=CC=C1)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CCc1ccccc1)[C@H]1C2C3CC4C5C3CC2C5C41
899,CHEMBL2432059,P35368,,YLVXPEMITKSDOS-RAOGCBAWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586613,DTCC01398027,2008170,55935,CN(CCC1=CC=CC=N1)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CCc1ccccn1)[C@H]1C2C3CC4C5C3CC2C5C41
900,CHEMBL2432060,P35368,,CKFQOWSPJPMWEK-IINHSQADSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586612,DTCC01398028,1235634,55935,CN(CCCC1=CC(=CC=C1)F)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CCCc1cccc(F)c1)[C@H]1C2C3CC4C5C3CC2C5C41
901,CHEMBL2432061,P35368,,ZFZXJOHWFSRUAO-LLOIJXFCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586611,DTCC01398029,1720366,55935,CN(CC1=CC(=C(C(=C1)OC)OC)OC)[C@H]2C3C4CC5C2C6C3CC4C56,COc1cc(CN(C)[C@H]2C3C4CC5C6C4CC3C6C52)cc(OC)c1OC
902,CHEMBL2432062,P35368,,SSQDVMAIIMMISV-SEDVZXITSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 10 uM by PDSP assay relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985401.0,DTCT0023207,12586610,DTCC01398030,1780918,55935,CN(CC1=CC2=C(C=C1)OCO2)[C@H]3C4C5CC6C3C7C4CC5C67,CN(Cc1ccc2c(c1)OCO2)[C@H]1C2C3CC4C5C3CC2C5C41
903,CHEMBL2432063,P35368,,BMHWWKPJPARTBN-RAOGCBAWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,=,9.4,NM,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600217,DTCC01398031,331096,55935,CN(CC1CCCCC1)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CC1CCCCC1)[C@H]1C2C3CC4C5C3CC2C5C41
904,CHEMBL243228,P35368,,BXZWRAYRDLNDSN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17254786.0,KI,=,44.6,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [125]HEAT from human adrenergic alpha-1b receptor expressed in CHO cells,,"1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.",Bioorg. Med. Chem. Lett.,2007.0,17.0,6.0,"Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA",,441868.0,DTCT0023207,2162365,DTCC00463769,1049173,23196,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)N4C(=O)C5=C(C4=O)N=CC=C5,CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccnc4C3=O)CC2)CC1
905,CHEMBL243229,P35368,,TVYZZMXYQYLCHO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17254786.0,KI,=,22.4,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [125]HEAT from human adrenergic alpha-1b receptor expressed in CHO cells,,"1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.",Bioorg. Med. Chem. Lett.,2007.0,17.0,6.0,"Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA",,441868.0,DTCT0023207,2162364,DTCC00463772,984444,23196,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)N4C(=O)C5=C(C4=O)C=NC=C5,CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccncc4C3=O)CC2)CC1
906,CHEMBL2436555,P35368,,QFNMPNWOYBWECY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24035337.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Prazosin from human recombinant alpha1B-adrenoceptor expressed in HEK cells after 90 mins by scintillation counting analysis,,"2-Amino-6-chloro-3,4-dihydroquinazoline: A novel 5-HT3 receptor antagonist with antidepressant character.",Bioorg. Med. Chem. Lett.,2013.0,23.0,21.0,"Dukat M, Alix K, Worsham J, Khatri S, Schulte MK",,988313.0,DTCT0023207,12618315,DTCC01399574,71471,56006,C1C2=C(C=CC(=C2)Cl)NC(=N1)N.Cl,NC1=NCc2cc(Cl)ccc2N1
907,CHEMBL243690,P35368,,GFECFRLDYQFMGJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17254786.0,KI,=,4108.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [125]HEAT from human adrenergic alpha-1b receptor expressed in CHO cells,,"1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.",Bioorg. Med. Chem. Lett.,2007.0,17.0,6.0,"Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA",,441868.0,DTCT0023207,2162373,DTCC00463743,110622,23196,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)N4C(=O)C5=C(C4=O)C(=C(C(=C5F)F)F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4c(F)c(F)c(F)c(F)c4C3=O)CC2)CC1
908,CHEMBL243692,P35368,,ZQQZHUBFRBFZEF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17254786.0,KI,=,1082.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [125]HEAT from human adrenergic alpha-1b receptor expressed in CHO cells,,"1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.",Bioorg. Med. Chem. Lett.,2007.0,17.0,6.0,"Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA",,441868.0,DTCT0023207,2162371,DTCC00463746,1599242,23196,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)N4C(=O)C5=CC(=C(C=C5C4=O)Cl)Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cc(Cl)c(Cl)cc4C3=O)CC2)CC1
909,CHEMBL243694,P35368,,DXHONOPMEUDNFH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17254786.0,KI,=,18.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [125]HEAT from human adrenergic alpha-1b receptor expressed in CHO cells,,"1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.",Bioorg. Med. Chem. Lett.,2007.0,17.0,6.0,"Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA",,441868.0,DTCT0023207,2162370,DTCC00463749,532332,23196,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)N4C(=O)C5=C(C4=O)C(=CC=C5)F,CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1
910,CHEMBL243694,P35368,,DXHONOPMEUDNFH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17254786.0,KI,=,127.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [125]HEAT from human adrenergic alpha-1b receptor expressed in CHO cells,,"1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.",Bioorg. Med. Chem. Lett.,2007.0,17.0,6.0,"Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA",,441868.0,DTCT0023207,2162369,DTCC00463749,532333,23196,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)N4C(=O)C5=C(C4=O)C(=CC=C5)F,CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4cccc(F)c4C3=O)CC2)CC1
911,CHEMBL243712,P35368,AMISULPRIDE,NTJOBXMMWNYJFB-UHFFFAOYSA-N,3,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19337725.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14728284,DTCC00458164,2103595,69290,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC
912,CHEMBL243864,P35368,,DJGBDGBJUAFKHX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17254786.0,KI,=,15.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [125]HEAT from human adrenergic alpha-1b receptor expressed in CHO cells,,"1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.",Bioorg. Med. Chem. Lett.,2007.0,17.0,6.0,"Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA",,441868.0,DTCT0023207,2162368,DTCC00463756,758140,23196,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)N4C(=O)C5=C(C4=O)C6=CC=CC=C6C=C5,CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccccc5c4C3=O)CC2)CC1
913,CHEMBL243866,P35368,,QPJSKVVDVIYOKV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17254786.0,KI,=,46.5,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [125]HEAT from human adrenergic alpha-1b receptor expressed in CHO cells,,"1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.",Bioorg. Med. Chem. Lett.,2007.0,17.0,6.0,"Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA",,441868.0,DTCT0023207,2162366,DTCC00463760,1049172,23196,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)N4C(=O)C5=C(C4=O)C6=C(C=CC(=C6)F)C=C5,CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1
914,CHEMBL243866,P35368,,QPJSKVVDVIYOKV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17254786.0,KI,=,269.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [125]HEAT from human adrenergic alpha-1b receptor expressed in CHO cells,,"1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.",Bioorg. Med. Chem. Lett.,2007.0,17.0,6.0,"Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA",,441868.0,DTCT0023207,2162367,DTCC00463760,1049171,23196,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)N4C(=O)C5=C(C4=O)C6=C(C=CC(=C6)F)C=C5,CC(C)Oc1ccccc1N1CCN(C2CCC(N3C(=O)c4ccc5ccc(F)cc5c4C3=O)CC2)CC1
915,CHEMBL244946,P35368,,WIHMMKGUBDZGEG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17867665.0,KI,>,1995.26,NM,,,,,,,,,,,,,,Antagonist activity at human Alpha1b adreno receptor,,"1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,2007.0,50.0,21.0,"Micheli F, Bonanomi G, Blaney FE, Braggio S, Capelli AM, Checchia A, Curcuruto O, Damiani F, Fabio RD, Donati D, Gentile G, Gribble A, Hamprecht D, Tedesco G, Terreni S, Tarsi L, Lightfoot A, Stemp G, Macdonald G, Smith A, Pecoraro M, Petrone M, Perini O, Piner J, Rossi T, Worby A, Pilla M, Valerio E, Griffante C, Mugnaini M, Wood M, Scott C, Andreoli M, Lacroix L, Schwarz A, Gozzi A, Bifone A, Ashby CR, Hagan JJ, Heidbreder C",,446398.0,DTCT0023207,2158140,DTCC00459015,1312948,23588,CC1=NC2=CC=CC(=C2C=C1)C3=NN=C(N3C)SCCCN4CCC5=C(CC4)C=C(C=C5)C6=CC(=NN6C)C,Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1
916,CHEMBL24619,P35368,,DNJKQYXTRBILHI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,IC50,=,206.0,NM,,,,,,,,,,,,,,Binding affinity was tested on cloned hamster Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34196.0,DTCT0023207,727949,DTCC00159624,160732,14595,COC1=C(C=C(C=C1)CC2C3=CC(=C(C=C3CCN2C4=NC5=CC(=C(C=C5C(=N4)N)OC)OC)OC)OC)OC,COc1ccc(CC2c3cc(OC)c(OC)cc3CCN2c2nc(N)c3cc(OC)c(OC)cc3n2)cc1OC
917,CHEMBL24777,P35368,RS-100975,WEZFJPKJUIGDPS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,79.43,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,706984,DTCC01739230,1358350,14595,CC1=CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,Cc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O
918,CHEMBL24777,P35368,RS-100975,WEZFJPKJUIGDPS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,79.43,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1264277,DTCC01739230,1358760,5563,CC1=CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,Cc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O
919,CHEMBL24777,P35368,RS-100975,WEZFJPKJUIGDPS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16420037.0,KI,=,79.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14734111,DTCC01739230,2105139,68752,CC1=CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,Cc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O
920,CHEMBL24778,P35368,SILODOSIN,PNCPYILNMDWPEY-QGZVFWFLSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,=,90.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15020831,DTCC00104037,2113787,70168,C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F
921,CHEMBL24778,P35368,SILODOSIN,PNCPYILNMDWPEY-QGZVFWFLSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,=,116.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15019596,DTCC00104037,2113787,70168,C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F
922,CHEMBL24778,P35368,SILODOSIN,PNCPYILNMDWPEY-QGZVFWFLSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,19.95,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,698843,DTCC00104037,224881,14595,C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F
923,CHEMBL24778,P35368,SILODOSIN,PNCPYILNMDWPEY-QGZVFWFLSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,541.4,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269750,DTCC00104037,224491,67126,C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F
924,CHEMBL24981,P35368,,NNPHPGSVPQWUHP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,12.59,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,730178,DTCC00160379,807865,14595,COC1=C(C=C(C=C1)Cl)N2CCN(CC2)CCCNC3=NC=CC(=N3)C(=O)N,COc1ccc(Cl)cc1N1CCN(CCCNc2nccc(C(N)=O)n2)CC1
925,CHEMBL250450,P35368,ISOQUERCETIN,OVSQVDMCBVZWGM-QSOFNFLRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14753429,DTCC00486067,2109951,69275,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
926,CHEMBL250699,P35368,A-803467,VHKBTPQDHDSBSP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17483457.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H](-)CGP-12177 from adrenergic beta-1 receptor,,"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.",Proc. Natl. Acad. Sci. U.S.A.,2007.0,104.0,20.0,"Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, Thomas J, Liu D, Krambis M, Liu Y, McGaraughty S, Chu K, Roeloffs R, Zhong C, Mikusa JP, Hernandez G, Gauvin D, Wade C, Zhu C, Pai M, Scanio M, Shi L, Drizin I, Gregg R, Matulenko M, Hakeem A, Gross M, Johnson M, Marsh K, Wagoner PK, Sullivan JP, Faltynek CR, Krafte DS",,466537.0,DTCT0023207,2351630,DTCC00003813,310509,25480,COC1=CC(=CC(=C1)NC(=O)C2=CC=C(O2)C3=CC=C(C=C3)Cl)OC,COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1
927,CHEMBL25121,P35368,,KWEAVTKRDHFTIH-WIKZRCHHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,147.91,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,702354,DTCC00159893,1162868,14595,CCC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)OC)=C(C)N1
928,CHEMBL251254,P35368,HYPEROSIDE,OVSQVDMCBVZWGM-DTGCRPNFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14748625,DTCC00487046,2109632,69275,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O,O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
929,CHEMBL252766,P35368,,WOYCDVDURLTMAW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18078311.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Displacement of [3H]PIB from adrenergic alpha-1b receptor at 10 uM,,"Synthesis and evaluation of N-methyl and S-methyl 11C-labeled 6-methylthio-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridines as radioligands for imaging beta-amyloid plaques in Alzheimer's disease.",J. Med. Chem.,2008.0,51.0,1.0,"Cai L, Liow JS, Zoghbi SS, Cuevas J, Baetas C, Hong J, Shetty HU, Seneca NM, Brown AK, Gladding R, Temme SS, Herman MM, Innis RB, Pike VW",,460347.0,DTCT0023207,2268448,DTCC00485075,1070293,24989,CN(C)C1=CC=C(C=C1)C2=CN3C=C(C=CC3=N2)SC,CSc1ccc2nc(-c3ccc(N(C)C)cc3)cn2c1
930,CHEMBL25300,P35368,,VXLRYJNESHCVDX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,1.26,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,703416,DTCC00159608,1487697,14595,CC1=CC(=C(C=C1O)C(C)C)OCCN(C)CC2=C(C(=C(C(=C2C)O)C)C)OC,COc1c(C)c(C)c(O)c(C)c1CN(C)CCOc1cc(C)c(O)cc1C(C)C
931,CHEMBL253597,P35368,,DHZBNHMEIOBPAE-JVVVGQRLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18067245.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Binding affinity to adrenergic alpha-1B at 10 uM,,Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.,J. Med. Chem.,2008.0,51.0,1.0,"Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW",,460118.0,DTCT0023207,2267464,DTCC00485513,1458632,24978,CC(=O)N(CC1=CC=CC=C1O[11CH3])C2=C(C=CN=C2)OC3=CC=CC=C3,COc1ccccc1CN(C(C)=O)c1cnccc1Oc1ccccc1
932,CHEMBL25467,P35368,SK&F-104856,WKXSXFYQPCWZOS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,23.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,901028,DTCC01739229,1694153,13230,CN1CCC2=C(C=CC3=C2C(=C(S3)C=C)C1)Cl,C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3
933,CHEMBL25467,P35368,SK&F-104856,WKXSXFYQPCWZOS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,19.95,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,700062,DTCC01739229,1681229,14595,CN1CCC2=C(C=CC3=C2C(=C(S3)C=C)C1)Cl,C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3
934,CHEMBL25467,P35368,SK&F-104856,WKXSXFYQPCWZOS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,25.12,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14734106,DTCC01739229,2105136,68596,CN1CCC2=C(C=CC3=C2C(=C(S3)C=C)C1)Cl,C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3
935,CHEMBL25467,P35368,SK&F-104856,WKXSXFYQPCWZOS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,31.62,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14734105,DTCC01739229,2105136,68596,CN1CCC2=C(C=CC3=C2C(=C(S3)C=C)C1)Cl,C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3
936,CHEMBL25467,P35368,SK&F-104856,WKXSXFYQPCWZOS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,23.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34333.0,DTCT0023207,1567364,DTCC01739229,1693759,17389,CN1CCC2=C(C=CC3=C2C(=C(S3)C=C)C1)Cl,C=Cc1sc2ccc(Cl)c3c2c1CN(C)CC3
937,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,9.9,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from human clone,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34465.0,DTCT0023207,743660,DTCC01739241,1208074,13167,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
938,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,37.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from hamster clones.,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34313.0,DTCT0023207,743661,DTCC01739241,1208074,13167,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
939,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8667368.0,KI,=,57.34,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor cloned receptor hamster smooth muscle using [3H]prazosin as radioligand,,"Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.",J. Med. Chem.,1996.0,39.0,11.0,"Quaglia W, Pigini M, Tayebati SK, Piergentili A, Giannella M, Leonardi A, Taddei C, Melchiorre C",,34319.0,DTCT0023207,1142451,DTCC01739241,1196152,13601,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
940,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,2.51,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,727938,DTCC01739241,1195465,14595,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
941,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,LOG KI,=,8.0,NM,,cell_based,,,,,,,,,,,,The binding affinity was evaluated on cloned human alpha-1B adrenergic receptor expressed in chinese hamster ovary(CHO) cells by using [3H]prazosin as radioligand.,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34622.0,DTCT0023207,1003834,DTCC01739241,1196584,15289,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
942,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,PKB,=,8.21,,,,,,,,,,,,,,,Antagonist affinity was expressed as apparent pKb at alpha-1B adrenergic receptor on isolated rat thoracic aorta (Alpha-1B adrenergic receptor).,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34195.0,DTCT0023207,1003841,DTCC01739241,1196584,15289,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
943,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10514291.0,KI,=,10.0,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned Alpha-1B adrenergic receptor,,WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.,J. Med. Chem.,1999.0,42.0,20.0,"Bolognesi ML, Budriesi R, Cavalli A, Chiarini A, Gotti R, Leonardi A, Minarini A, Poggesi E, Recanatini M, Rosini M, Tumiatti V, Melchiorre C",,34485.0,DTCT0023207,643636,DTCC01739241,1208385,15434,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
944,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11931617.0,KI,=,10.0,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,2002.0,45.0,8.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Gentili F, Marucci G, Carrieri A, Carotti A, Poggesi E, Leonardi A, Melchiorre C",,34488.0,DTCT0023207,1600006,DTCC01739241,1195712,17220,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
945,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12672251.0,KI,=,10.0,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant towards human recombinant Alpha-1B adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay,,"1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.",J. Med. Chem.,2003.0,46.0,8.0,"Brasili L, Sorbi C, Franchini S, Manicardi M, Angeli P, Marucci G, Leonardi A, Poggesi E",,34487.0,DTCT0023207,1134345,DTCC01739241,1195630,17773,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
946,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,KI,=,10.0,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi,,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34611.0,DTCT0023207,1620563,DTCC01739241,1197359,17579,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
947,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,10.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569134,DTCC01739241,1210534,31993,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
948,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,10.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496722,DTCC01739241,1200720,40937,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
949,CHEMBL25554,P35368,WB-4101,GYSZUJHYXCZAKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,10.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756628,DTCC01739241,1222592,53287,COC1=C(C(=CC=C1)OC)OCCNCC2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNCC1COc2ccccc2O1
950,CHEMBL255937,P35368,,WOZZEGNZSHRTMV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368722,DTCC00492164,196357,26380,COC1=C(C=CC2=C1CCC2C3=NC=CN3)Cl,COc1c(Cl)ccc2c1CCC2c1ncc[nH]1
951,CHEMBL255938,P35368,,JYPNWJCGFRQDFP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368721,DTCC00492165,392215,26380,CC1=C(C2=C(C=C1)C(CC2)C3=NC=CN3)NS(=O)(=O)C,Cc1ccc2c(c1NS(C)(=O)=O)CCC2c1ncc[nH]1
952,CHEMBL256040,P35368,,IEMSLTPIYQZIGD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,112.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295826,DTCC00501580,1636544,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=C(C=C4Cl)Cl)Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1
953,CHEMBL256040,P35368,,IEMSLTPIYQZIGD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,483.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295827,DTCC00501580,1636543,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=C(C=C4Cl)Cl)Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1
954,CHEMBL256041,P35368,,QJFXDZVKRFQGQF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,69.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295824,DTCC00501581,505278,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NCC4=CC(=CC=C4)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1
955,CHEMBL256041,P35368,,QJFXDZVKRFQGQF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,706.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295825,DTCC00501581,505277,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NCC4=CC(=CC=C4)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1
956,CHEMBL256597,P35368,,ZWNBANLWZZXEKO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,50.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295828,DTCC00501615,569577,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=CC=C4Cl)Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1
957,CHEMBL256597,P35368,,ZWNBANLWZZXEKO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,289.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295829,DTCC00501615,569576,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=CC=C4Cl)Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1
958,CHEMBL256804,P35368,,PIKIDBPDYRQPFX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,60.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295830,DTCC00501617,1182779,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=CC(=C(C=C4)F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1
959,CHEMBL256804,P35368,,PIKIDBPDYRQPFX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,963.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295831,DTCC00501617,1182778,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=CC(=C(C=C4)F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1
960,CHEMBL256853,P35368,,HZACYYQCKLSFDB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,214.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295840,DTCC00501773,569575,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=C(C=C4)OC)OC,COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1
961,CHEMBL256853,P35368,,HZACYYQCKLSFDB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,475.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295841,DTCC00501773,569574,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=C(C=C4)OC)OC,COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1
962,CHEMBL256982,P35368,,IWGVFEQPKZLBMA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368720,DTCC00492160,1005695,26380,CS(=O)(=O)NC1=C(C=CC2=C1CCCC2C3=NC=CN3)Cl,CS(=O)(=O)Nc1c(Cl)ccc2c1CCCC2c1ncc[nH]1
963,CHEMBL256983,P35368,,VFOKHHLQWNICHU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,=,600.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368719,DTCC00492161,2068431,26380,C1CC2=C(C=CC=C2C1C3=NC=CN3)C4=CC=NN4,c1cc(-c2ccn[nH]2)c2c(c1)C(c1ncc[nH]1)CC2
964,CHEMBL256983,P35368,,VFOKHHLQWNICHU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EMAX,=,32.0,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR relative to phenylephrine,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479652.0,DTCT0023207,2368764,DTCC00492161,2068431,26380,C1CC2=C(C=CC=C2C1C3=NC=CN3)C4=CC=NN4,c1cc(-c2ccn[nH]2)c2c(c1)C(c1ncc[nH]1)CC2
965,CHEMBL256984,P35368,,DHMOWBLMIPAURS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368723,DTCC00492163,228718,26380,CC1=C(C2=C(C=C1)C(CC2)C3=NC=CN3)OC,COc1c(C)ccc2c1CCC2c1ncc[nH]1
966,CHEMBL257077,P35368,,MHMZJEYRSGRQHH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,71.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295842,DTCC00501775,569573,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=CC(=CC=C4)Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1
967,CHEMBL257077,P35368,,MHMZJEYRSGRQHH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,277.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295843,DTCC00501775,569572,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=CC(=CC=C4)Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1
968,CHEMBL257097,P35368,,NXJNUASOAQRPKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,36.4,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295834,DTCC00501690,1248022,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=CC(=C4)F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1
969,CHEMBL257097,P35368,,NXJNUASOAQRPKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,259.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295835,DTCC00501690,1248021,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=CC(=C4)F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1
970,CHEMBL257098,P35368,,LHOVFJRBCVNIQC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,39.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295846,DTCC00501855,1119472,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=CC=CC=C4Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1
971,CHEMBL257098,P35368,,LHOVFJRBCVNIQC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,373.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295847,DTCC00501855,1119471,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=CC=CC=C4Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1
972,CHEMBL257799,P35368,,JMAPPYYTLHLIJH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368820,DTCC00492243,617918,26380,C1CC2=C(C1C3=NC=CN3)C=CC(=C2C4=CNN=C4)Cl,Clc1ccc2c(c1-c1cn[nH]c1)CCC2c1ncc[nH]1
973,CHEMBL257800,P35368,,QAFWYWHBAHTELS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368731,DTCC00492245,682574,26380,CS(=O)(=O)NC1=CC=CC2=C1CCC2C3=NC=CN3,CS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1
974,CHEMBL257801,P35368,,OMYKQBBXHBDIND-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368729,DTCC00112615,1426867,26380,CCCS(=O)(=O)NC1=CC=CC2=C1CCC2C3=NC=CN3,CCCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1
975,CHEMBL257976,P35368,,SIMGMPZLDHYMNW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368725,DTCC00492205,1005694,26380,CNC(=O)C1=CC=CC2=C1CCC2C3=NC=CN3,CNC(=O)c1cccc2c1CCC2c1ncc[nH]1
976,CHEMBL257977,P35368,,KATMPNHRKCPFCF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368726,DTCC00492207,1776762,26380,CS(=O)(=O)NC1=CC=CC2=C1CCCC2C3=NC=CN3,CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1
977,CHEMBL257977,P35368,,KATMPNHRKCPFCF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368727,DTCC00492207,1776761,26380,CS(=O)(=O)NC1=CC=CC2=C1CCCC2C3=NC=CN3,CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1
978,CHEMBL257977,P35368,,KATMPNHRKCPFCF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368728,DTCC00492207,1776760,26380,CS(=O)(=O)NC1=CC=CC2=C1CCCC2C3=NC=CN3,CS(=O)(=O)Nc1cccc2c1CCCC2c1ncc[nH]1
979,CHEMBL257978,P35368,DABUZALGRON,FOYWMEJSRSBQGB-UHFFFAOYSA-N,2,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368708,DTCC00492290,2003879,26380,CC1=C(C=CC(=C1NS(=O)(=O)C)Cl)OCC2=NCCN2,Cc1c(OCC2=NCCN2)ccc(Cl)c1NS(C)(=O)=O
980,CHEMBL258007,P35368,,BLXFHJKHZWXNDP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,=,791.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368733,DTCC00492249,1523634,26380,C1CC(C2=CC=CC=C2C1)C3=NC=CN3,c1ccc2c(c1)CCCC2c1ncc[nH]1
981,CHEMBL258007,P35368,,BLXFHJKHZWXNDP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EMAX,=,58.0,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR relative to phenylephrine,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479652.0,DTCT0023207,2368763,DTCC00492249,1523634,26380,C1CC(C2=CC=CC=C2C1)C3=NC=CN3,c1ccc2c(c1)CCCC2c1ncc[nH]1
982,CHEMBL258178,P35368,,FSOUVFKZLYLZCE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368734,DTCC00492291,811587,26380,C1CC2=CC=CC=C2C1C3=NC=CN3,c1ccc2c(c1)CCC2c1ncc[nH]1
983,CHEMBL258178,P35368,,FSOUVFKZLYLZCE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843266,DTCC00492291,823470,33580,C1CC2=CC=CC=C2C1C3=NC=CN3,c1ccc2c(c1)CCC2c1ncc[nH]1
984,CHEMBL260009,P35368,,XSJUZZWXFYDPDG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368709,DTCC00492779,1652903,26380,CC1=C(C=NO1)C2=C3CCC(C3=CC=C2)C4=NC=CN4,Cc1oncc1-c1cccc2c1CCC2c1ncc[nH]1
985,CHEMBL260116,P35368,,CDJSNQBVAYXVIN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368710,DTCC00492820,973178,26380,C1CC2=C(C=CC=C2C1C3=NC=CN3)C4=NC=CS4,c1cc(-c2nccs2)c2c(c1)C(c1ncc[nH]1)CC2
986,CHEMBL260575,P35368,,WOAORDZNFUQOSX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368713,DTCC00492823,1199167,26380,C1CC2=C(C=CC=C2C1C3=NC=CN3)C4=CC=CC=N4,c1ccc(-c2cccc3c2CCC3c2ncc[nH]2)nc1
987,CHEMBL260576,P35368,,DYDXENMSZODUFG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368712,DTCC00492824,9503,26380,C1CC2=C(C=CC=C2C1C3=NC=CN3)C4=CN=CC=C4,c1cncc(-c2cccc3c2CCC3c2ncc[nH]2)c1
988,CHEMBL260720,P35368,,MACSPWGTMJSVNZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,=,902.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368717,DTCC00492873,1458848,26380,CC1=C(C=NN1)C2=C3CCC(C3=CC=C2)C4=NC=CN4,Cc1[nH]ncc1-c1cccc2c1CCC2c1ncc[nH]1
989,CHEMBL260720,P35368,,MACSPWGTMJSVNZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EMAX,=,14.0,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR relative to phenylephrine,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479652.0,DTCT0023207,2368765,DTCC00492873,1458848,26380,CC1=C(C=NN1)C2=C3CCC(C3=CC=C2)C4=NC=CN4,Cc1[nH]ncc1-c1cccc2c1CCC2c1ncc[nH]1
990,CHEMBL260789,P35368,,RDVMPVYUEVZOKC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368714,DTCC00492828,1199166,26380,CN1C=CC(=N1)C2=C3CCC(C3=CC=C2)C4=NC=CN4,Cn1ccc(-c2cccc3c2CCC3c2ncc[nH]2)n1
991,CHEMBL261304,P35368,,RGODJQWSYIQDDR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368715,DTCC00492872,99617,26380,CN1C=C(C=N1)C2=C3CCC(C3=CC=C2)C4=NC=CN4,Cn1cc(-c2cccc3c2CCC3c2ncc[nH]2)cn1
992,CHEMBL262002,P35368,,JWAHBXONODWUEH-SGQNLQFHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,91.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,618658,DTCC00204490,204451,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@@H]2CC[C@H](C2)N3CCC(CC3)C4=CC=CC=C4C#N)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1
993,CHEMBL262217,P35368,,FSLHHCTXUZIEFO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,150.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,789401,DTCC00330539,498804,15485,COCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C#N)C3=CC(=CC=C3)F)C4=CC(=C(C=C4)F)F)C(=O)OC,COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C#N)(c3cccc(F)c3)CC2)C(=O)N1
994,CHEMBL267336,P35368,,AYXYFVWLDFTBIK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,15.85,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,708033,DTCC00159621,1099546,14595,COC1=C(C=C(C=C1)CCN2CCC(CC2)C3=NC(=C(O3)C4=CC=C(C=C4)F)COCC(F)(F)F)S(=O)(=O)N,COc1ccc(CCN2CCC(c3nc(COCC(F)(F)F)c(-c4ccc(F)cc4)o3)CC2)cc1S(N)(=O)=O
995,CHEMBL267930,P35368,SPIPERONE,DKGZKTPJOSAWFA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8917649.0,KI,=,7.08,NM,,,,,,,,,,,,,,Compound was tested for binding affinity against cloned Alpha-1B adrenergic receptor from hamster smooth muscle using radioligand ([3H]prazosin) binding assay,,"Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.",J. Med. Chem.,1996.0,39.0,23.0,"Giardinà D, Crucianelli M, Romanelli R, Leonardi A, Poggesi E, Melchiorre C",,34317.0,DTCT0023207,1405407,DTCC00136045,1786441,13894,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(=O)C4=CC=C(C=C4)F,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
996,CHEMBL267930,P35368,SPIPERONE,DKGZKTPJOSAWFA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,5.01,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14756806,DTCC00136045,2110966,68596,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(=O)C4=CC=C(C=C4)F,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
997,CHEMBL267930,P35368,SPIPERONE,DKGZKTPJOSAWFA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15951403.0,KI,=,3.09,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14756753,DTCC00136045,2110919,69226,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(=O)C4=CC=C(C=C4)F,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
998,CHEMBL268030,P35368,,SGJZRVNMCHXQCC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,10000.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1188762,DTCC00140604,1902014,3699,CC(C)OC1=CC=CC=C1N2CCN(CC2)CCN(C)C(=O)CN3CCCCC3=O,CC(C)Oc1ccccc1N1CCN(CCN(C)C(=O)CN2CCCCC2=O)CC1
999,CHEMBL268758,P35368,A-119637,HLVQBOYEHQRWHG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11354357.0,KI,=,4.66,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor,,Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.,Bioorg. Med. Chem. Lett.,2001.0,11.0,9.0,"Carroll WA, Sippy KB, Esbenshade TA, Buckner SA, Hancock AA, Meyer MD",,34336.0,DTCT0023207,701620,DTCC00143119,2015384,4794,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(NC3=O)SC=C4C5=CC=CC=C5,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3scc(-c4ccccc4)c3c2=O)CC1
1000,CHEMBL269538,P35368,HARMINE,BXNJHAXVSOCGBA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14643338.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,2003.0,13.0,24.0,"Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA",,34337.0,DTCT0023207,1119510,DTCC00132472,627749,6037,CC1=NC=CC2=C1NC3=C2C=CC(=C3)OC,COc1ccc2c(c1)[nH]c1c(C)nccc12
1001,CHEMBL27013,P35368,,ILQHFOKYOSAZBJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9822553.0,KI,=,0.11,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity at human cloned Alpha-1B adrenergic receptor in chinese hamster ovary cells by [3H]prazosin displacement.,,"Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.",J. Med. Chem.,1998.0,41.0,24.0,"Bolognesi ML, Budriesi R, Chiarini A, Poggesi E, Leonardi A, Melchiorre C",,34617.0,DTCT0023207,819265,DTCC00163628,713035,14970,CN(CCCCCCN(C)C(=O)C1=CC=CO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC
1002,CHEMBL270589,P35368,,GRLCSEWTOACLTP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,36.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295832,DTCC00501657,1700794,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=CC=C4F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1
1003,CHEMBL270589,P35368,,GRLCSEWTOACLTP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,299.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295833,DTCC00501657,1700793,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=CC=C4F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1
1004,CHEMBL270595,P35368,,OXEFHEYEQUISKC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor,Not Determined,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,820270.0,DTCT0023207,10479315,DTCC00502273,1928089,48255,C1CCN(C1)CCC2=CC=CC=N2,c1ccc(CCN2CCCC2)nc1
1005,CHEMBL271913,P35368,,AVIOZEGAUFSOTR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,81.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295838,DTCC00501730,1889797,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
1006,CHEMBL271913,P35368,,AVIOZEGAUFSOTR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,207.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295839,DTCC00501730,1889796,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
1007,CHEMBL272340,P35368,,MVVUJPWQKLPZEE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,107.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295844,DTCC00501812,439506,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=CC=CC=C4OC,COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
1008,CHEMBL272340,P35368,,MVVUJPWQKLPZEE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,223.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295845,DTCC00501812,439505,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=CC=CC=C4OC,COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
1009,CHEMBL273312,P35368,,KEHDGXFGMIOLCR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,958436,DTCC00148475,1373503,6217,CN1C=C(C=N1)C2=CC=CC=C2NCC3=NCCN3,Cn1cc(-c2ccccc2NCC2=NCCN2)cn1
1010,CHEMBL273312,P35368,,KEHDGXFGMIOLCR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,958439,DTCC00148475,1373503,6217,CN1C=C(C=N1)C2=CC=CC=C2NCC3=NCCN3,Cn1cc(-c2ccccc2NCC2=NCCN2)cn1
1011,CHEMBL273316,P35368,,KJZVGIURRPLUKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,=,63.1,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,941410,DTCC00149117,1081927,6217,CCN1C(=NC=N1)C2=CC=CC=C2NCC3=NCCN3,CCn1ncnc1-c1ccccc1NCC1=NCCN1
1012,CHEMBL273316,P35368,,KJZVGIURRPLUKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,94.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,941413,DTCC00149117,1081927,6217,CCN1C(=NC=N1)C2=CC=CC=C2NCC3=NCCN3,CCn1ncnc1-c1ccccc1NCC1=NCCN1
1013,CHEMBL274119,P35368,RACEMETHIONINE,FFEARJCKVFRZRR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14733396,DTCC00135493,2104905,69159,CSCCC(C(=O)O)N,CSCCC(N)C(=O)O
1014,CHEMBL274529,P35368,,KBBRTQPTKZOUOZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,10000.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1205417,DTCC00140606,517407,3699,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(=O)CC(=O)CN3CCCCC3=O,CC(C)Oc1ccccc1N1CCN(CC(=O)CC(=O)CN2CCCCC2=O)CC1
1015,CHEMBL274864,P35368,,WCWNYVYNQAPOOX-HNNXBMFYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15828846.0,KI,,,,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor; NT = not tested,Not Determined,"Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.",J. Med. Chem.,2005.0,48.0,8.0,"Konkel MJ, Wetzel JM, Cahir M, Craig DA, Noble SA, Gluchowski C",,302939.0,DTCT0023207,1825502,DTCC00142933,908430,19681,C[C@@H](CN1CCN(CC1)C2=CC(=C(C=C2F)F)F)N3C(=O)CC4(CCCC4)CC3=O,C[C@@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O
1016,CHEMBL275386,P35368,,HEOQNUWDRLFQCS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,940214,DTCC00149086,435970,6217,CCCN1C(=CC=N1)C2=CC=CC=C2NCC3=NCCN3,CCCn1nccc1-c1ccccc1NCC1=NCCN1
1017,CHEMBL275386,P35368,,HEOQNUWDRLFQCS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,940218,DTCC00149086,435970,6217,CCCN1C(=CC=N1)C2=CC=CC=C2NCC3=NCCN3,CCCn1nccc1-c1ccccc1NCC1=NCCN1
1018,CHEMBL275469,P35368,RWJ-38063,IIRJWNCOXHFIBK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,46120.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1207720,DTCC00140835,1227341,3699,CC(C)OC1=CC=CC=C1N2CCN(CC2)CCNC(=O)CN3CCCCC3=O,CC(C)Oc1ccccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1
1019,CHEMBL275844,P35368,,KCZJGPLQOLDCRP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,=,79.43,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,958430,DTCC00148440,1210070,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=CNN=C3,c1ccc(-c2cn[nH]c2)c(NCC2=NCCN2)c1
1020,CHEMBL275844,P35368,,KCZJGPLQOLDCRP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,72.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,958433,DTCC00148440,1210070,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=CNN=C3,c1ccc(-c2cn[nH]c2)c(NCC2=NCCN2)c1
1021,CHEMBL275902,P35368,,RVBLRIXGADEXMC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,954475,DTCC00149090,1146871,6217,CCN1C=CC=C1C2=CC=CC=C2NCC3=NCCN3,CCn1cccc1-c1ccccc1NCC1=NCCN1
1022,CHEMBL275902,P35368,,RVBLRIXGADEXMC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,954478,DTCC00149090,1146871,6217,CCN1C=CC=C1C2=CC=CC=C2NCC3=NCCN3,CCn1cccc1-c1ccccc1NCC1=NCCN1
1023,CHEMBL276733,P35368,,UKWYQJMWISEHPK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,971514,DTCC00148474,500370,6217,CCN1C=C(C=N1)C2=CC=CC=C2NCC3=NCCN3,CCn1cc(-c2ccccc2NCC2=NCCN2)cn1
1024,CHEMBL276733,P35368,,UKWYQJMWISEHPK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,971517,DTCC00148474,500370,6217,CCN1C=C(C=N1)C2=CC=CC=C2NCC3=NCCN3,CCn1cc(-c2ccccc2NCC2=NCCN2)cn1
1025,CHEMBL276932,P35368,,IJMJOPSALFMSMQ-MHAUTQJVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,281.84,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,722946,DTCC00159892,581837,14595,CCC1=C(C(C(=C(N1)CC)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)OC)=C(CC)N1
1026,CHEMBL277361,P35368,,ZWAHQJYEXSYDNK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,937610,DTCC00149121,1788070,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=NN3CC(F)(F)F,FC(F)(F)Cn1nccc1-c1ccccc1NCC1=NCCN1
1027,CHEMBL277361,P35368,,ZWAHQJYEXSYDNK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,937613,DTCC00149121,1788070,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=NN3CC(F)(F)F,FC(F)(F)Cn1nccc1-c1ccccc1NCC1=NCCN1
1028,CHEMBL277375,P35368,,XQORNBVCMJFJOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,=,5.01,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,942697,DTCC00148472,629451,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=NN3,c1ccc(-c2ccn[nH]2)c(NCC2=NCCN2)c1
1029,CHEMBL277375,P35368,,XQORNBVCMJFJOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,IC50,=,158.49,NM,,cell_based,,,,,,,,,,,,"Inhibitory concentration against radioligand binding to human Alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34484.0,DTCT0023207,942704,DTCC00148472,629451,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=NN3,c1ccc(-c2ccn[nH]2)c(NCC2=NCCN2)c1
1030,CHEMBL277375,P35368,,XQORNBVCMJFJOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,95.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,942701,DTCC00148472,629451,6217,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=NN3,c1ccc(-c2ccn[nH]2)c(NCC2=NCCN2)c1
1031,CHEMBL278716,P35368,,SOUVKJLYRGDDOT-VPYPWEPUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,15.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,636725,DTCC00153218,1499604,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@H]2CC[C@@H](C2)N3CCN(CC3)C4=CC=CC=C4C#N)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1
1032,CHEMBL278865,P35368,UPIDOSIN,DUCNHKDCVVSJLG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,31.62,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,724256,DTCC00159891,290438,14595,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)NCCCN3CCN(CC3)C4=CC=CC=C4OC)C5=CC=CC=C5,COc1ccccc1N1CCN(CCCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1
1033,CHEMBL278865,P35368,UPIDOSIN,DUCNHKDCVVSJLG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12904082.0,KI,=,3.9,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]-prazosin binding to cloned human Alpha-1B adrenergic receptor in CHO cells (chinese hamster ovary cells),,New potential uroselective NO-donor alpha1-antagonists.,J. Med. Chem.,2003.0,46.0,17.0,"Boschi D, Tron GC, Di Stilo A, Fruttero R, Gasco A, Poggesi E, Motta G, Leonardi A",,34462.0,DTCT0023207,1279437,DTCC00159891,303714,13339,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)NCCCN3CCN(CC3)C4=CC=CC=C4OC)C5=CC=CC=C5,COc1ccccc1N1CCN(CCCNC(=O)c2cccc3c(=O)c(C)c(-c4ccccc4)oc23)CC1
1034,CHEMBL27899,P35368,,ZUFDUHYRGVUXON-OBEQGSJMSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,173.78,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,729044,DTCC00160297,1519968,14595,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)OC(C)C)C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC(C)C)cc1
1035,CHEMBL279085,P35368,TALIPEXOLE,DHSSDEDRBUKTQY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,3890.45,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14738765,DTCC00151623,2106775,69012,C=CCN1CCC2=C(CC1)SC(=N2)N,C=CCN1CCc2nc(N)sc2CC1
1036,CHEMBL279136,P35368,,MXSYQDRTCADVLB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,10.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,874102,DTCC00329584,530898,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CO3,c1coc(-c2ccccc2OCC2=NCCN2)c1
1037,CHEMBL279136,P35368,,MXSYQDRTCADVLB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,110.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,874103,DTCC00329584,530898,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CO3,c1coc(-c2ccccc2OCC2=NCCN2)c1
1038,CHEMBL279436,P35368,,OZQHHXAYNRRVBN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,407.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,906003,DTCC00104050,853827,13230,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
1039,CHEMBL279436,P35368,,OZQHHXAYNRRVBN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,331.13,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,769353,DTCC00104050,853315,14735,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
1040,CHEMBL279436,P35368,,OZQHHXAYNRRVBN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,363.08,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,759206,DTCC00104050,853313,14735,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
1041,CHEMBL279436,P35368,,OZQHHXAYNRRVBN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,446.68,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,768270,DTCC00104050,853314,14735,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
1042,CHEMBL279436,P35368,,OZQHHXAYNRRVBN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,330.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1406006,DTCC00104050,854305,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
1043,CHEMBL279516,P35368,INDORAMIN,JXZZEXZZKAWDSP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,25.0,NM,,,,,,,,,,,,,,"The compound was tested for binding affinity against Alpha-1B adrenergic receptor, from hamster clones.",,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34314.0,DTCT0023207,733381,DTCC00159758,1980573,13167,C1CN(CCC1NC(=O)C2=CC=CC=C2)CCC3=CNC4=CC=CC=C43,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1
1044,CHEMBL279516,P35368,INDORAMIN,JXZZEXZZKAWDSP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,29.0,NM,,,,,,,,,,,,,,"The compound was tested for binding affinity against Alpha-1B adrenergic receptor, from human clones.",,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34466.0,DTCT0023207,733380,DTCC00159758,1980573,13167,C1CN(CCC1NC(=O)C2=CC=CC=C2)CCC3=CNC4=CC=CC=C43,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1
1045,CHEMBL279516,P35368,INDORAMIN,JXZZEXZZKAWDSP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,39.81,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,696335,DTCC00159758,1967379,14595,C1CN(CCC1NC(=O)C2=CC=CC=C2)CCC3=CNC4=CC=CC=C43,O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1
1046,CHEMBL282199,P35368,SB-269970,HWKROQUZSKPIKQ-MRXNPFEDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10669560.0,KI,<,10000.0,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).",J. Med. Chem.,2000.0,43.0,3.0,"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR",,32307.0,DTCT0023207,1103910,DTCC01739306,594874,16008,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)O,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1
1047,CHEMBL282214,P35368,SNAP-5036,NJWKVUCAVMYELV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,39.81,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,729053,DTCC01739235,2064733,14595,COC1=CC=C(C=C1)CCNCC2CCC3=CC=CC=C3C2,COc1ccc(CCNCC2CCc3ccccc3C2)cc1
1048,CHEMBL282971,P35368,,DVALOPXWVWHIHY-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11992776.0,KI,=,1000.0,NM,,,,,,,,,,,,,,The compound was tested for the binding affinity towards Alpha-1B adrenergic receptor,,Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,10.0,"Bromidge SM, Clarke SE, King FD, Lovell PJ, Newman H, Riley G, Routledge C, Serafinowska HT, Smith DR, Thomas DR",,34623.0,DTCT0023207,658632,DTCC00164417,1099585,4854,CC1=C(SC2=C1C=C(C=C2)Cl)S(=O)(=O)NC3=CC(=C(C=C3)OC)N4CCN5CCC[C@@H]5C4,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN2CCC[C@@H]2C1
1049,CHEMBL284103,P35368,,YMSCVVXGMWMEMM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,416.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,931821,DTCC00104045,982688,13230,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)NC,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1050,CHEMBL284103,P35368,,YMSCVVXGMWMEMM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,416.87,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,731351,DTCC00104045,969466,14595,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)NC,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1051,CHEMBL284103,P35368,,YMSCVVXGMWMEMM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,489.78,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,755417,DTCC00104045,982159,14735,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)NC,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1052,CHEMBL284470,P35368,,SZTNZABXFFPBMM-PKUSAGTQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,64.57,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,700049,DTCC00159777,1099551,14595,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1053,CHEMBL284470,P35368,,SZTNZABXFFPBMM-PKUSAGTQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,134.9,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,770569,DTCC00159777,1112121,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1054,CHEMBL286003,P35368,,DOMFTTQPMVIEJM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12672251.0,KI,=,45.71,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant towards human recombinant Alpha-1B adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay,,"1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.",J. Med. Chem.,2003.0,46.0,8.0,"Brasili L, Sorbi C, Franchini S, Manicardi M, Angeli P, Marucci G, Leonardi A, Poggesi E",,34486.0,DTCT0023207,1114618,DTCC00176257,1805655,17773,COC1=CC=CC=C1OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O,COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1
1055,CHEMBL286003,P35368,,DOMFTTQPMVIEJM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,46.77,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608860,DTCC00176257,1811898,47207,COC1=CC=CC=C1OCCNCC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O,COc1ccccc1OCCNCC1COC(c2ccccc2)(c2ccccc2)O1
1056,CHEMBL286565,P35368,,UNHGFWKSHHCRHF-JWQCQUIFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8667368.0,KI,=,195.2,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor hamster smooth muscle using [3H]prazosin as radioligand,,"Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.",J. Med. Chem.,1996.0,39.0,11.0,"Quaglia W, Pigini M, Tayebati SK, Piergentili A, Giannella M, Leonardi A, Taddei C, Melchiorre C",,34320.0,DTCT0023207,1170506,DTCC00177863,2000725,13601,CC1=CC=C(C=C1)[C@@H]2[C@H](OC3=CC=CC=C3O2)CNCCOC4=C(C=CC=C4OC)OC,COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccc(C)cc1
1057,CHEMBL286591,P35368,SNAP-1069,VVSOHUNZJUMVHS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,199.53,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,710405,DTCC01739252,1805525,14595,C1CN(CCC1NC(=O)C2=CC=CC=C2)CCCC(=O)C3=CC=CC=C3,O=C(CCCN1CCC(NC(=O)c2ccccc2)CC1)c1ccccc1
1058,CHEMBL287791,P35368,,AADBHVDMLFAXQC-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,=,54.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1538628,DTCC00184228,1979365,3808,CC1=C([C@H](CC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
1059,CHEMBL287935,P35368,,UVEKKXRFQCNLQE-DNQXCXABSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,PKB,=,5.55,,,,,,,,,,,,,,,Antagonist affinity was expressed as apparent pKb at Alpha-1B adrenergic receptor on isolated Guinea pig spleen (Alpha-1B),,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34193.0,DTCT0023207,985719,DTCC00177511,2065847,15289,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2[C@H](OC3=CC=CC=C3O2)C4=CC=CC=C4,COc1cccc(OC)c1OCCNC[C@H]1Oc2ccccc2O[C@@H]1c1ccccc1
1060,CHEMBL288768,P35368,,WLHRCQLHMHKOKG-JOCHJYFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,=,1040.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1544738,DTCC00183999,1272511,3808,CC1=C([C@H](CC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
1061,CHEMBL288772,P35368,,DLMPCEBSXNLTAT-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,=,366.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1523611,DTCC00184168,269411,3808,CC1=C([C@H](CC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=C(C=C(C=C4)F)C#N,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
1062,CHEMBL289339,P35368,,QVVUBPXTGZZTIW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,870.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,531380,DTCC00183830,819668,3807,CC1=CC=CC=C1C2(CCN(CC2)CCCNC(=O)C(C3=CC=C(C=C3)Cl)C(C)C)C#N,Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(Cl)cc2)C(C)C)CC1
1063,CHEMBL289480,P35368,RILMENIDINE,CQXADFVORZEARL-UHFFFAOYSA-N,3,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,46773500000000.0,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor by the displacement of [3H]prazosin,,,Bioorg. Med. Chem. Lett.,1994.0,4.0,19.0,,,34607.0,DTCT0023207,1681158,DTCC00181872,1079187,933,C1CC1C(C2CC2)NC3=NCCO3,C1COC(NC(C2CC2)C2CC2)=N1
1064,CHEMBL289916,P35368,,DQQUWTIATKHALF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,670.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,514500,DTCC00184159,1239720,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)C4=CC=CC=N4,Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccn3)CC2)c2ccc(C)cc2)cc1
1065,CHEMBL290387,P35368,,HEMYMELEKVSREK-SWLSCSKDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,35.1,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1276926,DTCC00182292,1713538,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C6=NC(=CN=C6S5)Cl)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5ncc(Cl)nc54)c3=O)C[C@@H]21
1066,CHEMBL290860,P35368,,YSPOTMDNGADFCJ-WUVHBKSUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7752182.0,KI,=,50.0,NM,,,,,,,,,,,,,,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,,Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.,J. Med. Chem.,1995.0,38.0,10.0,"Wetzel JM, Miao SW, Forray C, Borden LA, Branchek TA, Gluchowski C",,34326.0,DTCT0023207,1042391,DTCC00180713,1046186,12993,CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1067,CHEMBL291166,P35368,,PEDXQUUSXXYPJU-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,=,425.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1525705,DTCC00184145,529318,3808,CC1=C([C@H](CC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
1068,CHEMBL291303,P35368,,IATJRNATRBECGI-HNAYVOBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,6.46,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1278270,DTCC00208263,1261101,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=CC(=C(C=C5NC4=O)OC)OC,COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC
1069,CHEMBL291305,P35368,,AVJFJYZQNQJPAE-PGRDOPGGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,61.2,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1272586,DTCC00208331,1870337,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4CCC5=CC(=C(C=C5C4=O)OC)OC,COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2
1070,CHEMBL291528,P35368,,KHIULIFNYWCVQZ-MAUKXSAKSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,2.31,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1258648,DTCC00209032,1681739,16272,CC(C)C1=C(SC2=C1NC(=O)N(C2=O)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC)OC,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C(C)C)c(OC)sc4c3=O)C[C@@H]21
1071,CHEMBL291588,P35368,,KRBXRJXSCYGFMO-KBXCAEBGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,10.57,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1250499,DTCC00208882,1132174,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=CN=C5)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccncc4c3=O)C[C@@H]21
1072,CHEMBL291769,P35368,,DZVKSRJUFFUHHJ-LAUBAEHRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,16.28,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1251598,DTCC00208262,1805988,16272,CC1=CC(=C2C(=C1)C(=O)N(C(=O)N2)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC)C,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)cc(C)cc4c3=O)C[C@@H]21
1073,CHEMBL291839,P35368,,CAEZRWQRXPFXAO-XJKSGUPXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,1.63,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1274828,DTCC00208470,969963,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=CS5)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccsc4c3=O)C[C@@H]21
1074,CHEMBL291908,P35368,,GUUIENZLFCYGEL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,73.53,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1104014,DTCC00204243,497460,18073,CC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
1075,CHEMBL291951,P35368,,HJESDLDLPTXZBL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,199.53,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1261901,DTCC00201872,1293416,5563,CN(C)C1=CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,CN(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O
1076,CHEMBL292189,P35368,,NJLNPETVWRAQNN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,15.85,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1264292,DTCC00201652,647334,5563,CC1=C(NC(=O)N(C1=O)CCCN2CCN(CC2)C3=CC=CC=C3OCC(F)(F)F)C,Cc1[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)c1C
1077,CHEMBL292365,P35368,,JWAHBXONODWUEH-CTWZREHQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,70.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,652445,DTCC00204522,2044754,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@H]2CC[C@H](C2)N3CCC(CC3)C4=CC=CC=C4C#N)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1
1078,CHEMBL292366,P35368,,QVAVHYHWALAFMY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,15.84,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1115797,DTCC00204736,433019,18073,C1CCC2(C1)CC(=O)N(C=C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(C=CN1CCN1CCN(c3cc(Cl)ccc3Cl)CC1)CCCC2
1079,CHEMBL292399,P35368,,TZYSFWCODVUWBW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,127.8,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1121710,DTCC00203873,529541,18073,CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCOC3=C(C=CC(=C3)Cl)Cl,CN(CCOc1cc(Cl)ccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O
1080,CHEMBL292403,P35368,,IMRAKTMELIHZOK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,100.0,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1263002,DTCC00201788,96323,5563,CC1=CN(C(=O)NC1=O)CCCN2CCN(CC2)C3=CC=CC=C3OCC(F)(F)F,Cc1cn(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c(=O)[nH]c1=O
1081,CHEMBL292637,P35368,,XOWQUXFGRDTGSN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1127952,DTCC00204005,658767,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)[N+](=O)[O-])F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc([N+](=O)[O-])ccc2F)CC1
1082,CHEMBL292672,P35368,,OKRVZIFVSGDYMZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1110940,DTCC00203880,367918,18073,CN(CCCOC1=C(C=CC(=C1)Cl)Cl)CCN2C(=O)CC3(CCCC3)CC2=O,CN(CCCOc1cc(Cl)ccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O
1083,CHEMBL292686,P35368,,YQHUEAFWSKZKDZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,274.38,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1100237,DTCC00204272,1499600,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCC(CC3)C4=CC=CC=C4,O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2ccccc2)CC1
1084,CHEMBL292759,P35368,,OZYPUQNRUYTZDI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9925723.0,KI,=,2511.89,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity against adrenergic Alpha-1B adrenergic receptor,,"5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist.",J. Med. Chem.,1999.0,42.0,2.0,"Bromidge SM, Brown AM, Clarke SE, Dodgson K, Gager T, Grassam HL, Jeffrey PM, Joiner GF, King FD, Middlemiss DN, Moss SF, Newman H, Riley G, Routledge C, Wyman P",,34619.0,DTCT0023207,488050,DTCC00213933,2044834,15364,CN1CCN(CC1)C2=C(C=CC(=C2)NS(=O)(=O)C3=CC=C(C=C3)Br)OC,COc1ccc(NS(=O)(=O)c2ccc(Br)cc2)cc1N1CCN(C)CC1
1085,CHEMBL292801,P35368,NORTOPSENTIN B,XSZLSJCZRNPIOM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,130.0,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster Alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone),,,Bioorg. Med. Chem. Lett.,1996.0,6.0,17.0,,,32894.0,DTCT0023207,1309255,DTCC00216859,1326136,1778,C1=CC=C2C(=C1)C(=CN2)C3=CN=C(N3)C4=CNC5=C4C=CC(=C5)Br,Brc1ccc2c(-c3ncc(-c4c[nH]c5ccccc45)[nH]3)c[nH]c2c1
1086,CHEMBL292881,P35368,,YMBUQNAAUFTUND-SUMWQHHRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,2.11,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1277022,DTCC00209031,1649582,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(NC4=O)SC=C5,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4sccc4c3=O)C[C@@H]21
1087,CHEMBL293111,P35368,,XLTTZOVFXUSDEW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,52.89,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1134415,DTCC00204474,367917,18073,C1CCC2(CC1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
1088,CHEMBL293149,P35368,,JSPZPGCXQNWQIL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,15.85,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1268940,DTCC00201331,679493,5563,CC1=CNC(=O)N(C1=O)CCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,Cc1c[nH]c(=O)n(CCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O
1089,CHEMBL293236,P35368,,RXINGPJCQZSBIJ-XJKSGUPXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,3.37,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1269272,DTCC00209079,1293497,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=C(S5)C(=O)OC)NC4=O,COC(=O)c1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1
1090,CHEMBL293515,P35368,,FPRCXYVVQHMAFI-BUEREQSYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,1300.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,625717,DTCC00204531,1914049,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@@H]2CC[C@@H](C2)N3CCC(CC3)C4=CC=CC=N4)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1
1091,CHEMBL293539,P35368,,BQIVUTQNTYCGLI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,10.05,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1102620,DTCC00204659,949320,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)F)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2Cl)CC1
1092,CHEMBL293695,P35368,,KQQGSWIVATVKRC-HNAYVOBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,0.66,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1263436,DTCC00208620,1967955,16272,COC1=C(C2=C(C=C1)C(=O)N(C(=O)N2)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC)OC,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)c(OC)ccc4c3=O)C[C@@H]21
1093,CHEMBL293734,P35368,,RYACWLKZCHVEBC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,84.08,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1134419,DTCC00204748,1660984,18073,C1CCC2(C1)CCN(CC2)CCN3CCN(CC3)C4=CC=CC=C4Cl,Clc1ccccc1N1CCN(CCN2CCC3(CCCC3)CC2)CC1
1094,CHEMBL293968,P35368,,UWNYSEQNXHRAOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,264.47,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1130491,DTCC00204370,1499597,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1
1095,CHEMBL293980,P35368,,DNICHAOWVIITAI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1122884,DTCC00204010,367916,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=C(C=C4)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(Cl)cc2Cl)CC1
1096,CHEMBL294023,P35368,,HCBPQZXZGZQZNT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,790.88,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1097590,DTCC00204665,140311,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)C(F)(F)F)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(C(F)(F)F)ccc2Cl)CC1
1097,CHEMBL294027,P35368,,LKCYRIGBAXUBGO-WMLDXEAASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,7.14,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1280424,DTCC00209033,1100066,16272,CC1=C(SC2=C1NC(=O)N(C2=O)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC)OC,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(OC)sc4c3=O)C[C@@H]21
1098,CHEMBL294098,P35368,,GGFLSBNZVPANMF-SUMWQHHRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,2.58,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1249332,DTCC00208884,356202,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(NC=C5)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4[nH]ccc4c3=O)C[C@@H]21
1099,CHEMBL29410,P35368,,XGBXESVSCSHHQI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11992776.0,KI,=,1995.26,NM,,,,,,,,,,,,,,The compound was tested for the binding affinity towards Alpha-1B adrenergic receptor,,Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,10.0,"Bromidge SM, Clarke SE, King FD, Lovell PJ, Newman H, Riley G, Routledge C, Serafinowska HT, Smith DR, Thomas DR",,34623.0,DTCT0023207,671992,DTCC00163923,937407,4854,CC1=C(SC2=C1C=C(C=C2)Cl)S(=O)(=O)NC3=CC(=C(C=C3)OC)N4CCN5CCCCC5C4,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN2CCCCC2C1
1100,CHEMBL294235,P35368,,OATZTRPAOPUZBS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,54.08,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1121718,DTCC00204371,2044750,18073,C1CC(=O)N(C(=O)C1)CCN2CCN(CC2)C3=C(C=CC(=C3)Cl)Cl,O=C1CCCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
1101,CHEMBL29433,P35368,,DVALOPXWVWHIHY-SFHVURJKSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11992776.0,KI,=,1584.89,NM,,,,,,,,,,,,,,The compound was tested for the binding affinity towards Alpha-1B adrenergic receptor,,Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,10.0,"Bromidge SM, Clarke SE, King FD, Lovell PJ, Newman H, Riley G, Routledge C, Serafinowska HT, Smith DR, Thomas DR",,34623.0,DTCT0023207,658618,DTCC00164454,1227607,4854,CC1=C(SC2=C1C=C(C=C2)Cl)S(=O)(=O)NC3=CC(=C(C=C3)OC)N4CCN5CCC[C@H]5C4,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN2CCC[C@H]2C1
1102,CHEMBL294479,P35368,,LCWFAMJVXXNZKV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1125328,DTCC00203898,1239971,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCNCCOC3=C(C=CC(=C3)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCNCCOc1cc(Cl)ccc1Cl
1103,CHEMBL294646,P35368,,GFKRSFHMVDZUAR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,86.38,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1113564,DTCC00204907,1207205,18073,C1CC(=O)N(C1=O)CCN2CCN(CC2)C3=C(C=CC(=C3)Cl)Cl,O=C1CCC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
1104,CHEMBL294649,P35368,,ZNAPADWWBWFMCQ-HNNXBMFYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,<,10000.0,NM,,,,,,,,,,,,,,Binding affinity against Adrenogenic Alpha-1B receptor,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,16.0,,,32306.0,DTCT0023207,898518,DTCC00199702,787483,1269,CN1C=C(C2=CC=CC=C21)C(=O)C(=O)N[C@H]3CN4CCC3CC4,Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc21
1105,CHEMBL294705,P35368,,BFZPCLNPQUOCAP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1098965,DTCC00204232,690959,18073,CC1CN(CC(N1CCN2C(=O)CC3(CCCC3)CC2=O)C)C4=CC=CC=C4[N+](=O)[O-],CC1CN(c2ccccc2[N+](=O)[O-])CC(C)N1CCN1C(=O)CC2(CCCC2)CC1=O
1106,CHEMBL294829,P35368,,NBTWKPSAPGBCCD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1097599,DTCC00204231,140310,18073,CC1CN(CCN1CCN2C(=O)CC3(CCCC3)CC2=O)C4=CC=CC=C4[N+](=O)[O-],CC1CN(c2ccccc2[N+](=O)[O-])CCN1CCN1C(=O)CC2(CCCC2)CC1=O
1107,CHEMBL294868,P35368,,NNSHUVXTTHWUKK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1127948,DTCC00203992,140309,18073,CC(C)C1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,CC(C)c1ccc(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)cc1
1108,CHEMBL295001,P35368,,RLMGUPUESXPDFJ-HXUWFJFHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,=,805.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1553192,DTCC00183947,1563720,3808,CC1=C([C@H](CC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=C(C=C(C=C4)F)F,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
1109,CHEMBL295072,P35368,6-FLUORONOREPINEHPRINE,FOTRTWXNJQSQJS-LURJTMIESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19857969.0,KI,=,4000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human adrenergic Alpha-1B receptor expressed in CHO cell membrane,,Structural basis of the selectivity of the beta(2)-adrenergic receptor for fluorinated catecholamines.,Bioorg. Med. Chem.,2009.0,17.0,23.0,"Pooput C, Rosemond E, Karpiak J, Deflorian F, Vilar S, Costanzi S, Wess J, Kirk KL",,603939.0,DTCT0023207,3174239,DTCC01739849,598483,36739,C1=CC(=C(C(=C1[C@H](CN)O)F)O)O,NC[C@H](O)c1ccc(O)c(O)c1F
1110,CHEMBL295234,P35368,,CWOYLIJQLSNRRN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14643338.0,KI,,,,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor; ND=No data,Not Determined,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,2003.0,13.0,24.0,"Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA",,34626.0,DTCT0023207,1104939,DTCC00188761,2046015,6037,CC1=NCCC2=C1NC3=CC=CC=C23,CC1=NCCc2c1[nH]c1ccccc21
1111,CHEMBL295304,P35368,,DULYYRLDWDENEO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,34.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,522778,DTCC00183892,1692890,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)C4=CC=CC=C4,Cc1ccc(C(C(=O)NCCCN2CCC(c3ccccc3)CC2)c2ccc(C)cc2)cc1
1112,CHEMBL295395,P35368,,WIVOLWKUZIBRAF-OAQYLSRUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,=,842.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1524599,DTCC00183795,1078685,3808,CC1=C([C@H](CC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=C(C=C(C=C4)F)F,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3F)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
1113,CHEMBL29591,P35368,,NZGMDZHAJYWRGD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9822553.0,KI,=,1.07,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity at human cloned Alpha-1B adrenergic receptor in chinese hamster ovary cells by [3H]prazosin displacement.,,"Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.",J. Med. Chem.,1998.0,41.0,24.0,"Bolognesi ML, Budriesi R, Chiarini A, Poggesi E, Leonardi A, Melchiorre C",,34617.0,DTCT0023207,835862,DTCC00164084,1969408,14970,CN(CCSSCCN(C)C(=O)C1=CC=CO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,COc1cc2nc(N(C)CCSSCCN(C)C(=O)c3ccco3)nc(N)c2cc1OC
1114,CHEMBL296965,P35368,,ZQCNGXUHVDDWMJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,840.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,527609,DTCC00183748,787325,3807,C1CN(CCC1(C#N)C2=CC=CC=C2)CCCNC(=O)C(C3=CC=CC=C3)C4=CC=CC=C4,N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)c2ccccc2)CC1
1115,CHEMBL297667,P35368,,JKMSDGXSNFPBBL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,650.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,522781,DTCC00183863,1817396,3807,CC1=CC=C(C=C1)C(C(C)C)C(=O)NCCCN2CCC(CC2)(C#N)C3=CC=CC=C3C,Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)C(C)C)cc1
1116,CHEMBL298058,P35368,,FSTGDSJHLKDASP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,360.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,537102,DTCC00184678,1722480,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4C,Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1
1117,CHEMBL29846,P35368,,ZINLARKOVIPOJW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9925723.0,KI,=,1995.26,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity against Alpha-1B adrenergic receptor,,"5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist.",J. Med. Chem.,1999.0,42.0,2.0,"Bromidge SM, Brown AM, Clarke SE, Dodgson K, Gager T, Grassam HL, Jeffrey PM, Joiner GF, King FD, Middlemiss DN, Moss SF, Newman H, Riley G, Routledge C, Wyman P",,34618.0,DTCT0023207,491869,DTCC00164453,204550,15364,CC1=C(SC2=C1C=C(C=C2)Cl)S(=O)(=O)NC3=CC(=C(C=C3)OC)N4CCN(CC4)C,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN(C)CC1
1118,CHEMBL29846,P35368,,ZINLARKOVIPOJW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11992776.0,KI,=,1995.26,NM,,,,,,,,,,,,,,The compound was tested for the binding affinity towards Alpha-1B adrenergic receptor,,Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,10.0,"Bromidge SM, Clarke SE, King FD, Lovell PJ, Newman H, Riley G, Routledge C, Serafinowska HT, Smith DR, Thomas DR",,34623.0,DTCT0023207,683455,DTCC00164453,192604,4854,CC1=C(SC2=C1C=C(C=C2)Cl)S(=O)(=O)NC3=CC(=C(C=C3)OC)N4CCN(CC4)C,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN(C)CC1
1119,CHEMBL298579,P35368,,YXGDGGYNHGGLOW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,970.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,648970,DTCC00194745,626333,3936,C1CN(CCC1(C#N)C2=CC=CC=C2)CCCNC(=O)N3C(C4=C(COC4=O)NC3=O)C5=CC(=C(C=C5)F)F,N#CC1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1
1120,CHEMBL298595,P35368,,YSSOQZSAWAKBHU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,11.5,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1094801,DTCC00203879,29282,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCCN(CC3)C4=CC=CC=C4Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCCN(c2ccccc2Cl)CC1
1121,CHEMBL298612,P35368,,ZNAPADWWBWFMCQ-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,15848.93,NM,,,,,,,,,,,,,,Binding affinity against Adrenogenic Alpha-1B receptor,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,16.0,,,32306.0,DTCT0023207,903190,DTCC00199987,464443,1269,CN1C=C(C2=CC=CC=C21)C(=O)C(=O)N[C@@H]3CN4CCC3CC4,Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21
1122,CHEMBL298713,P35368,,VWLOQZCQYQZEHT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,45.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,720197,DTCC00194752,1871789,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
1123,CHEMBL298713,P35368,,VWLOQZCQYQZEHT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,45.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,799525,DTCC00194752,1883307,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
1124,CHEMBL298808,P35368,,JERWIURWZNDAMC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1126538,DTCC00204285,1979605,18073,CC1=CC(=C(C=C1)N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O)C,Cc1ccc(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c(C)c1
1125,CHEMBL298838,P35368,,WFGBZCWEOLNNPQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,50.12,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1277862,DTCC00201886,1067113,5563,C1CN(CCN1CCCN2C(=O)C(=CNC2=O)Cl)C3=C(C=C(C=C3)F)OCC(F)(F)F,O=c1[nH]cc(Cl)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1
1126,CHEMBL299022,P35368,,FIKCUNQQOIUGKX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,46.18,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1131865,DTCC00204229,433017,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4C#N,N#Cc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
1127,CHEMBL299253,P35368,,XOSAFCKSDPJGTM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,20.25,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1113568,DTCC00204861,949321,18073,C1CCC2(C1)CC(=O)N(C=C2)CCN3CCN(CC3)C4=CC=CC=C4Cl,O=C1CC2(C=CN1CCN1CCN(c3ccccc3Cl)CC1)CCCC2
1128,CHEMBL299452,P35368,,UZNAGRGAFAEPBA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,100.0,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1261892,DTCC00105140,323405,5563,C1CN(CCN1CCCN2C(=O)C=CNC2=O)C3=C(C=C(C=C3)F)OCC(F)(F)F,O=c1cc[nH]c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1
1129,CHEMBL299454,P35368,,BYHQOSOPNSLUAD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,35.94,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1100245,DTCC00204729,723190,18073,C1CCC2(C1)CCN(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4Cl,O=C1CC2(CCCC2)CCN1CCN1CCN(c2ccccc2Cl)CC1
1130,CHEMBL299539,P35368,,VOXOJYXJGWUWQI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,300.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,625714,DTCC00195026,1628884,3936,COC(=O)C1(CCN(CC1)CCCNC(=O)N2C(C3=C(COC3=O)NC2=O)C4=CC5=NON=C5C=C4)C6=CC=CC=C6,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3nonc3c2)CC1
1131,CHEMBL299691,P35368,,CYDFRMLIERPUGG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,62.62,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1117198,DTCC00203878,335210,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2F)CC1
1132,CHEMBL299691,P35368,,CYDFRMLIERPUGG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15828846.0,KI,=,67.0,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor,,"Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.",J. Med. Chem.,2005.0,48.0,8.0,"Konkel MJ, Wetzel JM, Cahir M, Craig DA, Noble SA, Gluchowski C",,302652.0,DTCT0023207,1825339,DTCC00203878,325774,19681,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2F)CC1
1133,CHEMBL299907,P35368,,UUWKLRJOWBMKIO-WMLDXEAASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,8.2,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1271518,DTCC00208869,1520495,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=CC=N5)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccnc4c3=O)C[C@@H]21
1134,CHEMBL299914,P35368,,SQCNBRHPDWAEHY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11459670.0,KI,=,1900.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards cloned human Alpha-1B adrenergic receptor,,Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2001.0,11.0,14.0,"DiPardo RM, Patane MA, Newton RC, Price R, Broten TP, Chang RS, Ransom RW, Di Salvo J, Freidinger RM, Bock MG",,34460.0,DTCT0023207,1642591,DTCC00207430,3192,4355,CC1=CC=C(C=C1)C2(CC(=O)N(C2=O)CCCN3CCC(CC3)(C#N)C4=CC=CC=C4C)C5=CC=C(C=C5)C,Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1
1135,CHEMBL299984,P35368,,UPQSZPLHQOSKNY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,390.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,652428,DTCC00195027,916584,3936,COC(=O)C1(CCN(CC1)CCCNC(=O)N2C(C3=C(COC3=O)NC2=O)C4=CC5=C(C=C4)OCO5)C6=CC=CC=C6,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc3c(c2)OCO3)CC1
1136,CHEMBL300152,P35368,,RPADCEVSPXUEKK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,13.11,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1114674,DTCC00204149,1046428,18073,CC(CN1CCN(CC1)C2=C(C=CC(=C2)Cl)Cl)N3C(=O)CC4(CCCC4)CC3=O,CC(CN1CCN(c2cc(Cl)ccc2Cl)CC1)N1C(=O)CC2(CCCC2)CC1=O
1137,CHEMBL300222,P35368,,KSCNWOYWUOCFLO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,250.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,631101,DTCC00194699,1046324,3936,COC(=O)C1(CCN(CC1)CCCNC(=O)N2C(C3=C(COC3=O)NC2=O)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1
1138,CHEMBL300222,P35368,,KSCNWOYWUOCFLO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,330.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,643378,DTCC00194699,1046325,3936,COC(=O)C1(CCN(CC1)CCCNC(=O)N2C(C3=C(COC3=O)NC2=O)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1
1139,CHEMBL300222,P35368,,KSCNWOYWUOCFLO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,500.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,647864,DTCC00194699,1046322,3936,COC(=O)C1(CCN(CC1)CCCNC(=O)N2C(C3=C(COC3=O)NC2=O)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1
1140,CHEMBL300272,P35368,,CEBCZNYBCKWKKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,1200.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,631072,DTCC00194993,884997,3936,COC(=O)C1(CCN(CC1)CCNC(=O)N2C(C3=C(COC3=O)NC2=O)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5,COC(=O)C1(c2ccccc2)CCN(CCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1
1141,CHEMBL300355,P35368,,UMVYPFAJDLQOIO-JWZKTCGFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,730.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,652442,DTCC00204607,433020,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@H]2CC[C@H](C2)N3CCC(CC3)(C#N)C4=CC=CC=C4)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1
1142,CHEMBL300540,P35368,,JWAHBXONODWUEH-AFKLWXAFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,130.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,634641,DTCC00204610,1078910,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@@H]2CC[C@@H](C2)N3CCC(CC3)C4=CC=CC=C4C#N)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1
1143,CHEMBL300766,P35368,,SOUVKJLYRGDDOT-WENCSYSZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,28.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,648989,DTCC00204304,1046430,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@@H]2CC[C@@H](C2)N3CCN(CC3)C4=CC=CC=C4C#N)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1
1144,CHEMBL300821,P35368,,SOUVKJLYRGDDOT-TYPXCFOJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,51.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,637868,DTCC00204303,140316,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@H]2CC[C@H](C2)N3CCN(CC3)C4=CC=CC=C4C#N)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1
1145,CHEMBL301019,P35368,,NJWNDAGSUKNZKV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1126641,DTCC00204472,107865,18073,COC1=CC=CC(=C1)N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1cccc(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1
1146,CHEMBL301024,P35368,,UMVYPFAJDLQOIO-LXWOLXCRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,120.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,636722,DTCC00204241,2076786,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@H]2CC[C@@H](C2)N3CCC(CC3)(C#N)C4=CC=CC=C4)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1
1147,CHEMBL301077,P35368,,OYCNDOVCOWSGBD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,130.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,639047,DTCC00194753,1143773,3936,COC(=O)C1(CCN(CC1)CCCNC(=O)N2C(C3=C(COC3=O)NC2=O)C4=CC=C(C=C4)[N+](=O)[O-])C5=CC=CC=C5,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc([N+](=O)[O-])cc2)CC1
1148,CHEMBL301078,P35368,,STIKULJYVCUQJQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9888842.0,KI,=,15.2,NM,,cell_based,,,,,,,,,,,CHO,The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1B adrenergic receptor in CHO cells,,Novel adrenoceptor antagonists with a tricyclic pyrrolodipyridazine skeleton.,J. Med. Chem.,1999.0,42.0,1.0,"Barlocco D, Cignarella G, Montesano F, Leonardi A, Mella M, Toma L",,34467.0,DTCT0023207,1439935,DTCC00194066,873547,15156,CN1C(=O)C2=C3C=CC(=NN3C=C2C(=N1)Cl)NCCN4CCN(CC4)C5=CC=CC=C5OC,COc1ccccc1N1CCN(CCNc2ccc3c4c(=O)n(C)nc(Cl)c4cn3n2)CC1
1149,CHEMBL301224,P35368,,RBBPCEWGOONAPO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,7.95,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1106955,DTCC00204710,819890,18073,C1CCC2(C1)CCN(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
1150,CHEMBL301224,P35368,,RBBPCEWGOONAPO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,PKB,=,6.42,,,,,,,,,,,,,,,Dissociation constant against guinea pig spleen alpha-1B adrenergic receptor in vitro was determined,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34192.0,DTCT0023207,1106960,DTCC00204710,819890,18073,C1CCC2(C1)CCN(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCC2)CCN1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
1151,CHEMBL301416,P35368,,PSJOYKASTCTBMB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11459670.0,KI,>,2000.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards cloned human Alpha-1B adrenergic receptor,,Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2001.0,11.0,14.0,"DiPardo RM, Patane MA, Newton RC, Price R, Broten TP, Chang RS, Ransom RW, Di Salvo J, Freidinger RM, Bock MG",,34460.0,DTCT0023207,1652620,DTCC00207434,1488184,4355,CC1=CC=C(C=C1)C2(C(=O)N(C(=O)O2)CCCN3CCC(CC3)(C#N)C4=CC=CC=C4C)C5=CC=C(C=C5)C,Cc1ccc(C2(c3ccc(C)cc3)OC(=O)N(CCCN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1
1152,CHEMBL301650,P35368,,CZJQYRRCGRRBAS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,6.31,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1265494,DTCC00201844,614611,5563,C1CN(CCN1CCCN2C(=O)C(=CNC2=O)C(F)(F)F)C3=CC=CC=C3OCC(F)(F)F,O=c1[nH]cc(C(F)(F)F)c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1
1153,CHEMBL301707,P35368,,AQASGOHUMGAWJJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,1.82,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1589495,DTCC00199939,1273373,17389,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1
1154,CHEMBL301707,P35368,,AQASGOHUMGAWJJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,1.82,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017499,DTCC00199939,1263598,21852,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1
1155,CHEMBL301707,P35368,,AQASGOHUMGAWJJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,1.82,NM,,,,,,,,,,,,,,Binding affinity to adrenergic Alpha-1B receptor,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753879.0,DTCT0023207,6001213,DTCC00199939,1284830,44951,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1
1156,CHEMBL301707,P35368,,AQASGOHUMGAWJJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,1.82,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE-2254 from human adrenergic Alpha-1B receptor expressed in HEK293 cells,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753882.0,DTCT0023207,6001189,DTCC00199939,1284830,44951,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1
1157,CHEMBL301726,P35368,,HPKLBVVRBBCHTN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9888842.0,KI,=,22.1,NM,,cell_based,,,,,,,,,,,CHO,The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1B adrenergic receptor in CHO cells,,Novel adrenoceptor antagonists with a tricyclic pyrrolodipyridazine skeleton.,J. Med. Chem.,1999.0,42.0,1.0,"Barlocco D, Cignarella G, Montesano F, Leonardi A, Mella M, Toma L",,34467.0,DTCT0023207,1442472,DTCC00193950,905906,15156,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)CCN3CCN(CC3)C4=CC=CC=C4OC)N,COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c(C(C)=O)c(N)c2=O)CC1
1158,CHEMBL302092,P35368,,DSQXAOLERDQQCP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,=,1225.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1135430,DTCC00222994,452609,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=C(C=C5)Cl)Cl)O,CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)c(Cl)c2)C3=O)CC1
1159,CHEMBL302192,P35368,,CTAPRHUYCGFSKX-LAUBAEHRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,63.1,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1256217,DTCC00209040,1326037,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4CC5=CC(=C(C=C5NC4)OC)OC,COc1cc2c(cc1OC)NCN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2
1160,CHEMBL302203,P35368,,KKPIEWMOXUDHDQ-HNAYVOBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,2.27,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1253845,DTCC00208998,1228058,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C(=CC=C5)OC)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(OC)cccc4c3=O)C[C@@H]21
1161,CHEMBL302246,P35368,,YCKRBYBOMGAOET-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1105354,DTCC00222569,1902880,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=CC=C5)F)O,CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1
1162,CHEMBL302495,P35368,,DGESRLVPERSCQG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,=,1063.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1044415,DTCC00221326,1014181,4980,COC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(S3)CO,COc1ccccc1N1CCN(Cc2ccc(CO)s2)CC1
1163,CHEMBL302637,P35368,NORTOPSENTIN A,BIGUXWQKCPFOAH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,520.0,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster Alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone),,,Bioorg. Med. Chem. Lett.,1996.0,6.0,17.0,,,32894.0,DTCT0023207,1301913,DTCC00216220,1552617,1778,C1=CC2=C(C=C1Br)NC=C2C3=CN=C(N3)C4=CNC5=C4C=CC(=C5)Br,Brc1ccc2c(-c3cnc(-c4c[nH]c5cc(Br)ccc45)[nH]3)c[nH]c2c1
1164,CHEMBL302698,P35368,,NEAKCLFZBLSGMR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,964127,DTCC00225634,594177,16733,CS(=O)(=O)C1=C(C=C(C=C1)C(F)(F)F)NCC2=NCCN2,CS(=O)(=O)c1ccc(C(F)(F)F)cc1NCC1=NCCN1
1165,CHEMBL302698,P35368,,NEAKCLFZBLSGMR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,<,10000.0,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,964121,DTCC00225634,594177,16733,CS(=O)(=O)C1=C(C=C(C=C1)C(F)(F)F)NCC2=NCCN2,CS(=O)(=O)c1ccc(C(F)(F)F)cc1NCC1=NCCN1
1166,CHEMBL302698,P35368,,NEAKCLFZBLSGMR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as percent maximal effect for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha1b; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218076.0,DTCT0023207,964132,DTCC00225634,594177,16733,CS(=O)(=O)C1=C(C=C(C=C1)C(F)(F)F)NCC2=NCCN2,CS(=O)(=O)c1ccc(C(F)(F)F)cc1NCC1=NCCN1
1167,CHEMBL302882,P35368,,AUJKXAIGSXKZBR-SJORKVTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,78.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,,Bioorg. Med. Chem. Lett.,1996.0,6.0,17.0,,,33015.0,DTCT0023207,1306791,DTCC00216221,1934823,1778,CN1C[C@@H](NC[C@H]1C2=CNC3=C2C=CC(=C3)Br)C4=CNC5=C4C(=CC(=C5Br)Br)O,CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12
1168,CHEMBL302882,P35368,,AUJKXAIGSXKZBR-SJORKVTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,80.0,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster Alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone),,,Bioorg. Med. Chem. Lett.,1996.0,6.0,17.0,,,32894.0,DTCT0023207,1306789,DTCC00216221,1934823,1778,CN1C[C@@H](NC[C@H]1C2=CNC3=C2C=CC(=C3)Br)C4=CNC5=C4C(=CC(=C5Br)Br)O,CN1C[C@H](c2c[nH]c3c(Br)c(Br)cc(O)c23)NC[C@H]1c1c[nH]c2cc(Br)ccc12
1169,CHEMBL302940,P35368,,URHATDOBWHTBOV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1097336,DTCC00221898,225600,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)OC)O,COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1
1170,CHEMBL302942,P35368,,URHATDOBWHTBOV-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1122750,DTCC00222068,744080,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)C[C@@H](CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)OC)O,COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1
1171,CHEMBL303248,P35368,,LWTOWQIZIKMJKD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1095921,DTCC00222683,1902882,15735,CC1=CC(=CC=C1)N2C(=O)C3=C(C2=O)C=C(C=C3)C(=O)NCC(CN4CCN(CC4)C5=CC=CC=C5OC(C)C)O,Cc1cccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)c1
1172,CHEMBL303282,P35368,TOPSENTIN,TVPNFKRGOFJQOO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,1150.0,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster Alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone),,,Bioorg. Med. Chem. Lett.,1996.0,6.0,17.0,,,32894.0,DTCT0023207,1321032,DTCC00216193,1358946,1778,C1=CC=C2C(=C1)C(=CN2)C3=CN=C(N3)C(=O)C4=CNC5=C4C=CC(=C5)O,O=C(c1ncc(-c2c[nH]c3ccccc23)[nH]1)c1c[nH]c2cc(O)ccc12
1173,CHEMBL303464,P35368,,VBMWRWYJANTSGH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,31.1,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34333.0,DTCT0023207,1593446,DTCC00218963,982315,17389,CC1=C2C(=NN(C(=O)C2=NO1)CCN3CCN(CC3)C4=CC=CC=C4OC)C5=CC=CC=C5,COc1ccccc1N1CCN(CCn2nc(-c3ccccc3)c3c(C)onc3c2=O)CC1
1174,CHEMBL303485,P35368,,FHHPURZYJUQVBM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1041004,DTCC00220168,2012627,4980,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=CS3)CO,CC(C)Oc1ccccc1N1CCN(Cc2cc(CO)cs2)CC1
1175,CHEMBL303627,P35368,,YCKRBYBOMGAOET-DEOSSOPVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1109359,DTCC00222133,1838570,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)C[C@H](CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=CC=C5)F)O,CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1
1176,CHEMBL303988,P35368,,AXGQSWAGPJPUTJ-OXJNMPFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,95.2,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1255085,DTCC00208601,1100067,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4CNC5=CC(=C(C=C5C4=O)OC)OC,COc1cc2c(cc1OC)C(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CN2
1177,CHEMBL304132,P35368,,CSXUKDQJFRHATO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1094609,DTCC00222525,1488333,15735,CC1=CC=C(C=C1)N2C(=O)C3=C(C2=O)C=C(C=C3)C(=O)NCCCN4CCN(CC4)C5=CC=CC=C5OC(C)C,Cc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1
1178,CHEMBL304215,P35368,,DQSYTGKEJVGVLB-IFXJQAMLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,3.33,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1251594,DTCC00208456,421581,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=C(C=C5)[N+](=O)[O-])NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc([N+](=O)[O-])ccc4c3=O)C[C@@H]21
1179,CHEMBL304591,P35368,,MVYCXEXQTMBCNB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,=,361.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1110726,DTCC00221998,1902881,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)OC,COc1ccc(N2C(=O)c3ccc(C(=O)NCCCN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1
1180,CHEMBL304977,P35368,,CCJMGYBFMJJAIY-DEOSSOPVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1115598,DTCC00222001,2000675,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)C[C@H](CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)O)O,CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1
1181,CHEMBL305029,P35368,,INRFQTYFEDZXNB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,=,413.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1048203,DTCC00220201,1079079,4980,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(S3)CN4CCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1
1182,CHEMBL305928,P35368,,DAIRUBYTBODIKT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,35481300000000.0,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor by the displacement of [3H]prazosin,,,Bioorg. Med. Chem. Lett.,1994.0,4.0,19.0,,,34607.0,DTCT0023207,1716081,DTCC00231110,1111931,933,C1CCCC(CC1)NC2=NCCO2,C1CCCC(NC2=NCCO2)CC1
1183,CHEMBL306377,P35368,,LAMFPOWZDAOQTK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,147911000000000.0,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor by the displacement of [3H]prazosin,,,Bioorg. Med. Chem. Lett.,1994.0,4.0,19.0,,,34607.0,DTCT0023207,1717662,DTCC00230999,172817,933,C1CC(C2=CC=CC=C2C1)NC3=NCCCO3,c1ccc2c(c1)CCCC2NC1=NCCCO1
1184,CHEMBL306792,P35368,,XBBHVMXFPPVGMX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,6.03,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,948369,DTCC00105729,29676,16733,CSC1=C(C=CC(=C1)F)NCC2=NCCN2,CSc1cc(F)ccc1NCC1=NCCN1
1185,CHEMBL306792,P35368,,XBBHVMXFPPVGMX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,15.14,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,948363,DTCC00105729,29676,16733,CSC1=C(C=CC(=C1)F)NCC2=NCCN2,CSc1cc(F)ccc1NCC1=NCCN1
1186,CHEMBL306792,P35368,,XBBHVMXFPPVGMX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,78.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,948374,DTCC00105729,29676,16733,CSC1=C(C=CC(=C1)F)NCC2=NCCN2,CSc1cc(F)ccc1NCC1=NCCN1
1187,CHEMBL30713,P35368,ALPHA-METHYLTRYPTAMINE,QSQQQURBVYWZKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23602445.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Prazosin from human recombinant adrenergic alpha1B receptor expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,964972.0,DTCT0023207,12464768,DTCC01739501,1995571,54821,CC(CC1=CNC2=CC=CC=C21)N,CC(N)Cc1c[nH]c2ccccc12
1188,CHEMBL308671,P35368,,ZEGBQBDRCBJTSW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,1658.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1102340,DTCC00222681,1228202,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)F)O,CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(F)cc2)C3=O)CC1
1189,CHEMBL309106,P35368,,LQTJOPPTSIYEES-SANMLTNESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1125074,DTCC00221995,257864,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)C[C@H](CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)N(C)C)O,CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1
1190,CHEMBL3094311,P35368,,NHUZHVAPAIJQRS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24238903.0,INHIBITION,=,-11.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha-1B receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279109.0,DTCT0023207,12962160,DTCC01413925,1127501,56656,C1=CC(=CC=C1CN)OCC2=CC=C(C=C2)Cl.Cl,NCc1ccc(OCc2ccc(Cl)cc2)cc1
1191,CHEMBL3094312,P35368,,KKYAPAJUTFYVRD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24238903.0,INHIBITION,=,-2.4,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha-1B receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279109.0,DTCT0023207,12962118,DTCC01413926,351566,56656,C1=CC=C(C(=C1)COC2=CC=C(C=C2)CN)OC(F)(F)F.Cl,NCc1ccc(OCc2ccccc2OC(F)(F)F)cc1
1192,CHEMBL3094313,P35368,,XVKBXJCHXRLYAQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24238903.0,INHIBITION,=,-3.8,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha-1B receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279109.0,DTCT0023207,12962076,DTCC01413927,933254,56656,C1=CC(=CC(=C1)OC(F)(F)F)COC2=CC=C(C=C2)CN.Cl,NCc1ccc(OCc2cccc(OC(F)(F)F)c2)cc1
1193,CHEMBL3094314,P35368,,NLGKYLSBSOGION-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24238903.0,INHIBITION,=,4.1,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha-1B receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279109.0,DTCT0023207,12962034,DTCC01413928,901389,56656,C1=CC(=CC=C1CN)OCC2=CC=C(C=C2)OC(F)(F)F.Cl,NCc1ccc(OCc2ccc(OC(F)(F)F)cc2)cc1
1194,CHEMBL3094316,P35368,,RSZFCDGHJLBYEB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24238903.0,INHIBITION,=,0.5,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha-1B receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279109.0,DTCT0023207,12963262,DTCC01413930,1708845,56656,C1=CC=C(C=C1)COC2=CC=C(C=C2)CN.Cl,NCc1ccc(OCc2ccccc2)cc1
1195,CHEMBL3094317,P35368,,VCEAPZBMHGKMHI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24238903.0,INHIBITION,=,13.6,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha-1B receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279109.0,DTCT0023207,12963220,DTCC01413931,1256448,56656,C1=CC=C(C(=C1)COC2=CC=C(C=C2)CN)F.Cl,NCc1ccc(OCc2ccccc2F)cc1
1196,CHEMBL3094318,P35368,,CYPDLWIUOMSUJR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24238903.0,INHIBITION,=,24.8,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha-1B receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279109.0,DTCT0023207,12962287,DTCC01413932,1737126,56656,C1=CC(=CC(=C1)F)COC2=CC=C(C=C2)CN.Cl,NCc1ccc(OCc2cccc(F)c2)cc1
1197,CHEMBL3094319,P35368,,YYONFKYBFNEIKC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24238903.0,INHIBITION,=,-12.6,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha-1B receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279109.0,DTCT0023207,12962245,DTCC01413933,965453,56656,C1=CC(=CC=C1CN)OCC2=CC=C(C=C2)F.Cl,NCc1ccc(OCc2ccc(F)cc2)cc1
1198,CHEMBL3094320,P35368,,UZVSKGBBGCJIRV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24238903.0,INHIBITION,=,11.4,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha-1B receptor (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279109.0,DTCT0023207,12962203,DTCC01413934,1644990,56656,C1=CC(=CC(=C1)Cl)COC2=CC=C(C=C2)CN.Cl,NCc1ccc(OCc2cccc(Cl)c2)cc1
1199,CHEMBL309518,P35368,,AACTUBFOGVFADC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,10.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,924151,DTCC00240380,529914,2766,CSC1=CC2=C(C=C1)S(=O)(=O)N(C2=O)CCCCN3CCC(CC3)N4C5=CC=CC=C5OC4=O,CSc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O
1200,CHEMBL309949,P35368,,MMSKDIBKZJETID-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,676.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,922825,DTCC00239629,723596,2766,C1CCC2=CC3=C(C=C2C1)N(C(=O)O3)C4CCN(CC4)CCCCN5C(=O)C6=CC=CC=C6S5(=O)=O,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc4c(cc32)CCCC4)CC1
1201,CHEMBL309969,P35368,,HUIUQPNWNWZOTQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,=,2992.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1439666,DTCC00238602,3816,5035,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=NO3)CN4CCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)no2)CC1
1202,CHEMBL310335,P35368,,WDSZUSABLKNHCZ-VUWPPUDQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,251189000000000.0,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor by the displacement of [3H]prazosin,,,Bioorg. Med. Chem. Lett.,1994.0,4.0,19.0,,,34607.0,DTCT0023207,1716072,DTCC00230998,1532281,933,CCC[C@H]1CCCCC1NC2=NCCO2,CCC[C@H]1CCCCC1NC1=NCCO1
1203,CHEMBL3104091,P35368,,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24365159.0,KI,=,3162.28,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from adrenergic alpha1B receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283839.0,DTCT0023207,12984247,DTCC01417357,351604,56928,CN1CCC2=C(C1)C3=CC=CC4=C3N2C5=CC=CC=C5CC4,CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1
1204,CHEMBL3104091,P35368,,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24365159.0,KI,=,3310.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from adrenergic alpha1B receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283839.0,DTCT0023207,12984116,DTCC01417357,351604,56928,CN1CCC2=C(C1)C3=CC=CC4=C3N2C5=CC=CC=C5CC4,CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1
1205,CHEMBL3104092,P35368,,RQBRUGMHSQYCNU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24365159.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from adrenergic alpha1B receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283839.0,DTCT0023207,12984193,DTCC01417358,1030177,56928,CN1CCC2=C(C1)C3=CC=CC4=C3N2CC5=CC=CC=C5C4,CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1
1206,CHEMBL3104093,P35368,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24365159.0,KI,=,2238.72,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from adrenergic alpha1B receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283839.0,DTCT0023207,12984152,DTCC01417359,577788,56928,CN1CCC2=C(C1)C3=C4N2CCC5=CC=CC=C5C4=CC=C3,CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1
1207,CHEMBL3104093,P35368,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24365159.0,KI,=,2240.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from adrenergic alpha1B receptor (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283839.0,DTCT0023207,12984080,DTCC01417359,577788,56928,CN1CCC2=C(C1)C3=C4N2CCC5=CC=CC=C5C4=CC=C3,CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1
1208,CHEMBL310471,P35368,,RBXJHORKDXVNCU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11055359.0,KI,=,3915.0,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards COS cell membrane expressing the human Alpha-1B adrenergic receptor,,Novel heterocycles as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,20.0,"Li X, McCoy KA, Murray WV, Jolliffe L, Pulito V",,34342.0,DTCT0023207,908254,DTCC00235216,1806265,3968,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NNC(=C3)CN4CCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)[nH]n2)CC1
1209,CHEMBL310599,P35368,,LZZIGVORZVSTNT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,0.75,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1550921,DTCC00236744,1435262,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=CC=CC=C4Cl,CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2Cl)CC1
1210,CHEMBL310599,P35368,,LZZIGVORZVSTNT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,9.12,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1550918,DTCC00236744,1435262,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=CC=CC=C4Cl,CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2Cl)CC1
1211,CHEMBL310604,P35368,HOMOCYSTEINE,FFFHZYDWPBMWHY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14743982,DTCC00239847,2108578,69159,C(CS)C(C(=O)O)N,NC(CCS)C(=O)O
1212,CHEMBL310768,P35368,,XERNBNISTSVJGK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,=,4251.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1429496,DTCC00238621,486251,5035,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NC(=CS3)CN4CCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)cs2)CC1
1213,CHEMBL310890,P35368,,HYROFOKEXWNSCZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,=,1735.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1412283,DTCC00238032,96731,5035,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NC(=CS3)CN4CCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)cs2)CC1
1214,CHEMBL311014,P35368,,UPBBTGBTRMORRK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,1650.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,920591,DTCC00239819,1305674,2766,COC1=CC2=C(C=C1)N(C(=O)O2)C3CCN(CC3)CCCCN4C(=O)C5=CC=CC=C5S4(=O)=O,COc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1
1215,CHEMBL311247,P35368,,RZJPYZWXIJSYFQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,3.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,898450,DTCC00240076,1046803,2766,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCCN4C(=O)C5=CC=CC=C5C4=O,O=C1c2ccccc2C(=O)N1CCCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
1216,CHEMBL311290,P35368,,JWKSOUFQGFGEKE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,1958.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,932697,DTCC00240088,1175386,2766,COC(=O)C1=CC2=C(C=C1)N(C(=O)O2)C3CCN(CC3)CCCCN4C(=O)C5=CC=CC=C5S4(=O)=O,COC(=O)c1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1
1217,CHEMBL311479,P35368,,CYGUSDVXGIEDMH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,2.01,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1540131,DTCC00236795,949664,16317,CN1C(=O)C(=CC(=N1)C2=CC=CC=C2)NCCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1
1218,CHEMBL311479,P35368,,CYGUSDVXGIEDMH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,8.7,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1540128,DTCC00236795,949664,16317,CN1C(=O)C(=CC(=N1)C2=CC=CC=C2)NCCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1
1219,CHEMBL311890,P35368,,ZZNMPZNCGBNJBR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,14.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,911393,DTCC00240050,626807,2766,C1CN(CCC1N2C3=CC=CC=C3OC2=O)CCCCN4C(=O)C5=CC=CC=C5S4(=O)=O,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1
1220,CHEMBL312871,P35368,,MWOOWQMUFWOYRV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,1174.9,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,768263,DTCC00250952,270108,14735,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC6=C(C=C5)OCO6)C(=O)N,CC1=C(C(N)=O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
1221,CHEMBL313160,P35368,,BTYBILKFYYEYRM-PKUSAGTQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,162.18,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,737803,DTCC00251364,1723167,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=C(C=C2)[N+](=O)[O-])OC)C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])c(OC)c1
1222,CHEMBL313251,P35368,,GUTLHNWEBBMLCC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,977.24,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,744197,DTCC00251457,140811,14735,CC1=C(C(C(=C(N1)C)C(=O)O)C2=CC3=C(C=C2)OCO3)C(=O)NCCCN4CCC(CC4)(C5=CC=CC=C5)C6=CC=CC=C6,CC1=C(C(=O)O)C(c2ccc3c(c2)OCO3)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
1223,CHEMBL31354,P35368,"WAY-100,635",SBPRIAGPYFYCRT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15951403.0,KI,=,660.69,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14730746,DTCC00166968,2104040,69226,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4,COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
1224,CHEMBL31354,P35368,"WAY-100,635",SBPRIAGPYFYCRT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16915381.0,KI,=,322.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14730747,DTCC00166968,2104041,69409,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4,COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
1225,CHEMBL31354,P35368,"WAY-100,635",SBPRIAGPYFYCRT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20605276.0,KI,=,66.07,NM,,cell_based,,,,,,,,,,,CHO,Displacement [3H]prazosin of human recombinant Alpha-1B adrenergic receptor expressed in CHO cells by rapid filtration technique,,"1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: structure-affinity/activity relationship at alpha1-adrenoceptor subtypes and at 5-HT1A receptors.",Eur. J. Med. Chem.,2010.0,45.0,9.0,"Franchini S, Prandi A, Baraldi A, Sorbi C, Tait A, Buccioni M, Marucci G, Cilia A, Pirona L, Fossa P, Cichero E, Brasili L",,658238.0,DTCT0023207,3464104,DTCC00166968,502437,40734,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4,COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
1226,CHEMBL31354,P35368,"WAY-100,635",SBPRIAGPYFYCRT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21520940.0,KI,=,322.0,NM,,,,,,,,,,,,,,Inhibition of adrenergic Alpha-1B receptor,,"Design, Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of Bridgehead Iodinated Analogues of N-{2-[4-(2-Methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) as Potential SPECT Ligands for the 5-HT(1A) Receptor.",J. Med. Chem.,2011.0,54.0,10.0,"Al Hussainy R, Verbeek J, van der Born D, Braker AH, Leysen JE, Knol RJ, Booij J, Herscheid JK",,747462.0,DTCT0023207,5942740,DTCC00166968,509294,44583,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4,COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
1227,CHEMBL313631,P35368,,YXPIBYSOCFGTHG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12361399.0,KI,>,10000.0,NM,,,,,,,,,,,,,,The binding affinity towards the Alpha-1B adrenergic receptor; No affinity,,Homoazanicotine: a structure-affinity study for nicotinic acetylcholine (nACh) receptor binding.,J. Med. Chem.,2002.0,45.0,21.0,"Ferretti G, Dukat M, Giannella M, Piergentili A, Pigini M, Quaglia W, Damaj MI, Martin BR, Glennon RA",,32305.0,DTCT0023207,1236404,DTCC00252054,886449,17003,CN1CCN=C1CC2=CN=CC=C2,CN1CCN=C1Cc1cccnc1
1228,CHEMBL313953,P35368,,OXDMFICMRHFYME-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,162.18,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,757911,DTCC00251771,1371022,14735,CC(C)C1=C(C(C(=C(N1)C(C)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC(C)C1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C(C)C)N1
1229,CHEMBL313990,P35368,,CAQYVHKVLYTXRT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,24.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,931370,DTCC00240361,433358,2766,C1CN(CCC1N2C3=CC=CC=C3OC2=O)CCCCN4C(=O)C5=C(S4(=O)=O)C=CC(=C5)Cl,O=C1c2cc(Cl)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1
1230,CHEMBL31410,P35368,CORYNANTHEINE,BLGXFZZNTVWLAY-DKJBZYCGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,517.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,935331,DTCC00167117,336305,13230,COC(=O)[C@@H]1[C@H](CC[C@@H]2[C@@H]1C[C@H]3C4=C(CCN3C2)C5=CC=CC=C5N4)O,COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12
1231,CHEMBL314960,P35368,,WFSGQIXIGIQILN-LVYIWIAJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,123.03,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,733858,DTCC00251245,1079418,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)Cl)C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)cc1
1232,CHEMBL315392,P35368,,SNLNBLRAKFOCGE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,1174.9,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,732588,DTCC00250949,173021,14735,CC1=C(C(C(=C(N1)C)C(=O)N(C)C)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,CC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)N(C)C)=C(C)N1
1233,CHEMBL315538,P35368,,VHYJQKUBUIGDCY-PKUSAGTQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,204.17,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,737789,DTCC00251250,755838,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)OC)C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(OC)cc1
1234,CHEMBL315914,P35368,,CACGBSVXIXSELL-PKUSAGTQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,269.15,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,765607,DTCC00251694,1273215,14735,CC1=CC=C(C=C1)C2C(=C(NC(=C2C(=O)OC)C)C)C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C)cc1
1235,CHEMBL316100,P35368,,YVYVBMJSGUJZBA-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,140.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1327814,DTCC00254802,1175567,15798,C1CN(CCC1(C#N)C2=CC=C(C=C2)F)CCCNC(=O)C3=CNC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F,N#CC1(c2ccc(F)cc2)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1
1236,CHEMBL316358,P35368,,YKHANSHTGFUQLD-RUZDIDTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,440.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1347127,DTCC00254070,820434,15798,CN1C=C([C@H](NC1=O)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=C(C=C(C=C4)F)C#N,CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O
1237,CHEMBL316495,P35368,,XWUSTWDFKOHGNW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,181.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1210657,DTCC00262603,1870950,3366,CCCC1=C(C(C(=C(N1)CC)C(=O)NCC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,CCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1
1238,CHEMBL316677,P35368,,RWUWDRWYNJXVCA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,26.92,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1598604,DTCC00264837,1435552,17389,CC1=NC2=C(C(=O)N1CCCN3CCN(CC3)C4=CC=CC=C4OC)NC5=CC=CC=C52,COc1ccccc1N1CCN(CCCn2c(C)nc3c([nH]c4ccccc43)c2=O)CC1
1239,CHEMBL317555,P35368,,KSEKFOIGJKOAJY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,14.45,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1592121,DTCC00265024,627097,17389,CCOC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,CCOc1ccccc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1
1240,CHEMBL317556,P35368,,PQUQESDZEDVJQI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,2041.74,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1583218,DTCC00264736,30441,17389,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=C(C=C4)C(C)(C)C)NC5=CC=CC=C52,Cc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(C(C)(C)C)cc2)CC1
1241,CHEMBL318257,P35368,,YNZFNGNFBKOQRH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,LOG KI,=,6.51,NM,,cell_based,,,,,,,,,,,,The binding affinity was evaluated on cloned human alpha-1B adrenergic receptor expressed in chinese hamster ovary(CHO) cells by using [3H]prazosin as radioligand.,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34622.0,DTCT0023207,988014,DTCC00268098,1839089,15289,COC1=C(C(=CC=C1)OC)OCCNCC2C(CC3=CC=CC=C3O2)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1Oc2ccccc2CC1c1ccccc1
1242,CHEMBL318257,P35368,,YNZFNGNFBKOQRH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,LOG KI,=,6.58,NM,,cell_based,,,,,,,,,,,,The binding affinity was evaluated on cloned human Alpha-1B adrenergic receptor expressed in chinese hamster ovary(CHO) cells by using [3H]prazosin as radioligand.,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34621.0,DTCT0023207,991728,DTCC00268098,1839088,15289,COC1=C(C(=CC=C1)OC)OCCNCC2C(CC3=CC=CC=C3O2)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1Oc2ccccc2CC1c1ccccc1
1243,CHEMBL318257,P35368,,YNZFNGNFBKOQRH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,PKB,=,5.54,,,,,,,,,,,,,,,Antagonist affinity was expressed as apparent pKb at Alpha-1B adrenergic receptor on isolated Guinea pig spleen (Alpha-1B),,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34193.0,DTCT0023207,991735,DTCC00268098,1839088,15289,COC1=C(C(=CC=C1)OC)OCCNCC2C(CC3=CC=CC=C3O2)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1Oc2ccccc2CC1c1ccccc1
1244,CHEMBL318544,P35368,,CGRLAWJJBVDUOY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,79.43,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,622405,DTCC00264160,401350,4573,CCCNC(=O)C1=CC=CC=C1NCC2=NCCN2,CCCNC(=O)c1ccccc1NCC1=NCCN1
1245,CHEMBL318544,P35368,,CGRLAWJJBVDUOY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,77.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,622406,DTCC00264160,401350,4573,CCCNC(=O)C1=CC=CC=C1NCC2=NCCN2,CCCNC(=O)c1ccccc1NCC1=NCCN1
1246,CHEMBL318544,P35368,,CGRLAWJJBVDUOY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,=,79.43,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1151622,DTCC00264160,401692,5253,CCCNC(=O)C1=CC=CC=C1NCC2=NCCN2,CCCNC(=O)c1ccccc1NCC1=NCCN1
1247,CHEMBL318544,P35368,,CGRLAWJJBVDUOY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,IC50,=,1698.24,NM,,,,,,,,,,,,,,In vitro binding affinity against cloned human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32514.0,DTCT0023207,1151627,DTCC00264160,401692,5253,CCCNC(=O)C1=CC=CC=C1NCC2=NCCN2,CCCNC(=O)c1ccccc1NCC1=NCCN1
1248,CHEMBL318544,P35368,,CGRLAWJJBVDUOY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,MAX,=,77.0,%,,,,,,,,,,,,,,Activation of human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts as percent maximal effect relative to phenylephrine,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32512.0,DTCT0023207,1151623,DTCC00264160,401692,5253,CCCNC(=O)C1=CC=CC=C1NCC2=NCCN2,CCCNC(=O)c1ccccc1NCC1=NCCN1
1249,CHEMBL3187195,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,263.9,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269817,DTCC00046242,1519572,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F
1250,CHEMBL319345,P35368,,WLWSNVBUVBRFDK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,LOG KI,=,55.0,,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1598607,DTCC00265025,1532651,17389,C1CN(CCN1CCN2C(=O)C3=C(C4=CC=CC=C4N3)NC2=O)C5=CC=C(C=C5)CC#N,N#CCc1ccc(N2CCN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC2)cc1
1251,CHEMBL319553,P35368,,OZXBSTCCARQDBM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,632140,DTCC00264677,1723290,4573,CC(C)OC(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)OC(=O)c1ccccc1NCC1=NCCN1
1252,CHEMBL319553,P35368,,OZXBSTCCARQDBM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,IC50,=,1778.28,NM,,,,,,,,,,,,,,Concentration required for 50% inhibition of binding against human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,34483.0,DTCT0023207,632143,DTCC00264677,1723290,4573,CC(C)OC(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)OC(=O)c1ccccc1NCC1=NCCN1
1253,CHEMBL319972,P35368,,HQVAUISTGQUBJI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,100000000000.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34620.0,DTCT0023207,1576424,DTCC00265053,562401,17389,CC(C)(C)C1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,CC(C)(C)c1ccc(N2CCN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC2)cc1
1254,CHEMBL320397,P35368,,OPLHOPJAFJJLPX-HNNXBMFYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,360.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34333.0,DTCT0023207,1572522,DTCC00265066,1947371,17389,COC1=C(C=C2CCN3CC4=C(C[C@H]3C2=C1)C=CC(=C4OC)O)O,COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21
1255,CHEMBL320419,P35368,,PIZWZQQKQFIBPD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,646736,DTCC00264132,140951,4573,CCCCNC(=O)C1=CC=CC=C1NCC2=NCCN2,CCCCNC(=O)c1ccccc1NCC1=NCCN1
1256,CHEMBL320419,P35368,,PIZWZQQKQFIBPD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,IC50,=,1949.84,NM,,,,,,,,,,,,,,Concentration required for 50% inhibition of binding against human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,34483.0,DTCT0023207,646740,DTCC00264132,140951,4573,CCCCNC(=O)C1=CC=CC=C1NCC2=NCCN2,CCCCNC(=O)c1ccccc1NCC1=NCCN1
1257,CHEMBL320736,P35368,,QJNQCJFRBTWUEL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,177.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1210668,DTCC00263116,1585321,3366,CCC1=C(C(C(=C(N1)COCC(F)(F)F)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCC(F)(F)F)N1
1258,CHEMBL320910,P35368,,MASRFDLCKBXBBM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,635650,DTCC00263834,1980297,4573,C1CCC(C1)NC(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(NC1CCCC1)c1ccccc1NCC1=NCCN1
1259,CHEMBL3215892,P35368,,MTATYSOUXXNXHF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23141912.0,INHIBITION,=,1.13,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886901.0,DTCT0023207,11493449,DTCC01463309,1041440,52134,C1CN(CCN1)CC2=C3C=CN(C3=CC=C2)S(=O)(=O)C4=CC=CC=C4Br.Cl.Cl,O=S(=O)(c1ccccc1Br)n1ccc2c(CN3CCNCC3)cccc21
1260,CHEMBL3216590,P35368,,WNDMPEJJAWXNBF-CKUXDGONSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23902232.0,KI,=,35.48,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human alpha-1B adrenoreceptor expressed in CHO cells after 30 mins,,"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective a1D-adrenoceptor antagonist.",J. Med. Chem.,2013.0,56.0,16.0,"Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, Chiodini G, Gobbi M, Laurino P, Micucci M, Straniero V, Valoti E",,978686.0,DTCT0023207,12543789,DTCC01464005,1877794,55571,COC1=C(C2=C(CCN2)C=C1)OCCNC[C@H]3COC4=CC=CC=C4O3.Cl.Cl,COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)NCC2
1261,CHEMBL3216680,P35368,,VMYAFGIFDMTJOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19447527.0,ACTIVITY,,,,,,,,,,,,,,,,,Antagonist activity at Alpha-1B adrenoceptor in guinea pig spleen assessed as inhibition of noradrenaline-induced contraction after 30 mins,Dose-dependent effect,"Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.",Eur. J. Med. Chem.,2009.0,44.0,10.0,"Kulig K, Sapa J, Nowaczyk A, Filipek B, Malawska B",,588344.0,DTCT0023207,3041060,DTCC01464094,38118,35555,CCOC1=CC=CC=C1N2CCN(CC2)CC(CN3CCC(C3=O)(C4=CC=CC=C4)C5=CC=CC=C5)O.Cl.Cl,CCOc1ccccc1N1CCN(CC(O)CN2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1
1262,CHEMBL3216680,P35368,,VMYAFGIFDMTJOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19447527.0,KD,=,280.54,NM,,,,,,,,,,,,,,Antagonist activity at Alpha-1B adrenoceptor in guinea pig spleen assessed as inhibition of noradrenaline-induced contraction after 30 mins,,"Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.",Eur. J. Med. Chem.,2009.0,44.0,10.0,"Kulig K, Sapa J, Nowaczyk A, Filipek B, Malawska B",,588344.0,DTCT0023207,3040987,DTCC01464094,38118,35555,CCOC1=CC=CC=C1N2CCN(CC2)CC(CN3CCC(C3=O)(C4=CC=CC=C4)C5=CC=CC=C5)O.Cl.Cl,CCOc1ccccc1N1CCN(CC(O)CN2CCC(c3ccccc3)(c3ccccc3)C2=O)CC1
1263,CHEMBL3217244,P35368,,WNDMPEJJAWXNBF-QCUBGVIVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23902232.0,KI,=,371.54,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human alpha-1B adrenoreceptor expressed in CHO cells after 30 mins,,"6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective a1D-adrenoceptor antagonist.",J. Med. Chem.,2013.0,56.0,16.0,"Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, Chiodini G, Gobbi M, Laurino P, Micucci M, Straniero V, Valoti E",,978686.0,DTCT0023207,12543788,DTCC01464657,1656965,55571,COC1=C(C2=C(CCN2)C=C1)OCCNC[C@@H]3COC4=CC=CC=C4O3.Cl.Cl,COc1ccc2c(c1OCCNC[C@@H]1COc3ccccc3O1)NCC2
1264,CHEMBL3217984,P35368,,YVENIGOVHPMTDH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329323.0,DTCT0023207,13584566,DTCC01464882,1030631,39761,CN1CCC2C(C1)C3=C4N2C5=CC=CC=C5CSC4=CC=C3,CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3
1265,CHEMBL322405,P35368,,ULNCHYOWDJEHCE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,840.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1223352,DTCC00263334,938455,3366,CC1=C(C(C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(COCCN)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1
1266,CHEMBL322688,P35368,,MLGILCIYEMBRNJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,24.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,493844,DTCC00267551,486556,3405,C1CN(CCC12CC(=O)C3=C(O2)C=CC(=C3)NS(=O)(=O)CC4=CC=CC=C4)CCC5=CC=CC6=CC=CC=C65,O=C1CC2(CCN(CCc3cccc4ccccc34)CC2)Oc2ccc(NS(=O)(=O)Cc3ccccc3)cc21
1267,CHEMBL3233142,P35368,,LHAPOGAFBLSJJQ-GUTACTQSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24559051.0,INHIBITION,>,50.0,%,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) at 100 nM,,Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,2014.0,57.0,6.0,"Li P, Zhang Q, Robichaud AJ, Lee T, Tomesch J, Yao W, Beard JD, Snyder GL, Zhu H, Peng Y, Hendrick JP, Vanover KE, Davis RE, Mates S, Wennogle LP",,1334893.0,DTCT0023207,13624908,DTCC01472158,1268946,57999,CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12
1268,CHEMBL3233142,P35368,,LHAPOGAFBLSJJQ-GUTACTQSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24559051.0,KI,=,31.0,NM,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin),,Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,2014.0,57.0,6.0,"Li P, Zhang Q, Robichaud AJ, Lee T, Tomesch J, Yao W, Beard JD, Snyder GL, Zhu H, Peng Y, Hendrick JP, Vanover KE, Davis RE, Mates S, Wennogle LP",,1339955.0,DTCT0023207,13624861,DTCC01472158,1268946,57999,CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12
1269,CHEMBL3233143,P35368,,WPJSNLWFVMFFSG-FPOVZHCZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24559051.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin),Not Determined,Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,2014.0,57.0,6.0,"Li P, Zhang Q, Robichaud AJ, Lee T, Tomesch J, Yao W, Beard JD, Snyder GL, Zhu H, Peng Y, Hendrick JP, Vanover KE, Davis RE, Mates S, Wennogle LP",,1339955.0,DTCT0023207,13624862,DTCC01472159,168840,57999,C1CN(C[C@@H]2[C@H]1N3CCNC4=CC=CC2=C43)CCCC(=O)C5=CC=C(C=C5)F,O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCN3)c1ccc(F)cc1
1270,CHEMBL3233411,P35368,,FINYFOYZAZLCFE-FPOVZHCZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24559051.0,KI,=,294.0,NM,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin),,Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,2014.0,57.0,6.0,"Li P, Zhang Q, Robichaud AJ, Lee T, Tomesch J, Yao W, Beard JD, Snyder GL, Zhu H, Peng Y, Hendrick JP, Vanover KE, Davis RE, Mates S, Wennogle LP",,1339955.0,DTCT0023207,13624863,DTCC01472429,1781302,57999,CN1CCN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC5=NOC6=CC=CC=C65,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCc3noc4ccccc34)CC[C@@H]12
1271,CHEMBL3233412,P35368,,ZJYUQATUAGWNGI-FPOVZHCZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24559051.0,KI,=,66.0,NM,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin),,Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,2014.0,57.0,6.0,"Li P, Zhang Q, Robichaud AJ, Lee T, Tomesch J, Yao W, Beard JD, Snyder GL, Zhu H, Peng Y, Hendrick JP, Vanover KE, Davis RE, Mates S, Wennogle LP",,1339955.0,DTCT0023207,13624864,DTCC01472430,1942765,57999,CN1CCN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC5=NOC6=C5C=CC(=C6)F,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCc3noc4cc(F)ccc34)CC[C@@H]12
1272,CHEMBL3233427,P35368,,CSRUCKYTDYTZMI-VXKWHMMOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24559051.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin),Not Determined,Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,2014.0,57.0,6.0,"Li P, Zhang Q, Robichaud AJ, Lee T, Tomesch J, Yao W, Beard JD, Snyder GL, Zhu H, Peng Y, Hendrick JP, Vanover KE, Davis RE, Mates S, Wennogle LP",,1339955.0,DTCT0023207,13624865,DTCC01472445,622630,57999,C1CC2=C3C(=CC=C2)[C@@H]4CN(CC[C@@H]4N3C1)CCCC(=O)C5=CC=C(C=C5)F,O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCC3)c1ccc(F)cc1
1273,CHEMBL3233432,P35368,,DLXKEWOEEPMPHX-PMACEKPBSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24559051.0,KI,=,104.0,NM,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin),,Discovery of a tetracyclic quinoxaline derivative as a potent and orally active multifunctional drug candidate for the treatment of neuropsychiatric and neurological disorders.,J. Med. Chem.,2014.0,57.0,6.0,"Li P, Zhang Q, Robichaud AJ, Lee T, Tomesch J, Yao W, Beard JD, Snyder GL, Zhu H, Peng Y, Hendrick JP, Vanover KE, Davis RE, Mates S, Wennogle LP",,1339955.0,DTCT0023207,13624866,DTCC01472450,1528256,57999,C1CN(C[C@@H]2[C@H]1N3CCOC4=CC=CC2=C43)CCCC(=O)C5=CC=C(C=C5)F,O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3)c1ccc(F)cc1
1274,CHEMBL323579,P35368,,FLMJQBHJNDEDJH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,236.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1210680,DTCC00262930,1585323,3366,CCC1=C(C(C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1
1275,CHEMBL323579,P35368,,FLMJQBHJNDEDJH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,326.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1225887,DTCC00262930,1585324,3366,CCC1=C(C(C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1
1276,CHEMBL323579,P35368,,FLMJQBHJNDEDJH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,326.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1245081,DTCC00262930,1585325,3366,CCC1=C(C(C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1
1277,CHEMBL323579,P35368,,FLMJQBHJNDEDJH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,505.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1225899,DTCC00262930,1585322,3366,CCC1=C(C(C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN)N1
1278,CHEMBL323778,P35368,,VRHQGOAVVGUACS-HXUWFJFHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12392747.0,KI,=,309.03,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.,Bioorg. Med. Chem. Lett.,2002.0,12.0,22.0,"Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR",,34624.0,DTCT0023207,1580072,DTCC00285623,2077664,5235,C1C[C@@H](N(C1)S(=O)(=O)C2=CC3=C(C=C2)C=CN3)CCN4CCC(CC4)N5C6=CC=CC=C6OC5=O,O=c1oc2ccccc2n1C1CCN(CC[C@H]2CCCN2S(=O)(=O)c2ccc3cc[nH]c3c2)CC1
1279,CHEMBL324090,P35368,ABANOQUIL,ANZIISNSHPKVRV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,0.08,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from human clone,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34465.0,DTCT0023207,732133,DTCC00290445,1403884,13167,COC1=C(C=C2CN(CCC2=C1)C3=NC4=CC(=C(C=C4C(=C3)N)OC)OC)OC,COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2
1280,CHEMBL324090,P35368,ABANOQUIL,ANZIISNSHPKVRV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,0.11,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from hamster clones.,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34313.0,DTCT0023207,732134,DTCC00290445,1403884,13167,COC1=C(C=C2CN(CCC2=C1)C3=NC4=CC(=C(C=C4C(=C3)N)OC)OC)OC,COc1cc2c(cc1OC)CN(c1cc(N)c3cc(OC)c(OC)cc3n1)CC2
1281,CHEMBL325648,P35368,,IIGMRZNQNZVRHU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1172818,DTCC00107193,1371484,5253,C1CCN(CC1)C2=CC=CC=C2NCC3=CN=CN3,c1ccc(N2CCCCC2)c(NCc2cnc[nH]2)c1
1282,CHEMBL325745,P35368,,JFEAROLAZKGICP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,=,316.23,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1139015,DTCC00107194,1597390,5253,CCCNC(=O)C1=CC=CC=C1NCC2=CN=CN2,CCCNC(=O)c1ccccc1NCc1cnc[nH]1
1283,CHEMBL325745,P35368,,JFEAROLAZKGICP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,IC50,=,3019.95,NM,,,,,,,,,,,,,,In vitro binding affinity against cloned human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32514.0,DTCT0023207,1139020,DTCC00107194,1597390,5253,CCCNC(=O)C1=CC=CC=C1NCC2=CN=CN2,CCCNC(=O)c1ccccc1NCc1cnc[nH]1
1284,CHEMBL325745,P35368,,JFEAROLAZKGICP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,MAX,=,89.0,%,,,,,,,,,,,,,,Activation of human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts as percent maximal effect relative to phenylephrine,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32512.0,DTCT0023207,1139016,DTCC00107194,1597390,5253,CCCNC(=O)C1=CC=CC=C1NCC2=CN=CN2,CCCNC(=O)c1ccccc1NCc1cnc[nH]1
1285,CHEMBL326067,P35368,,XHSSQAAKENOPTK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1167799,DTCC00290622,917698,5253,C1=CC=C(C(=C1)C2=CN=CO2)NCC3=CN=CN3,c1ccc(-c2cnco2)c(NCc2cnc[nH]2)c1
1286,CHEMBL326702,P35368,ABT-866,ROUIPNDCVDWYEH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368735,DTCC01742256,553487,26380,CCS(=O)(=O)NC1=CC=CC(=C1)CC2=CN=CN2,CCS(=O)(=O)Nc1cccc(Cc2cnc[nH]2)c1
1287,CHEMBL326837,P35368,,ATKNWVZEWKNQHH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1161300,DTCC00291038,1818549,5253,CCN(CC)C(=O)C1=CC=CC=C1OCC2=CN=CN2,CCN(CC)C(=O)c1ccccc1OCc1cnc[nH]1
1288,CHEMBL326837,P35368,,ATKNWVZEWKNQHH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,IC50,<,30199.52,NM,,,,,,,,,,,,,,In vitro binding affinity against cloned human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32514.0,DTCT0023207,1161303,DTCC00291038,1818549,5253,CCN(CC)C(=O)C1=CC=CC=C1OCC2=CN=CN2,CCN(CC)C(=O)c1ccccc1OCc1cnc[nH]1
1289,CHEMBL327005,P35368,,QUOSOWBVNOKBLO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,=,100.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1158814,DTCC00290556,1306220,5253,C1CN=C(N1)COC2=CC=CC=C2C3=CC=NO3,c1ccc(-c2ccno2)c(OCC2=NCCN2)c1
1290,CHEMBL327005,P35368,,QUOSOWBVNOKBLO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,MAX,=,81.0,%,,,,,,,,,,,,,,Activation of human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts as percent maximal effect relative to phenylephrine,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32512.0,DTCT0023207,1158815,DTCC00290556,1306220,5253,C1CN=C(N1)COC2=CC=CC=C2C3=CC=NO3,c1ccc(-c2ccno2)c(OCC2=NCCN2)c1
1291,CHEMBL327327,P35368,,MYUYYJFZKXHBBD-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,>,2000.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1335603,DTCC00254403,1467785,15798,CC1=C([C@H](NC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=CC=N4,CC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1
1292,CHEMBL327712,P35368,,JZHXLYHEWUWHQL-LVYIWIAJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,114.82,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,746558,DTCC00251891,1596926,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=C(C=C2)Cl)Cl)C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(Cl)c(Cl)c1
1293,CHEMBL327716,P35368,,LPFHZQURBIZPDW-AREMUKBSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,285.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1329175,DTCC00255017,949860,15798,COCC1=C([C@H](NC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=CC=C4C#N,COCC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1
1294,CHEMBL327775,P35368,,JAXIKFIDJJLTAT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,165.96,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,741794,DTCC00251363,594427,14735,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C#N,CC1=C(C#N)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(C)N1
1295,CHEMBL327931,P35368,,XETGFITVYCWVGB-KDJFERLWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,41.69,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,733865,DTCC00251668,1785583,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=C(C=C2)Cl)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)C4=CC=CC=C4,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc(Cl)c([N+](=O)[O-])c1
1296,CHEMBL328268,P35368,,ACXCLVVRXJUJEC-VWLOTQADSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,110.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1349657,DTCC00254663,1273259,15798,CC1=C([C@@H](NC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC(=O)N1C
1297,CHEMBL328658,P35368,,WWSQNSZOZLXYNN-RUZDIDTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,158.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1347141,DTCC00254711,1532543,15798,CC1=C([C@H](NC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=CC=C4C#N,CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1
1298,CHEMBL328763,P35368,,KQUFPVZMSZOANN-AREMUKBSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,35.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1334398,DTCC00254888,1882472,15798,COCC1=C([C@H](NC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=C(C=C(C=C4)F)C#N,COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1
1299,CHEMBL3287723,P35368,,AOYJKNKRKBOUAP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24735492.0,INHIBITION,=,-17.1,%,,,,,,,,,,,,,,Binding affinity to human adrenergic alpha1B receptor at 10 uM by radioligand displacement assay,,Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence.,J. Med. Chem.,2014.0,57.0,10.0,"Dhanya RP, Sheffler DJ, Dahl R, Davis M, Lee PS, Yang L, Nickols HH, Cho HP, Smith LH, D'Souza MS, Conn PJ, Der-Avakian A, Markou A, Cosford ND",,1361657.0,DTCT0023207,13779762,DTCC01498697,200946,59335,CC1=C(C=CC(=C1O)C(=O)CC(C)(C)C)OCCCCOC2=C(C=CC(=C2)C(=O)O)OC,COc1ccc(C(=O)O)cc1OCCCCOc1ccc(C(=O)CC(C)(C)C)c(O)c1C
1300,CHEMBL329035,P35368,,IFVRVNMRXMDJCL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,LOG KI,=,6.84,NM,,cell_based,,,,,,,,,,,,The binding affinity was evaluated on cloned human Alpha-1B adrenergic receptor expressed in chinese hamster ovary(CHO) cells by using [3H]prazosin as radioligand.,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34621.0,DTCT0023207,1009930,DTCC00268094,161915,15289,COC1=C(C(=CC=C1)OC)OCCNCC2=CC3=CC=CC=C3OC2C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1=Cc2ccccc2OC1c1ccccc1
1301,CHEMBL329143,P35368,,HFLJPWVGDQIPJB-JOCHJYFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,160.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1329185,DTCC00254805,1882471,15798,C1CN(CCC1(C2=CC=C(C=C2)F)O)CCCNC(=O)C3=CNC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F,O=C1NC=C(C(=O)NCCCN2CCC(O)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1
1302,CHEMBL329272,P35368,,LQIINDYUOVEHJZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,652420,DTCC00264591,949970,4573,C1CCC(C1)OC(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(OC1CCCC1)c1ccccc1NCC1=NCCN1
1303,CHEMBL329383,P35368,SB-357134,BLWHAZZXRHTFJE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11140733.0,KI,>,7943.28,NM,,,,,,,,,,,,,,Compound was evaluated for binding affinity against Alpha-1B adrenergic receptor,,"Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).",Bioorg. Med. Chem. Lett.,2001.0,11.0,1.0,"Bromidge SM, Clarke SE, Gager T, Griffith K, Jeffrey P, Jennings AJ, Joiner GF, King FD, Lovell PJ, Moss SF, Newman H, Riley G, Rogers D, Routledge C, Serafinowska H, Smith DR",,32301.0,DTCT0023207,1502065,DTCC01741824,1101604,4218,COC1=C(C=C(C=C1)S(=O)(=O)NC2=C(C(=CC(=C2)Br)F)Br)N3CCNCC3,COc1ccc(S(=O)(=O)Nc2cc(Br)cc(F)c2Br)cc1N1CCNCC1
1304,CHEMBL3297829,P35368,,RUSICYIVUADRSX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,1.91,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793029,DTCC01502604,1866608,59712,CN(CC1=CC=CC=C1)C(=O)CCCC(=O)NC2=CC3=C(C=C2)SC4=C3NC(=O)N(C4=O)CCN5CCN(CC5)C6=CC=CC=C6OC,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)N(C)Cc5ccccc5)cc43)c2=O)CC1
1305,CHEMBL3298017,P35368,,NTYDVUXIVLYUEG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,6.46,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793030,DTCC01502792,1802271,59712,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=C(S4)C=CC(=C5)NC(=O)CCCC(=O)NCCC6=CC=CC=C6)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1
1306,CHEMBL3298018,P35368,,FKPDOXLGSMSHFA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,7.41,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793031,DTCC01502793,2029655,59712,CN(CCCC(=O)NC1=CC2=C(C=C1)SC3=C2NC(=O)N(C3=O)CCN4CCN(CC4)C5=CC=CC=C5OC)CC6=CC=CC=C6,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)Cc5ccccc5)cc43)c2=O)CC1
1307,CHEMBL3298019,P35368,,NTCOZURJKJMLEZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,1.66,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793032,DTCC01502794,1289758,59712,CN(C)CCCC(=O)NC1=CC2=C(C=C1)SC3=C2NC(=O)N(C3=O)CCN4CCN(CC4)C5=CC=CC=C5OC,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCN(C)C)cc43)c2=O)CC1
1308,CHEMBL3298020,P35368,,HBKDXPFFGLQBAS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,38.9,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793033,DTCC01502795,1387657,59712,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=CC=C4OC)SC5=C2C=C(C=C5)NC(=O)C6=CC=CC=C6,COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1
1309,CHEMBL3298021,P35368,,PTNLKWJYWYHWJE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,30.2,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793034,DTCC01502796,869955,59712,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=CC=C4OC)SC5=C2C=C(C=C5)NC(=O)CC6=CC=CC=C6,COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1
1310,CHEMBL3298022,P35368,,WJFLJWNZAPQFEZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,19.05,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793035,DTCC01502797,1645846,59712,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=CC=C4OC)SC5=C2C=C(C=C5)NC(=O)CCCC(=O)NCC6=CC=CC=C6,COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1
1311,CHEMBL3298023,P35368,,HJMLYMYAWJITOM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,6.46,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793036,DTCC01502798,1484274,59712,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=CC=C4OC)SC5=C2C=C(C=C5)NC(=O)CCCC(=O)NCCC6=CC=CC=C6,COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCC(=O)NCCc5ccccc5)cc43)c2=O)CC1
1312,CHEMBL3298024,P35368,,OMRDBXLTKZZDHE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,7.59,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793037,DTCC01502799,189342,59712,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=CC=C4OC)SC5=C2C=C(C=C5)NC(=O)CCCNC(=O)CC6=CC=CC=C6,COc1ccccc1N1CCN(CCn2c(C)nc3c(sc4ccc(NC(=O)CCCNC(=O)Cc5ccccc5)cc43)c2=O)CC1
1313,CHEMBL3298745,P35368,,DVKRGBKLBUBBRE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,10.0,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793023,DTCC01503518,1964106,59712,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=C(S4)C=CC(=C5)NC(=O)C6=CC=CC=C6)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)c5ccccc5)cc43)c2=O)CC1
1314,CHEMBL3298746,P35368,,QUGYQBYWGZYWAK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,28.18,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793024,DTCC01503519,1613610,59712,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=C(S4)C=CC(=C5)NC(=O)CC6=CC=CC=C6)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)Cc5ccccc5)cc43)c2=O)CC1
1315,CHEMBL3298747,P35368,,WBCDPYPSNVABPM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,33.88,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793025,DTCC01503520,772274,59712,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=C(S4)C=CC(=C5)NC(=O)CCCC6=CC=CC=C6)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCc5ccccc5)cc43)c2=O)CC1
1316,CHEMBL3298748,P35368,,VZCKRSFEOTUZRB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,36.31,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793026,DTCC01503521,417891,59712,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=C(S4)C=CC(=C5)NC(=O)CCCCC6=CC=CC=C6)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCCc5ccccc5)cc43)c2=O)CC1
1317,CHEMBL3298749,P35368,,RJBQBCGUVQKYIY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,2.69,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793027,DTCC01503522,92590,59712,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=C(S4)C=CC(=C5)NC(=O)CCC(=O)NCC6=CC=CC=C6)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCC(=O)NCc5ccccc5)cc43)c2=O)CC1
1318,CHEMBL3298750,P35368,,QOHXQKYNPKCPIA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24992070.0,KI,=,0.8320000000000001,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]BE2254 from human alpha1b receptor expressed in HEK293 cells,,"High affinity ligands and potent antagonists for the a1D-adrenergic receptor. Novel 3,8-disubstituted [1]benzothieno[3,2-d]pyrimidine derivatives.",Eur. J. Med. Chem.,2014.0,83.0,,"Romeo G, Salerno L, Pittalà V, Modica MN, Siracusa MA, Materia L, Buccioni M, Marucci G, Minneman KP",,1368300.0,DTCT0023207,13793028,DTCC01503523,869959,59712,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)C4=C(C5=C(S4)C=CC(=C5)NC(=O)CCCC(=O)NCC6=CC=CC=C6)NC3=O,COc1ccccc1N1CCN(CCn2c(=O)[nH]c3c(sc4ccc(NC(=O)CCCC(=O)NCc5ccccc5)cc43)c2=O)CC1
1319,CHEMBL329928,P35368,,DQJYNCPVANWHMM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,158.49,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,651318,DTCC00264669,1467893,4573,CCOC(=O)C1=CC=CC=C1NCC2=NCCN2,CCOC(=O)c1ccccc1NCC1=NCCN1
1320,CHEMBL329928,P35368,,DQJYNCPVANWHMM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,105.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,651319,DTCC00264669,1467893,4573,CCOC(=O)C1=CC=CC=C1NCC2=NCCN2,CCOC(=O)c1ccccc1NCC1=NCCN1
1321,CHEMBL329971,P35368,,LYDYJVWPPIHVMH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,245.47,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1592118,DTCC00264804,627100,17389,CCC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=CC=C4OC)NC5=CC=CC=C52,CCc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2OC)CC1
1322,CHEMBL330198,P35368,,KZBOJCCPPXNSRU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,1000000000000000.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34620.0,DTCT0023207,1594623,DTCC00264420,303326,17389,CCCCC1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,CCCCc1ccc(N2CCN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC2)cc1
1323,CHEMBL330353,P35368,,KXAHJMMPIMPUFG-GOSISDBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12392747.0,KI,<,10000.0,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.,Bioorg. Med. Chem. Lett.,2002.0,12.0,22.0,"Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR",,34624.0,DTCT0023207,1567893,DTCC00260550,756214,5235,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC4=C(C=C3)C=CN4,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2ccc3cc[nH]c3c2)CC1
1324,CHEMBL330401,P35368,,WDDPQFVKUCBXKP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,479.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1243872,DTCC00262823,1618017,3366,CC1=C(C(C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=C(C=C4)OC)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,COc1ccc(C2(c3ccccc3)CCN(CCCNC(=O)C3=C(COCCN)NC(C)=C(C(N)=O)C3c3ccc([N+](=O)[O-])cc3)CC2)cc1
1325,CHEMBL330599,P35368,,PDAVXRWJDNCAQA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,LOG KI,=,6.11,NM,,cell_based,,,,,,,,,,,,The binding affinity was evaluated on cloned human alpha-1B adrenergic receptor expressed in chinese hamster ovary(CHO) cells by using [3H]prazosin as radioligand.,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34622.0,DTCT0023207,982310,DTCC00268326,1742361,15289,COC1=C(C(=CC=C1)OC)OCCNCC2C(CC3=CC=CC=C3C2=O)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1C(=O)c2ccccc2CC1c1ccccc1
1326,CHEMBL3310035,P35368,,RQPAEAIGXOANQF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from adrenergic alpha1B receptor (unknown origin) expressed in HEKT cells at 10 uM after 90 mins by microbeta counting analysis,Not Active,,J. Nat. Prod.,2014.0,77.0,5.0,,,1451626.0,DTCT0023207,13892120,DTCC01510285,655458,57486,CC1=CC2=CC(=C(C(=C2C(=O)O1)O)O)CCC(=O)OC,COC(=O)CCc1cc2cc(C)oc(=O)c2c(O)c1O
1327,CHEMBL3311308,P35368,,FQUAFMNPXPXOJE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24881566.0,IC50,>,39810.72,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor assessed as intracellular calcium by summary (Abse5) assay,,Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).,Bioorg. Med. Chem. Lett.,2014.0,24.0,14.0,"Sparks SM, Chen G, Collins JL, Danger D, Dock ST, Jayawickreme C, Jenkinson S, Laudeman C, Leesnitzer MA, Liang X, Maloney P, McCoy DC, Moncol D, Rash V, Rimele T, Vulimiri P, Way JM, Ross S",,1455275.0,DTCT0023207,13918447,DTCC01511540,558563,60691,CC1=CC(=C(C(=C1)C)NS(=O)(=O)C2=CC=C(C=C2)OC)C,COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1
1328,CHEMBL331803,P35368,,LDBILOUYTWRBLS-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12392747.0,KI,=,89.13,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.,Bioorg. Med. Chem. Lett.,2002.0,12.0,22.0,"Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR",,34624.0,DTCT0023207,1577244,DTCC00286201,950219,5235,C1C[C@@H](N(C1)S(=O)(=O)C2=CC3=C(C=C2)C=CN3)CCN4CCC(CC4)C5=CC6=CC=CC=C6N5,O=S(=O)(c1ccc2cc[nH]c2c1)N1CCC[C@@H]1CCN1CCC(c2cc3ccccc3[nH]2)CC1
1329,CHEMBL332701,P35368,,SIGPAXROBLPQJS-QGZVFWFLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10669560.0,LOG KI,,,,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor; ND means no data.,Not Determined,"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).",J. Med. Chem.,2000.0,43.0,3.0,"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR",,32308.0,DTCT0023207,1094717,DTCC00290855,1306219,16008,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC(=C3)OC,COc1cccc(S(=O)(=O)N2CCC[C@@H]2CCN2CCC(C)CC2)c1
1330,CHEMBL333784,P35368,,OQCUZRRTKCFWET-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10669560.0,KI,=,1995.26,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).",J. Med. Chem.,2000.0,43.0,3.0,"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR",,32307.0,DTCT0023207,1125185,DTCC00290914,1532929,16008,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC(=C(C=C3)Cl)Cl,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2ccc(Cl)c(Cl)c2)CC1
1331,CHEMBL333980,P35368,,YVHLXJWWXOTYST-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,=,7900.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1385887,DTCC00299859,1436171,17528,CC(C)NC1=C(C(=C(C=C1)C2=CC=CC=C2)CC(=O)NCC3=CC=C(C=C3)C(=N)N)OC,COc1c(NC(C)C)ccc(-c2ccccc2)c1CC(=O)NCc1ccc(C(=N)N)cc1
1332,CHEMBL3341769,P35368,,UNSHPSDZXKDZDW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,323.59,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951049,DTCC01525906,1140710,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCOCC4,COc1ccccc1N1CCN(CC2COC3(CCOCC3)O2)CC1
1333,CHEMBL3342852,P35368,,AKODHNGEOUFORT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,141.25,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951048,DTCC01525905,1846488,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCSCC4,COc1ccccc1N1CCN(CC2COC3(CCSCC3)O2)CC1
1334,CHEMBL3342853,P35368,,LRLMUKKGKWCSTQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,16.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951050,DTCC01525907,914712,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)CC5=CC=CC=C5,COc1ccccc1N1CCN(CC2COC3(CCN(Cc4ccccc4)CC3)O2)CC1
1335,CHEMBL3342854,P35368,,IKKMDDGWCWRWDI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,478.63,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951051,DTCC01525908,1943327,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCS(=O)CC4,COc1ccccc1N1CCN(CC2COC3(CC[S+]([O-])CC3)O2)CC1
1336,CHEMBL3342855,P35368,,BQWXWYVQIVCGBP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,288.4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951052,DTCC01525909,1657955,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCS(=O)(=O)CC4,COc1ccccc1N1CCN(CC2COC3(CCS(=O)(=O)CC3)O2)CC1
1337,CHEMBL3342856,P35368,,BQGYIRQTWGRQRL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,42.66,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951053,DTCC01525910,687781,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCNCC4,COc1ccccc1N1CCN(CC2COC3(CCNCC3)O2)CC1
1338,CHEMBL3342857,P35368,,YMCAXSPZJNPMHX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,154.88,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951054,DTCC01525911,397517,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)C5=CC=CC=C5,COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccc4)CC3)O2)CC1
1339,CHEMBL3342858,P35368,,FHQARSACZPJNBL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,1000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951055,DTCC01525912,2009161,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)C5=CC=CC=N5,COc1ccccc1N1CCN(CC2COC3(CCN(c4ccccn4)CC3)O2)CC1
1340,CHEMBL3342859,P35368,,LVRQFEKCQMNAQB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,67.61,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951056,DTCC01525913,2073603,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)C(=O)C5=CC=CC=C5,COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccccc4)CC3)O2)CC1
1341,CHEMBL3342860,P35368,,AEOKAVWIADBGHU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,63.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951057,DTCC01525914,1814367,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)C(=O)C5=CC=C(C=C5)C(F)(F)F,COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccc(C(F)(F)F)cc4)CC3)O2)CC1
1342,CHEMBL3342861,P35368,,RMARPDOMKGOSCL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,158.49,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951058,DTCC01525915,1910936,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)C(=O)C5=CC=CO5,COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)c4ccco4)CC3)O2)CC1
1343,CHEMBL3342862,P35368,,OKPOTQGIJMVOCK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,109.65,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951059,DTCC01525916,1593174,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)C(=O)C5CCCCC5,COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCCC4)CC3)O2)CC1
1344,CHEMBL3342863,P35368,,PCMIZIOZMQFVGQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,158.49,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951060,DTCC01525917,1560840,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)C(=O)C5CCCN5,COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C4CCCN4)CC3)O2)CC1
1345,CHEMBL3342864,P35368,,ZPEUIKDDMPOHBF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,1000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951061,DTCC01525918,299532,60014,CC(=O)N1CCC2(CC1)OCC(O2)CN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CC2COC3(CCN(C(C)=O)CC3)O2)CC1
1346,CHEMBL3342865,P35368,,RPHOENXERNUVOJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,1000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951062,DTCC01525919,816733,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)C(=O)C(F)(F)F,COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)C(F)(F)F)CC3)O2)CC1
1347,CHEMBL3342866,P35368,,BVRXELLJAMJMOD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,85.11,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951063,DTCC01525920,946218,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)S(=O)(=O)C5=CC=CC=C5,COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccccc4)CC3)O2)CC1
1348,CHEMBL3342867,P35368,,VQLNHQYXLDPOCF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,8.32,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951064,DTCC01525921,1814368,60014,CC1=CC=C(C=C1)S(=O)(=O)N2CCC3(CC2)OCC(O3)CN4CCN(CC4)C5=CC=CC=C5OC,COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(C)cc4)CC3)O2)CC1
1349,CHEMBL3342868,P35368,,POAIEWIIIXKJRN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,69.18,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951065,DTCC01525922,623203,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)S(=O)(=O)C5=CC=C(C=C5)Cl,COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(Cl)cc4)CC3)O2)CC1
1350,CHEMBL3342869,P35368,,QCESWGLBLOFLSN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,147.91,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951066,DTCC01525923,1528886,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)S(=O)(=O)C5=CC=C(C=C5)OC(F)(F)F,COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)O2)CC1
1351,CHEMBL3342870,P35368,,KTBIQCRMHWZGGG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,109.65,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951067,DTCC01525924,1171768,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)S(=O)(=O)C5=CC=C(C=C5)[N+](=O)[O-],COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4ccc([N+](=O)[O-])cc4)CC3)O2)CC1
1352,CHEMBL3342871,P35368,,YGIDWKQNKMDZJW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,69.18,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951068,DTCC01525925,1749843,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)S(=O)(=O)C5=CC=CC(=C5)[N+](=O)[O-],COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccc([N+](=O)[O-])c4)CC3)O2)CC1
1353,CHEMBL3342872,P35368,,BHUCMEWUSAGOPR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,85.11,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951069,DTCC01525926,1976387,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)S(=O)(=O)C5=CC=CS5,COc1ccccc1N1CCN(CC2COC3(CCN(S(=O)(=O)c4cccs4)CC3)O2)CC1
1354,CHEMBL3342873,P35368,,BWIJSERURKMDCF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,363.08,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951070,DTCC01525927,1431809,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)S(=O)(=O)C,COc1ccccc1N1CCN(CC2COC3(CCN(S(C)(=O)=O)CC3)O2)CC1
1355,CHEMBL3342874,P35368,,FNKLENUNYYYGFY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,81.28,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951071,DTCC01525928,429880,60014,COC1=CC=CC=C1N2CCN(CC2)CC3COC4(O3)CCN(CC4)C(=O)NC5=CC=CC=C5,COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)Nc4ccccc4)CC3)O2)CC1
1356,CHEMBL3342875,P35368,,TXHNBTNTYPCQQT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,239.88,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951072,DTCC01525929,1367332,60014,CCCCNC(=O)N1CCC2(CC1)OCC(O2)CN3CCN(CC3)C4=CC=CC=C4OC,CCCCNC(=O)N1CCC2(CC1)OCC(CN1CCN(c3ccccc3OC)CC1)O2
1357,CHEMBL3342876,P35368,,MUMWILQJBILXOV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25261823.0,KI,=,128.82,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at a<alpha>1 and 5-HT1A receptors.",Eur. J. Med. Chem.,2014.0,87.0,,"Franchini S, Battisti UM, Baraldi A, Prandi A, Fossa P, Cichero E, Tait A, Sorbi C, Marucci G, Cilia A, Pirona L, Brasili L",,1440679.0,DTCT0023207,13951073,DTCC01525930,623204,60014,CC(C)(C)NC(=O)N1CCC2(CC1)OCC(O2)CN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CC2COC3(CCN(C(=O)NC(C)(C)C)CC3)O2)CC1
1358,CHEMBL3343975,P35368,,FGYOUZJTBKNABF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,28.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961204,DTCC01527019,849662,60105,C1=CC=C2C(=C1)C(=CC=N2)NCCNC3=CC=NC4=CC=CC=C43,c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1
1359,CHEMBL3343975,P35368,,FGYOUZJTBKNABF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,28.18,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961192,DTCC01527019,849662,60105,C1=CC=C2C(=C1)C(=CC=N2)NCCNC3=CC=NC4=CC=CC=C43,c1ccc2c(NCCNc3ccnc4ccccc34)ccnc2c1
1360,CHEMBL3343976,P35368,,YKNISNOKAVDJNX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,19.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961205,DTCC01527020,1910967,60105,CC1=CC2=C(C=CN=C2C=C1)NCCNC3=C4C=C(C=CC4=NC=C3)C,Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1
1361,CHEMBL3343976,P35368,,YKNISNOKAVDJNX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,19.05,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961193,DTCC01527020,1910967,60105,CC1=CC2=C(C=CN=C2C=C1)NCCNC3=C4C=C(C=CC4=NC=C3)C,Cc1ccc2nccc(NCCNc3ccnc4ccc(C)cc34)c2c1
1362,CHEMBL3343977,P35368,,ZEJCAUGJSXGWIE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,47.86,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961194,DTCC01527021,1108420,60105,CC1=CC2=NC=CC(=C2C=C1)NCCNC3=C4C=CC(=CC4=NC=C3)C,Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1
1363,CHEMBL3343977,P35368,,ZEJCAUGJSXGWIE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,48.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961206,DTCC01527021,1108420,60105,CC1=CC2=NC=CC(=C2C=C1)NCCNC3=C4C=CC(=CC4=NC=C3)C,Cc1ccc2c(NCCNc3ccnc4cc(C)ccc34)ccnc2c1
1364,CHEMBL3343978,P35368,,YUGFJKZNDFXBRF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,50.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961207,DTCC01527022,623247,60105,COC1=CC2=NC=CC(=C2C=C1)NCCNC3=C4C=CC(=CC4=NC=C3)OC,COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1
1365,CHEMBL3343978,P35368,,YUGFJKZNDFXBRF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,50.12,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961195,DTCC01527022,623247,60105,COC1=CC2=NC=CC(=C2C=C1)NCCNC3=C4C=CC(=CC4=NC=C3)OC,COc1ccc2c(NCCNc3ccnc4cc(OC)ccc34)ccnc2c1
1366,CHEMBL3343979,P35368,,DZTKYUPHGYMDEB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,39.81,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961196,DTCC01527023,1625904,60105,CC1=C2C(=CC=C1)C(=CC=N2)NCCNC3=CC=NC4=C(C=CC=C34)C,Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12
1367,CHEMBL3343979,P35368,,DZTKYUPHGYMDEB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,40.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961208,DTCC01527023,1625904,60105,CC1=C2C(=CC=C1)C(=CC=N2)NCCNC3=CC=NC4=C(C=CC=C34)C,Cc1cccc2c(NCCNc3ccnc4c(C)cccc34)ccnc12
1368,CHEMBL3343980,P35368,,WBBAPMUEBOCQHN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,151.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961211,DTCC01527024,978466,60105,CC1=CC2=C(C=CN=C2C=C1)NCCCCCCCNC3=C4C=C(C=CC4=NC=C3)C,Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1
1369,CHEMBL3343980,P35368,,WBBAPMUEBOCQHN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,151.36,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961199,DTCC01527024,978466,60105,CC1=CC2=C(C=CN=C2C=C1)NCCCCCCCNC3=C4C=C(C=CC4=NC=C3)C,Cc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(C)cc34)c2c1
1370,CHEMBL3343981,P35368,,PXQYFYKYPSFRJV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,147.91,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961200,DTCC01527025,1204080,60105,COC1=CC2=C(C=CN=C2C=C1)NCCCCCCCNC3=C4C=C(C=CC4=NC=C3)OC,COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1
1371,CHEMBL3343981,P35368,,PXQYFYKYPSFRJV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,148.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961212,DTCC01527025,1204080,60105,COC1=CC2=C(C=CN=C2C=C1)NCCCCCCCNC3=C4C=C(C=CC4=NC=C3)OC,COc1ccc2nccc(NCCCCCCCNc3ccnc4ccc(OC)cc34)c2c1
1372,CHEMBL3343982,P35368,,LTACTAZJIYCENM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,51.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961213,DTCC01527026,1910968,60105,CC1=CC2=NC=CC(=C2C=C1)NCCCCCCCNC3=C4C=CC(=CC4=NC=C3)C,Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1
1373,CHEMBL3343982,P35368,,LTACTAZJIYCENM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,51.29,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961201,DTCC01527026,1910968,60105,CC1=CC2=NC=CC(=C2C=C1)NCCCCCCCNC3=C4C=CC(=CC4=NC=C3)C,Cc1ccc2c(NCCCCCCCNc3ccnc4cc(C)ccc34)ccnc2c1
1374,CHEMBL3343983,P35368,,UZQGZSISQVAYCO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,34.67,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961202,DTCC01527027,1367361,60105,COC1=CC2=NC=CC(=C2C=C1)NCCCCCCCNC3=C4C=CC(=CC4=NC=C3)OC,COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1
1375,CHEMBL3343983,P35368,,UZQGZSISQVAYCO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,35.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961214,DTCC01527027,1367361,60105,COC1=CC2=NC=CC(=C2C=C1)NCCCCCCCNC3=C4C=CC(=CC4=NC=C3)OC,COc1ccc2c(NCCCCCCCNc3ccnc4cc(OC)ccc34)ccnc2c1
1376,CHEMBL3343984,P35368,,XGRRECSBDVKHCC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,154.88,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961203,DTCC01527028,1943385,60105,COC1=CC=CC2=C(C=CN=C21)NCCCCCCCNC3=C4C=CC=C(C4=NC=C3)OC,COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12
1377,CHEMBL3343984,P35368,,XGRRECSBDVKHCC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,155.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961215,DTCC01527028,1943385,60105,COC1=CC=CC2=C(C=CN=C21)NCCCCCCCNC3=C4C=CC=C(C4=NC=C3)OC,COc1cccc2c(NCCCCCCCNc3ccnc4c(OC)cccc34)ccnc12
1378,CHEMBL3349545,P35368,,IPBOROXXRHATRV-UNMCSNQZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873568.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor was evaluated by cloned receptor binding assay,,Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivity.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Patane MA, DiPardo RM, Price RP, Chang RS, Ransom RW, O'Malley SS, Di Salvo J, Bock MG",,33013.0,DTCT0023207,1117927,DTCC01528746,582680,2771,CCOC(=O)[C@H]1CN(CC[C@H]1C2=CC=CC=C2)CCCCN3C(=O)C4=C(S3(=O)=O)C=CC(=C4)Cl,CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@H]1c1ccccc1
1379,CHEMBL335129,P35368,,JJIYSOTZFHZHQI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1367944,DTCC00319310,109130,17528,C1=CC=C(C=C1)CS(=O)(=O)NC2=C(C(=C(C=C2)F)CC(=O)NCC3=CC=NC=C3)F,O=C(Cc1c(F)ccc(NS(=O)(=O)Cc2ccccc2)c1F)NCc1ccncc1
1380,CHEMBL335731,P35368,,TVKDDIPFFFMLKI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9986714.0,KI,=,9.05,NM,,,,,,,,,,,,,,The binding affinity towards Alpha-1B adrenergic receptor in the COS cell line.,,"Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.",J. Med. Chem.,1999.0,42.0,3.0,"Leonardi A, Motta G, Boi C, Testa R, Poggesi E, De Benedetti PG, Menziani MC",,32304.0,DTCT0023207,1352432,DTCC00320266,498696,15565,COC1=C(C(=CC=C1)OC)OCC(=O)N2CCN(CC2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4OC)CC3)nc(N)c2cc1OC
1381,CHEMBL336302,P35368,,VEKDJUKJLMGDLS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1379470,DTCC00319466,1208438,17528,CN(C)C1=CC=C(C=C1)CNC(=O)CC2=C(C=CC(=C2F)NS(=O)(=O)CC3=CC=CC=C3)F,CN(C)c1ccc(CNC(=O)Cc2c(F)ccc(NS(=O)(=O)Cc3ccccc3)c2F)cc1
1382,CHEMBL337862,P35368,,RJDGUOVDCSODNG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,864921,DTCC00107772,1662353,5326,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=CC=C3,c1ccc(-c2ccccc2NCC2=NCCN2)cc1
1383,CHEMBL337862,P35368,,RJDGUOVDCSODNG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,864922,DTCC00107772,1662353,5326,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=CC=C3,c1ccc(-c2ccccc2NCC2=NCCN2)cc1
1384,CHEMBL338029,P35368,,OTPCOGQCPMOGMX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12904082.0,KI,=,1.2,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]-prazosin binding to cloned human Alpha-1B adrenergic receptor in CHO cells (chinese hamster ovary cells),,New potential uroselective NO-donor alpha1-antagonists.,J. Med. Chem.,2003.0,46.0,17.0,"Boschi D, Tron GC, Di Stilo A, Fruttero R, Gasco A, Poggesi E, Motta G, Leonardi A",,34462.0,DTCT0023207,1282803,DTCC00301662,1882983,13339,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)NCCCN3CCN(CC3)C4=CC=CC=C4OCCCO[N+](=O)[O-])C5=CC=CC=C5,Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCCCO[N+](=O)[O-])CC3)cccc2c1=O
1385,CHEMBL338115,P35368,6-METHOXY-HARMALAN,HMBHRMFLDKKSCT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14643338.0,KI,,,,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor; ND=Not determined,Not Determined,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,2003.0,13.0,24.0,"Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA",,34338.0,DTCT0023207,1099603,DTCC01742985,1306588,6037,CC1=NCCC2=C1NC3=C2C=C(C=C3)OC,COc1ccc2[nH]c3c(c2c1)CCN=C3C
1386,CHEMBL338608,P35368,,NXDKJWPLVWUKRS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12904082.0,KI,=,4.7,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to cloned human Alpha-1B adrenergic receptor in CHO cells (chinese hamster ovary cells),,New potential uroselective NO-donor alpha1-antagonists.,J. Med. Chem.,2003.0,46.0,17.0,"Boschi D, Tron GC, Di Stilo A, Fruttero R, Gasco A, Poggesi E, Motta G, Leonardi A",,34461.0,DTCT0023207,1278308,DTCC00301578,595032,13339,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)NCCCN3CCN(CC3)C4=CC=CC=C4OCC5=NO[N+](=C5C)[O-])C6=CC=CC=C6,Cc1c(-c2ccccc2)oc2c(C(=O)NCCCN3CCN(c4ccccc4OCc4no[n+]([O-])c4C)CC3)cccc2c1=O
1387,CHEMBL3392246,P35368,,KPTMOEWLVJTEEX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,85.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,925804,DTCC01539438,434007,13230,CC1=C(C(C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1388,CHEMBL3392247,P35368,,ZCZTWAKGRMWSEI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,234.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,929395,DTCC01539439,1240992,13230,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1cccc([N+](=O)[O-])c1
1389,CHEMBL3400593,P35368,,SIJYLSGWXFVBCP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25813897.0,EC50,=,3.5,NM,,,,,,,,,,,,,,Antagonist activity at alpha-1B adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay,,a-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.,Bioorg. Med. Chem.,2015.0,23.0,9.0,"Zareba P, Dudek M, Lustyk K, Siwek A, Starowicz G, Bednarski M, Nowinski L, Razny K, Sapa J, Malawska B, Kulig K",,1465128.0,DTCT0023207,14064369,DTCC01544003,1549109,61652,CC1=CC=CC=C1N2CCN(CC2)CCCCN3CCCC3=O.Cl,Cc1ccccc1N1CCN(CCCCN2CCCC2=O)CC1
1390,CHEMBL3400594,P35368,,GWZKQAZNJFCKIR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25813897.0,EC50,=,131.1,NM,,,,,,,,,,,,,,Antagonist activity at alpha-1B adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay,,a-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.,Bioorg. Med. Chem.,2015.0,23.0,9.0,"Zareba P, Dudek M, Lustyk K, Siwek A, Starowicz G, Bednarski M, Nowinski L, Razny K, Sapa J, Malawska B, Kulig K",,1465128.0,DTCT0023207,14064370,DTCC01544004,1452103,61652,C1CC(=O)N(C1)CCCCN2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F.Cl,O=C1CCCN1CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
1391,CHEMBL3400595,P35368,,NNUSMILRKBXCPT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25813897.0,EC50,=,165.3,NM,,,,,,,,,,,,,,Antagonist activity at alpha-1B adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay,,a-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.,Bioorg. Med. Chem.,2015.0,23.0,9.0,"Zareba P, Dudek M, Lustyk K, Siwek A, Starowicz G, Bednarski M, Nowinski L, Razny K, Sapa J, Malawska B, Kulig K",,1465128.0,DTCT0023207,14064371,DTCC01544005,157830,61652,C1CC(=O)N(C1)CCCCN2CCN(CC2)C3=CC=CC=C3O.Cl,O=C1CCCN1CCCCN1CCN(c2ccccc2O)CC1
1392,CHEMBL3400596,P35368,,BYFPUJBOVOWOEM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25813897.0,EC50,=,46.9,NM,,,,,,,,,,,,,,Antagonist activity at alpha-1B adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay,,a-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.,Bioorg. Med. Chem.,2015.0,23.0,9.0,"Zareba P, Dudek M, Lustyk K, Siwek A, Starowicz G, Bednarski M, Nowinski L, Razny K, Sapa J, Malawska B, Kulig K",,1465128.0,DTCT0023207,14064372,DTCC01544006,385275,61652,C1CC(=O)N(C1)CCCCN2CCN(CC2)C3=C(C=C(C=C3)F)F.Cl,O=C1CCCN1CCCCN1CCN(c2ccc(F)cc2F)CC1
1393,CHEMBL3400597,P35368,,RFFLBWRKQXJYFL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25813897.0,EC50,=,2.53,NM,,,,,,,,,,,,,,Antagonist activity at alpha-1B adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay,,a-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.,Bioorg. Med. Chem.,2015.0,23.0,9.0,"Zareba P, Dudek M, Lustyk K, Siwek A, Starowicz G, Bednarski M, Nowinski L, Razny K, Sapa J, Malawska B, Kulig K",,1465128.0,DTCT0023207,14064373,DTCC01544007,1355437,61652,C1CC(=O)N(C1)CCCCN2CCN(CC2)C3=CC=CC=C3Cl.Cl,O=C1CCCN1CCCCN1CCN(c2ccccc2Cl)CC1
1394,CHEMBL3400598,P35368,,QTKHTYAETVTSLH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25813897.0,EC50,=,288.7,NM,,,,,,,,,,,,,,Antagonist activity at alpha-1B adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay,,a-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.,Bioorg. Med. Chem.,2015.0,23.0,9.0,"Zareba P, Dudek M, Lustyk K, Siwek A, Starowicz G, Bednarski M, Nowinski L, Razny K, Sapa J, Malawska B, Kulig K",,1465128.0,DTCT0023207,14064374,DTCC01544008,1834919,61652,C1CC(=O)N(C1)CCCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4.Cl,O=C1CCCN1CCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1
1395,CHEMBL341553,P35368,,SADVXXIUDIEKNM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1390783,DTCC00319251,1818912,17528,C1CNCCC1CNC(=O)C2=C(C=CC(=C2)NS(=O)(=O)CC3=CC=CC=C3)SC4=CC=CC=C4,O=C(NCC1CCNCC1)c1cc(NS(=O)(=O)Cc2ccccc2)ccc1Sc1ccccc1
1396,CHEMBL341665,P35368,,JSMDVVKGKQQXSH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9822553.0,KI,=,0.166,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity at human cloned Alpha-1B adrenergic receptor in chinese hamster ovary cells by [3H]prazosin displacement.,,"Design, synthesis, and biological activity of prazosin-related antagonists. Role of the piperazine and furan units of prazosin on the selectivity for alpha1-adrenoreceptor subtypes.",J. Med. Chem.,1998.0,41.0,24.0,"Bolognesi ML, Budriesi R, Chiarini A, Poggesi E, Leonardi A, Melchiorre C",,34617.0,DTCT0023207,823081,DTCC00331347,1212229,14970,CN(C)CC1=CC(=CC=C1)C(=O)N(C)CCCCCCN(C)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,COc1cc2nc(N(C)CCCCCCN(C)C(=O)c3cccc(CN(C)C)c3)nc(N)c2cc1OC
1397,CHEMBL341747,P35368,,NBTBSFIAXGORAY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,862329,DTCC00328942,1981053,5326,CC1=C(SN=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1cnsc1-c1ccccc1OCC1=NCCN1
1398,CHEMBL341747,P35368,,NBTBSFIAXGORAY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,334908,DTCC00328942,1981053,5326,CC1=C(SN=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1cnsc1-c1ccccc1OCC1=NCCN1
1399,CHEMBL341838,P35368,,FQUQPNDGBZDOFM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,2630.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,781315,DTCC00330390,1694487,15485,COCC1=C(C(N(C(=O)N1)C(=O)N2CCC(CC2)N3CCC(CC3)(C4=CC=CC=C4)C(=O)OC)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)C(c2ccc(F)c(F)c2)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1
1400,CHEMBL341849,P35368,,JCWKQYAUPMXURC-SMFUYQKNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,13.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1103934,DTCC00330263,809691,15486,C[C@@H]1CN(CCN1CCCNC(=O)N2C(C(=C(NC2=O)C)C(=O)OC)C3=CC(=C(C=C3)F)F)C4=CC=CC=C4[N+](=O)[O-],COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3[N+](=O)[O-])C[C@H]2C)C1c1ccc(F)c(F)c1
1401,CHEMBL342062,P35368,,XBRXTUGRUXGBPX-SJORKVTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8917649.0,KI,=,0.135,NM,,tissue,,,,,,,,,,,,Compound was tested for binding affinity against human hippocampus Alpha-1B adrenergic receptor using radioligand ([3H]-prazosin) binding assay,,"Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.",J. Med. Chem.,1996.0,39.0,23.0,"Giardinà D, Crucianelli M, Romanelli R, Leonardi A, Poggesi E, Melchiorre C",,34614.0,DTCT0023207,1437397,DTCC00326744,2078102,13894,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@H]4[C@@H]3CCCC4)C(=O)C5=CC=CO5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC
1402,CHEMBL342062,P35368,,XBRXTUGRUXGBPX-SJORKVTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8917649.0,KI,=,0.6920000000000001,NM,,,,,,,,,,,,,,Compound was tested for binding affinity against cloned Alpha-1B adrenergic receptor from hamster smooth muscle using radioligand ([3H]prazosin) binding assay,,"Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.",J. Med. Chem.,1996.0,39.0,23.0,"Giardinà D, Crucianelli M, Romanelli R, Leonardi A, Poggesi E, Melchiorre C",,34317.0,DTCT0023207,1437394,DTCC00326744,2078102,13894,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@H]4[C@@H]3CCCC4)C(=O)C5=CC=CO5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC
1403,CHEMBL342064,P35368,,KKSBBZJXYCLTSE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,15500.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,774228,DTCC00331289,2046122,15485,CCC1=C(C(N(C(=O)N1)C(=O)N2CCC(CC2)N3CCC(CC3)(C4=CC=CC=C4)C(=O)OC)C5=C(C=C(C=C5)F)F)C(=O)N,CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)N2CCC(N3CCC(C(=O)OC)(c4ccccc4)CC3)CC2)C(=O)N1
1404,CHEMBL342111,P35368,,XAFUDJXOIRWNFS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,1490.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,789398,DTCC00330634,1948058,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC3(CC2)C4=CC=CC=C4OC3=O)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)C(=O)Oc2ccccc23)C1c1ccc(F)c(F)c1
1405,CHEMBL342126,P35368,,ABJKTLXATIQLEH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,20.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,810559,DTCC00330394,1819047,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)(c3ccc(F)cc3)CC2)C1c1ccc(F)c(F)c1
1406,CHEMBL342324,P35368,,GLMXXNANUJWHRB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,871554,DTCC00330005,1630134,5326,CC1=NC(=CC=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1cccc(-c2ccccc2OCC2=NCCN2)n1
1407,CHEMBL342324,P35368,,GLMXXNANUJWHRB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,871555,DTCC00330005,1630134,5326,CC1=NC(=CC=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1cccc(-c2ccccc2OCC2=NCCN2)n1
1408,CHEMBL342347,P35368,,BLFCXMMGSUUVCS-CUXXENAFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,1500.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,533567,DTCC00331235,205913,15470,CC1=C(C(N(C(=N1)C)CCC[C@@H](C)CN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1
1409,CHEMBL342392,P35368,,WFLQZFCVIXHCON-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,INHIBITION,=,22.0,%,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined at a concentration of 30 uM,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210606.0,DTCT0023207,1374542,DTCC00319516,1500877,17528,C1=CC=C(C=C1)CS(=O)(=O)NC2=CC(=C(C=C2)SC3=CC=CC=C3)C(=O)NCC4=CC=C(C=C4)C(=N)N,N=C(N)c1ccc(CNC(=O)c2cc(NS(=O)(=O)Cc3ccccc3)ccc2Sc2ccccc2)cc1
1410,CHEMBL342543,P35368,,YARZXKRRRMSSKW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,700.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,815110,DTCC00330376,465918,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)OC(=O)C)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(OC(C)=O)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
1411,CHEMBL342731,P35368,,LXRTYSPGPRSKRZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,7.5,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1126563,DTCC00330324,680775,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
1412,CHEMBL343173,P35368,,AQUBGXSYJSSYPL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,=,7000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1382008,DTCC00319346,788795,17528,C1=CC=C(C=C1)CCNC2=C(C(=C(C=C2)C3=CC=CC=C3)CC(=O)NCC4=CC=C(C=C4)C(=N)N)F,N=C(N)c1ccc(CNC(=O)Cc2c(-c3ccccc3)ccc(NCCc3ccccc3)c2F)cc1
1413,CHEMBL343283,P35368,,LPHYFVMMGUVREO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9986714.0,KI,=,8.56,NM,,,,,,,,,,,,,,The binding affinity towards Alpha-1B adrenergic receptor in the COS cell line.,,"Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.",J. Med. Chem.,1999.0,42.0,3.0,"Leonardi A, Motta G, Boi C, Testa R, Poggesi E, De Benedetti PG, Menziani MC",,32304.0,DTCT0023207,1341635,DTCC00319987,918076,15565,COC1=CC=CC=C1OCC(=O)N2CCN(CC2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)COc4ccccc4OC)CC3)nc(N)c2cc1OC
1414,CHEMBL344294,P35368,,IJAUTLCFHWJTKE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,872894,DTCC00330006,983020,5326,CC1=CC(=NC=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1ccnc(-c2ccccc2OCC2=NCCN2)c1
1415,CHEMBL344294,P35368,,IJAUTLCFHWJTKE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,IC50,=,2454.71,NM,,,,,,,,,,,,,,Binding affinity of compound towards human Alpha-1B adrenergic receptor expressed in rat fibroblast membranes,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34481.0,DTCT0023207,872899,DTCC00330006,983020,5326,CC1=CC(=NC=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1ccnc(-c2ccccc2OCC2=NCCN2)c1
1416,CHEMBL344294,P35368,,IJAUTLCFHWJTKE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,872895,DTCC00330006,983020,5326,CC1=CC(=NC=C1)C2=CC=CC=C2OCC3=NCCN3,Cc1ccnc(-c2ccccc2OCC2=NCCN2)c1
1417,CHEMBL344339,P35368,,ONHPZAPIATURQR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,310.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,785508,DTCC00330439,465919,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC3(CCCC4=CC=CC=C43)CC2)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCCc4ccccc43)CC2)C1c1ccc(F)c(F)c1
1418,CHEMBL344432,P35368,,HETKYUVAGHVYTA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11728188.0,KI,=,26.4,NM,,,,,,,,,,,,,,Binding affinity was determined on human cloned alpha-1B adrenergic receptor,,"trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.",J. Med. Chem.,2001.0,44.0,25.0,"Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R",,34339.0,DTCT0023207,1465671,DTCC00321785,76937,16537,COC1=CC=CC2=C1CCCC2CCCNCCOC3=CC=CC=N3,COc1cccc2c1CCCC2CCCNCCOc1ccccn1
1419,CHEMBL344525,P35368,,HGFSCAYRXIIXIL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,17.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1126537,DTCC00330965,390237,15486,CC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)N3C(C(=C(NC3=O)C)C(=O)OC)C4=CC(=C(C=C4)F)F,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C)CC2)C1c1ccc(F)c(F)c1
1420,CHEMBL344551,P35368,,YDKBQJBGZGYDNW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,79.43,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,880546,DTCC00329291,173883,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=NN3,c1ccc(-c2ccn[nH]2)c(OCC2=NCCN2)c1
1421,CHEMBL344551,P35368,,YDKBQJBGZGYDNW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,39.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,880547,DTCC00329291,173883,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=NN3,c1ccc(-c2ccn[nH]2)c(OCC2=NCCN2)c1
1422,CHEMBL344619,P35368,,VRSFUZBVJMNUTQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1382005,DTCC00319306,1786356,17528,C1=CC=C(C=C1)CS(=O)(=O)NC2=CC(=C(C=C2)SC3=CC=CC=C3)C(=O)NCC4=CC=NC=C4,O=C(NCc1ccncc1)c1cc(NS(=O)(=O)Cc2ccccc2)ccc1Sc1ccccc1
1423,CHEMBL344957,P35368,,BWPVUBRWPURGHZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,868787,DTCC00328971,692280,5326,CC1=CSC(=N1)C2=CC=CC=C2OCC3=NCCN3,Cc1csc(-c2ccccc2OCC2=NCCN2)n1
1424,CHEMBL344957,P35368,,BWPVUBRWPURGHZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,868788,DTCC00328971,692280,5326,CC1=CSC(=N1)C2=CC=CC=C2OCC3=NCCN3,Cc1csc(-c2ccccc2OCC2=NCCN2)n1
1425,CHEMBL346380,P35368,,WOEAXPAQYOXTOS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,5.75,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,990103,DTCC00344728,227044,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=CC=CS3,c1csc(-c2ccccc2NCC2=NCCN2)c1
1426,CHEMBL346465,P35368,,PWTSJGTVQUBKFO-WOJGMQOQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1004675,DTCC00344891,259324,5345,CCO/N=C(\C)/C1=CC=CC=C1NCC2=NCCN2,CCO/N=C(\C)c1ccccc1NCC1=NCCN1
1427,CHEMBL346649,P35368,,HVJHLWDXQXIFIC-CCFHIKDMSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,390.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1408281,DTCC00339148,1786596,15010,CCOC(=O)C1=C(NC(=C(C1C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC)C)C,CCOC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1428,CHEMBL347268,P35368,,SPPYMDUFKYIYOR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,95.5,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1013395,DTCC00345020,454102,5345,CC1=NOC(=C1)C2=CC=CC=C2NCC3=NCCN3,Cc1cc(-c2ccccc2NCC2=NCCN2)on1
1429,CHEMBL347499,P35368,,JUEGCEMTUPDDGU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,1180.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1429023,DTCC00339233,1274200,15010,CCOC(=O)C1(CCN(CC1)CCCNC(=O)C2=C(NC(=C(C2C3=CC=C(C=C3)[N+](=O)[O-])C(=O)C)C)C)C4=CC=CC=C4,CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(C)=O)C2c2ccc([N+](=O)[O-])cc2)CC1
1430,CHEMBL347501,P35368,,PBRNXCWKTJNIAH-CCFHIKDMSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,1600.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1431342,DTCC00339147,271179,15010,CC1=C(C(C(=C(N1)C)C(=O)OCCO)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)OCCO)C2c2ccc([N+](=O)[O-])cc2)CC1
1431,CHEMBL347522,P35368,,SNGBYOSTSPYKJF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,5250.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1439266,DTCC00339368,1662490,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)C)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1
1432,CHEMBL347559,P35368,,LSGFCPKEHQTYII-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,1020.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1441680,DTCC00339636,1915614,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C#N)C3=CC=CC=C3)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)=C(C)N1
1433,CHEMBL347920,P35368,,GETLEMAHEPUIBB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,991221,DTCC00344911,325144,5345,CC1=NOC(=N1)C2=CC=CC=C2NCC3=NCCN3,Cc1noc(-c2ccccc2NCC2=NCCN2)n1
1434,CHEMBL349082,P35368,,SUBLOIVGKGUTMT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,338.84,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,999993,DTCC00344738,2066764,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=NC=CN=C3,c1ccc(-c2cnccn2)c(NCC2=NCCN2)c1
1435,CHEMBL350906,P35368,,UVRHJIRCYLAJKN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,980915,DTCC00344761,1683340,5345,C1CN=C(N1)CNC2=CC=CC=C2C3=C(C=CC=N3)C(F)(F)F,FC(F)(F)c1cccnc1-c1ccccc1NCC1=NCCN1
1436,CHEMBL351542,P35368,,PTJZNEIRBPOVRN-LZYBPNLTSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,985363,DTCC00344888,292564,5345,CO/N=C/C1=CC=CC=C1NCC2=NCCN2,CO/N=C/c1ccccc1NCC1=NCCN1
1437,CHEMBL351542,P35368,,PTJZNEIRBPOVRN-LZYBPNLTSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,IC50,=,162.18,NM,,,,,,,,,,,,,,In vitro binding affinity against human Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34482.0,DTCT0023207,985366,DTCC00344888,292564,5345,CO/N=C/C1=CC=CC=C1NCC2=NCCN2,CO/N=C/c1ccccc1NCC1=NCCN1
1438,CHEMBL351543,P35368,,KMJVEYIACAOTSD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,991217,DTCC00345217,1262598,5345,CC1=CC=C(S1)C2=CC=CC=C2NCC3=NCCN3,Cc1ccc(-c2ccccc2NCC2=NCCN2)s1
1439,CHEMBL352225,P35368,,VSSYIFVXYPNECD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1009615,DTCC00344760,1839984,5345,CC1=NC=C(O1)C2=CC=CC=C2NCC3=NCCN3,Cc1ncc(-c2ccccc2NCC2=NCCN2)o1
1440,CHEMBL353972,P35368,ATIPAMEZOLE,HSWPZIDYAHLZDD-UHFFFAOYSA-N,1,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20809632.0,KI,=,1949.84,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]-prazosin from human adrenergic alpha-1b receptor expressed in CHO cells after 120 mins by liquid scintillation counting,,"Rigid analogues of the a2-adrenergic blocker Atipamezole: small changes, big consequences.",J. Med. Chem.,2010.0,53.0,19.0,"Vacher B, Funes P, Chopin P, Cussac D, Heusler P, Tourette A, Marien M",,664774.0,DTCT0023207,3531924,DTCC00362572,328592,41136,CCC1(CC2=CC=CC=C2C1)C3=CN=CN3,CCC1(c2cnc[nH]2)Cc2ccccc2C1
1441,CHEMBL355910,P35368,,GKHZZRFAPCFEBL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,3920.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1406009,DTCC00338873,109372,15010,CCOC(=O)C1(CCN(CC1)CCCNC(=O)C2=C(NC(=C(C2C3=CC=C(C=C3)[N+](=O)[O-])C(=O)NC)C)C)C4=CC=CC=C4,CCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(=O)NC)C2c2ccc([N+](=O)[O-])cc2)CC1
1442,CHEMBL356195,P35368,,NGYBTBMSZNTFFJ-LICLKQGHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1013399,DTCC00344866,1618955,5345,C/C(=N\OC)/C1=CC=CC=C1NCC2=NCCN2,CO/N=C(\C)c1ccccc1NCC1=NCCN1
1443,CHEMBL356571,P35368,,UZMKDOUDIGKWHV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,84.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,791151,DTCC00330334,1851166,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(c3ccc(Cl)cc3)(c3ccc(Cl)cc3)CC2)C1c1ccc(F)c(F)c1
1444,CHEMBL356584,P35368,SNAP-6201,YCUQRVLXIFFFNB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,260.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,704215,DTCC01743486,1327499,15484,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)N,CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
1445,CHEMBL356584,P35368,SNAP-6201,YCUQRVLXIFFFNB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,250.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,791134,DTCC01743486,1339351,15485,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)N,CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
1446,CHEMBL356584,P35368,SNAP-6201,YCUQRVLXIFFFNB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,260.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1115705,DTCC01743486,1327511,15486,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)N,CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
1447,CHEMBL356605,P35368,,VARULOWOKPYQRB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,79.43,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,872879,DTCC00329379,1176404,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CN=CC=C3,c1cncc(-c2ccccc2OCC2=NCCN2)c1
1448,CHEMBL356605,P35368,,VARULOWOKPYQRB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,IC50,=,1288.25,NM,,,,,,,,,,,,,,Binding affinity of compound towards human Alpha-1B adrenergic receptor expressed in rat fibroblast membranes,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34481.0,DTCT0023207,872884,DTCC00329379,1176404,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CN=CC=C3,c1cncc(-c2ccccc2OCC2=NCCN2)c1
1449,CHEMBL356605,P35368,,VARULOWOKPYQRB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,111.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,872880,DTCC00329379,1176404,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CN=CC=C3,c1cncc(-c2ccccc2OCC2=NCCN2)c1
1450,CHEMBL356623,P35368,,OSZRVROELVKVLK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,5500.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1413008,DTCC00339537,1883403,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OCCO)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)OCCO)(c3ccccc3)CC2)=C(C)N1
1451,CHEMBL356829,P35368,,PAPWWRYYLPOWNO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,2740.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1416812,DTCC00330041,1851282,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1
1452,CHEMBL356829,P35368,,PAPWWRYYLPOWNO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,3700.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,717840,DTCC00330041,1839813,15484,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1
1453,CHEMBL356923,P35368,,ZHIOWBPYEDMEAK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,45000.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1427757,DTCC00339553,983129,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(CN(C)C)C3=CC=CC=C3)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)NC,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1454,CHEMBL356978,P35368,,RFEHYTXXQXNSOO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,67.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,722573,DTCC00329806,390233,15484,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=CC=C4)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(F)c1
1455,CHEMBL357061,P35368,,XRPJJJVZPOUKHY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,1570.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1427760,DTCC00338975,1883404,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OCCOC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,COCCOC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C2=C(C)NC(C)=C(C(N)=O)C2c2ccc([N+](=O)[O-])cc2)CC1
1456,CHEMBL357129,P35368,,QLXHLSBDLHEIEV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,1.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,857270,DTCC00329403,627835,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CN3,c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1
1457,CHEMBL357129,P35368,,QLXHLSBDLHEIEV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,IC50,=,269.15,NM,,,,,,,,,,,,,,Binding affinity of compound towards human Alpha-1B adrenergic receptor expressed in rat fibroblast membranes,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34481.0,DTCT0023207,857275,DTCC00329403,627835,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CN3,c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1
1458,CHEMBL357129,P35368,,QLXHLSBDLHEIEV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,104.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,857271,DTCC00329403,627835,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CN3,c1c[nH]c(-c2ccccc2OCC2=NCCN2)c1
1459,CHEMBL357131,P35368,,KTSCUAMGSPLOJT-VUUJKMBOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,430.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,542910,DTCC00330648,1015378,15470,CC1=C(C(N(C(=N1)C)CCC[C@H](C)CN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
1460,CHEMBL357172,P35368,,CMSFKMOGRSBIOR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,58.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1135492,DTCC00330656,1871795,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=CC(=C(C(=C4)F)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1
1461,CHEMBL357439,P35368,,FVPNEWFMSBECIY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,410.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1132977,DTCC00108203,390238,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=C(C=C3)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccc(OC)cc3)CC2)C1c1ccc(F)c(F)c1
1462,CHEMBL357628,P35368,,PGWWSFHSBLBNGD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,610.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,807672,DTCC00330868,2013879,15485,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C#N)C3=CC=CC=C3)C4=C(C=C(C=C4)F)F)C(=O)N,CCC1=C(C(N)=O)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)C(=O)N1
1463,CHEMBL357681,P35368,,COYXUFNFFWVLGI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,3070.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1441689,DTCC00338817,627976,15010,CCNC(=O)C1=C(NC(=C(C1C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC)C)C,CCNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1464,CHEMBL357828,P35368,,JMWBXYKHUPFCLZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,240.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,540129,DTCC00331174,1500994,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1
1465,CHEMBL357842,P35368,,ZOBKHHUMXIJHCW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,160.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,523970,DTCC00330997,336694,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=C(C=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(F)cc1F
1466,CHEMBL3582268,P35368,,CNMNBFPDHZVEGX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26005522.0,IC50,<,5.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-Prazosin from human alpha-1B adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,5.0,,,1497771.0,DTCT0023207,14440311,DTCC01648090,1691535,62748,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC5=C(C=C(C=C5)O)OC4=O)N)OC,COc1cc2nc(N3CCN(C(=O)c4cc5ccc(O)cc5oc4=O)CC3)nc(N)c2cc1OC
1467,CHEMBL3582269,P35368,,OLJMQMOCFLSIIF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26005522.0,IC50,<,5.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-Prazosin from human alpha-1B adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,5.0,,,1497771.0,DTCT0023207,14440310,DTCC01648091,1721537,62748,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CN(N=N4)C5=CC6=C(C=C(C=C6)O)OC5=O)N)OC,COc1cc2nc(N3CCN(C(=O)c4cn(-c5cc6ccc(O)cc6oc5=O)nn4)CC3)nc(N)c2cc1OC
1468,CHEMBL3582270,P35368,,PXYNXQORCWJBOI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26005522.0,IC50,=,1.2,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-Prazosin from human alpha-1B adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,5.0,,,1497771.0,DTCT0023207,14440309,DTCC01648092,980140,62748,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)N3C=C(N=N3)C(=O)N4CCN(CC4)C5=NC6=CC(=C(C=C6C(=N5)N)OC)OC,CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1
1469,CHEMBL3582270,P35368,,PXYNXQORCWJBOI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26005522.0,KI,=,0.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-Prazosin from human alpha-1B adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,5.0,,,1497771.0,DTCT0023207,14440348,DTCC01648092,980140,62748,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)N3C=C(N=N3)C(=O)N4CCN(CC4)C5=NC6=CC(=C(C=C6C(=N5)N)OC)OC,CCN(CC)c1ccc2cc(-n3cc(C(=O)N4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1
1470,CHEMBL3582271,P35368,,MGYNRIYGDOFIPG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26005522.0,IC50,=,16.3,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-Prazosin from human alpha-1B adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,5.0,,,1497771.0,DTCT0023207,14440308,DTCC01648093,1336349,62748,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=S)NC4=CC(=C(C=C4)C5=C6C=CC(=O)C=C6OC7=C5C=CC(=C7)O)C(=O)O)N)OC,COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC
1471,CHEMBL3582271,P35368,,MGYNRIYGDOFIPG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26005522.0,KI,=,7.3,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-Prazosin from human alpha-1B adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,5.0,,,1497771.0,DTCT0023207,14440349,DTCC01648093,1336349,62748,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=S)NC4=CC(=C(C=C4)C5=C6C=CC(=O)C=C6OC7=C5C=CC(=C7)O)C(=O)O)N)OC,COc1cc2nc(N3CCN(C(=S)Nc4ccc(-c5c6ccc(=O)cc-6oc6cc(O)ccc56)c(C(=O)O)c4)CC3)nc(N)c2cc1OC
1472,CHEMBL3582272,P35368,,KDSUSJUAJOGNPC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26005522.0,IC50,=,52.4,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-Prazosin from human alpha-1B adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,5.0,,,1497771.0,DTCT0023207,14440307,DTCC01648094,1271098,62748,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)N3C=C(N=N3)CN4CCN(CC4)C5=NC6=CC(=C(C=C6C(=N5)N)OC)OC,CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1
1473,CHEMBL3582272,P35368,,KDSUSJUAJOGNPC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26005522.0,KI,=,29.9,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-Prazosin from human alpha-1B adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,5.0,,,1497771.0,DTCT0023207,14440350,DTCC01648094,1271098,62748,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)N3C=C(N=N3)CN4CCN(CC4)C5=NC6=CC(=C(C=C6C(=N5)N)OC)OC,CCN(CC)c1ccc2cc(-n3cc(CN4CCN(c5nc(N)c6cc(OC)c(OC)cc6n5)CC4)nn3)c(=O)oc2c1
1474,CHEMBL358253,P35368,,LGQDRXMJPKYZFZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,215.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1415563,DTCC00338782,1404509,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)C3=CC=CC=C3)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)NC,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1475,CHEMBL358313,P35368,,BLFCXMMGSUUVCS-OORIHMLWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,810.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,539203,DTCC00331236,1565369,15470,CC1=C(C(N(C(=N1)C)CCC[C@H](C)CN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCC[C@H](C)CN2CCN(c3ccccc3C(N)=O)CC2)C1c1ccc(F)c(F)c1
1476,CHEMBL358406,P35368,,RZIZBETWVGIROJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,156.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1407215,DTCC00339369,983128,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C(=O)Oc3ccccc3)(c3ccccc3)CC2)=C(C)N1
1477,CHEMBL358489,P35368,,WPSYNFMKLRQHSU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,110.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,721267,DTCC00329378,1839812,15484,CC1=CC(=CC=C1)C2C(=C(NC(=O)N2C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC)C)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1cccc(C)c1
1478,CHEMBL358590,P35368,,PFFBXNUVJKJZBG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,1450.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,788055,DTCC00330216,1915507,15485,CCC1=C(C(N(C(=O)N1)C(=O)NCCC(C)N2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)N,CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
1479,CHEMBL358590,P35368,,PFFBXNUVJKJZBG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,1480.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,772965,DTCC00330216,1915508,15485,CCC1=C(C(N(C(=O)N1)C(=O)NCCC(C)N2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)N,CCC1=C(C(N)=O)C(c2ccc(F)c(F)c2)N(C(=O)NCCC(C)N2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
1480,CHEMBL358595,P35368,,RCMQHQAAIDPTGY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,130.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,718915,DTCC00329577,423001,15484,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
1481,CHEMBL358595,P35368,,RCMQHQAAIDPTGY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,160.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,728744,DTCC00329577,423003,15484,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
1482,CHEMBL358595,P35368,,RCMQHQAAIDPTGY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,360.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,704206,DTCC00329577,423002,15484,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C(=O)N1
1483,CHEMBL358685,P35368,,NHQBBQYXJYNTCW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,676.08,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,996424,DTCC00344876,1295109,5345,CC1=NC(=NO1)C2=CC=CC=C2NCC3=NCCN3,Cc1nc(-c2ccccc2NCC2=NCCN2)no1
1484,CHEMBL358785,P35368,,JWSQOVQOBFTBTR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,250.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,785547,DTCC00330636,1786490,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC3(CC2)C4=CC=CC=C4CC(=O)O3)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OC(=O)Cc2ccccc23)C1c1ccc(F)c(F)c1
1485,CHEMBL358795,P35368,,XQFNJNZLLWMIES-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,220.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1130377,DTCC00330414,551629,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=CC(=C(C(=C4)F)F)F)C(=O)C,CC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C1c1cc(F)c(F)c(F)c1
1486,CHEMBL358802,P35368,,QFTZHTMOMYVJRT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,881746,DTCC00329588,1724022,5326,C1CN=C(N1)COC2=CC=CC=C2C3=NC=CC=N3,c1cnc(-c2ccccc2OCC2=NCCN2)nc1
1487,CHEMBL358802,P35368,,QFTZHTMOMYVJRT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,881747,DTCC00329588,1724022,5326,C1CN=C(N1)COC2=CC=CC=C2C3=NC=CC=N3,c1cnc(-c2ccccc2OCC2=NCCN2)nc1
1488,CHEMBL359012,P35368,,PIXIENULWHGBCZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,490.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,807669,DTCC00329711,1274084,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC3(CC2)C4=CC=CC=C4CCO3)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CC2)OCCc2ccccc23)C1c1ccc(F)c(F)c1
1489,CHEMBL359173,P35368,,WCGXKZZNDLNAMK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,77.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,726086,DTCC00330551,1683142,15484,CC1=CC=C(C=C1)C2C(=C(NC(=O)N2C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC)C)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc(C)cc1
1490,CHEMBL359375,P35368,,GUAVMGVSYJRNOX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,530.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1435495,DTCC00339474,1662489,15010,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C)C3=CC=CC=C3)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(C)(c3ccccc3)CC2)=C(C)N1
1491,CHEMBL359421,P35368,,YXSIJTCCPXNLJX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,93.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,531625,DTCC00330888,1113006,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCC(CC2)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCC(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
1492,CHEMBL359430,P35368,,IYHKQABMQSZQIQ-VWRCBCJMSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,1700.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,514790,DTCC00330817,498809,15470,CC1=C(C(N(C(=N1)C)CCC[C@@H](C)CN2CCC(CC2)(C#N)C3=CC=CC=C3)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCC[C@@H](C)CN2CCC(C#N)(c3ccccc3)CC2)C1c1ccc(F)c(F)c1
1493,CHEMBL359433,P35368,,SPQUMXVYBSRSIK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,150.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1132980,DTCC00108194,226862,15486,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC(=CC=C3)[N+](=O)[O-])C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCN(c3cccc([N+](=O)[O-])c3)CC2)C1c1ccc(F)c(F)c1
1494,CHEMBL3601200,P35368,,ITIDAHAJICCYKL-IBGZPJMESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26125514.0,EC50,>,10000.0,NM,,,,,,,,,,,,,,Agonist activity at human alpha1B-adrenergic receptor,,Discovery of Novel Indazole Derivatives as Highly Potent and Selective Human ß3-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects.,J. Med. Chem.,2015.0,58.0,15.0,"Wada Y, Shirahashi H, Iwanami T, Ogawa M, Nakano S, Morimoto A, Kasahara K, Tanaka E, Takada Y, Ohashi S, Mori M, Shuto S",,1509437.0,DTCT0023207,14492605,DTCC01655844,94372,63245,CC1=C2C=CC(=CC2=NN1)OCCNC[C@@H](C3=CC(=CC=C3)NS(=O)(=O)C)O,Cc1[nH]nc2cc(OCCNC[C@H](O)c3cccc(NS(C)(=O)=O)c3)ccc12
1495,CHEMBL3608450,P35368,,XYYAWEJOUNEPTR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26227772.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to alpha1B adrenoceptor (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512434.0,DTCT0023207,14522417,DTCC01659060,2010933,63285,CN1CC(C2=CC(=C(C3=C2C1CC4=CC5=C(C=C43)OCO5)OC)OC)C6=CC=CC=C6,COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2c1ccccc1)OCO4
1496,CHEMBL3609360,P35368,,IVAFCEYIMKCAJY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26238322.0,IC50,=,560.0,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human alpha1B adrenoceptor assessed as inhibition of norepinephrine-induced increase of intracellular calcium level by cell based assay,,Indolylpiperidine derivatives as potent and selective a1B adrenoceptor antagonists.,Bioorg. Med. Chem. Lett.,2015.0,25.0,18.0,"Hayashi R, Ohmori E, Moriwaki M, Kumagai H, Isogaya M",,1513492.0,DTCT0023207,14516550,DTCC01659974,580398,63465,C1CN(CCC1C2=CNC3=C2C=CC(=C3)F)CCCN4CCC5=CC=CC=C5C4,Fc1ccc2c(C3CCN(CCCN4CCc5ccccc5C4)CC3)c[nH]c2c1
1497,CHEMBL362954,P35368,,NEQHKSNFFVEGHN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16153828.0,KI,=,102.8,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity towards human alpha-1B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,,Bioisosteric phentolamine analogs as potent alpha-adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2005.0,15.0,21.0,"Hong SS, Bavadekar SA, Lee SI, Patil PN, Lalchandani SG, Feller DR, Miller DD",,320869.0,DTCT0023207,1859051,DTCC00407392,2079018,19790,CC1=CC=C(C=C1)N(C2=CC(=CC=C2)OC)NC3=NCCN3,COc1cccc(N(NC2=NCCN2)c2ccc(C)cc2)c1
1498,CHEMBL3633184,P35368,,BUYVTPGEWYQFCF-RSPOEFSDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26428869.0,ACTIVITY,=,0.82,%,,cell_based,,,,,,,,,,,,Agonist activity at adrenergic a1B receptor (unknown origin) expressed in CHO cells assessed as calcium mobilization at 3 uM,,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,2015.0,25.0,22.0,"Uruno Y, Konishi Y, Suwa A, Takai K, Tojo K, Nakako T, Sakai M, Enomoto T, Matsuda H, Kitamura A, Sumiyoshi T",,1525740.0,DTCT0023207,14591894,DTCC01670182,839209,64203,CCOC(=O)N1[C@@H]2CC[C@H]1CC(C2)CN3CC[C@H](C3)N4CC5=CC=CC=C5NC4=O,CCOC(=O)N1[C@H]2CC[C@@H]1CC(CN1CC[C@@H](N3Cc4ccccc4NC3=O)C1)C2
1499,CHEMBL3633184,P35368,,BUYVTPGEWYQFCF-RSPOEFSDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26428869.0,INHIBITION,=,-15.0,%,,cell_based,,,,,,,,,,,,Antagonist activity at adrenergic a1B receptor (unknown origin) expressed in CHO cells assessed as calcium mobilization at 3 uM,,"Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists.",Bioorg. Med. Chem. Lett.,2015.0,25.0,22.0,"Uruno Y, Konishi Y, Suwa A, Takai K, Tojo K, Nakako T, Sakai M, Enomoto T, Matsuda H, Kitamura A, Sumiyoshi T",,1525898.0,DTCT0023207,14591848,DTCC01670182,839209,64203,CCOC(=O)N1[C@@H]2CC[C@H]1CC(C2)CN3CC[C@H](C3)N4CC5=CC=CC=C5NC4=O,CCOC(=O)N1[C@H]2CC[C@@H]1CC(CN1CC[C@@H](N3Cc4ccccc4NC3=O)C1)C2
1500,CHEMBL3633757,P35368,,AJIMVLSQIMXLNV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26475518.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Displacement of [3H]-Prazosin from recombinant human adrenergic alpha1B receptor at 10 uM after 1.5 hrs by Microbeta scintillation counting analysis relative to control,,Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT2A receptor.,Bioorg. Med. Chem. Lett.,2015.0,25.0,22.0,"Ponnala S, Kapadia N, Madapa S, Alberts IL, Harding WW",,1527245.0,DTCT0023207,14599097,DTCC01670761,1077577,64247,CN1CCC2=CC(=C(C3=C2C1CC4=CC5=C(C=C43)OCO5)OCC6=CC=C(C=C6)Br)OC,COc1cc2c3c(c1OCc1ccc(Br)cc1)-c1cc4c(cc1CC3N(C)CC2)OCO4
1501,CHEMBL36622,P35368,,GYSZUJHYXCZAKI-CQSZACIVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,72.44,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756645,DTCC00177755,1222593,53287,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=CC=CC=C3O2,COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1
1502,CHEMBL366563,P35368,,LEVWYRKDKASIDU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14727072,DTCC00370225,2103226,69159,C(C(C(=O)O)N)SSCC(C(=O)O)N,NC(CSSCC(N)C(=O)O)C(=O)O
1503,CHEMBL369154,P35368,,PDRJBDSCLNHWKG-OXJNMPFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,1.64,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1284108,DTCC00376306,128600,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=C(C=C5)C(=O)OC)NC4=O,COC(=O)c1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1
1504,CHEMBL371300,P35368,,WBYHTZYHAFNBKW-ZETCQYMHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16392816.0,KI,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against adrenergic alpha-1B receptor,,1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity.,J. Med. Chem.,2006.0,49.0,1.0,"May JA, Dantanarayana AP, Zinke PW, McLaughlin MA, Sharif NA",,329330.0,DTCT0023207,1882011,DTCC00412210,1852068,20195,C[C@@H](CN1C2=C(C=CC(=C2)O)C=N1)N,C[C@H](N)Cn1ncc2ccc(O)cc21
1505,CHEMBL37212,P35368,,WCVUOUODFRTVDL-UHFFFAOYSA-M,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12672251.0,KI,=,20.42,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant towards human recombinant Alpha-1B adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay,,"1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.",J. Med. Chem.,2003.0,46.0,8.0,"Brasili L, Sorbi C, Franchini S, Manicardi M, Angeli P, Marucci G, Leonardi A, Poggesi E",,34487.0,DTCT0023207,1134357,DTCC00176057,937542,17773,C[N+](C)(CCOC1=CC=CC=C1)CC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)[O-])O,C[N+](C)(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1
1506,CHEMBL3739505,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,1876.0,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27914,DTCC00065911,678360,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=CC=CC=C5F,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3F)CC2)cc1
1507,CHEMBL3739513,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,406.2,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27912,DTCC00065909,613463,65595,COC1=CC=C(C=C1)N2CCN(CC2)CCC3=CC=C(C=C3)CN4C(=O)C5=CC=CC=C5C4=O,COc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1
1508,CHEMBL3739533,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,12.57,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27884,DTCC00065905,1837187,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=CC=CC=N5,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccn3)CC2)cc1
1509,CHEMBL3739542,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,250.4,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27924,DTCC00065921,1616241,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=CC=CC=C5C(F)(F)F,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3C(F)(F)F)CC2)cc1
1510,CHEMBL3739762,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,180.0,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27922,DTCC00065919,1712265,65595,[C-]#[N+]C1=CC=CC=C1N2CCN(CC2)CCC3=CC=C(C=C3)CN4C(=O)C5=CC=CC=C5C4=O,[C-]#[N+]c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1
1511,CHEMBL3739897,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,79.43,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,,"Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent 1and 5-HT1Areceptor ligand: an in vitro and computational study",MedChemComm,2015.0,6.0,4.0,"Franchini S, Baraldi A, Sorbi C, Pellati F, Cichero E, Battisti UM, Angeli P, Cilia A, Brasili L",,1541088.0,DTCT0023207,9686,DTCC00066480,528770,65331,C1[C@H](OC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4.C(=O)(C(=O)O)O,c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1
1512,CHEMBL3739900,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,1007.0,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27885,DTCC00065904,1837186,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)CC5=CC=CC=C5,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(Cc3ccccc3)CC2)cc1
1513,CHEMBL3739932,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,114.82,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,,"Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent 1and 5-HT1Areceptor ligand: an in vitro and computational study",MedChemComm,2015.0,6.0,4.0,"Franchini S, Baraldi A, Sorbi C, Pellati F, Cichero E, Battisti UM, Angeli P, Cilia A, Brasili L",,1541088.0,DTCT0023207,9687,DTCC00066479,1143075,65331,C1[C@@H](OC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4.C(=O)(C(=O)O)O,c1ccc(OCCNC[C@H]2COC(c3ccccc3)(c3ccccc3)O2)cc1
1514,CHEMBL3740019,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,28.91,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27910,DTCC00065907,95189,65595,CC1=CC=C(C=C1)N2CCN(CC2)CCC3=CC=C(C=C3)CN4C(=O)C5=CC=CC=C5C4=O,Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1
1515,CHEMBL3740042,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,948.8,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27883,DTCC00065906,1065943,65595,CC1=CC=CC=C1N2CCN(CC2)CCC3=CC=C(C=C3)CN4C(=O)C5=CC=CC=C5C4=O,Cc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1
1516,CHEMBL3740351,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,433.3,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27913,DTCC00065910,95190,65595,CCOC1=CC=CC=C1N2CCN(CC2)CCC3=CC=C(C=C3)CN4C(=O)C5=CC=CC=C5C4=O,CCOc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1
1517,CHEMBL3740374,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,72.44,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,,"Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent 1and 5-HT1Areceptor ligand: an in vitro and computational study",MedChemComm,2015.0,6.0,4.0,"Franchini S, Baraldi A, Sorbi C, Pellati F, Cichero E, Battisti UM, Angeli P, Cilia A, Brasili L",,1541088.0,DTCT0023207,9685,DTCC00066481,268803,65331,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=CC=CC=C3O2.C(=O)(C(=O)O)O,COc1cccc(OC)c1OCCNC[C@@H]1COc2ccccc2O1
1518,CHEMBL3740558,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,121.9,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27927,DTCC00065924,62732,65595,CC(=O)C1=CC=C(C=C1)N2CCN(CC2)CCC3=CC=C(C=C3)CN4C(=O)C5=CC=CC=C5C4=O,CC(=O)c1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1
1519,CHEMBL3740847,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,684.0,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27915,DTCC00065912,1772299,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=CC=C(C=C5)F,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3)CC2)cc1
1520,CHEMBL3740874,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,34.76,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27917,DTCC00065914,95191,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=C(C=C(C=C5)C#N)F,N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)c(F)c1
1521,CHEMBL3741079,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,1003.0,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27921,DTCC00065918,95192,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=CC=C(C=C5)Br,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Br)cc3)CC2)cc1
1522,CHEMBL3741161,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,787.5,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27916,DTCC00065913,581140,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=C(C=C(C=C5)F)F,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(F)cc3F)CC2)cc1
1523,CHEMBL3741260,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,769.4,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27923,DTCC00065920,1616239,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=CC=C(C=C5)C#N,N#Cc1ccc(N2CCN(CCc3ccc(CN4C(=O)c5ccccc5C4=O)cc3)CC2)cc1
1524,CHEMBL3741318,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,100.9,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27911,DTCC00065908,1837188,65595,COC1=CC=CC=C1N2CCN(CC2)CCC3=CC=C(C=C3)CN4C(=O)C5=CC=CC=C5C4=O,COc1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1
1525,CHEMBL3741483,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,794.4,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27919,DTCC00065916,872521,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=CC=C(C=C5)Cl,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(Cl)cc3)CC2)cc1
1526,CHEMBL3741658,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,875.3,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27886,DTCC00065903,451132,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=CC=CC=C5,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3)CC2)cc1
1527,CHEMBL3741808,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,5.754,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,,"Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent 1and 5-HT1Areceptor ligand: an in vitro and computational study",MedChemComm,2015.0,6.0,4.0,"Franchini S, Baraldi A, Sorbi C, Pellati F, Cichero E, Battisti UM, Angeli P, Cilia A, Brasili L",,1541088.0,DTCT0023207,9684,DTCC00066482,1563132,65331,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2COC3=CC=CC=C3O2.C(=O)(C(=O)O)O,COc1cccc(OC)c1OCCNC[C@H]1COc2ccccc2O1
1528,CHEMBL3742103,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,31.62,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27920,DTCC00065917,774775,65595,CC1=C(C=C(C=C1)Cl)N2CCN(CC2)CCC3=CC=C(C=C3)CN4C(=O)C5=CC=CC=C5C4=O,Cc1ccc(Cl)cc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1
1529,CHEMBL3742198,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,781.5,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27918,DTCC00065915,1324785,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=CC=CC=C5Cl,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccccc3Cl)CC2)cc1
1530,CHEMBL3742253,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,19.69,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27925,DTCC00065922,256430,65595,C1CN(CCN1CCC2=CC=C(C=C2)CN3C(=O)C4=CC=CC=C4C3=O)C5=CC=C(C=C5)C(F)(F)F,O=C1c2ccccc2C(=O)N1Cc1ccc(CCN2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1
1531,CHEMBL3742276,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26643219.0,IC50,=,199.0,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic alpha1B receptor (unknown origin) by firefly and renilla dual glo luciferase assay,,"Synthesis, structure-activity relationship and biological evaluation of novel arylpiperzines as 1A/1D-AR subselective antagonists for BPH.",Bioorg. Med. Chem.,2015.0,23.0,24.0,"Xu F, Chen H, Xu J, Liang X, He X, Shao B, Sun X, Li B, Deng X, Yuan M.",,1541511.0,DTCT0023207,27926,DTCC00065923,1712266,65595,CS(=O)(=O)C1=CC=CC=C1N2CCN(CC2)CCC3=CC=C(C=C3)CN4C(=O)C5=CC=CC=C5C4=O,CS(=O)(=O)c1ccccc1N1CCN(CCc2ccc(CN3C(=O)c4ccccc4C3=O)cc2)CC1
1532,CHEMBL3752576,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26739781.0,KI,=,1258.93,NM,,,,,,,,,,,,,,Binding affinity to alpha-1B adrenergic receptor (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016.0,26.0,3.0,"Cozzi NV, Daley PF.",,1550144.0,DTCT0023207,62478,DTCC00070939,1531285,65871,C=CCN(CCC1=CNC2=CC=CC=C21)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccccc12
1533,CHEMBL3752900,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26739781.0,KI,=,794.33,NM,,,,,,,,,,,,,,Binding affinity to alpha-1B adrenergic receptor (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016.0,26.0,3.0,"Cozzi NV, Daley PF.",,1550144.0,DTCT0023207,62480,DTCC00070941,203699,65871,C=CCN(CCC1=CNC2=C1C=C(C=C2)Cl)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12
1534,CHEMBL3753318,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26739781.0,KI,=,1778.28,NM,,,,,,,,,,,,,,Binding affinity to alpha-1B adrenergic receptor (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016.0,26.0,3.0,"Cozzi NV, Daley PF.",,1550144.0,DTCT0023207,61520,DTCC00070943,1174224,65871,CC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12
1535,CHEMBL3754166,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26739781.0,KI,=,1995.26,NM,,,,,,,,,,,,,,Binding affinity to alpha-1B adrenergic receptor (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016.0,26.0,3.0,"Cozzi NV, Daley PF.",,1550144.0,DTCT0023207,61519,DTCC00070942,852078,65871,C=CCN(CCC1=CNC2=C1C=C(C=C2)Br)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12
1536,CHEMBL3754496,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26739781.0,KI,<,10000.0,NM,,,,,,,,,,,,,,Binding affinity to alpha-1B adrenergic receptor (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016.0,26.0,3.0,"Cozzi NV, Daley PF.",,1550144.0,DTCT0023207,62479,DTCC00070940,981005,65871,C=CCN(CCC1=CNC2=C1C=C(C=C2)F)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12
1537,CHEMBL3763166,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26653033.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Adrenergic alpha1B receptor (unknown origin) at 10 uM,,"Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.",J. Med. Chem.,2016.0,59.0,1.0,"Lin SY, Yeh TK, Kuo CC, Song JS, Cheng MF, Liao FY, Chao MW, Huang HL, Chen YL, Yang CY, Wu MH, Hsieh CL, Hsiao W, Peng YH, Wu JS, Lin LM, Sun M, Chao YS, Shih C, Wu SY, Pan SL, Hung MS, Ueng SH.",,1553767.0,DTCT0023207,91849,DTCC00075195,807224,66086,C1C2=C(C=CC(=C2)S(=O)(=O)NNC3=CC=C(C=C3)Br)NC1=O,O=C1Cc2cc(S(=O)(=O)NNc3ccc(Br)cc3)ccc2N1
1538,CHEMBL37883,P35368,,JAHHZJFOTROQSY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12672251.0,KI,=,63.1,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant towards human recombinant Alpha-1B adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay,,"1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.",J. Med. Chem.,2003.0,46.0,8.0,"Brasili L, Sorbi C, Franchini S, Manicardi M, Angeli P, Marucci G, Leonardi A, Poggesi E",,34487.0,DTCT0023207,1135565,DTCC00176086,743616,17773,C1C(OC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4.C(=O)(C(=O)O)O,c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1
1539,CHEMBL37883,P35368,,JAHHZJFOTROQSY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,63.1,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608859,DTCC00176086,749968,47207,C1C(OC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4.C(=O)(C(=O)O)O,c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1
1540,CHEMBL37883,P35368,,JAHHZJFOTROQSY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,63.1,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cell membrane after 30 mins by liquid scintillation counting,,"Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent 1and 5-HT1Areceptor ligand: an in vitro and computational study",MedChemComm,2015.0,6.0,4.0,"Franchini S, Baraldi A, Sorbi C, Pellati F, Cichero E, Battisti UM, Angeli P, Cilia A, Brasili L",,1541088.0,DTCT0023207,9688,DTCC00176086,754615,65331,C1C(OC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4.C(=O)(C(=O)O)O,c1ccc(OCCNCC2COC(c3ccccc3)(c3ccccc3)O2)cc1
1541,CHEMBL37962,P35368,,QVDSNJHEPXTSHN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12672251.0,KI,=,257.04,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant towards human recombinant Alpha-1B adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay,,"1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.",J. Med. Chem.,2003.0,46.0,8.0,"Brasili L, Sorbi C, Franchini S, Manicardi M, Angeli P, Marucci G, Leonardi A, Poggesi E",,34487.0,DTCT0023207,1135576,DTCC00176058,1325647,17773,CN(CCOC1=CC=CC=C1)CC2COC(O2)(C3=CC=CC=C3)C4=CC=CC=C4.C(=O)(C(=O)O)O,CN(CCOc1ccccc1)CC1COC(c2ccccc2)(c2ccccc2)O1
1542,CHEMBL3797529,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26954848.0,KI,>,1200.0,NM,,,,,,,,,,,,,,Displacement of 7-methoxy-[3H]-prazosin from human alpha1B adrenergic receptor expressed in CHO-K1 cell membranes incubated for 60 mins by liquid scintillation counting analysis,,"Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active 1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related Gene (hERG) Liabilities.",J. Med. Chem.,2016.0,59.0,7.0,"Sakauchi N, Kohara Y, Sato A, Suzaki T, Imai Y, Okabe Y, Imai S, Saikawa R, Nagabukuro H, Kuno H, Fujita H, Kamo I, Yoshida M.",,1575806.0,DTCT0023207,247905,DTCC00091252,1099076,66873,C1=CC=C(C=C1)CN2C=C(C=C(C2=N)C(=O)N)Cl,N=c1c(C(N)=O)cc(Cl)cn1Cc1ccccc1
1543,CHEMBL3808408,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,610.2,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269816,DTCC00094277,807416,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OC,COc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2
1544,CHEMBL3808417,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,2162.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269812,DTCC00094281,256688,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=C(C=C(C=C3)Cl)OC,COc1cc(Cl)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2
1545,CHEMBL3808511,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,980.5,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269715,DTCC00094407,1583774,67126,CC(CC1=CC(=C2C(=C1)C=CN2CCCO)C(=O)N)NCCOC3=C(C=C(C=C3)F)Br,CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccc(F)cc1Br
1546,CHEMBL3808572,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,180.1,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269805,DTCC00094412,969029,67126,CC(CC1=CC(=C2C(=C1)C=CN2CCCO)C(=O)N)NCCOC3=CC=CC=C3OCC(F)(F)F,CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCC(F)(F)F
1547,CHEMBL3808595,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,1361.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269827,DTCC00094270,678631,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=C(C=C(C=C3)F)Br,CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1Br
1548,CHEMBL3808632,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,640.6,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269818,DTCC00094278,2064313,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC4=CC=CC=C4,CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCc1ccccc1
1549,CHEMBL3808717,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,7583.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269713,DTCC00094419,1162440,67126,CCC1=CC(=C(C=C1)OCC(F)(F)F)OCCNC(C)CC2=CC(=C3C(=C2)C=CN3CCCO)C(=O)N,CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1
1550,CHEMBL3808726,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,32.7,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269807,DTCC00094287,2064315,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=C(C=CC(=C3)Br)OCC(F)(F)F,CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Br)ccc1OCC(F)(F)F
1551,CHEMBL3808878,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,5992.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269821,DTCC00094275,1260160,67126,CC1=CC=CC=C1OCCNC(C)CC2=CC3=C(C(=C2)C(=O)N)N(CC3)CCCO,Cc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2
1552,CHEMBL3808896,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,168.9,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269819,DTCC00094279,289988,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=C(C=CC(=C3)F)OC,COc1ccc(F)cc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2
1553,CHEMBL3808981,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,2959.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269749,DTCC00094406,451427,67126,C[C@@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=C(C=CC(=C3)Cl)OCC(F)(F)F,C[C@@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F
1554,CHEMBL3808999,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,4320.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269682,DTCC00094408,2064316,67126,CCC1=CC=CC=C1OCCNC(C)CC2=CC(=C3C(=C2)C=CN3CCCO)C(=O)N,CCc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1
1555,CHEMBL3809032,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,2248.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269809,DTCC00094284,160300,67126,CCC1=CC(=C(C=C1)OCCNC(C)CC2=CC3=C(C(=C2)C(=O)N)N(CC3)CCCO)OC,CCc1ccc(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(OC)c1
1556,CHEMBL3809093,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,130.6,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269804,DTCC00094411,905103,67126,CC(CC1=CC(=C2C(=C1)C=CN2CCCO)C(=O)N)NCCOC3=CC=CC=C3OCC4=CC=CC=C4,CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1ccccc1OCc1ccccc1
1557,CHEMBL3809175,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,866.1,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269813,DTCC00094282,1740754,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=C(C=C(C=C3)Br)OC,COc1cc(Br)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2
1558,CHEMBL3809248,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,35.6,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269664,DTCC00094410,1066234,67126,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C3C(=C2)C=CN3CCCO)C(=O)N,CCOc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1
1559,CHEMBL3809314,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269679,DTCC00094744,1390570,67126,CC1=CC(=C(C=C1)OCC(F)(F)F)OCCN[C@@H](C)CC2=CC(=C3C(=C2)C=CN3CCCO)C(=O)N,Cc1ccc(OCC(F)(F)F)c(OCCN[C@@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1
1560,CHEMBL3809319,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,262.9,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269683,DTCC00094409,1195031,67126,CC(CC1=CC(=C2C(=C1)C=CN2CCCO)C(=O)N)NCCOC3=CC=CC=C3OC,COc1ccccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1
1561,CHEMBL3809490,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,2862.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269714,DTCC00094420,1772570,67126,CC1=CC(=C(C=C1)OCC(F)(F)F)OCCN[C@H](C)CC2=CC(=C3C(=C2)C=CN3CCCO)C(=O)N,Cc1ccc(OCC(F)(F)F)c(OCCN[C@H](C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1
1562,CHEMBL3809500,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,3139.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269820,DTCC00094274,807415,67126,CC1=CC(=C(C(=C1)C)OCCNC(C)CC2=CC3=C(C(=C2)C(=O)N)N(CC3)CCCO)C,Cc1cc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c(C)c1
1563,CHEMBL3809532,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,3266.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269823,DTCC00094272,581423,67126,CC1=C(C(=CC=C1)C)OCCNC(C)CC2=CC3=C(C(=C2)C(=O)N)N(CC3)CCCO,Cc1cccc(C)c1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2
1564,CHEMBL3809543,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,4807.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269824,DTCC00094273,969026,67126,CC1=C(C(=C(C=C1)C)OCCNC(C)CC2=CC3=C(C(=C2)C(=O)N)N(CC3)CCCO)C,Cc1ccc(C)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1C
1565,CHEMBL3809600,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,1284.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269815,DTCC00094280,2032577,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=C(C=C(C=C3)F)OC,COc1cc(F)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2
1566,CHEMBL3809630,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,158.5,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269810,DTCC00094285,646500,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=C(C=C(C=C3)F)OCC(F)(F)F,CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc(F)cc1OCC(F)(F)F
1567,CHEMBL3809676,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,936.6,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269778,DTCC00094414,807418,67126,CC(CC1=CC(=C2C(=C1)C=CN2CCCO)C(=O)N)NCCOC3=C(C=C(C=C3)F)OC,COc1cc(F)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1
1568,CHEMBL3809781,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,2768.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269825,DTCC00094271,1131186,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC4=C(C=C3)OCO4,CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccc2c(c1)OCO2
1569,CHEMBL3809794,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,169.6,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269746,DTCC00094416,1487259,67126,CC(CC1=CC(=C2C(=C1)C=CN2CCCO)C(=O)N)NCCOC3=C(C=C(C=C3)Br)OC,COc1cc(Br)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1
1570,CHEMBL3809840,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,2197.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269748,DTCC00094418,1195032,67126,CC1=CC(=C(C=C1)OCC(F)(F)F)OCCNC(C)CC2=CC(=C3C(=C2)C=CN3CCCO)C(=O)N,Cc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc(C(N)=O)c3c(ccn3CCCO)c2)c1
1571,CHEMBL3810005,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,1206.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269811,DTCC00094286,2064314,67126,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=C(C=CC(=C3)Cl)OCC(F)(F)F,CC(Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F
1572,CHEMBL3810110,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,70.9,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269806,DTCC00094413,1260161,67126,CC(CC1=CC(=C2C(=C1)C=CN2CCCO)C(=O)N)NCCOC3=C(C=CC(=C3)F)OC,COc1ccc(F)cc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1
1573,CHEMBL3810145,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,287.1,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269747,DTCC00094417,1292527,67126,CC(CC1=CC(=C2C(=C1)C=CN2CCCO)C(=O)N)NCCOC3=C(C=CC(=C3)Cl)OCC(F)(F)F,CC(Cc1cc(C(N)=O)c2c(ccn2CCCO)c1)NCCOc1cc(Cl)ccc1OCC(F)(F)F
1574,CHEMBL3810187,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,8488.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269808,DTCC00094288,1805112,67126,CCC1=CC(=C(C=C1)OCC(F)(F)F)OCCNC(C)CC2=CC3=C(C(=C2)C(=O)N)N(CC3)CCCO,CCc1ccc(OCC(F)(F)F)c(OCCNC(C)Cc2cc3c(c(C(N)=O)c2)N(CCCO)CC3)c1
1575,CHEMBL3810198,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,5320.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269822,DTCC00094276,1195025,67126,CCC1=CC=CC=C1OCCNC(C)CC2=CC3=C(C(=C2)C(=O)N)N(CC3)CCCO,CCc1ccccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2
1576,CHEMBL3810220,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,617.6,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269814,DTCC00094283,1195026,67126,CC1=CC(=C(C=C1)OCCNC(C)CC2=CC3=C(C(=C2)C(=O)N)N(CC3)CCCO)OC,COc1cc(C)ccc1OCCNC(C)Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2
1577,CHEMBL3810346,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,1736.0,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269780,DTCC00094405,1487258,67126,C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=C(C=CC(=C3)Cl)OCC(F)(F)F,C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1cc(Cl)ccc1OCC(F)(F)F
1578,CHEMBL3810401,P35368,,,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27031406.0,IC50,=,835.9,NM,,,,,,,,,,,,,,Antagonist activity at human alpha-1B adrenergic receptor transfected in HEK293 cells assessed as reduction in agonist-induced calcium mobilization after 10 mins,,"Design, Synthesis, and Biological Evaluation of Indoline and Indole Derivatives as Potent and Selective 1A-Adrenoceptor Antagonists.",J. Med. Chem.,2016.0,59.0,8.0,"Zhao F, Li J, Chen Y, Tian Y, Wu C, Xie Y, Zhou Y, Wang J, Xie X, Liu H.",,1579181.0,DTCT0023207,269779,DTCC00094415,1616518,67126,CC(CC1=CC(=C2C(=C1)C=CN2CCCO)C(=O)N)NCCOC3=C(C=C(C=C3)Cl)OC,COc1cc(Cl)ccc1OCCNC(C)Cc1cc(C(N)=O)c2c(ccn2CCCO)c1
1579,CHEMBL382972,P35368,,BGFYEOBLDYCILL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,0.794,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870362,DTCC00409511,1852038,20070,CC1=CC=CC=C1COC2=CC=CC=C2OCCNCCOC3=C(C=CC=C3OC)OC,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1C
1580,CHEMBL383938,P35368,,KGWXTAUOHMLWSB-LMOVPXPDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,19.05,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993372,DTCC00435532,1872928,21490,COC1=C(C2=C(CCCC2)C=C1)OCCNC[C@H]3COC4=CC=CC=C4O3.Cl,COc1ccc2c(c1OCCNC[C@H]1COc3ccccc3O1)CCCC2
1581,CHEMBL385371,P35368,,BXAUNYRCMJYSAD-BOXHHOBZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,371.54,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993364,DTCC00435613,1744167,21490,COC1=C(C2=CC=CC=C2C=C1)OCCNC[C@H]3COC4=C(O3)C=C5CCCCC5=C4.Cl,COc1ccc2ccccc2c1OCCNC[C@H]1COc2cc3c(cc2O1)CCCC3
1582,CHEMBL386005,P35368,,DYXJVPXSKMEWAK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,10.72,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017519,DTCC00110944,778592,21852,COC1=C(C=C(C=C1)Cl)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,COc1ccc(Cl)cc1N1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1
1583,CHEMBL387832,P35368,,GAFGMUJBSNDSHX-BGYRXZFFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,76.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104164,DTCC00454848,175170,22924,C1CC(CCC1NS(=O)(=O)C2=CC=C(C=C2)OC(F)F)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1
1584,CHEMBL387833,P35368,,QLLKZBYEHJGRHK-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,300.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104160,DTCC00111483,2079491,22924,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCC(F)F)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC
1585,CHEMBL387833,P35368,,QLLKZBYEHJGRHK-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,278.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195234,DTCC00111483,2084408,23970,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCC(F)F)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC
1586,CHEMBL388361,P35368,,ACYCBNFGNBHQEP-YHBQERECSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,148.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104185,DTCC00454822,1405743,22924,CC(C)OC1=CC=CC=C1C2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC
1587,CHEMBL388361,P35368,,ACYCBNFGNBHQEP-YHBQERECSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,148.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195240,DTCC00454822,1410650,23970,CC(C)OC1=CC=CC=C1C2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC
1588,CHEMBL388884,P35368,,CKDALLRCYSNSRF-JKSUJKDBSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17276073.0,KI,=,0.309,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic alpha-1b receptor expressed in CHO cells,,Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.,Bioorg. Med. Chem.,2007.0,15.0,6.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Leonardi A, Poggesi E, Giardinà D",,442028.0,DTCT0023207,2146166,DTCC00460420,1744406,23212,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5=CC=C(O5)Br)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccc(Br)o4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
1589,CHEMBL388897,P35368,,CQABPCACTMBCQC-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,82.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104180,DTCC00454829,1308140,22924,COC1=C(C=C(C=C1)Cl)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OC5CC5,COc1ccc(Cl)cc1S(=O)(=O)NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1
1590,CHEMBL389104,P35368,,ZIIYCNPQTIYWFF-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,275.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104176,DTCC00454833,1631456,22924,C1CC(CCC1NS(=O)(=O)C2=CC3=C(C=C2)OCO3)N4CCC(CC4)C5=CC=CC=C5OC6CC6,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2
1591,CHEMBL389978,P35368,,YJXHORZMAAZIFY-ZWKOTPCHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17276073.0,KI,=,3.16,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic alpha-1b receptor expressed in CHO cells,,Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.,Bioorg. Med. Chem.,2007.0,15.0,6.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Leonardi A, Poggesi E, Giardinà D",,442028.0,DTCT0023207,2146161,DTCC00460425,714367,23212,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5=CC=CN5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccc[nH]4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
1592,CHEMBL390129,P35368,,ACYCBNFGNBHQEP-ZRZAMGCNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,144.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104119,DTCC00454820,1755667,22924,CC(C)OC1=CC=CC=C1C2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC
1593,CHEMBL390129,P35368,,ACYCBNFGNBHQEP-ZRZAMGCNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,151.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195241,DTCC00454820,1760380,23970,CC(C)OC1=CC=CC=C1C2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC
1594,CHEMBL390184,P35368,,NHRXMVNDSUMAIN-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,470.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104184,DTCC00454825,790253,22924,CC(C)OC1=CC=CC=C1C2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)F)F,CC(C)Oc1ccccc1C1CCN(C2CCC(NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1
1595,CHEMBL390192,P35368,,WDZOSSNSOBKEMP-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,703.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104169,DTCC00454841,952037,22924,COC1=C(C=C(C=C1)Cl)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F,COc1ccc(Cl)cc1S(=O)(=O)NC1CCC(N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1
1596,CHEMBL390473,P35368,,AEJCTJSNUNXYQL-YHBQERECSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,1487.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104155,DTCC00454853,1755668,22924,CC(C)OC1=C(C=C(C=C1)F)C2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC
1597,CHEMBL391016,P35368,,XOZBPBSXMJMBOL-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,192.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166071,DTCC00464389,2084295,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CN=CC=C4,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cccnc3)CC2)CC1
1598,CHEMBL391017,P35368,,KCWSSYYCEGZXTI-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,268.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166069,DTCC00464391,1700441,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CN=C4)OC,COc1ccncc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
1599,CHEMBL391035,P35368,,KAHFZGUOPFFVHW-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,177.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166086,DTCC00464369,1507215,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=C(C=C4)Cl)Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1
1600,CHEMBL391107,P35368,,BXGCCZDRUAOMRC-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,111.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166123,DTCC00464295,1312914,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC=C4,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccccc3)CC2)CC1
1601,CHEMBL391530,P35368,,YJXYZPLPRPNAPZ-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,109.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166104,DTCC00464324,666166,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC
1602,CHEMBL391530,P35368,,YJXYZPLPRPNAPZ-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,112.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166080,DTCC00464324,666167,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC
1603,CHEMBL391530,P35368,,YJXYZPLPRPNAPZ-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,106.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195228,DTCC00464324,666279,23970,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC(=C(C=C4)OC)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC
1604,CHEMBL392066,P35368,,SHLHJQDYUNFBDK-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,714.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166097,DTCC00464336,1182358,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)F)OC,COc1ccc(F)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
1605,CHEMBL392354,P35368,,OXLSTDPYCCQCDK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214239,DTCC00473133,2036288,24162,C1CCC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=C(C=C(C=C5)F)F.C(=O)O,O=C(c1ccc(F)cc1F)N1CCN(c2ccc(OC3CCN(C4CCCC4)CC3)cc2)C(=O)C1
1606,CHEMBL392377,P35368,,STAISUAHBRKLLH-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,1254.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166105,DTCC00464322,2019953,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=C(C=C4)OC(F)(F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1
1607,CHEMBL392532,P35368,,KEQCAAQBOMIVCB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214255,DTCC00473105,1841332,24162,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=C(C=C(C=C4)F)F.C(=O)O,CC(C)N1CCC(Oc2ccc(N3CCN(C(=O)c4ccc(F)cc4F)CC3=O)cc2)CC1
1608,CHEMBL392713,P35368,,JQJNQYUMEBRJKC-FERBBOLQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214261,DTCC00473098,585289,24162,C[C@H]1CCCN1CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC(=CC(=C4)F)F.C(=O)O,C[C@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3cc(F)cc(F)c3)CC2=O)cc1
1609,CHEMBL392760,P35368,WAY-181187,RYBOXBBYCVOYNO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17948978.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Displacement of radio ligand from alpha-1B adrenergic receptor at 100 nM,,"Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist.",J. Med. Chem.,2007.0,50.0,23.0,"Cole DC, Stock JR, Lennox WJ, Bernotas RC, Ellingboe JW, Boikess S, Coupet J, Smith DL, Leung L, Zhang GM, Feng X, Kelly MF, Galante R, Huang P, Dawson LA, Marquis K, Rosenzweig-Lipson S, Beyer CE, Schechter LE",,451172.0,DTCT0023207,2203166,DTCC00003286,2020054,24044,C1=CC=C2C(=C1)C(=CN2S(=O)(=O)C3=C(N=C4N3C=CS4)Cl)CCN,NCCc1cn(S(=O)(=O)c2c(Cl)nc3sccn23)c2ccccc12
1610,CHEMBL393104,P35368,,KAHFZGUOPFFVHW-MEMLXQNLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,596.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166085,DTCC00464372,179912,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=C(C=C4)Cl)Cl,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1
1611,CHEMBL393105,P35368,,JOQJONDKZULBPP-MXVIHJGJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,348.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166083,DTCC00464379,115294,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C(=CC=C4)Cl)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1
1612,CHEMBL393725,P35368,,CHYHMJYTWVQCFW-ZRZAMGCNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,162.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166100,DTCC00464330,795032,23441,CC1=CC(=C(C=C1)OC)S(=O)(=O)NC2CCC(CC2)N3CCN(CC3)C4=CC=CC=C4OC(C)C,COc1ccc(C)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
1613,CHEMBL394015,P35368,,NOBSINPJDRJYCC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214274,DTCC00473054,876544,24162,C1CCN(C1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC(=CC(=C4)F)F,O=C(c1cc(F)cc(F)c1)N1CCN(c2ccc(OCCCN3CCCC3)cc2)C(=O)C1
1614,CHEMBL394139,P35368,,NSNRTJGFOUKUCV-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,1855.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166078,DTCC00464382,601352,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)Cl)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3cc(Cl)ccc3F)CC2)CC1
1615,CHEMBL394144,P35368,,JHRLWHBYMHILPR-FSRHSHDFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,1584.89,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214268,DTCC00473088,488851,24162,C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F.C(=O)O,C[C@@H]1CCCN1CCCOc1ccc(N2CCN(C(=O)c3ccc(F)cc3)CC2=O)cc1
1616,CHEMBL398812,P35368,,HWRLDLIRHAWZST-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214281,DTCC00473046,876543,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=C(C=C(C=C4)F)F.C(=O)O,O=C(c1ccc(F)cc1F)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1
1617,CHEMBL398996,P35368,,AFNIUHMJOXEVTF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214249,DTCC00473109,455484,24162,CS(=O)(=O)C1=CC=C(C=C1)C(=O)N2CCN(C(=O)C2)C3=CC=C(C=C3)OC4CCN(CC4)C5CCC5.C(=O)O,CS(=O)(=O)c1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1
1618,CHEMBL399195,P35368,,MMNXGMKPQQFESW-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,103.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166119,DTCC00464299,435088,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=CC=C4F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccccc3F)CC2)CC1
1619,CHEMBL400224,P35368,,BPXYTXXFLQUXFX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214246,DTCC00111969,1296466,24162,C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=CC=C(C=C5)C(=O)N6CCC6.C(=O)O,O=C(c1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1)N1CCC1
1620,CHEMBL400612,P35368,,KENVEDVQQZAGDU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214271,DTCC00473080,1587654,24162,C1CCCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)C#N.C(=O)O,N#Cc1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCCC4)cc3)C(=O)C2)cc1
1621,CHEMBL402003,P35368,,QFWHXAUYMHHEEF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368815,DTCC00492288,1588043,26380,C1CC2=C(C1C3=NC=CN3)C=CC(=C2C4=CC=NN4)Cl,Clc1ccc2c(c1-c1ccn[nH]1)CCC2c1ncc[nH]1
1622,CHEMBL402143,P35368,,QCFZUTYIUYQTPW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19329329.0,KI,=,325.0,NM,,,,,,,,,,,,,,Inhibition of human cloned Alpha-1B adrenergic receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563503.0,DTCT0023207,2623686,DTCC00501513,1588595,33115,COC1=C(C=CC=C1OCCF)C(C2CCN(CC2)CCC3=CC=C(C=C3)F)O,COc1c(OCCF)cccc1C(O)C1CCN(CCc2ccc(F)cc2)CC1
1623,CHEMBL402388,P35368,,IEVQENKCCRQYBX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368724,DTCC00492206,1620607,26380,COC1=CC=CC2=C1CCC2C3=NC=CN3,COc1cccc2c1CCC2c1ncc[nH]1
1624,CHEMBL40303,P35368,,ZZLUJXKQWVKZFY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,1100.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,542694,DTCC00183864,787324,3807,C1CCC(CC1)C(C2=CC=CC=C2)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4,N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCCC2)CC1
1625,CHEMBL40317,P35368,2-FLUORONOREPINEHPRINE,SBUQBFTXTZSRMH-QMMMGPOBSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19857969.0,KI,=,134000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human adrenergic Alpha-1B receptor expressed in CHO cell membrane,,Structural basis of the selectivity of the beta(2)-adrenergic receptor for fluorinated catecholamines.,Bioorg. Med. Chem.,2009.0,17.0,23.0,"Pooput C, Rosemond E, Karpiak J, Deflorian F, Vilar S, Costanzi S, Wess J, Kirk KL",,603939.0,DTCT0023207,3174223,DTCC01739838,1536520,36739,C1=C(C(=CC(=C1O)O)F)[C@H](CN)O,NC[C@H](O)c1cc(O)c(O)cc1F
1626,CHEMBL40325,P35368,,JGLLHUJRQIQLNY-IFMALSPDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11931617.0,KI,=,27.54,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,2002.0,45.0,8.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Gentili F, Marucci G, Carrieri A, Carotti A, Poggesi E, Leonardi A, Melchiorre C",,34488.0,DTCT0023207,1606509,DTCC00184471,808107,17220,COC1=C(C(=CC=C1)OC)OCCNC[C@H]2C[C@@H](C3=CC=CC=C3S2)C4=CC=CC=C4,COc1cccc(OC)c1OCCNC[C@H]1C[C@H](c2ccccc2)c2ccccc2S1
1627,CHEMBL403280,P35368,,NIQWPNGICRVKCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,76.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295836,DTCC00501691,1987395,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=C(C=C4)F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1
1628,CHEMBL403280,P35368,,NIQWPNGICRVKCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,475.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295837,DTCC00501691,1987394,25739,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NC(=O)NC4=C(C=C(C=C4)F)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1
1629,CHEMBL404566,P35368,,VHKRHCDBRNOWND-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368730,DTCC00492246,1394498,26380,CCS(=O)(=O)NC1=CC=CC2=C1CCC2C3=NC=CN3,CCS(=O)(=O)Nc1cccc2c1CCC2c1ncc[nH]1
1630,CHEMBL40464,P35368,,LGOIHIKKLMYNBC-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,=,1200.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1555887,DTCC00184231,529319,3808,CC1=C([C@H](CC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=CC=C4C#N,CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
1631,CHEMBL405355,P35368,NIGULDIPINE,SVJMLYUFVDMUHP-XIFFEERXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,85.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,926943,DTCC00495018,1500665,13230,CC1=C([C@@H](C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1
1632,CHEMBL405355,P35368,NIGULDIPINE,SVJMLYUFVDMUHP-XIFFEERXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7752182.0,KI,=,55.0,NM,,,,,,,,,,,,,,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,,Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.,J. Med. Chem.,1995.0,38.0,10.0,"Wetzel JM, Miao SW, Forray C, Borden LA, Branchek TA, Gluchowski C",,34326.0,DTCT0023207,1042384,DTCC00495018,1499366,12993,CC1=C([C@@H](C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1
1633,CHEMBL405355,P35368,NIGULDIPINE,SVJMLYUFVDMUHP-XIFFEERXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8667368.0,KI,=,25.01,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor hamster smooth muscle using [3H]prazosin as radioligand,,"Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.",J. Med. Chem.,1996.0,39.0,11.0,"Quaglia W, Pigini M, Tayebati SK, Piergentili A, Giannella M, Leonardi A, Taddei C, Melchiorre C",,34320.0,DTCT0023207,1157692,DTCC00495018,1488380,13601,CC1=C([C@@H](C(=C(N1)C)C(=O)OCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1
1634,CHEMBL406316,P35368,,ZXQIPWRUBBPGML-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368718,DTCC00492877,1199165,26380,C1CC2=C(C=CC=C2C1C3=NC=CN3)C4=CNN=C4,c1cc(-c2cn[nH]c2)c2c(c1)C(c1ncc[nH]1)CC2
1635,CHEMBL406348,P35368,,FYRLXCDBIMGTKV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368716,DTCC00492871,1652902,26380,CN1C(=CC=N1)C2=C3CCC(C3=CC=C2)C4=NC=CN4,Cn1nccc1-c1cccc2c1CCC2c1ncc[nH]1
1636,CHEMBL40650,P35368,A-131701,OLPQNRLJYOGSGV-WMLDXEAASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9379432.0,KI,=,6.95,NM,,,,,,,,,,,,,,Binding affinity against human adrenergic receptor subtype Alpha-1B adrenergic receptor using [3H]prazosin as radioligand,,"Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antagonist for the symptomatic treatment of benign prostatic hyperplasia.",J. Med. Chem.,1997.0,40.0,20.0,"Meyer MD, Altenbach RJ, Basha FZ, Carroll WA, Drizin I, Elmore SW, Ehrlich PP, Lebold SA, Tietje K, Sippy KB, Wendt MD, Plata DJ, Plagge F, Buckner SA, Brune ME, Hancock AA, Kerwin JF",,34330.0,DTCT0023207,494720,DTCC01739799,970714,14344,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C6=C(S5)C=CC=N6)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21
1637,CHEMBL407308,P35368,,MWTDIAXAEKTMKO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,9.0,"Whitlock GA, Conlon K, McMurray G, Roberts LR, Stobie A, Thurlow RJ",,479651.0,DTCT0023207,2368711,DTCC00492825,1426868,26380,C1CC2=C(C=CC=C2C1C3=NC=CN3)C4=NC=CO4,c1cc(-c2ncco2)c2c(c1)C(c1ncc[nH]1)CC2
1638,CHEMBL408034,P35368,,SOVSIIXOGWZFQB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1106951,DTCC00204350,1402938,18073,C1CN(CCN1CCN2C(=O)C=CC2=O)C3=C(C=CC(=C3)Cl)Cl,O=C1C=CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
1639,CHEMBL413707,P35368,,CCRVXKJAWVLEMD-OAQYLSRUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12392747.0,KI,=,30.2,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.,Bioorg. Med. Chem. Lett.,2002.0,12.0,22.0,"Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR",,34624.0,DTCT0023207,1589107,DTCC00285625,1500488,5235,C1C[C@@H](N(C1)S(=O)(=O)C2=CC3=C(C=C2)C=CN3)CCN4CCC(CC4)OC5=CC=C(C=C5)F,O=S(=O)(c1ccc2cc[nH]c2c1)N1CCC[C@@H]1CCN1CCC(Oc2ccc(F)cc2)CC1
1640,CHEMBL414185,P35368,,CGAOZWXESGMCAM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,0.39799999999999996,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,634602,DTCC00148579,1403599,4573,COC(=O)C1=CC=CC=C1NCC2=NCCN2,COC(=O)c1ccccc1NCC1=NCCN1
1641,CHEMBL414185,P35368,,CGAOZWXESGMCAM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,107.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,634603,DTCC00148579,1403599,4573,COC(=O)C1=CC=CC=C1NCC2=NCCN2,COC(=O)c1ccccc1NCC1=NCCN1
1642,CHEMBL414185,P35368,,CGAOZWXESGMCAM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,0.39799999999999996,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,978500,DTCC00148579,1392839,5345,COC(=O)C1=CC=CC=C1NCC2=NCCN2,COC(=O)c1ccccc1NCC1=NCCN1
1643,CHEMBL414185,P35368,,CGAOZWXESGMCAM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,=,0.39799999999999996,NM,,cell_based,,,,,,,,,,,,"Effective concentration showing agonistic activity towards Human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells was determined",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34479.0,DTCT0023207,941535,DTCC00148579,1405936,6217,COC(=O)C1=CC=CC=C1NCC2=NCCN2,COC(=O)c1ccccc1NCC1=NCCN1
1644,CHEMBL414628,P35368,,JZKXKHVOIUMWCS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11140733.0,KI,=,1000.0,NM,,,,,,,,,,,,,,Compound was evaluated for binding affinity against Alpha-1B adrenergic receptor,,"Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).",Bioorg. Med. Chem. Lett.,2001.0,11.0,1.0,"Bromidge SM, Clarke SE, Gager T, Griffith K, Jeffrey P, Jennings AJ, Joiner GF, King FD, Lovell PJ, Moss SF, Newman H, Riley G, Rogers D, Routledge C, Serafinowska H, Smith DR",,32301.0,DTCT0023207,1501041,DTCC00345450,1714894,4218,COC1=C(C=C(C=C1)S(=O)(=O)N2CCC3=C2C=C(C=C3)I)N4CCNCC4,COc1ccc(S(=O)(=O)N2CCc3ccc(I)cc32)cc1N1CCNCC1
1645,CHEMBL415887,P35368,,XDIYJVCTGIMGBN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,6.6,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,518586,DTCC00184618,1722481,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCN(CC3)C4=CC=CC=C4C,Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3C)CC2)c2ccc(C)cc2)cc1
1646,CHEMBL416073,P35368,,CYPCIJWPPPMXEY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,2000.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,518589,DTCC00183833,172303,3807,C1CCC(C1)C(C2=CC=CC=C2)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4,N#CC1(c2ccccc2)CCN(CCCNC(=O)C(c2ccccc2)C2CCCC2)CC1
1647,CHEMBL41677,P35368,,BGURRFIDCHOENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,450.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,541800,DTCC00183401,204218,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1
1648,CHEMBL41677,P35368,,BGURRFIDCHOENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11459670.0,KI,=,170.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards cloned human Alpha-1B adrenergic receptor,,Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2001.0,11.0,14.0,"DiPardo RM, Patane MA, Newton RC, Price R, Broten TP, Chang RS, Ransom RW, Di Salvo J, Freidinger RM, Bock MG",,34460.0,DTCT0023207,1671444,DTCC00183401,193092,4355,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1
1649,CHEMBL417350,P35368,,UNUWGGCGYVIFOC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,960.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,538119,DTCC00184094,1881760,3807,CC1=CC=CC=C1C2(CCN(CC2)CCCNC(=O)C(C3=CC=C(C=C3)F)C(C)C)C#N,Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)cc2)C(C)C)CC1
1650,CHEMBL417758,P35368,,GRHNWNVQLGTXTE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,398.11,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1266606,DTCC00105131,452343,5563,CC1=CNC(=O)N(C1=O)CC(C)(C)CN2CCN(CC2)C3=CC=CC=C3OCC(F)(F)F,Cc1c[nH]c(=O)n(CC(C)(C)CN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O
1651,CHEMBL417939,P35368,,VNNMLVMVVPXAQV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,8.21,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1130499,DTCC00203881,1946634,18073,CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCOC3=CC=CC=C3OC,COc1ccccc1OCCN(C)CCN1C(=O)CC2(CCCC2)CC1=O
1652,CHEMBL417954,P35368,,BVVTZMMHKZWLED-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,100.0,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1281162,DTCC00201723,582208,5563,C1CN(CCN1CCCN2C(=O)C(=CNC2=O)F)C3=C(C=C(C=C3)F)OCC(F)(F)F,O=c1[nH]cc(F)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1
1653,CHEMBL417999,P35368,,XQGXNWSIVZTZLW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,976118,DTCC00149082,1177868,6217,CCN1C=CC(=N1)C2=CC=CC=C2NCC3=NCCN3,CCn1ccc(-c2ccccc2NCC2=NCCN2)n1
1654,CHEMBL417999,P35368,,XQGXNWSIVZTZLW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,976121,DTCC00149082,1177868,6217,CCN1C=CC(=N1)C2=CC=CC=C2NCC3=NCCN3,CCn1ccc(-c2ccccc2NCC2=NCCN2)n1
1655,CHEMBL418112,P35368,,KYBQSIXBWBXIFN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,158.49,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1252296,DTCC00201761,1805914,5563,COC1=CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,COc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O
1656,CHEMBL41844,P35368,,DZEZXWSJRQPUTM-KDJFERLWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9857099.0,KI,=,700.0,NM,,,,,,,,,,,,,,Binding affinity was determined for the alpha-1B adrenergic receptor,,Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1998.0,41.0,26.0,"Nagarathnam D, Wetzel JM, Miao SW, Marzabadi MR, Chiu G, Wong WC, Hong X, Fang J, Forray C, Branchek TA, Heydorn WE, Chang RS, Broten T, Schorn TW, Gluchowski C",,34639.0,DTCT0023207,1439269,DTCC00184082,1694620,15010,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1657,CHEMBL41844,P35368,,DZEZXWSJRQPUTM-KDJFERLWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,700.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,515491,DTCC00184082,1692889,3807,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)OC,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(C(=O)OC)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1658,CHEMBL418531,P35368,,PQRGVSYFNXKMPS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10843225.0,KI,=,10000.0,NM,,cell_based,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor expressed in COS cell membranes,,Novel arylpiperazines as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,10.0,"Li X, Murray WV, Jolliffe L, Pulito V",,34332.0,DTCT0023207,1185575,DTCC00140614,646704,3699,CC(C)OC1=C(C=CC(=C1)F)N2CCN(CC2)CCNC(=O)CN3CCCCC3=O,CC(C)Oc1cc(F)ccc1N1CCN(CCNC(=O)CN2CCCCC2=O)CC1
1659,CHEMBL418882,P35368,,NZGIGUXZZCUKJN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,=,1878.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1015895,DTCC00220200,1370686,4980,COC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(S3)C=O,COc1ccccc1N1CCN(Cc2ccc(C=O)s2)CC1
1660,CHEMBL418926,P35368,,IPBOROXXRHATRV-IRLDBZIGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873568.0,KI,=,1400.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor was evaluated by cloned receptor binding assay,,Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivity.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Patane MA, DiPardo RM, Price RP, Chang RS, Ransom RW, O'Malley SS, Di Salvo J, Bock MG",,33013.0,DTCT0023207,1127193,DTCC00242371,356594,2771,CCOC(=O)[C@H]1CN(CC[C@@H]1C2=CC=CC=C2)CCCCN3C(=O)C4=C(S3(=O)=O)C=CC(=C4)Cl,CCOC(=O)[C@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1
1661,CHEMBL419164,P35368,,SPDFHNLNFIMTBW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,>,2000.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,453926,DTCC00267495,486555,3405,CS(=O)(=O)NC1=CC2=C(C=C1)C(=O)CC3(O2)CCN(CC3)CCC4=CC=CC=N4,CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3ccccn3)CC1)CC2=O
1662,CHEMBL419448,P35368,,FFVMPJRYEFKURT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,958957,DTCC00225632,787761,16733,CS(=O)(=O)C1=C(C=CC=C1F)NCC2=NCCN2,CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1
1663,CHEMBL419448,P35368,,FFVMPJRYEFKURT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,2290.87,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,958951,DTCC00225632,787761,16733,CS(=O)(=O)C1=C(C=CC=C1F)NCC2=NCCN2,CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1
1664,CHEMBL419448,P35368,,FFVMPJRYEFKURT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as percent maximal effect for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha1b; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218076.0,DTCT0023207,958962,DTCC00225632,787761,16733,CS(=O)(=O)C1=C(C=CC=C1F)NCC2=NCCN2,CS(=O)(=O)c1c(F)cccc1NCC1=NCCN1
1665,CHEMBL419497,P35368,,LDXAPIWITLZXNM-DEOSSOPVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,320.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34327.0,DTCT0023207,1363084,DTCC00254381,465023,15798,CN1C=C([C@@H](NC1=O)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=C(C=C4)F,CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)NC1=O
1666,CHEMBL41959,P35368,,JVWYCGQDBYDWDA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,>,3000.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,533219,DTCC00183422,75390,3807,COC(=O)C1(CCN(CC1)CCNC(=O)CCC2=CC=C(C=C2)[N+](=O)[O-])C3=CC=CC=C3,COC(=O)C1(c2ccccc2)CCN(CCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1
1667,CHEMBL419624,P35368,,RHILFWFBQHFQIB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,20000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1102335,DTCC00222279,1293657,15735,CCOC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=CC=C5)F)O,CCOc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1
1668,CHEMBL41994,P35368,,HTUPLSKAYCKZRG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,900.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,539885,DTCC00184113,1143647,3807,CC1=CC=CC=C1C2(CCN(CC2)CCCNC(=O)C(C3=CC(=C(C=C3)F)F)C(C)C)C#N,Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1
1669,CHEMBL41994,P35368,,HTUPLSKAYCKZRG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,1200.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,536067,DTCC00184113,1143645,3807,CC1=CC=CC=C1C2(CCN(CC2)CCCNC(=O)C(C3=CC(=C(C=C3)F)F)C(C)C)C#N,Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1
1670,CHEMBL41994,P35368,,HTUPLSKAYCKZRG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,1400.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,534166,DTCC00184113,1143646,3807,CC1=CC=CC=C1C2(CCN(CC2)CCCNC(=O)C(C3=CC(=C(C=C3)F)F)C(C)C)C#N,Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(F)c(F)c2)C(C)C)CC1
1671,CHEMBL41996,P35368,,GVKWLDRHBDGOOP-OAQYLSRUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,>,2000.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1528052,DTCC00183929,1013786,3808,CC1=C([C@H](CC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=N4,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
1672,CHEMBL42,P35368,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,39.81,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14758359,DTCC00134115,2109020,68596,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
1673,CHEMBL42,P35368,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,10.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329323.0,DTCT0023207,13582468,DTCC00134115,58495,39761,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
1674,CHEMBL420060,P35368,,HIHZDNKKIUQQSC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,92.0,NM,,,,,,,,,,,,,,"The compound was tested for binding affinity against Alpha-1B adrenergic receptor, from human clones.",,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34466.0,DTCT0023207,738738,DTCC00252714,1818547,13167,CC1=C(N(C(=O)N(C1=O)C)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,COc1ccccc1N1CCN(CCCNc2c(C)c(=O)n(C)c(=O)n2C)CC1
1675,CHEMBL420060,P35368,,HIHZDNKKIUQQSC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,535.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from hamster clones.,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34313.0,DTCT0023207,738739,DTCC00252714,1818547,13167,CC1=C(N(C(=O)N(C1=O)C)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,COc1ccccc1N1CCN(CCCNc2c(C)c(=O)n(C)c(=O)n2C)CC1
1676,CHEMBL420060,P35368,,HIHZDNKKIUQQSC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,39.81,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,698839,DTCC00252714,1805526,14595,CC1=C(N(C(=O)N(C1=O)C)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,COc1ccccc1N1CCN(CCCNc2c(C)c(=O)n(C)c(=O)n2C)CC1
1677,CHEMBL420060,P35368,,HIHZDNKKIUQQSC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,63.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14734692,DTCC00252714,2105338,68596,CC1=C(N(C(=O)N(C1=O)C)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,COc1ccccc1N1CCN(CCCNc2c(C)c(=O)n(C)c(=O)n2C)CC1
1678,CHEMBL420060,P35368,,HIHZDNKKIUQQSC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,125.89,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14734694,DTCC00252714,2105338,68596,CC1=C(N(C(=O)N(C1=O)C)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,COc1ccccc1N1CCN(CCCNc2c(C)c(=O)n(C)c(=O)n2C)CC1
1679,CHEMBL420060,P35368,,HIHZDNKKIUQQSC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16420037.0,KI,=,40.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14734693,DTCC00252714,2105342,68752,CC1=C(N(C(=O)N(C1=O)C)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,COc1ccccc1N1CCN(CCCNc2c(C)c(=O)n(C)c(=O)n2C)CC1
1680,CHEMBL420184,P35368,,BTAVBIPIYWDCNO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1036788,DTCC00220077,1661165,4980,COC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(S3)CN4CCCCC4=O,COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3=O)s2)CC1
1681,CHEMBL420205,P35368,,DUFHNVVBRSIXJN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,3.77,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1541215,DTCC00236184,172877,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=CC=CC=C4F,CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2F)CC1
1682,CHEMBL420205,P35368,,DUFHNVVBRSIXJN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,8.42,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1541212,DTCC00236184,172877,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=CC=CC=C4F,CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2F)CC1
1683,CHEMBL42053,P35368,,VSLQTFZJPROMOL-BDPMCISCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,>,2000.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1547075,DTCC00183724,690717,3808,CC1=C([C@H](CC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCC(C)CN3CCC(CC3)(C#N)C4=CC=CC=N4,CC1=C(C(=O)NCC(C)CN2CCC(C#N)(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
1684,CHEMBL420578,P35368,,XXDFZPIGFGKHOT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,108.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,922820,DTCC00239599,1914459,2766,CC1=CC(=C2C(=C1)N(C(=O)O2)C3CCN(CC3)CCCCN4C(=O)C5=CC=CC=C5S4(=O)=O)C,Cc1cc(C)c2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1
1685,CHEMBL420683,P35368,,FVHLKYRSFYIRKU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,880537,DTCC00290107,2046108,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CC=N3,c1ccc(-c2ccccc2OCC2=NCCN2)nc1
1686,CHEMBL420683,P35368,,FVHLKYRSFYIRKU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,IC50,=,2041.74,NM,,,,,,,,,,,,,,Binding affinity of compound towards human Alpha-1B adrenergic receptor expressed in rat fibroblast membranes,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34481.0,DTCT0023207,880542,DTCC00290107,2046108,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CC=N3,c1ccc(-c2ccccc2OCC2=NCCN2)nc1
1687,CHEMBL420683,P35368,,FVHLKYRSFYIRKU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,880538,DTCC00290107,2046108,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CC=N3,c1ccc(-c2ccccc2OCC2=NCCN2)nc1
1688,CHEMBL420683,P35368,,FVHLKYRSFYIRKU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1166712,DTCC00290107,2045647,5253,C1CN=C(N1)COC2=CC=CC=C2C3=CC=CC=N3,c1ccc(-c2ccccc2OCC2=NCCN2)nc1
1689,CHEMBL420959,P35368,,LQABNCQTZIOQJK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,49.08,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1529463,DTCC00236796,917092,16317,CC1=NN(C(=O)C(=C1C(=O)C)NCCCCN2CCN(CC2)C3=C(C=CC(=C3)Cl)OC)C,COc1ccc(Cl)cc1N1CCN(CCCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1
1690,CHEMBL420959,P35368,,LQABNCQTZIOQJK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,7.39,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1529460,DTCC00236796,917092,16317,CC1=NN(C(=O)C(=C1C(=O)C)NCCCCN2CCN(CC2)C3=C(C=CC(=C3)Cl)OC)C,COc1ccc(Cl)cc1N1CCN(CCCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1
1691,CHEMBL421011,P35368,,JQBLEBHNQPKFKG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,1995.26,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,633391,DTCC00264097,335898,4573,CCN(CC)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCN(CC)C(=O)c1ccccc1NCC1=NCCN1
1692,CHEMBL421011,P35368,,JQBLEBHNQPKFKG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,IC50,=,5888.44,NM,,,,,,,,,,,,,,Concentration required for 50% inhibition of binding against human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,34483.0,DTCT0023207,633395,DTCC00264097,335898,4573,CCN(CC)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCN(CC)C(=O)c1ccccc1NCC1=NCCN1
1693,CHEMBL421011,P35368,,JQBLEBHNQPKFKG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,32.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,633392,DTCC00264097,335898,4573,CCN(CC)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCN(CC)C(=O)c1ccccc1NCC1=NCCN1
1694,CHEMBL421011,P35368,,JQBLEBHNQPKFKG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,1995.26,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,872873,DTCC00264097,336681,5326,CCN(CC)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCN(CC)C(=O)c1ccccc1NCC1=NCCN1
1695,CHEMBL421011,P35368,,JQBLEBHNQPKFKG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,32.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,872874,DTCC00264097,336681,5326,CCN(CC)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCN(CC)C(=O)c1ccccc1NCC1=NCCN1
1696,CHEMBL421011,P35368,,JQBLEBHNQPKFKG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,=,1995.26,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1171546,DTCC00264097,336193,5253,CCN(CC)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCN(CC)C(=O)c1ccccc1NCC1=NCCN1
1697,CHEMBL421011,P35368,,JQBLEBHNQPKFKG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,MAX,=,32.0,%,,,,,,,,,,,,,,Activation of human alpha-1B-adrenoceptor receptors expressed in rat-1 fibroblasts as percent maximal effect relative to phenylephrine,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32512.0,DTCT0023207,1171547,DTCC00264097,336193,5253,CCN(CC)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCN(CC)C(=O)c1ccccc1NCC1=NCCN1
1698,CHEMBL421098,P35368,,HQIAPQIELKADEN-ZTKZIYFRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1395605,DTCC00299857,1883186,17528,CC(C)NC1=CC(=O)C(=C(C1=O)CC(=O)NCC2=CC=C(C=C2)C(=N)N)C3=CC=CC=C3,CC(C)NC1=CC(=O)C(c2ccccc2)=C(CC(=O)NCc2ccc(C(=N)N)cc2)C1=O
1699,CHEMBL421297,P35368,,GNTLDZVFSGMZMM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,=,615.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1025946,DTCC00220451,852981,4980,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=CS3)CN4CCCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCCC3=O)cs2)CC1
1700,CHEMBL421324,P35368,,DSMKEQAYQKRDDL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11055359.0,KI,=,4456.0,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards COS cell membrane expressing the human Alpha-1B adrenergic receptor,,Novel heterocycles as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,20.0,"Li X, McCoy KA, Murray WV, Jolliffe L, Pulito V",,34342.0,DTCT0023207,915158,DTCC00235244,873960,3968,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NOC(=C3)CN4CCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)on2)CC1
1701,CHEMBL42156,P35368,,PHYBBVYOJUKUNL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,910.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,528593,DTCC00184211,269407,3807,COC(=O)C1(CCN(CC1)CCCNC(=O)CCC2=CC=C(C=C2)[N+](=O)[O-])C3=CC=CC=C3,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)CCc2ccc([N+](=O)[O-])cc2)CC1
1702,CHEMBL42220,P35368,,CGCLDRKORPAFBZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,570.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,537105,DTCC00184244,755119,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4OC,COc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2ccc(C)cc2)c2ccc(C)cc2)CC1
1703,CHEMBL42231,P35368,,BJGAWQMDTQOSCU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11931617.0,KI,=,12.3,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,2002.0,45.0,8.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Gentili F, Marucci G, Carrieri A, Carotti A, Poggesi E, Leonardi A, Melchiorre C",,34488.0,DTCT0023207,1630760,DTCC00184524,1195713,17220,COC1=C(C(=CC=C1)OC)OCCNCC2CC(C3=CC=CC=C3C2)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1Cc2ccccc2C(c2ccccc2)C1
1704,CHEMBL422477,P35368,,IVWFVGKPGDSCOS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,=,15.85,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,891931,DTCC00329271,205898,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CSC=C3,c1ccc(-c2ccsc2)c(OCC2=NCCN2)c1
1705,CHEMBL422477,P35368,,IVWFVGKPGDSCOS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,=,103.0,%,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts by calcium mobilization of Gq coupled PLC as percent phenylephrine (40 uM) response,,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34468.0,DTCT0023207,891932,DTCC00329271,205898,5326,C1CN=C(N1)COC2=CC=CC=C2C3=CSC=C3,c1ccc(-c2ccsc2)c(OCC2=NCCN2)c1
1706,CHEMBL423018,P35368,,XFNOYNVDQOQPCY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14584940.0,KI,=,79.43,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity measured in CHO cells expressing human cloned Alpha-1B adrenergic receptor expressed as pKi,,Prazosin-related compounds. Effect of transforming the piperazinylquinazoline moiety into an aminomethyltetrahydroacridine system on the affinity for alpha1-adrenoreceptors.,J. Med. Chem.,2003.0,46.0,23.0,"Rosini M, Antonello A, Cavalli A, Bolognesi ML, Minarini A, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34609.0,DTCT0023207,1631885,DTCC00332191,745352,17579,COC1=C(C=C2C(=C1)C(=C3CC(CC3=N2)CNC(=O)C4=CC=CO4)N)OC,COc1cc2nc3c(c(N)c2cc1OC)CC(CNC(=O)c1ccco1)C3
1707,CHEMBL423294,P35368,CYCLAZOSIN,XBRXTUGRUXGBPX-DLBZAZTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8917649.0,KI,=,0.309,NM,,,,,,,,,,,,,,Compound was tested for binding affinity against cloned Alpha-1B adrenergic receptor from hamster smooth muscle using radioligand ([3H]prazosin) binding assay,,"Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.",J. Med. Chem.,1996.0,39.0,23.0,"Giardinà D, Crucianelli M, Romanelli R, Leonardi A, Poggesi E, Melchiorre C",,34317.0,DTCT0023207,1439799,DTCC00159953,918135,13894,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5=CC=CO5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
1708,CHEMBL423294,P35368,CYCLAZOSIN,XBRXTUGRUXGBPX-DLBZAZTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,0.2,NM,,,,,,,,,,,,,,Binding affinity was tested on cloned hamster Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34316.0,DTCT0023207,729041,DTCC00159953,905553,14595,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5=CC=CO5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
1709,CHEMBL423294,P35368,CYCLAZOSIN,XBRXTUGRUXGBPX-DLBZAZTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17276073.0,KI,=,0.135,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic alpha-1b receptor expressed in CHO cells,,Synthesis and alpha(1)-adrenoceptor antagonist activity of derivatives and isosters of the furan portion of (+)-cyclazosin.,Bioorg. Med. Chem.,2007.0,15.0,6.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Leonardi A, Poggesi E, Giardinà D",,442028.0,DTCT0023207,2146110,DTCC00159953,909030,23212,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5=CC=CO5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
1710,CHEMBL423294,P35368,CYCLAZOSIN,XBRXTUGRUXGBPX-DLBZAZTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19719240.0,KI,=,0.324,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.,J. Med. Chem.,2009.0,52.0,15.0,"Giardinà D, Martarelli D, Sagratini G, Angeli P, Ballinari D, Gulini U, Melchiorre C, Poggesi E, Pompei P",,574169.0,DTCT0023207,2880171,DTCC00159953,920985,34689,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5=CC=CO5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
1711,CHEMBL42335,P35368,,KAXNWVHHUKHNDK-JOCHJYFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,>,2000.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1523620,DTCC00183905,1370301,3808,CC1=C([C@H](CC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=C(C=C(C=C4)F)C#N,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
1712,CHEMBL423540,P35368,,YFKSJPJLKCHZEX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,13678408.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory activity against thrombin was determined,,Synthesis and crystal structures of substituted benzenes and benzoquinones as tissue factor VIIa inhibitors.,J. Med. Chem.,2003.0,46.0,20.0,"Parlow JJ, Stevens AM, Stegeman RA, Stallings WC, Kurumbail RG, South MS",,210605.0,DTCT0023207,1377109,DTCC00319307,1208437,17528,CN(C)C1=CC=C(C=C1)CNC(=O)C2=C(C=CC(=C2)NS(=O)(=O)CC3=CC=CC=C3)SC4=CC=CC=C4,CN(C)c1ccc(CNC(=O)c2cc(NS(=O)(=O)Cc3ccccc3)ccc2Sc2ccccc2)cc1
1713,CHEMBL42361,P35368,,XAMUVRYPQULOBI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,1200.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,521753,DTCC00184170,1046210,3807,CC(C)C(C1=CC=CC=C1)C(=O)NCCCN2CCC(CC2)(C#N)C3=CC=CC=C3,CC(C)C(C(=O)NCCCN1CCC(C#N)(c2ccccc2)CC1)c1ccccc1
1714,CHEMBL424494,P35368,,VOWPOPUYBMDWNA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579841.0,KI,=,410.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moiety.,J. Med. Chem.,1999.0,42.0,23.0,"Murali Dhar TG, Nagarathnam D, Marzabadi MR, Lagu B, Wong WC, Chiu G, Tyagarajan S, Miao SW, Zhang F, Sun W, Tian D, Shen Q, Zhang J, Wetzel JM, Forray C, Chang RS, Broten TP, Schorn TW, Chen TB, O'Malley S, Ransom R, Schneck K, Bendesky R, Harrell CM, Vyas KP",,34458.0,DTCT0023207,786895,DTCC00330961,1371958,15485,CC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCC3(CCC4=CC=CC=C43)CC2)C5=CC(=C(C=C5)F)F)C(=O)OC,COC(=O)C1=C(C)NC(=O)N(C(=O)NCCCN2CCC3(CCc4ccccc43)CC2)C1c1ccc(F)c(F)c1
1715,CHEMBL424658,P35368,,FTDBTBLFOYBMNU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9986714.0,KI,=,4.43,NM,,,,,,,,,,,,,,The binding affinity towards Alpha-1B adrenergic receptor in the COS cell line.,,"Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.",J. Med. Chem.,1999.0,42.0,3.0,"Leonardi A, Motta G, Boi C, Testa R, Poggesi E, De Benedetti PG, Menziani MC",,32304.0,DTCT0023207,1345648,DTCC00320564,1273982,15565,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)CCC(=O)C4=CC=CC=C4)N)OC,COc1cc2nc(N3CCN(C(=O)CCC(=O)c4ccccc4)CC3)nc(N)c2cc1OC
1716,CHEMBL42472,P35368,,DASDCIRXSWKVTA-RBBKRZOGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11931617.0,KI,=,0.0398,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,2002.0,45.0,8.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Gentili F, Marucci G, Carrieri A, Carotti A, Poggesi E, Leonardi A, Melchiorre C",,34488.0,DTCT0023207,1606498,DTCC00184504,1423489,17220,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2C[C@@H](C3=CC=CC=C3O2)C4=CC=CC=C4,COc1cccc(OC)c1OCCNC[C@@H]1C[C@H](c2ccccc2)c2ccccc2O1
1717,CHEMBL42514,P35368,,IDZICZAULARHJJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,680.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,530396,DTCC00184143,28838,3807,CC1=CC=CC=C1C2(CCN(CC2)CCCNC(=O)C(C3=CC(=CC=C3)F)C(C)C)C#N,Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C(c2cccc(F)c2)C(C)C)CC1
1718,CHEMBL425190,P35368,SB-714786,RMCSKUADBRROSI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15887956.0,KI,=,1000.0,NM,,,,,,,,,,,,,,Binding affinity for human alpha-1B adrenergic receptor ,,"Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist.",J. Med. Chem.,2005.0,48.0,10.0,"Ward SE, Harrington FP, Gordon LJ, Hopley SC, Scott CM, Watson JM",,304013.0,DTCT0023207,1828127,DTCC00001076,908444,19205,CC1=NC2=C(C=C1)C(=CC=C2)OCCN3CCN(CC3)CC4=CC=CC5=C4N=CC=C5,Cc1ccc2c(OCCN3CCN(Cc4cccc5cccnc45)CC3)cccc2n1
1719,CHEMBL42539,P35368,,UNHGFWKSHHCRHF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8667368.0,KI,=,51.38,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor hamster smooth muscle using [3H]prazosin as radioligand,,"Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.",J. Med. Chem.,1996.0,39.0,11.0,"Quaglia W, Pigini M, Tayebati SK, Piergentili A, Giannella M, Leonardi A, Taddei C, Melchiorre C",,34320.0,DTCT0023207,1140302,DTCC00104652,1326258,13601,CC1=CC=C(C=C1)C2C(OC3=CC=CC=C3O2)CNCCOC4=C(C=CC=C4OC)OC,COc1cccc(OC)c1OCCNCC1Oc2ccccc2OC1c1ccc(C)cc1
1720,CHEMBL42558,P35368,,ONMIMCVGCGOVHM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11931617.0,KI,=,2.82,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,2002.0,45.0,8.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Gentili F, Marucci G, Carrieri A, Carotti A, Poggesi E, Leonardi A, Melchiorre C",,34488.0,DTCT0023207,1613939,DTCC00184965,679311,17220,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2CC3=CC=CC=C3,COc1cccc(OC)c1OCCNCCOc1ccccc1Cc1ccccc1
1721,CHEMBL426317,P35368,,PGGCRGAETLNAJC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16458504.0,KI,=,378.0,NM,,,,,,,,,,,,,,Binding affinity to alpha 1B adrenergic receptor by radioligand binding assay,,"Synthesis, in vitro and in vivo evaluation of [O-methyl-11C] 2-{4-[4-(3-methoxyphenyl)piperazin-1-yl]-butyl}-4-methyl-2H-[1,2,4]-triazine-3,5-dione: a novel agonist 5-HT1A receptor PET ligand.",Bioorg. Med. Chem. Lett.,2006.0,16.0,8.0,"Prabhakaran J, Parsey RV, Majo VJ, Hsiung SC, Milak MS, Tamir H, Simpson NR, Van Heertum RL, Mann JJ, Dileep Kumar JS",,346847.0,DTCT0023207,1918081,DTCC00419919,661040,20646,CN1C(=O)C=NN(C1=O)CCCCN2CCN(CC2)C3=CC(=CC=C3)OC,COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1
1722,CHEMBL42640,P35368,,QUEBXCYEKJNKLS-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,=,330.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1524607,DTCC00184235,464243,3808,CC1=C([C@H](CC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=CC=C4C#N,CC1=C(C(=O)NCCCN2CCC(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
1723,CHEMBL427552,P35368,,UKNCZUARTFPATM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,2.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870355,DTCC00409486,2014773,20070,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC(=CC=C3)OC,COc1cccc(COc2ccccc2OCCNCCOc2c(OC)cccc2OC)c1
1724,CHEMBL42763,P35368,,ORUJCINTLKUHJM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,1900.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,455650,DTCC00184128,1946386,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4C(F)(F)F,Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C(F)(F)F)CC2)c2ccc(C)cc2)cc1
1725,CHEMBL428197,P35368,,VZKPTHAFKKTYRC-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,301.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166109,DTCC00464314,408406,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=CC=C(C=C4)F,CC(C)Oc1ccccc1N1CCN(C2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)CC1
1726,CHEMBL429076,P35368,,MDOKTLACQIDXQG-HZCBDIJESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,131.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166093,DTCC00464350,1247671,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)Br)OC,COc1ccc(Br)cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
1727,CHEMBL429453,P35368,,LVRHAAKFXRNPFH-PSWAGMNNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,326.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195243,DTCC00111807,924597,23970,CCN(C1CCC(CC1)N2CCN(CC2)C3=CC=CC=C3OC(C)C)S(=O)(=O)C4=CC(=C(C=C4)OC)OC,CCN(C1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1
1728,CHEMBL429458,P35368,,OXAGECQHLDNVCY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214276,DTCC00473052,1841331,24162,C1CCN(C1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F.C(=O)O,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OCCCN3CCCC3)cc2)C(=O)C1
1729,CHEMBL429623,P35368,,FFXLCCZAXLBJFW-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,85.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166090,DTCC00464358,989161,23441,CC(C)OC1=CC=CC=C1N2CCN(CC2)C3CCC(CC3)NS(=O)(=O)C4=C(C=CC(=C4)[N+](=O)[O-])OC,COc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1
1730,CHEMBL429697,P35368,,FPRCXYVVQHMAFI-GNMOFYLKSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,350.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,623524,DTCC00204561,1174984,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@@H]2CC[C@H](C2)N3CCC(CC3)C4=CC=CC=N4)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1
1731,CHEMBL430368,P35368,,BKLPUYQJSHHECO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214256,DTCC00473104,1491100,24162,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC(=CC(=C4)F)F.C(=O)O,CC(C)N1CCC(Oc2ccc(N3CCN(C(=O)c4cc(F)cc(F)c4)CC3=O)cc2)CC1
1732,CHEMBL43048,P35368,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12761331.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14730538,DTCC00186878,2104160,68767,CC(CC1=CC2=C(C=C1)OCO2)NC,CNC(C)Cc1ccc2c(c1)OCO2
1733,CHEMBL430706,P35368,,CKOGHPCHAYJBFY-JOCHJYFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12392747.0,KI,=,1.29,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties.,Bioorg. Med. Chem. Lett.,2002.0,12.0,22.0,"Forbes IT, Douglas S, Gribble AD, Ife RJ, Lightfoot AP, Garner AE, Riley GJ, Jeffrey P, Stevens AJ, Stean TO, Thomas DR",,34624.0,DTCT0023207,1567002,DTCC00285707,756213,5235,C1C[C@@H](N(C1)S(=O)(=O)C2=CC3=C(C=C2)C=CN3)CCN4CCC(CC4)C5=CNC6=CC=CC=C65,O=S(=O)(c1ccc2cc[nH]c2c1)N1CCC[C@@H]1CCN1CCC(c2c[nH]c3ccccc23)CC1
1734,CHEMBL430717,P35368,,ZZMFJJDBKSYGRM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,IC50,=,1.2,NM,,,,,,,,,,,,,,Binding affinity was tested on cloned hamster Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34196.0,DTCT0023207,725370,DTCC00159868,128090,14595,CC(C)C1=C(C(=CC=C1)OC)OCC(=O)N2CCN(CC2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC
1735,CHEMBL430717,P35368,,ZZMFJJDBKSYGRM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9986714.0,KI,=,0.45,NM,,,,,,,,,,,,,,The binding affinity towards Alpha-1B adrenergic receptor in the COS cell line.,,"Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.",J. Med. Chem.,1999.0,42.0,3.0,"Leonardi A, Motta G, Boi C, Testa R, Poggesi E, De Benedetti PG, Menziani MC",,32304.0,DTCT0023207,1341643,DTCC00159868,141554,15565,CC(C)C1=C(C(=CC=C1)OC)OCC(=O)N2CCN(CC2)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N3CCN(C(=O)COc4c(OC)cccc4C(C)C)CC3)nc(N)c2cc1OC
1736,CHEMBL43116,P35368,,ZQKYJYUHIBOEHV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,LOG KI,=,9.27,NM,,cell_based,,,,,,,,,,,,The binding affinity was evaluated on cloned human Alpha-1B adrenergic receptor expressed in chinese hamster ovary(CHO) cells by using [3H]prazosin as radioligand.,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34621.0,DTCT0023207,1011132,DTCC00184847,291657,15289,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1
1737,CHEMBL43116,P35368,,ZQKYJYUHIBOEHV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,PKB,=,7.87,,,,,,,,,,,,,,,Antagonist affinity was expressed as apparent pKb at Alpha-1B adrenergic receptor on isolated Guinea pig spleen (Alpha-1B),,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34193.0,DTCT0023207,1011136,DTCC00184847,291657,15289,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1
1738,CHEMBL43116,P35368,,ZQKYJYUHIBOEHV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,0.537,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870348,DTCC00184847,304959,20070,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1
1739,CHEMBL43116,P35368,,ZQKYJYUHIBOEHV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20801662.0,KI,=,0.537,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human adrenergic Alpha-1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel a1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and a1d computational study.",Bioorg. Med. Chem.,2010.0,18.0,19.0,"Carrieri A, Piergentili A, Del Bello F, Giannella M, Pigini M, Leonardi A, Fanelli F, Quaglia W",,663468.0,DTCT0023207,3496707,DTCC00184847,292691,40937,COC1=C(C(=CC=C1)OC)OCCNCCOC2=CC=CC=C2OCC3=CC=CC=C3,COc1cccc(OC)c1OCCNCCOc1ccccc1OCc1ccccc1
1740,CHEMBL431298,P35368,SB-271046,LOCQRDBFWSXQQI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11992776.0,KI,=,1995.26,NM,,,,,,,,,,,,,,The compound was tested for the binding affinity towards Alpha-1B adrenergic receptor,,Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,10.0,"Bromidge SM, Clarke SE, King FD, Lovell PJ, Newman H, Riley G, Routledge C, Serafinowska HT, Smith DR, Thomas DR",,34623.0,DTCT0023207,684623,DTCC01739329,323024,4854,CC1=C(SC2=C1C=C(C=C2)Cl)S(=O)(=O)NC3=CC(=C(C=C3)OC)N4CCNCC4,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1
1741,CHEMBL431354,P35368,,JBWGJAYPUVCZHV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,168.28,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1117202,DTCC00204652,1628993,18073,CC1=CC(=C(C=C1)C)N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,Cc1ccc(C)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1
1742,CHEMBL431357,P35368,,ZKXYOSOZCXVQNK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1131873,DTCC00204026,172525,18073,CN(CCCN(C)C1=C(C=CC(=C1)Cl)Cl)CCN2C(=O)CC3(CCCC3)CC2=O,CN(CCCN(C)c1cc(Cl)ccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O
1743,CHEMBL431362,P35368,,IQRXOCGLSGCNLE-VWLOTQADSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,1650.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1116887,DTCC00222210,1163563,15735,CC1=CC=C(C=C1)N2C(=O)C3=C(C2=O)C=C(C=C3)C(=O)NC[C@@H](CN4CCN(CC4)C5=CC=CC=C5OC(C)C)O,Cc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1
1744,CHEMBL431367,P35368,ROXINDOLE,HGEYJZMMUGWEOT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,2.82,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14742490,DTCC00223728,2108071,69012,C1CN(CC=C1C2=CC=CC=C2)CCCCC3=CNC4=C3C=C(C=C4)O,Oc1ccc2[nH]cc(CCCCN3CC=C(c4ccccc4)CC3)c2c1
1745,CHEMBL431631,P35368,,QBFJWYVQWOPOQH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,175.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,502392,DTCC00267611,1806616,3405,COC1=CC=CC=C1CCN2CCC3(CC2)CC(=O)C4=C(O3)C=C(C=C4)NS(=O)(=O)C,COc1ccccc1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2
1746,CHEMBL431720,P35368,,YWCSJTNACFIWMO-LAUBAEHRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,1.32,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1272582,DTCC00208680,1423746,16272,CC1=C(C2=C(C=C1)C(=O)N(C(=O)N2)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC)C,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)c(C)ccc4c3=O)C[C@@H]21
1747,CHEMBL431943,P35368,,NEUNGUZCDMOARR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,57.65,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1129299,DTCC00204436,302676,18073,C1CCC2(CC1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4Cl,O=C1CC2(CCCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1
1748,CHEMBL432,P35368,,SFLSHLFXELFNJZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,2511.89,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14730726,DTCC00133866,2104168,68596,C1=CC(=C(C=C1C(CN)O)O)O,NCC(O)c1ccc(O)c(O)c1
1749,CHEMBL432,P35368,,SFLSHLFXELFNJZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12065700.0,KI,=,7585.78,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14730625,DTCC00133866,2104181,69360,C1=CC(=C(C=C1C(CN)O)O)O,NCC(O)c1ccc(O)c(O)c1
1750,CHEMBL432026,P35368,,NTTOSPBYGRNOJQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,36.3,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1222225,DTCC00262929,1163999,3366,CCC1=C(C(C(=C(N1)COCCN)C(=O)N)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,CCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(N)=O)=C(COCCN)N1
1751,CHEMBL432147,P35368,,DQYOZIINFGPXBN-KBXCAEBGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,3.1,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1272578,DTCC00208883,550166,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=NC=C5)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cnccc4c3=O)C[C@@H]21
1752,CHEMBL432192,P35368,,BBAKYBVOEXDMMA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,619887,DTCC00264130,205142,4573,CCC(C)NC(=O)C1=CC=CC=C1NCC2=NCCN2,CCC(C)NC(=O)c1ccccc1NCC1=NCCN1
1753,CHEMBL432302,P35368,,IMPIFDDTYWWFKQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,539882,DTCC00184656,1239719,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=N4,Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccn3)CC2)c2ccc(C)cc2)cc1
1754,CHEMBL432947,P35368,,SSVDRIUIQGHMLI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,37.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,914899,DTCC00240024,594324,2766,CC1=CC2=C(C=C1)OC(=O)N2C3CCN(CC3)CCCCN4C(=O)C5=CC=CC=C5S4(=O)=O,Cc1ccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c2c1
1755,CHEMBL433014,P35368,,VFAAIQVGFDCSDY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,61.66,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1572516,DTCC00264810,627098,17389,CCOC1=CC=CC=C1N2CCN(CC2)CCN3C=NC4=C(C3=O)NC5=CC=CC=C54,CCOc1ccccc1N1CCN(CCn2cnc3c([nH]c4ccccc43)c2=O)CC1
1756,CHEMBL433203,P35368,,LJYQENYAAXKGDW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,13.8,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1586893,DTCC00264432,76264,17389,COC1=CC=CC=C1N2CCN(CC2)CCN3C=NC4=C(C3=O)NC5=CC=CC=C54,COc1ccccc1N1CCN(CCn2cnc3c([nH]c4ccccc43)c2=O)CC1
1757,CHEMBL433284,P35368,,UMVYPFAJDLQOIO-MRJKTFCFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,210.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,648986,DTCC00204562,2044755,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@@H]2CC[C@H](C2)N3CCC(CC3)(C#N)C4=CC=CC=C4)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCC(C#N)(c4ccccc4)CC3)C2)C(=O)N1
1758,CHEMBL433832,P35368,,JWAHBXONODWUEH-BOSRLCDASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,36.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,619906,DTCC00204619,1785089,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@H]2CC[C@@H](C2)N3CCC(CC3)C4=CC=CC=C4C#N)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4C#N)CC3)C2)C(=O)N1
1759,CHEMBL434074,P35368,,VMGZXQADEXNHID-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,=,69.18,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,979634,DTCC00344972,809858,5345,CC1=NC(=CS1)C2=CC=CC=C2NCC3=NCCN3,Cc1nc(-c2ccccc2NCC2=NCCN2)cs1
1760,CHEMBL434228,P35368,,PXWNTBGUQKWMOQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9986714.0,KI,=,5.43,NM,,,,,,,,,,,,,,The binding affinity towards Alpha-1B adrenergic receptor in the COS cell line.,,"Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.",J. Med. Chem.,1999.0,42.0,3.0,"Leonardi A, Motta G, Boi C, Testa R, Poggesi E, De Benedetti PG, Menziani MC",,32304.0,DTCT0023207,1335627,DTCC00320588,369205,15565,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)CC(=O)C4=CC=CC=C4)N)OC,COc1cc2nc(N3CCN(C(=O)CC(=O)c4ccccc4)CC3)nc(N)c2cc1OC
1761,CHEMBL43491,P35368,,RQTZTSPFFYDZKA-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,=,100.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1533990,DTCC00184027,819673,3808,CC1=C([C@H](CC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=C(C=C(C=C4)F)C#N,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
1762,CHEMBL435576,P35368,,CQRJIWLCJUYMPE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,23.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,540849,DTCC00184653,302435,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCN(CC3)C4=CC=CC=C4,Cc1ccc(C(C(=O)NCCCN2CCN(c3ccccc3)CC2)c2ccc(C)cc2)cc1
1763,CHEMBL43594,P35368,,LEVRYVCMBBJQLU-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,>,2000.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1538631,DTCC00183949,302437,3808,CC1=C([C@H](CC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=C(C=C(C=C4)F)C#N,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
1764,CHEMBL436407,P35368,,JYFJUOGHGPLWFO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,34.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,527843,DTCC00330724,141658,15470,CC1=C(C(N(C(=N1)C)CCCCCN2CCN(CC2)C3=CC=CC=C3C(=O)OC)C4=CC(=C(C=C4)F)F)C(=O)OC,COC(=O)C1=C(C)N=C(C)N(CCCCCN2CCN(c3ccccc3C(=O)OC)CC2)C1c1ccc(F)c(F)c1
1765,CHEMBL43651,P35368,,SETQMFVPTQZLOH-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,>,2000.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1524610,DTCC00183894,172309,3808,CC1=C([C@H](CC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4C#N,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1C
1766,CHEMBL436760,P35368,BROMOTOPSENTIN,YHGQVXFIJGWOFP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,740.0,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster Alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone),,,Bioorg. Med. Chem. Lett.,1996.0,6.0,17.0,,,32894.0,DTCT0023207,1295658,DTCC00407616,1649665,1778,C1=CC2=C(C=C1O)NC=C2C(=O)C3=NC=C(N3)C4=CNC5=C4C=CC(=C5)Br,O=C(c1ncc(-c2c[nH]c3cc(Br)ccc23)[nH]1)c1c[nH]c2cc(O)ccc12
1767,CHEMBL436955,P35368,,FVVZSOKZMFBYMX-GMUIIQOCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,426.58,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993377,DTCC00435700,1619921,21490,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC3=CC4=CC=CC=C4C=C3O2.Cl,COc1cccc(OC)c1OCCNC[C@@H]1COc2cc3ccccc3cc2O1
1768,CHEMBL43749,P35368,,CWPRAFYRGKYFIO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,3300.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,543533,DTCC00183921,1111407,3807,COC(=O)C1(CCN(CC1)CCCNC(=O)CC2=CC=C(C=C2)[N+](=O)[O-])C3=CC=CC=C3,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc([N+](=O)[O-])cc2)CC1
1769,CHEMBL43799,P35368,,RLWVXIUJPCHTSK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,>,3000.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,526567,DTCC00183749,2076570,3807,CC1=CC=C(C=C1)CC(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1
1770,CHEMBL43799,P35368,,RLWVXIUJPCHTSK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11459670.0,KI,>,3000.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards cloned human Alpha-1B adrenergic receptor,,Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2001.0,11.0,14.0,"DiPardo RM, Patane MA, Newton RC, Price R, Broten TP, Chang RS, Ransom RW, Di Salvo J, Freidinger RM, Bock MG",,34460.0,DTCT0023207,1668849,DTCC00183749,2065231,4355,CC1=CC=C(C=C1)CC(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)Cc2ccc(C)cc2)CC1
1771,CHEMBL43860,P35368,,FKKPXTRMLVLGJG-JOCHJYFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,=,37.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1543382,DTCC00184030,1402715,3808,CC1=C([C@H](CC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
1772,CHEMBL438673,P35368,,KBDQCTAMVLZQJL-BGYRXZFFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,86.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195232,DTCC00466779,1345711,23970,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCN(CC3)C4=CC=CC=C4OCC(F)(F)F)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC
1773,CHEMBL43905,P35368,,JGLLHUJRQIQLNY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11931617.0,KI,=,1.15,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,2002.0,45.0,8.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Gentili F, Marucci G, Carrieri A, Carotti A, Poggesi E, Leonardi A, Melchiorre C",,34488.0,DTCT0023207,1624210,DTCC00184501,1649331,17220,COC1=C(C(=CC=C1)OC)OCCNCC2CC(C3=CC=CC=C3S2)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2S1
1774,CHEMBL439197,P35368,,PPAIEDLGYFCKEB-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,92.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104172,DTCC00454837,175168,22924,C1CC(CCC1NS(=O)(=O)C2=CC3=C(C=C2)OCCO3)N4CCC(CC4)C5=CC=CC=C5OCC(F)(F)F,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2
1775,CHEMBL439346,P35368,,JQLOQIYDEYNBTQ-UNTBIKODSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17125266.0,KI,=,85.11,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human adrenergic alpha 1B receptor expressed in CHO cells,,"WB4101-related compounds: new, subtype-selective alpha1-adrenoreceptor antagonists (or inverse agonists?).",J. Med. Chem.,2006.0,49.0,24.0,"Pallavicini M, Budriesi R, Fumagalli L, Ioan P, Chiarini A, Bolchi C, Ugenti MP, Colleoni S, Gobbi M, Valoti E",,412941.0,DTCT0023207,1993375,DTCC00435716,1263542,21490,COC1=C(C2=CC=CC=C2C=C1)OCCNC[C@@H]3COC4=CC=CC=C4O3.Cl,COc1ccc2ccccc2c1OCCNC[C@@H]1COc2ccccc2O1
1776,CHEMBL439822,P35368,,VNALJYKFTZMOJJ-PDGQHHTCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1013403,DTCC00344877,551800,5345,CC/C(=N/OC)/C1=CC=CC=C1NCC2=NCCN2,CC/C(=N/OC)c1ccccc1NCC1=NCCN1
1777,CHEMBL440118,P35368,,OHZRADJFNIULBZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,37.57,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1113560,DTCC00204274,1174982,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCC(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2cc(Cl)ccc2Cl)CC1
1778,CHEMBL44042,P35368,,ZJHCRGOBWWAXOV-JOCHJYFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937710.0,KI,>,2000.0,NM,,,,,,,,,,,,,,In vitro antagonism at Alpha-1B adrenergic receptor,,"Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.",Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Nantermet PG, Barrow JC, Selnick HG, Homnick CF, Freidinger RM, Chang RS, O'Malley SS, Reiss DR, Broten TP, Ransom RW, Pettibone DJ, Olah T, Forray C",,32300.0,DTCT0023207,1538638,DTCC00183922,432795,3808,CC1=C([C@H](CC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4C#N,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccccc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)CC(=O)N1
1779,CHEMBL440499,P35368,,OALIYDQKZULGGT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11055359.0,KI,=,3080.0,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards COS cell membrane expressing the human Alpha-1B adrenergic receptor,,Novel heterocycles as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,20.0,"Li X, McCoy KA, Murray WV, Jolliffe L, Pulito V",,34342.0,DTCT0023207,911643,DTCC00234415,906391,3968,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NN(C(=C3)CN4CCCCC4=O)C,CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)n(C)n2)CC1
1780,CHEMBL440865,P35368,,KFPKZTLATJJXHG-WMLDXEAASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,0.92,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1250503,DTCC00105358,1423747,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=CC=C5Cl)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(Cl)c4c3=O)C[C@@H]21
1781,CHEMBL44124,P35368,,SEKGPRMGBHNTFK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,537099,DTCC00184217,1370300,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4,Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1
1782,CHEMBL44124,P35368,,SEKGPRMGBHNTFK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11459670.0,KI,>,2000.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards cloned human Alpha-1B adrenergic receptor,,Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2001.0,11.0,14.0,"DiPardo RM, Patane MA, Newton RC, Price R, Broten TP, Chang RS, Ransom RW, Di Salvo J, Freidinger RM, Bock MG",,34460.0,DTCT0023207,1670238,DTCC00184217,1358836,4355,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4,Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1
1783,CHEMBL441412,P35368,,XEIJZOXXUFREDJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,EC50,<,100000.0,NM,,cell_based,,,,,,,,,,,,"Agonism of human alpha-1B adrenergic receptor, expressed in rat 1 fibroblast cells",,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34478.0,DTCT0023207,953178,DTCC00149088,1725628,6217,CC1=CC=C(N1C)C2=CC=CC=C2NCC3=NCCN3,Cc1ccc(-c2ccccc2NCC2=NCCN2)n1C
1784,CHEMBL441412,P35368,,XEIJZOXXUFREDJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12643939.0,MAX RESPONSE,=,0.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to human alpha-1B adrenergic receptor compared to percent of the 40 mM phenylephrine response.,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,2003.0,13.0,6.0,"Speake JD, Navas F, Bishop MJ, Garrison DT, Bigham EC, Hodson SJ, Saussy DL, Liacos JA, Irving PE, Sherman BW",,34470.0,DTCT0023207,953181,DTCC00149088,1725628,6217,CC1=CC=C(N1C)C2=CC=CC=C2NCC3=NCCN3,Cc1ccc(-c2ccccc2NCC2=NCCN2)n1C
1785,CHEMBL442059,P35368,,WDZOSSNSOBKEMP-OYRHEFFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,216.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104170,DTCC00454840,175169,22924,COC1=C(C=C(C=C1)Cl)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCC(F)(F)F,COc1ccc(Cl)cc1S(=O)(=O)NC1CCC(N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1
1786,CHEMBL44288,P35368,,HUIYDWXIISSZPP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,570.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,515488,DTCC00183858,916443,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C(=O)N,Cc1ccc(C(C(=O)NCCCN2CCC(C(N)=O)(c3ccccc3)CC2)c2ccc(C)cc2)cc1
1787,CHEMBL44294,P35368,,CXSHNGLATCDICJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,280.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,533222,DTCC00104641,1337739,3807,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4Cl,Cc1ccc(C(C(=O)NCCCN2CCC(C#N)(c3ccccc3Cl)CC2)c2ccc(C)cc2)cc1
1788,CHEMBL44403,P35368,,UZPNDQMXOWZSMG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11931617.0,KI,=,1.23,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant on CHO cells expressing Human recombinant Alpha-1B adrenergic receptor,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,2002.0,45.0,8.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Gentili F, Marucci G, Carrieri A, Carotti A, Poggesi E, Leonardi A, Melchiorre C",,34488.0,DTCT0023207,1626929,DTCC00184827,905794,17220,COC1=C(C(=CC=C1)OC)OCCNCC2CC(C3=CC=CC=C3C2=O)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1CC(c2ccccc2)c2ccccc2C1=O
1789,CHEMBL444590,P35368,,KKPMYWNQZNRGIK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11728188.0,KI,=,7.88,NM,,,,,,,,,,,,,,Binding affinity was determined on human cloned alpha-1B adrenergic receptor,,"trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.",J. Med. Chem.,2001.0,44.0,25.0,"Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R",,34339.0,DTCT0023207,1462092,DTCC00281278,270974,16537,COC1=CC=CC2=C1CCCC2CCCN3CCN(CC3)C4=CC=CC=N4,COc1cccc2c1CCCC2CCCN1CCN(c2ccccn2)CC1
1790,CHEMBL444648,P35368,,ZKCCIZZQIDHSIW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,1949.84,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534299,DTCC00116826,1727550,41150,CCOC(=O)CN1C(=O)C(N(C1=O)CC(CN2CCN(CC2)C3=CC=CC=C3OC)O)(C4=CC=CC=C4)C5=CC=CC=C5,CCOC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O
1791,CHEMBL44496,P35368,,HPZXFJLEWNDGNJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10937709.0,KI,=,1700.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]HEAT to cloned human alpha-1B adrenergic receptor.,,Phenylacetamides as selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,15.0,"Patane MA, DiPardo RM, Newton RC, Price RP, Broten TP, Chang RS, Ransom RW, Di Salvo J, Nagarathnam D, Forray C, Gluchowski C, Bock MG",,34344.0,DTCT0023207,525706,DTCC00183771,819669,3807,CC(C1=CC=C(C=C1)[N+](=O)[O-])C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C(=O)OC,COC(=O)C1(c2ccccc2)CCN(CCCNC(=O)C(C)c2ccc([N+](=O)[O-])cc2)CC1
1792,CHEMBL445071,P35368,,QOFCJVQVURHXTF-XJKSGUPXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,1.01,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1277018,DTCC00208434,1261102,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=CSC=C5NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cscc4c3=O)C[C@@H]21
1793,CHEMBL445325,P35368,,VPUVFWFLLOJNOU-OXJNMPFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,15.3,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1255073,DTCC00208301,356203,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C=NC5=CC(=C(C=C5C4=O)OC)OC,COc1cc2ncn(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1OC
1794,CHEMBL445332,P35368,SALVINORIN A,OBSYBRPAKCASQB-AGQYDFLVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12192085.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14728532,DTCC00395210,2103589,69286,CC(=O)O[C@H]1C[C@H]([C@@]2(CC[C@H]3C(=O)O[C@@H](C[C@@]3([C@H]2C1=O)C)C4=COC=C4)C)C(=O)OC,COC(=O)[C@@H]1C[C@H](OC(C)=O)C(=O)[C@H]2[C@@]1(C)CC[C@H]1C(=O)O[C@H](c3ccoc3)C[C@]21C
1795,CHEMBL445577,P35368,,ZTAFSHDVHGVXTJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,32.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1123979,DTCC00330398,292415,15486,CCC1=C(C(N(C(=O)N1)C(=O)NCCCN2CCN(CC2)C3=CC=CC=C3C(=O)N)C4=C(C=C(C=C4)F)F)C(=O)OC,CCC1=C(C(=O)OC)C(c2ccc(F)cc2F)N(C(=O)NCCCN2CCN(c3ccccc3C(N)=O)CC2)C(=O)N1
1796,CHEMBL446180,P35368,,NQYDFNJSOIGZSU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15828846.0,KI,=,1100.0,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor,,"Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.",J. Med. Chem.,2005.0,48.0,8.0,"Konkel MJ, Wetzel JM, Cahir M, Craig DA, Noble SA, Gluchowski C",,302652.0,DTCT0023207,1825351,DTCC00399698,325777,19681,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=C(C=C4)F)F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2F)CC1
1797,CHEMBL448147,P35368,,MIWWMVGPFZMLEG-NSHDSACASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841434,DTCC00536112,758934,33622,C1[C@@H](CN2C1=NC=C2)C3=CC=CC=C3C4=NC=CO4,c1ccc([C@H]2Cc3nccn3C2)c(-c2ncco2)c1
1798,CHEMBL448198,P35368,,YVSNFTJWRKZTPD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,933.25,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534308,DTCC00559753,1180015,41150,CCOC1=CC=CC=C1N2CCN(CC2)CC(CN3C(=O)N(C(=O)C3(C4=CC=CC=C4)C5=CC=CC=C5)C(C)C(=O)OC)O,CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C(C)C(=O)OC)C(=O)C2(c2ccccc2)c2ccccc2)CC1
1799,CHEMBL448620,P35368,SNAP-5089,FIIXCJGBCCCOQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7562902.0,KI,=,269.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]prazosin binding to human Alpha-1B adrenergic receptor expressed in CHO cells,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 2. Structure-activity relationships and therapeutic applications.,J. Med. Chem.,1995.0,38.0,19.0,"Ruffolo RR, Bondinell W, Hieble JP",,34343.0,DTCT0023207,916498,DTCC00008485,1273745,13230,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1800,CHEMBL448620,P35368,SNAP-5089,FIIXCJGBCCCOQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7752182.0,KI,=,220.0,NM,,,,,,,,,,,,,,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,,Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.,J. Med. Chem.,1995.0,38.0,10.0,"Wetzel JM, Miao SW, Forray C, Borden LA, Branchek TA, Gluchowski C",,34326.0,DTCT0023207,1045895,DTCC00008485,1272468,12993,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1801,CHEMBL448620,P35368,SNAP-5089,FIIXCJGBCCCOQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7752182.0,KI,=,410.0,NM,,,,,,,,,,,,,,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,,Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.,J. Med. Chem.,1995.0,38.0,10.0,"Wetzel JM, Miao SW, Forray C, Borden LA, Branchek TA, Gluchowski C",,34326.0,DTCT0023207,1027371,DTCC00008485,1272469,12993,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1802,CHEMBL448620,P35368,SNAP-5089,FIIXCJGBCCCOQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,13.49,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,721764,DTCC00008485,1260612,14595,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1803,CHEMBL448620,P35368,SNAP-5089,FIIXCJGBCCCOQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,125.89,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,721767,DTCC00008485,1260612,14595,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1804,CHEMBL448620,P35368,SNAP-5089,FIIXCJGBCCCOQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,218.78,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,741763,DTCC00008485,1273214,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1805,CHEMBL448620,P35368,SNAP-5089,FIIXCJGBCCCOQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,220.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1243848,DTCC00008485,1261676,3366,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1806,CHEMBL448620,P35368,SNAP-5089,FIIXCJGBCCCOQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,74.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,727447,DTCC00008485,1262446,15484,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1807,CHEMBL448620,P35368,SNAP-5089,FIIXCJGBCCCOQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579843.0,KI,=,180.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor (recombinant human receptor) using [3H]prazosin.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.,J. Med. Chem.,1999.0,42.0,23.0,"Wong WC, Sun W, Lagu B, Tian D, Marzabadi MR, Zhang F, Nagarathnam D, Miao SW, Wetzel JM, Peng J, Forray C, Chang RS, Chen TB, Ransom R, O'Malley S, Broten TP, Kling P, Vyas KP, Zhang K, Gluchowski C",,34328.0,DTCT0023207,519969,DTCC00008485,1274093,15470,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
1808,CHEMBL448802,P35368,,MIWWMVGPFZMLEG-LLVKDONJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,1400.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841428,DTCC00536111,952837,33622,C1[C@H](CN2C1=NC=C2)C3=CC=CC=C3C4=NC=CO4,c1ccc([C@@H]2Cc3nccn3C2)c(-c2ncco2)c1
1809,CHEMBL448908,P35368,,IPPGENORPYHMGX-GFCCVEGCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841463,DTCC00536164,1017518,33622,C1[C@H](CN2C1=NC=C2)C3=CC=CC=C3N4C=CC=N4,c1ccc(-n2cccn2)c([C@@H]2Cc3nccn3C2)c1
1810,CHEMBL449057,P35368,,MBDYMQCXLMADKW-MOPGFXCFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569151,DTCC00527826,1470783,31993,C1[C@H](OC[C@H](O1)C2=CC=CC=C2)CNCCOC3=CC=CC=C3,c1ccc(OCCNC[C@@H]2CO[C@H](c3ccccc3)CO2)cc1
1811,CHEMBL449250,P35368,,XKTRZPQOQOCNJU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14978194.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14742280,DTCC00568834,2107518,69180,CCCN1CCOC2C1CCC3=C2C=C(C=C3)C(=O)N,CCCN1CCOC2c3cc(C(N)=O)ccc3CCC21
1812,CHEMBL449279,P35368,,KMKRWMBSKDDVCW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843267,DTCC00537312,143846,33580,C1C(CC2=CC=CC=C21)C3=NC=CN3,c1ccc2c(c1)CC(c1ncc[nH]1)C2
1813,CHEMBL449284,P35368,,SPZWSHWMHHYVPO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,=,1100.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843284,DTCC00537514,1535538,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3Cl,Clc1ccccc1C1Cc2nccn2C1
1814,CHEMBL449284,P35368,,SPZWSHWMHHYVPO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EMAX,=,20.0,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR relative to phenylephrine,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499395.0,DTCT0023207,2843337,DTCC00537514,1535538,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3Cl,Clc1ccccc1C1Cc2nccn2C1
1815,CHEMBL450018,P35368,,MJGIIZLIKBMVQO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,251.19,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,644641,DTCC00264116,691565,4573,CCN(C)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCN(C)C(=O)c1ccccc1NCC1=NCCN1
1816,CHEMBL450018,P35368,,MJGIIZLIKBMVQO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,IC50,=,10471.29,NM,,,,,,,,,,,,,,Concentration required for 50% inhibition of binding against human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,34483.0,DTCT0023207,644646,DTCC00264116,691565,4573,CCN(C)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCN(C)C(=O)c1ccccc1NCC1=NCCN1
1817,CHEMBL450018,P35368,,MJGIIZLIKBMVQO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,98.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,644642,DTCC00264116,691565,4573,CCN(C)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCN(C)C(=O)c1ccccc1NCC1=NCCN1
1818,CHEMBL452437,P35368,,QZFPTSHPKIDPDG-YLJYHZDGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,269.15,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569143,DTCC00527366,404334,31993,COC1=CC=CC=C1OCCNC[C@@H]2COC[C@@H](O2)C3=CC=CC=C3,COc1ccccc1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1
1819,CHEMBL454246,P35368,REDIOCIDE A,ZAVYYYQORHVVFN-BDGVIKSFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22650618.0,IC50,=,215.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of adrenergic receptor 1b receptor expressed in HEK293 cells assessed as inhibition of calcium influx after 10 mins by Fluo-4-AM based fluorimetry,,"Rediocide A, an Insecticide, induces G-protein-coupled receptor desensitization via activation of conventional protein kinase C.",J. Nat. Prod.,2012.0,75.0,6.0,"Cui L, Li J, Xie X",,863153.0,DTCT0023207,11411027,DTCC00538857,1449749,51361,C[C@H]1C[C@H]2[C@@]34[C@@H]([C@H]5[C@@]6([C@@H]([C@@H]3[C@H]7[C@](O7)([C@H]([C@@]2([C@H]1OC(=O)/C=C/C=C/[C@@H]([C@H]8CC[C@@H]([C@@H]8C)C[C@@]6(C)O)OC(=O)CC(C)C)O)O)CO)OC(O5)(O4)C9=CC=CC=C9)O)C,CC(C)CC(=O)O[C@H]1/C=C/C=C/C(=O)O[C@H]2[C@@H](C)C[C@@H]3[C@]2(O)[C@H](O)[C@@]2(CO)O[C@H]2[C@H]2[C@H]4OC5(c6ccccc6)O[C@@H]([C@@H](C)[C@@]23O5)[C@@]4(O)[C@](C)(O)C[C@H]2CC[C@H]1[C@H]2C
1820,CHEMBL458001,P35368,,IIGRUZXPSNFKHF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19146417.0,KI,=,630.96,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from adrenergic Alpha-1B receptor expressed in CHO cells,,"The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.",J. Med. Chem.,2009.0,52.0,3.0,"Wroblowski B, Wigglesworth MJ, Szekeres PG, Smith GD, Rahman SS, Nicholson NH, Muir AI, Hall A, Heer JP, Garland SL, Coates WJ",,516617.0,DTCT0023207,2696207,DTCC00549916,371611,32399,C1CN(CCN1)C2=C(C(=O)N(N=C2)CC3=CC(=CC=C3)NC(=O)C4=CC=C(C=C4)C5=CC=CC=C5)Cl,O=C(Nc1cccc(Cn2ncc(N3CCNCC3)c(Cl)c2=O)c1)c1ccc(-c2ccccc2)cc1
1821,CHEMBL458002,P35368,,ADETWEPXXIGKFW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19146417.0,KI,=,562.34,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from adrenergic Alpha-1B receptor expressed in CHO cells,,"The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.",J. Med. Chem.,2009.0,52.0,3.0,"Wroblowski B, Wigglesworth MJ, Szekeres PG, Smith GD, Rahman SS, Nicholson NH, Muir AI, Hall A, Heer JP, Garland SL, Coates WJ",,516617.0,DTCT0023207,2696208,DTCC00549917,371612,32399,CC1=C(C=C(C=C1)CN2C(=O)C(=C(C=N2)N3CCNCC3)Cl)NC(=O)C4=CC=C(C=C4)C5=CC=CC=C5,Cc1ccc(Cn2ncc(N3CCNCC3)c(Cl)c2=O)cc1NC(=O)c1ccc(-c2ccccc2)cc1
1822,CHEMBL458220,P35368,,OZAJLQLEAWUZSC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19146417.0,KI,=,1445.44,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from adrenergic Alpha-1B receptor expressed in CHO cells,,"The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.",J. Med. Chem.,2009.0,52.0,3.0,"Wroblowski B, Wigglesworth MJ, Szekeres PG, Smith GD, Rahman SS, Nicholson NH, Muir AI, Hall A, Heer JP, Garland SL, Coates WJ",,516617.0,DTCT0023207,2696209,DTCC00549918,920677,32399,CC1=C(C=CC=C1NC(=O)C2=CC=C(C=C2)C3=CC=CC=C3)CN4C(=O)C(=C(C=N4)N5CCNCC5)Cl,Cc1c(Cn2ncc(N3CCNCC3)c(Cl)c2=O)cccc1NC(=O)c1ccc(-c2ccccc2)cc1
1823,CHEMBL459730,P35368,,OQIBXTHHXDTIBJ-OAQYLSRUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18754613.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Displacement of [125I]prazosin from cloned adrenergic Alpha-1B receptor,,"Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.",J. Med. Chem.,2008.0,51.0,18.0,"Donohue SR, Pike VW, Finnema SJ, Truong P, Andersson J, Gulyás B, Halldin C",,512512.0,DTCT0023207,2562862,DTCC00529017,2036926,31906,C1[C@@H](C(=NN1/C(=N/S(=O)(=O)C2=CC=C(C=C2)C#N)/N)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,N#Cc1ccc(S(=O)(=O)/N=C(\N)N2C[C@H](c3ccccc3)C(c3ccc(Cl)cc3)=N2)cc1
1824,CHEMBL464099,P35368,N-METHYLLAUROTETANINE,ZFLRVRLYWHNAEC-AWEZNQCLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25695425.0,KI,>,950.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant adrenergic alpha1B receptor expressed in HEKT cell membranes by radioligand binding assay,,Semisynthetic Studies on and Biological Evaluation of N-Methyllaurotetanine Analogues as Ligands for 5-HT Receptors.,J. Nat. Prod.,2015.0,78.0,4.0,"Madapa S, Harding WW",,1499794.0,DTCT0023207,14439261,DTCC00005857,624816,62678,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C43)OC)O)OC)OC,COc1cc2c(cc1O)C[C@H]1c3c(cc(OC)c(OC)c3-2)CCN1C
1825,CHEMBL465599,P35368,,QJISVABLQCOWQF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843275,DTCC00537380,175919,33580,C1CC2=C(CC1C3=CC=CC=C3Cl)NC=N2,Clc1ccccc1C1CCc2nc[nH]c2C1
1826,CHEMBL465963,P35368,,SQVDOAJVRQASHO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843271,DTCC00537378,2048212,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3,c1ccc(C2Cc3nccn3C2)cc1
1827,CHEMBL465963,P35368,,SQVDOAJVRQASHO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843272,DTCC00537378,2048213,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3,c1ccc(C2Cc3nccn3C2)cc1
1828,CHEMBL465963,P35368,,SQVDOAJVRQASHO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843273,DTCC00537378,2048214,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3,c1ccc(C2Cc3nccn3C2)cc1
1829,CHEMBL465963,P35368,,SQVDOAJVRQASHO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843283,DTCC00537378,2048216,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3,c1ccc(C2Cc3nccn3C2)cc1
1830,CHEMBL466012,P35368,,PIDATBLWKGYAEW-MRXNPFEDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2842538,DTCC00536167,436519,33622,CNC(=O)C1=CC=CC(=C1)C2=CC=CC=C2[C@@H]3CC4=NC=CN4C3,CNC(=O)c1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1
1831,CHEMBL466046,P35368,,KMOFNRDXTFJLAO-LLVKDONJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841409,DTCC00536030,1664559,33622,C1[C@H](CN2C1=NC=C2)C3=CC=CC=C3C#N,N#Cc1ccccc1[C@@H]1Cc2nccn2C1
1832,CHEMBL466296,P35368,,FNAMNTIDTBOHMV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843268,DTCC00537313,1178442,33580,C1CC2=C(CC1C3=CC=CC=C3)NC=N2,c1ccc(C2CCc3nc[nH]c3C2)cc1
1833,CHEMBL466296,P35368,,FNAMNTIDTBOHMV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843269,DTCC00537313,1178443,33580,C1CC2=C(CC1C3=CC=CC=C3)NC=N2,c1ccc(C2CCc3nc[nH]c3C2)cc1
1834,CHEMBL466296,P35368,,FNAMNTIDTBOHMV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843270,DTCC00537313,1178444,33580,C1CC2=C(CC1C3=CC=CC=C3)NC=N2,c1ccc(C2CCc3nc[nH]c3C2)cc1
1835,CHEMBL466634,P35368,,NOCWBSIDJYRURZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,=,990.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2842568,DTCC00536233,175908,33622,C1C(CN2C1=NC=C2)C3=C(C=CC(=C3)F)C4=NC=CO4,Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1
1836,CHEMBL466634,P35368,,NOCWBSIDJYRURZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EMAX,=,41.0,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR relative to 10 uM phenylephrine,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500047.0,DTCT0023207,2842664,DTCC00536233,175908,33622,C1C(CN2C1=NC=C2)C3=C(C=CC(=C3)F)C4=NC=CO4,Fc1ccc(-c2ncco2)c(C2Cc3nccn3C2)c1
1837,CHEMBL466635,P35368,,PUGMNVJZHKJJKF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2842591,DTCC00536237,36266,33622,C1C(CN2C1=NC=C2)C3=C(C=C(C=C3)F)N4C=CC=N4,Fc1ccc(C2Cc3nccn3C2)c(-n2cccn2)c1
1838,CHEMBL466869,P35368,,QQOAUSLLNSKQPA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843278,DTCC00537383,1178445,33580,COC1=CC=CC=C1C2CCC3=C(C2)NC=N3,COc1ccccc1C1CCc2nc[nH]c2C1
1839,CHEMBL466875,P35368,,XHDKEXKFBSPYHK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843280,DTCC00537512,240481,33580,COC1=CC=C(C=C1)C2CCC3=C(C2)NC=N3,COc1ccc(C2CCc3nc[nH]c3C2)cc1
1840,CHEMBL466876,P35368,,PAMROTRMNXQKOE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843281,DTCC00537513,1341591,33580,COCC1=CC=CC=C1C2CCC3=C(C2)NC=N3,COCc1ccccc1C1CCc2nc[nH]c2C1
1841,CHEMBL466876,P35368,,PAMROTRMNXQKOE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843282,DTCC00537513,1341590,33580,COCC1=CC=CC=C1C2CCC3=C(C2)NC=N3,COCc1ccccc1C1CCc2nc[nH]c2C1
1842,CHEMBL466914,P35368,,BZMHRUWVNNKWDQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843274,DTCC00537379,758951,33580,C1CC2=NC=CN2CC1C3=CC=CC=C3,c1ccc(C2CCc3nccn3C2)cc1
1843,CHEMBL466915,P35368,,UPEUOWBPLHAKGL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843277,DTCC00537382,952857,33580,C1CC2=C(CC1C3=CC=C(C=C3)Cl)NC=N2,Clc1ccc(C2CCc3nc[nH]c3C2)cc1
1844,CHEMBL466916,P35368,,PKWGMVNCXHYOBP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843279,DTCC00537384,111389,33580,COC1=CC=CC(=C1)C2CCC3=C(C2)NC=N3,COc1cccc(C2CCc3nc[nH]c3C2)c1
1845,CHEMBL467094,P35368,NANTENINE,WSVWKHTVFGTTKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19963380.0,KI,=,1191.0,NM,,,,,,,,,,,,,,Displacement of [3H]Prazosin from human adrenergic Alpha-1B receptor,,Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.,Bioorg. Med. Chem. Lett.,2010.0,20.0,2.0,"Legendre O, Pecic S, Chaudhary S, Zimmerman SM, Fantegrossi WE, Harding WW",,604278.0,DTCT0023207,3169935,DTCC00115128,663129,36881,CN1CCC2=CC(=C(C3=C2C1CC4=CC5=C(C=C43)OCO5)OC)OC,COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4
1846,CHEMBL467259,P35368,,MXXSIQQCMWZCJR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2842556,DTCC00536231,2080349,33622,C1C(CN2C1=NC=C2)C3=C(C=CC=C3F)C4=CN=CN=C4,Fc1cccc(-c2cncnc2)c1C1Cc2nccn2C1
1847,CHEMBL467495,P35368,,NMYFTUWMFYFIEY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843285,DTCC00537515,1821206,33580,C1C(CN2C1=NC=C2)C3=CC=C(C=C3)Cl,Clc1ccc(C2Cc3nccn3C2)cc1
1848,CHEMBL467688,P35368,,JOZLKCRZSXEYJL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,Not Determined,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843286,DTCC00537516,1470867,33580,COC1=CC=CC=C1C2CC3=NC=CN3C2,COc1ccccc1C1Cc2nccn2C1
1849,CHEMBL467915,P35368,,DCZFXJLVCNQIPP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,Not Determined,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843290,DTCC00537590,920495,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3OC(F)F,FC(F)Oc1ccccc1C1Cc2nccn2C1
1850,CHEMBL467916,P35368,,KMOFNRDXTFJLAO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843292,DTCC00537592,1049952,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3C#N,N#Cc1ccccc1C1Cc2nccn2C1
1851,CHEMBL468710,P35368,,IXNQNKUBBRFMIS-LLVKDONJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,Not Determined,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841440,DTCC00536113,79176,33622,C1[C@H](CN2C1=NC=C2)C3=CC=CC=C3C4=NC=CS4,c1ccc([C@@H]2Cc3nccn3C2)c(-c2nccs2)c1
1852,CHEMBL468711,P35368,,JVQZWPGHLBOWKN-CQSZACIVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,=,760.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841446,DTCC00536114,791032,33622,C1[C@H](CN2C1=NC=C2)C3=CC=CC=C3C4=CN=CC=C4,c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1
1853,CHEMBL468711,P35368,,JVQZWPGHLBOWKN-CQSZACIVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EMAX,=,54.0,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR relative to 10 uM phenylephrine,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500047.0,DTCT0023207,2842663,DTCC00536114,791032,33622,C1[C@H](CN2C1=NC=C2)C3=CC=CC=C3C4=CN=CC=C4,c1cncc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1
1854,CHEMBL469127,P35368,,FQZYLYAFBBAGRL-CYBMUJFWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841475,DTCC00536166,1726196,33622,CNS(=O)(=O)CCC1=CC=CC=C1[C@@H]2CC3=NC=CN3C2,CNS(=O)(=O)CCc1ccccc1[C@@H]1Cc2nccn2C1
1855,CHEMBL470432,P35368,,FZGWDCDUMFWUEO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19261477.0,IC50,=,144.54,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin form human recombinant Alpha-1B adrenergic receptor,,Novel antagonists of serotonin-4 receptors: synthesis and biological evaluation of pyrrolothienopyrazines.,Bioorg. Med. Chem.,2009.0,17.0,6.0,"Lemaître S, Lepailleur A, Bureau R, Butt-Gueulle S, Lelong-Boulouard V, Duchatelle P, Boulouard M, Dumuis A, Daveu C, Lezoualc'h F, Pfeiffer B, Dauphin F, Rault S",,564588.0,DTCT0023207,2613032,DTCC00570224,1082935,33265,CCCN1CCC(CC1)COC2=NC3=C(C(=CS3)C)N4C2=CC=C4,CCCN1CCC(COc2nc3scc(C)c3n3cccc23)CC1
1856,CHEMBL475306,P35368,BMS-561388,DKAPUZDMFUBEBM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19361210.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha-1b receptor,,"8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.",J. Med. Chem.,2009.0,52.0,9.0,"Gilligan PJ, He L, Clarke T, Tivitmahaisoon P, Lelas S, Li YW, Heman K, Fitzgerald L, Miller K, Zhang G, Marshall A, Krause C, McElroy J, Ward K, Shen H, Wong H, Grossman S, Nemeth G, Zaczek R, Arneric SP, Hartig P, Robertson DW, Trainor G",,502383.0,DTCT0023207,2732261,DTCC00009080,533395,34047,CC1=C(C=CC(=C1)OC)C2=C3N=C(N=C(N3N=C2C)N(CCOC)CCOC)C,COCCN(CCOC)c1nc(C)nc2c(-c3ccc(OC)cc3C)c(C)nn12
1857,CHEMBL476839,P35368,,MJKRYUCQHJLOIV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19329329.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cloned Alpha-1B adrenergic receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563503.0,DTCT0023207,2623689,DTCC00551715,1103808,33115,CC1=CC=C(C=C1)CCN2CCC(CC2)C(C3=C(C(=CC=C3)OCCF)OC)O,COc1c(OCCF)cccc1C(O)C1CCN(CCc2ccc(C)cc2)CC1
1858,CHEMBL479,P35368,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,15.85,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14741306,DTCC00137035,2104838,68596,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
1859,CHEMBL479683,P35368,,OLLHYYCQHNBTQC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24582985.0,INHIBITION,=,2.9,%,,,,,,,,,,,,,,Inhibition of alpha1B adrenergic receptor (unknown origin) at 10 uM by radioligand binding assay relative to control,,5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.,Bioorg. Med. Chem. Lett.,2014.0,24.0,6.0,"Williams DA, Zaidi SA, Zhang Y",,1296940.0,DTCT0023207,13068445,DTCC00537969,1127642,57600,C1=CC=C(C=C1)CCC2=CC(=O)C3=C(C=CC=C3O2)O,O=c1cc(CCc2ccccc2)oc2cccc(O)c12
1860,CHEMBL481322,P35368,,CMNAOKMSNCWOHS-LLVKDONJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841402,DTCC00533250,1082565,33622,COCC1=C(C=CC2=C1CC[C@H]2C3=NC=CN3)Cl,COCc1c(Cl)ccc2c1CC[C@H]2c1ncc[nH]1
1861,CHEMBL483993,P35368,,RPKIJOOZVCXURK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19361210.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha-1b receptor,,"8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.",J. Med. Chem.,2009.0,52.0,9.0,"Gilligan PJ, He L, Clarke T, Tivitmahaisoon P, Lelas S, Li YW, Heman K, Fitzgerald L, Miller K, Zhang G, Marshall A, Krause C, McElroy J, Ward K, Shen H, Wong H, Grossman S, Nemeth G, Zaczek R, Arneric SP, Hartig P, Robertson DW, Trainor G",,502383.0,DTCT0023207,2732275,DTCC00569334,1821565,34047,CC1=CC(=C(C=C1OC)C)C2=C3N=C(N=C(N3N=C2C)N(CCOC)CCOC)C,COCCN(CCOC)c1nc(C)nc2c(-c3cc(C)c(OC)cc3C)c(C)nn12
1862,CHEMBL484102,P35368,,VDYXCGVNXROZOL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,954.99,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534303,DTCC00559682,1822777,41150,CN1C(=O)C(N(C1=O)CC(CN2CCN(CC2)C3=CC=CC=C3OC)O)(C4=CC=CC=C4)C5=CC=CC=C5,COc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1
1863,CHEMBL484158,P35368,,MHRACNFYWWSGFM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19361210.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha-1b receptor,,"8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.",J. Med. Chem.,2009.0,52.0,9.0,"Gilligan PJ, He L, Clarke T, Tivitmahaisoon P, Lelas S, Li YW, Heman K, Fitzgerald L, Miller K, Zhang G, Marshall A, Krause C, McElroy J, Ward K, Shen H, Wong H, Grossman S, Nemeth G, Zaczek R, Arneric SP, Hartig P, Robertson DW, Trainor G",,502383.0,DTCT0023207,2732274,DTCC00569381,1243945,34047,CCC(CC)NC1=NC(=NC2=C(C(=NN21)C)C3=CC(=C(C=C3Cl)OC)F)C,CCC(CC)Nc1nc(C)nc2c(-c3cc(F)c(OC)cc3Cl)c(C)nn12
1864,CHEMBL490632,P35368,,PPXOTGGYVKBLCQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19329329.0,KI,,,,,,,,,,,,,,,,,Inhibition of human cloned Alpha-1B adrenergic receptor by competitive binding experiment,Not Determined,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563503.0,DTCT0023207,2623690,DTCC00551773,1906510,33115,CC1=CC=C(C=C1)CCN2CCC(CC2)C(=O)C3=C(C(=CC=C3)OCCF)OC,COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(C)cc2)CC1
1865,CHEMBL490865,P35368,,SQEHFDDHHDUNCK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,851.14,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534304,DTCC00559683,1408182,41150,CCOC1=CC=CC=C1N2CCN(CC2)CC(CN3C(=O)N(C(=O)C3(C4=CC=CC=C4)C5=CC=CC=C5)C)O,CCOc1ccccc1N1CCN(CC(O)CN2C(=O)N(C)C(=O)C2(c2ccccc2)c2ccccc2)CC1
1866,CHEMBL49137,P35368,,QZUXRMOPAGPTIY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,3311.31,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1647149,DTCC00193167,1773711,1335,CC1=C(C=CC2=NC=CN=C12)NC3=NCCN3,Cc1c(NC2=NCCN2)ccc2nccnc12
1867,CHEMBL492785,P35368,,ZUVHIOFWBBSJDZ-MOPGFXCFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569146,DTCC00527318,404333,31993,C1[C@H](O[C@@H](CO1)C2=CC=CC=C2)CNCCOC3=CC=CC=C3,c1ccc(OCCNC[C@@H]2COC[C@@H](c3ccccc3)O2)cc1
1868,CHEMBL492834,P35368,,UWNHCVXSZHPSOC-XLIONFOSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569147,DTCC00527317,1756348,31993,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2CO[C@@H](CO2)C3=CC=CC=C3,COc1cccc(OC)c1OCCNC[C@@H]1CO[C@H](c2ccccc2)CO1
1869,CHEMBL492835,P35368,,ZUVHIOFWBBSJDZ-RTBURBONSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569145,DTCC00527319,1503062,31993,C1[C@H](O[C@H](CO1)C2=CC=CC=C2)CNCCOC3=CC=CC=C3,c1ccc(OCCNC[C@@H]2COC[C@H](c3ccccc3)O2)cc1
1870,CHEMBL493,P35368,BROMOCRIPTINE,OZVBMTJYIDMWIL-AYFBDAFISA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,1.38,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14728429,DTCC00137993,2103627,69012,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
1871,CHEMBL493041,P35368,,QZFPTSHPKIDPDG-XLIONFOSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,302.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569144,DTCC00527365,338776,31993,COC1=CC=CC=C1OCCNC[C@@H]2COC[C@H](O2)C3=CC=CC=C3,COc1ccccc1OCCNC[C@@H]1COC[C@@H](c2ccccc2)O1
1872,CHEMBL493042,P35368,,GEQVVCLGCINCDF-XLIONFOSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569142,DTCC00527367,1982875,31993,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC[C@H](O2)C3=CC=CC=C3,COc1cccc(OC)c1OCCNC[C@@H]1COC[C@@H](c2ccccc2)O1
1873,CHEMBL493043,P35368,,GEQVVCLGCINCDF-YLJYHZDGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569141,DTCC00527368,1470778,31993,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC[C@@H](O2)C3=CC=CC=C3,COc1cccc(OC)c1OCCNC[C@@H]1COC[C@H](c2ccccc2)O1
1874,CHEMBL493283,P35368,,DSZAPUPSEUYRJU-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,74.13,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569139,DTCC00527828,1821099,31993,COC1=CC=CC=C1OCCNC[C@@H]2COC(CO2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1ccccc1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1
1875,CHEMBL493284,P35368,,XDMUHNCCYHIUIM-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,125.89,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569138,DTCC00527829,532960,31993,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COC(CO2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1cccc(OC)c1OCCNC[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1
1876,CHEMBL493285,P35368,,ZCYQPTKLMLTYQD-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,120.23,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569137,DTCC00527830,1632178,31993,C1[C@H](OC(CO1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4,c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1
1877,CHEMBL493285,P35368,,ZCYQPTKLMLTYQD-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,52.48,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756641,DTCC00527830,1644154,53287,C1[C@H](OC(CO1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4,c1ccc(OCCNC[C@@H]2COCC(c3ccccc3)(c3ccccc3)O2)cc1
1878,CHEMBL493486,P35368,,HIASEHRDTBGCHW-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,56.23,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569136,DTCC00527831,273197,31993,COC1=CC=CC=C1OCCNC[C@@H]2COCC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1
1879,CHEMBL493486,P35368,,HIASEHRDTBGCHW-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,21.88,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756634,DTCC00527831,285310,53287,COC1=CC=CC=C1OCCNC[C@@H]2COCC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1ccccc1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1
1880,CHEMBL493661,P35368,,UWNHCVXSZHPSOC-YLJYHZDGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569148,DTCC00527316,1374014,31993,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2CO[C@H](CO2)C3=CC=CC=C3,COc1cccc(OC)c1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1
1881,CHEMBL493697,P35368,,MFUWMPKHVOQTMZ-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,323.59,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569135,DTCC00527872,856305,31993,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COCC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1
1882,CHEMBL493697,P35368,,MFUWMPKHVOQTMZ-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,=,194.98,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756653,DTCC00527872,868330,53287,COC1=C(C(=CC=C1)OC)OCCNC[C@@H]2COCC(O2)(C3=CC=CC=C3)C4=CC=CC=C4,COc1cccc(OC)c1OCCNC[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1
1883,CHEMBL49395,P35368,,PVKUNRLEOHFACD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,3235.94,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1664976,DTCC00193422,1806184,1335,C1CN=C(N1)NC2=CC3=NC=CN=C3C=C2,c1cnc2cc(NC3=NCCN3)ccc2n1
1884,CHEMBL494908,P35368,,FBLWRLZXMWQVMJ-YLJYHZDGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,281.84,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569150,DTCC00527827,1308898,31993,COC1=CC=CC=C1OCCNC[C@@H]2CO[C@H](CO2)C3=CC=CC=C3,COc1ccccc1OCCNC[C@@H]1CO[C@@H](c2ccccc2)CO1
1885,CHEMBL495289,P35368,,BQBVUOHGBBXQLG-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,141.25,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569140,DTCC00527369,532954,31993,C1[C@H](OCC(O1)(C2=CC=CC=C2)C3=CC=CC=C3)CNCCOC4=CC=CC=C4,c1ccc(OCCNC[C@@H]2COC(c3ccccc3)(c3ccccc3)CO2)cc1
1886,CHEMBL497963,P35368,,UZLFJOXUSYBNKZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18433113.0,KI,=,199.53,NM,,,,,,,,,,,,,,Displacement of radioligand from human cloned adrenergic Alpha-1B receptor,,"Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists.",J. Med. Chem.,2008.0,51.0,10.0,"Ward SE, Eddershaw PJ, Scott CM, Gordon LJ, Lovell PJ, Moore SH, Smith PW, Starr KR, Thewlis KM, Watson JM",,556327.0,DTCT0023207,2558014,DTCC00541566,1115098,28818,CC1=NC2=C(C=C1)C(=CC=C2)OCCN3CCC(CC3)CC4=CC(=CC=C4)NS(=O)(=O)C,Cc1ccc2c(OCCN3CCC(Cc4cccc(NS(C)(=O)=O)c4)CC3)cccc2n1
1887,CHEMBL49851,P35368,,RORFUFVFDXKMOM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9888842.0,KI,=,13.6,NM,,cell_based,,,,,,,,,,,CHO,The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1B adrenergic receptor in CHO cells,,Novel adrenoceptor antagonists with a tricyclic pyrrolodipyridazine skeleton.,J. Med. Chem.,1999.0,42.0,1.0,"Barlocco D, Cignarella G, Montesano F, Leonardi A, Mella M, Toma L",,34467.0,DTCT0023207,1437604,DTCC00193952,1902564,15156,CN1C(=O)C2=C3C=CC(=NN3C=C2C(=N1)Cl)NCCN4CCN(CC4)C5=CC=CC=C5Cl,Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5Cl)CC4)ccc3c2c1=O
1888,CHEMBL50,P35368,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14729951,DTCC00135230,2104025,69275,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
1889,CHEMBL500266,P35368,,UYVXBQGHGSQVBW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,851.14,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534307,DTCC00559752,274917,41150,CC(C(=O)OC)N1C(=O)C(N(C1=O)CC(CN2CCN(CC2)C3=CC=CC=C3OC)O)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C(C)N1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O
1890,CHEMBL50081,P35368,,FMYNAWYOKZCTHQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,350.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,623511,DTCC00194596,787440,3936,C1CN(CCN1CCCNC(=O)N2C(C3=C(COC3=O)NC2=O)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5C(=O)N,NC(=O)c1ccccc1N1CCN(CCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1
1891,CHEMBL501404,P35368,,BFDKAMOCQFIESP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2842562,DTCC00536232,1632264,33622,C1C(CN2C1=NC=C2)C3=C(C=C(C=C3)F)C4=NC=CO4,Fc1ccc(C2Cc3nccn3C2)c(-c2ncco2)c1
1892,CHEMBL501920,P35368,,CQPRHMLRHXLMEL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,Not Determined,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843288,DTCC00537588,436539,33580,COC1=CC=C(C=C1)C2CC3=NC=CN3C2,COc1ccc(C2Cc3nccn3C2)cc1
1893,CHEMBL503007,P35368,,CLVNHGRETDEYIG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20813529.0,KD,=,1258.93,NM,,,,,,,,,,,,,,Antagonist activity at adrenergic Alpha-1B receptor in guinea pig spleen,,Search for influence of spatial properties on affinity at a1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.,Bioorg. Med. Chem. Lett.,2010.0,20.0,20.0,"Handzlik J, Pertz HH, Görnemann T, Jähnichen S, Kiec-Kononowicz K",,665019.0,DTCT0023207,3534306,DTCC00559748,112934,41150,COC1=CC=CC=C1N2CCN(CC2)CC(CN3C(=O)N(C(=O)C3(C4=CC=CC=C4)C5=CC=CC=C5)CC(=O)OC)O,COC(=O)CN1C(=O)N(CC(O)CN2CCN(c3ccccc3OC)CC2)C(c2ccccc2)(c2ccccc2)C1=O
1894,CHEMBL503269,P35368,,SNFFBYPCULSUGT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843276,DTCC00537381,758952,33580,C1CC2=C(CC1C3=CC(=CC=C3)Cl)NC=N2,Clc1cccc(C2CCc3nc[nH]c3C2)c1
1895,CHEMBL50490,P35368,,LUSDCJGCJWYOSQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,120.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,622429,DTCC00194925,1467106,3936,C1CN(CCC1(C2=CC=CC=C2)C3=CC=CC=C3)CCCNC(=O)N4C(C5=C(COC5=O)NC4=O)C6=CC(=C(C=C6)F)F,O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCC(c3ccccc3)(c3ccccc3)CC1)C(=O)N2
1896,CHEMBL505414,P35368,,LOWJTSZIULCLQH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2842544,DTCC00536168,823456,33622,C1C(CN2C1=NC=C2)C3=C(C=C(C=C3)F)C4=CN=CN=C4,Fc1ccc(C2Cc3nccn3C2)c(-c2cncnc2)c1
1897,CHEMBL506214,P35368,,OGTPHDYRZSEDNM-GFCCVEGCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19361210.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha-1b receptor,,"8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.",J. Med. Chem.,2009.0,52.0,9.0,"Gilligan PJ, He L, Clarke T, Tivitmahaisoon P, Lelas S, Li YW, Heman K, Fitzgerald L, Miller K, Zhang G, Marshall A, Krause C, McElroy J, Ward K, Shen H, Wong H, Grossman S, Nemeth G, Zaczek R, Arneric SP, Hartig P, Robertson DW, Trainor G",,502383.0,DTCT0023207,2732276,DTCC00569325,273673,34047,CC[C@@H](C)NC1=NC(=NC2=C(C(=NN21)C)C3=C(C=C(C=C3C)OC)OC)C,CC[C@@H](C)Nc1nc(C)nc2c(-c3c(C)cc(OC)cc3OC)c(C)nn12
1898,CHEMBL506744,P35368,,VQAGIJGIBIOPGW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2842550,DTCC00536169,500938,33622,C1C(CN2C1=NC=C2)C3=C(C=CC(=C3)F)C4=CN=CN=C4,Fc1ccc(-c2cncnc2)c(C2Cc3nccn3C2)c1
1899,CHEMBL507755,P35368,,OZJCKBRXCUUNCT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843287,DTCC00537517,273291,33580,COC1=CC=CC(=C1)C2CC3=NC=CN3C2,COc1cccc(C2Cc3nccn3C2)c1
1900,CHEMBL508084,P35368,,QUSFXAATAPEOAD-GFCCVEGCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,Not Determined,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841458,DTCC00536116,662191,33622,CN1C=C(C=N1)C2=CC=CC=C2[C@@H]3CC4=NC=CN4C3,Cn1cc(-c2ccccc2[C@@H]2Cc3nccn3C2)cn1
1901,CHEMBL509350,P35368,,FRRVMSCOMUYFGM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2842579,DTCC00536235,436520,33622,C1C(CN2C1=NC=C2)C3=C(C=CC(=C3)F)C4=CC=NN4,Fc1ccc(-c2ccn[nH]2)c(C2Cc3nccn3C2)c1
1902,CHEMBL510023,P35368,,JODPZPWJZRBJSA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2842585,DTCC00536236,1756443,33622,C1C(CN2C1=NC=C2)C3=C(C=CC(=C3)F)N4C=CC=N4,Fc1ccc(-n2cccn2)c(C2Cc3nccn3C2)c1
1903,CHEMBL51019,P35368,,MMQFQBJKZBLBRZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,340.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,633410,DTCC00195061,367810,3936,COC(=O)C1(CCN(CC1)CCCCNC(=O)N2C(C3=C(COC3=O)NC2=O)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5,COC(=O)C1(c2ccccc2)CCN(CCCCNC(=O)N2C(=O)NC3=C(C(=O)OC3)C2c2ccc(F)c(F)c2)CC1
1904,CHEMBL51074,P35368,,NZTHPWQOSONJAR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9888842.0,KI,=,15.6,NM,,cell_based,,,,,,,,,,,CHO,The compound was tested for binding affinity on [3H]- prazosin as specific ligand on Human cloned alpha-1B adrenergic receptor in CHO cells,,Novel adrenoceptor antagonists with a tricyclic pyrrolodipyridazine skeleton.,J. Med. Chem.,1999.0,42.0,1.0,"Barlocco D, Cignarella G, Montesano F, Leonardi A, Mella M, Toma L",,34467.0,DTCT0023207,1439941,DTCC00194036,2065076,15156,CN1C(=O)C2=C3C=CC(=NN3C=C2C(=N1)Cl)NCCN4CCN(CC4)C5=CC=CC=C5,Cn1nc(Cl)c2cn3nc(NCCN4CCN(c5ccccc5)CC4)ccc3c2c1=O
1905,CHEMBL511211,P35368,,BXJSKCZBNVAQEJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2842573,DTCC00536234,2048200,33622,C1C(CN2C1=NC=C2)C3=C(C=C(C=C3)F)C4=CC=NN4,Fc1ccc(C2Cc3nccn3C2)c(-c2ccn[nH]2)c1
1906,CHEMBL511411,P35368,,BVXHLVHSYQUGBZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,=,1770.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843289,DTCC00537589,1696664,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3F,Fc1ccccc1C1Cc2nccn2C1
1907,CHEMBL511411,P35368,,BVXHLVHSYQUGBZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EMAX,=,36.0,%,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR relative to phenylephrine,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499395.0,DTCT0023207,2843338,DTCC00537589,1696664,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3F,Fc1ccccc1C1Cc2nccn2C1
1908,CHEMBL511576,P35368,,RNYVEHHLLLFHRP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,,,,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,Not Determined,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843291,DTCC00537591,1950381,33580,C1C(CN2C1=NC=C2)C3=CC=CC=C3C(=O)N,NC(=O)c1ccccc1C1Cc2nccn2C1
1909,CHEMBL511577,P35368,,VLRKQMQYVWMCDX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19394220.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human cloned adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.,Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Whitlock GA, Brennan PE, Roberts LR, Stobie A",,499391.0,DTCT0023207,2843293,DTCC00537593,985221,33580,COCC1=CC=CC=C1C2CC3=NC=CN3C2,COCc1ccccc1C1Cc2nccn2C1
1910,CHEMBL512062,P35368,,NGKTVUYBFUWABZ-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841415,DTCC00536031,791031,33622,C1[C@H](CN2C1=NC=C2)C3=CC=CC=C3C4=CC=CC=C4,c1ccc(-c2ccccc2[C@@H]2Cc3nccn3C2)cc1
1911,CHEMBL512289,P35368,,PEIDTOAIWXQRBC-CQSZACIVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841452,DTCC00536115,2048197,33622,C1[C@H](CN2C1=NC=C2)C3=CC=CC=C3C4=CC=NC=C4,c1ccc([C@@H]2Cc3nccn3C2)c(-c2ccncc2)c1
1912,CHEMBL513691,P35368,,OUQNCXBFEAQBPY-GFCCVEGCSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,6500.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841422,DTCC00536110,533041,33622,C1[C@H](CN2C1=NC=C2)C3=CC=CC=C3C4=CN=CN=C4,c1ccc([C@@H]2Cc3nccn3C2)c(-c2cncnc2)c1
1913,CHEMBL513871,P35368,,FKMTZJPWARGCCN-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19414260.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,CHO,Agonist activity at human adrenergic Alpha-1B receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,,"6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.",Bioorg. Med. Chem. Lett.,2009.0,19.0,11.0,"Roberts LR, Fish PV, Ian Storer R, Whitlock GA",,500046.0,DTCT0023207,2841469,DTCC00536165,1632260,33622,CS(=O)(=O)NC1=CC=CC(=C1)C2=CC=CC=C2[C@@H]3CC4=NC=CN4C3,CS(=O)(=O)Nc1cccc(-c2ccccc2[C@@H]2Cc3nccn3C2)c1
1914,CHEMBL514874,P35368,WAY-100635,HORQTONVLZMNKK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,=,66.07,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608875,DTCC00008878,1844195,47207,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4.Cl,COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
1915,CHEMBL515170,P35368,,MSJCAWWJIHDUAU-OSTNNTLRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17428923.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of adrenergic Alpha-1B receptor at 20 uM,Not Active,Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe.,Proc. Natl. Acad. Sci. U.S.A.,2007.0,104.0,16.0,"Carter PH, Liu RQ, Foster WR, Tamasi JA, Tebben AJ, Favata M, Staal A, Cvijic ME, French MH, Dell V, Apanovitch D, Lei M, Zhao Q, Cunningham M, Decicco CP, Trzaskos JM, Feyen JH",,505739.0,DTCT0023207,2401776,DTCC00557371,1210869,29253,CC[C@H]1C(=O)NC2=C(C(=C(C=C2)F)F)[C@@](O1)(/C=C/C3CC3)C(F)(F)F,CC[C@@H]1O[C@](/C=C/C2CC2)(C(F)(F)F)c2c(ccc(F)c2F)NC1=O
1916,CHEMBL515472,P35368,,QCFZUTYIUYQTPW-JOCHJYFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19329329.0,KI,=,500.0,NM,,,,,,,,,,,,,,Inhibition of human cloned Alpha-1B adrenergic receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563503.0,DTCT0023207,2623687,DTCC00551712,554033,33115,COC1=C(C=CC=C1OCCF)[C@@H](C2CCN(CC2)CCC3=CC=C(C=C3)F)O,COc1c(OCCF)cccc1[C@H](O)C1CCN(CCc2ccc(F)cc2)CC1
1917,CHEMBL516088,P35368,,HVJOIRMQZXEGPW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19329329.0,KI,=,550.0,NM,,,,,,,,,,,,,,Inhibition of human cloned Alpha-1B adrenergic receptor by competitive binding experiment,,Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.,Bioorg. Med. Chem.,2009.0,17.0,8.0,"Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F",,563503.0,DTCT0023207,2623688,DTCC00551713,1264819,33115,COC1=C(C=CC=C1OCCF)C(=O)C2CCN(CC2)CCC3=CC=C(C=C3)F,COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1
1918,CHEMBL51871,P35368,,DTQNYMCALLNMCV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10673105.0,KI,=,210.0,NM,,,,,,,,,,,,,,Displacement of [3H]- prazosin from human recombinant Alpha-1B adrenergic receptor,,"Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,2.0,"Lagu B, Tian D, Chiu G, Nagarathnam D, Fang J, Shen Q, Forray C, Ransom RW, Chang RS, Vyas KP, Zhang K, Gluchowski C",,34341.0,DTCT0023207,643349,DTCC00194595,1078812,3936,C1CN(CCN1CCCNC(=O)N2C(C3=C(COC3=O)NC2=O)C4=CC(=C(C=C4)F)F)C5=CC=CC=C5[N+](=O)[O-],O=C1OCC2=C1C(c1ccc(F)c(F)c1)N(C(=O)NCCCN1CCN(c3ccccc3[N+](=O)[O-])CC1)C(=O)N2
1919,CHEMBL521665,P35368,,FBLWRLZXMWQVMJ-XLIONFOSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,=,263.03,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569149,DTCC00527315,1599894,31993,COC1=CC=CC=C1OCCNC[C@@H]2CO[C@@H](CO2)C3=CC=CC=C3,COc1ccccc1OCCNC[C@@H]1CO[C@H](c2ccccc2)CO1
1920,CHEMBL521694,P35368,,MBDYMQCXLMADKW-RTBURBONSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569130,DTCC00527825,856304,31993,C1[C@H](OC[C@@H](O1)C2=CC=CC=C2)CNCCOC3=CC=CC=C3,c1ccc(OCCNC[C@@H]2CO[C@@H](c3ccccc3)CO2)cc1
1921,CHEMBL522460,P35368,,CWPKTBMRVATCBL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20684563.0,KI,=,19.0,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010.0,53.0,17.0,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659613.0,DTCT0023207,13844186,DTCC00545443,1363815,40772,CC1=CC=CC=C1CN2CCC(CC2)N3CCC(CC3)N4C5=CC=CC=C5NC4=O,Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1
1922,CHEMBL522708,P35368,,WQRVLZPCOXHNAI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18433113.0,KI,=,158.49,NM,,,,,,,,,,,,,,Displacement of radioligand from human cloned adrenergic Alpha-1B receptor,,"Discovery of potent, orally bioavailable, selective 5-HT1A/B/D receptor antagonists.",J. Med. Chem.,2008.0,51.0,10.0,"Ward SE, Eddershaw PJ, Scott CM, Gordon LJ, Lovell PJ, Moore SH, Smith PW, Starr KR, Thewlis KM, Watson JM",,556327.0,DTCT0023207,2558001,DTCC00540698,404503,28818,CC1=NC2=C(C=C1)C(=CC=C2)OCCN3CCC(CC3)CC4=CC(=CC=C4)N5CCCS5(=O)=O,Cc1ccc2c(OCCN3CCC(Cc4cccc(N5CCCS5(=O)=O)c4)CC3)cccc2n1
1923,CHEMBL53,P35368,APOMORPHINE,VMWNQDUVQKEIOC-CYBMUJFWSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,676.08,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14732409,DTCC00135381,2104358,69012,CN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
1924,CHEMBL531,P35368,PERGOLIDE,YEHCICAEULNIGD-MZMPZRCHSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,691.83,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14734791,DTCC00142656,2105102,69012,CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
1925,CHEMBL532818,P35368,,OBEXOFONJDJASX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,323.59,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961197,DTCC00119756,2009189,60105,COC1=CC=CC2=C(C=CN=C21)NCCNC3=C4C=CC=C(C4=NC=C3)OC,COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12
1926,CHEMBL532818,P35368,,OBEXOFONJDJASX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,324.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961209,DTCC00119756,2009189,60105,COC1=CC=CC2=C(C=CN=C21)NCCNC3=C4C=CC=C(C4=NC=C3)OC,COc1cccc2c(NCCNc3ccnc4c(OC)cccc34)ccnc12
1927,CHEMBL533979,P35368,,OQGAVEZMVJJWSH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,147.91,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-prazosin from human alpha1B adrenergic receptor transfected in COS1 cells,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436284.0,DTCT0023207,13961198,DTCC00120166,1846541,60105,C1=CC=C2C(=C1)C(=CC=N2)NCCCCCCCNC3=CC=NC4=CC=CC=C43,c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1
1928,CHEMBL533979,P35368,,OQGAVEZMVJJWSH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25288493.0,KI,=,148.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human alpha1B adrenergic receptor transfected in COS1 cells assessed as compound required to occupy 50% of receptor,,Human a1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines.,Bioorg. Med. Chem.,2014.0,22.0,21.0,"Chen J, Campbell AP, Urmi KF, Wakelin LP, Denny WA, Griffith R, Finch AM",,1436285.0,DTCT0023207,13961210,DTCC00120166,1846541,60105,C1=CC=C2C(=C1)C(=CC=N2)NCCCCCCCNC3=CC=NC4=CC=CC=C43,c1ccc2c(NCCCCCCCNc3ccnc4ccccc34)ccnc2c1
1929,CHEMBL534512,P35368,,NTMBNTAWSSELPH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214288,DTCC00578684,488849,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)Cl.Cl,O=C(c1ccc(Cl)cc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1
1930,CHEMBL534737,P35368,,HRQFLVPRFGMKJO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214277,DTCC00578689,1263897,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4CC4.Cl,O=C(C1CC1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1
1931,CHEMBL534958,P35368,,PJJQGSLLJOVYBM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214285,DTCC00578690,195993,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)C#N.Cl,N#Cc1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCC4)cc3)C(=O)C2)cc1
1932,CHEMBL535631,P35368,,UUVMYIPSOIHEGH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214258,DTCC00578702,1555422,24162,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)F.Cl,CC(C)N1CCC(Oc2ccc(N3CCN(C(=O)c4ccc(F)cc4)CC3=O)cc2)CC1
1933,CHEMBL53675,P35368,,AXOUSXBEKHBGLU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,79.43,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1274402,DTCC00201626,2033395,5563,CCC1=CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,CCc1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O
1934,CHEMBL536991,P35368,,QBEYTQZMQMRCRI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,1584.89,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214289,DTCC00578666,1555421,24162,CC1=CC=C(C=C1)C(=O)N2CCN(C(=O)C2)C3=CC=C(C=C3)OCCCN4CCCCC4.Cl,Cc1ccc(C(=O)N2CCN(c3ccc(OCCCN4CCCCC4)cc3)C(=O)C2)cc1
1935,CHEMBL537218,P35368,,UDGQQGZVMXRRQI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,2511.89,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214278,DTCC00578667,67020,24162,CC(C)(C)C(=O)N1CCN(C(=O)C1)C2=CC=C(C=C2)OCCCN3CCCCC3.Cl,CC(C)(C)C(=O)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1
1936,CHEMBL537219,P35368,,YUWFKFBORNVPBT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,3162.28,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214251,DTCC00578669,455483,24162,C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=CC=C(C=C5)F.Cl,O=C(c1ccc(F)cc1)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1
1937,CHEMBL537403,P35368,WAY-100635,QDUDBLVWOSYWID-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22000209.0,KI,=,322.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]prazosin from Alpha-1B receptor expressed in HEK293 EBNA cells by radioligand binding assay,,"Design, synthesis and in vitro evaluation of bridgehead fluoromethyl analogs of N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)cyclohexanecarboxamide (WAY-100635) for the 5-HT(1A) receptor.",Eur. J. Med. Chem.,2011.0,46.0,12.0,"Al Hussainy R, Verbeek J, van der Born D, Booij J, Herscheid JK",,774871.0,DTCT0023207,7512869,DTCC00022305,653058,46334,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4.Cl.Cl.Cl,COc1ccccc1N1CCN(CCN(C(=O)C2CCCCC2)c2ccccn2)CC1
1938,CHEMBL538397,P35368,,NZOIFXLLVJGITJ-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,401.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104162,DTCC00454850,1242766,22924,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCCF)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC
1939,CHEMBL538397,P35368,,NZOIFXLLVJGITJ-SZPZYZBQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17904840.0,KI,=,354.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,22.0,"Chiu G, Li S, Cai H, Connolly PJ, Peng S, Stauber K, Pulito V, Liu J, Middleton SA",,450223.0,DTCT0023207,2195236,DTCC00454850,1247758,23970,COC1=C(C=C(C=C1)S(=O)(=O)NC2CCC(CC2)N3CCC(CC3)C4=CC=CC=C4OCCF)OC,COc1ccc(S(=O)(=O)NC2CCC(N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC
1940,CHEMBL539093,P35368,,MNOZJGDIRIYZSQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,LOG KI,,,,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,Not Determined,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214259,DTCC00581782,1808850,24162,CC(C)N1CCC(CC1)OC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=C(C=C4)Cl.Cl,CC(C)N1CCC(Oc2ccc(N3CCN(C(=O)c4ccc(Cl)cc4)CC3=O)cc2)CC1
1941,CHEMBL540035,P35368,,JKURLTYDYMJPLW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,13.8,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,945823,DTCC00580139,140543,16733,CCSC1=CC=CC=C1NCC2=NCCN2.Cl,CCSc1ccccc1NCC1=NCCN1
1942,CHEMBL540035,P35368,,JKURLTYDYMJPLW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,75.86,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,945817,DTCC00580139,140543,16733,CCSC1=CC=CC=C1NCC2=NCCN2.Cl,CCSc1ccccc1NCC1=NCCN1
1943,CHEMBL540035,P35368,,JKURLTYDYMJPLW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,82.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,945828,DTCC00580139,140543,16733,CCSC1=CC=CC=C1NCC2=NCCN2.Cl,CCSc1ccccc1NCC1=NCCN1
1944,CHEMBL540542,P35368,,OGDPWAJDPLTWOW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,2.19,NM,,,,,,,,,,,,,,Agonist potency at alpha-1b adrenoceptors assayed in rat-1 fibroblasts expressing human alpha-1b,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218077.0,DTCT0023207,974039,DTCC00580072,1305527,16733,CSC1=CC=CC=C1NCC2=NCCN2.Cl,CSc1ccccc1NCC1=NCCN1
1945,CHEMBL540542,P35368,,OGDPWAJDPLTWOW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,66.07,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,974033,DTCC00580072,1305527,16733,CSC1=CC=CC=C1NCC2=NCCN2.Cl,CSc1ccccc1NCC1=NCCN1
1946,CHEMBL540542,P35368,,OGDPWAJDPLTWOW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,105.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha-1b,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218075.0,DTCT0023207,974044,DTCC00580072,1305527,16733,CSC1=CC=CC=C1NCC2=NCCN2.Cl,CSc1ccccc1NCC1=NCCN1
1947,CHEMBL540633,P35368,,XAMKLIVWXRZDBC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,2511.89,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214254,DTCC00581876,1905616,24162,C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=CC=CC=C5.Cl,O=C(c1ccccc1)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1
1948,CHEMBL540634,P35368,,DFUGESMXMUMLJG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,2511.89,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214252,DTCC00581877,844085,24162,C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)N4CCN(CC4=O)C(=O)C5=CC=C(C=C5)Cl.Cl,O=C(c1ccc(Cl)cc1)N1CCN(c2ccc(OC3CCN(C4CCC4)CC3)cc2)C(=O)C1
1949,CHEMBL542139,P35368,SB-271046A,RMXZRJYGJMSDQK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9925723.0,KI,=,1995.26,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity against adrenergic Alpha-1B adrenergic receptor,,"5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist.",J. Med. Chem.,1999.0,42.0,2.0,"Bromidge SM, Brown AM, Clarke SE, Dodgson K, Gager T, Grassam HL, Jeffrey PM, Joiner GF, King FD, Middlemiss DN, Moss SF, Newman H, Riley G, Routledge C, Wyman P",,34619.0,DTCT0023207,504137,DTCC00022257,1272843,15364,CC1=C(SC2=C1C=C(C=C2)Cl)S(=O)(=O)NC3=CC(=C(C=C3)OC)N4CCNCC4.Cl,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1
1950,CHEMBL542402,P35368,,CLJWUQUYJYUFLN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,974055,DTCC00574861,691182,16733,CS(=O)C1=CC=CC=C1NCC2=NCCN2.Cl,C[S+]([O-])c1ccccc1NCC1=NCCN1
1951,CHEMBL542402,P35368,,CLJWUQUYJYUFLN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,794.33,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,974049,DTCC00574861,691182,16733,CS(=O)C1=CC=CC=C1NCC2=NCCN2.Cl,C[S+]([O-])c1ccccc1NCC1=NCCN1
1952,CHEMBL542402,P35368,,CLJWUQUYJYUFLN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as percent maximal effect for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha1b; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218076.0,DTCT0023207,974060,DTCC00574861,691182,16733,CS(=O)C1=CC=CC=C1NCC2=NCCN2.Cl,C[S+]([O-])c1ccccc1NCC1=NCCN1
1953,CHEMBL543741,P35368,BMY-7378,NIBOMXUDFLRHRV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,630.96,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,713669,DTCC00022228,969465,14595,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O.Cl.Cl,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
1954,CHEMBL543741,P35368,BMY-7378,NIBOMXUDFLRHRV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12672251.0,KI,=,707.95,NM,,cell_based,,,,,,,,,,,CHO,Affinity constant towards human recombinant Alpha-1B adrenergic receptor using [3H]prazosin (from CHO cells) as radioligand by radioligand binding assay,,"1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.",J. Med. Chem.,2003.0,46.0,8.0,"Brasili L, Sorbi C, Franchini S, Manicardi M, Angeli P, Marucci G, Leonardi A, Poggesi E",,34487.0,DTCT0023207,1113515,DTCC00022228,969618,17773,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O.Cl.Cl,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
1955,CHEMBL543741,P35368,BMY-7378,NIBOMXUDFLRHRV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21514979.0,KI,=,50.12,NM,,,,,,,,,,,,,,Binding affinity to adrenergic Alpha-1B receptor,,"Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for a(1)-adrenoceptor subtypes.",Eur. J. Med. Chem.,2011.0,46.0,7.0,"Romeo G, Materia L, Modica MN, Pittalà V, Salerno L, Siracusa MA, Manetti F, Botta M, Minneman KP",,753879.0,DTCT0023207,6001210,DTCC00022228,993521,44951,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O.Cl.Cl,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
1956,CHEMBL544290,P35368,,RIZMQYKRNDNKEZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,941908,DTCC00574815,204703,16733,CS(=O)(=O)C1=CC=CC=C1NCC2=NCCN2.Cl,CS(=O)(=O)c1ccccc1NCC1=NCCN1
1957,CHEMBL544290,P35368,,RIZMQYKRNDNKEZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,1288.25,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,941902,DTCC00574815,204703,16733,CS(=O)(=O)C1=CC=CC=C1NCC2=NCCN2.Cl,CS(=O)(=O)c1ccccc1NCC1=NCCN1
1958,CHEMBL544290,P35368,,RIZMQYKRNDNKEZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as percent maximal effect for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha1b; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218076.0,DTCT0023207,941913,DTCC00574815,204703,16733,CS(=O)(=O)C1=CC=CC=C1NCC2=NCCN2.Cl,CS(=O)(=O)c1ccccc1NCC1=NCCN1
1959,CHEMBL54943,P35368,CYSTEINE,XUJNEKJLAYXESH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14732627,DTCC00201307,2103464,69159,C(C(C(=O)O)N)S,NC(CS)C(=O)O
1960,CHEMBL549764,P35368,,RZKGYUBITDXCBT-QHEXFSSWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19719240.0,KI,=,22.39,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.,J. Med. Chem.,2009.0,52.0,15.0,"Giardinà D, Martarelli D, Sagratini G, Angeli P, Ballinari D, Gulini U, Melchiorre C, Poggesi E, Pompei P",,574169.0,DTCT0023207,2880169,DTCC00587661,694911,34689,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@@H]3CCCC4)C(=O)C5COC6=CC=CC=C6O5)N)OC,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@@H]43)nc(N)c2cc1OC
1961,CHEMBL55290,P35368,,IGRIBIYYAXAWCQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,39.81,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1250016,DTCC00201680,257627,5563,CC1=NNC(=O)N(C1=O)CCCN2CCN(CC2)C3=CC=CC=C3OCC(F)(F)F,Cc1n[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O
1962,CHEMBL55319,P35368,,SYPZJTHVWQUCJS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,13.61,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1115789,DTCC00204041,1499599,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCCN1CCN(c2cc(Cl)ccc2Cl)CC1
1963,CHEMBL553276,P35368,,QBOMVICVWJRPCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,61.66,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,956283,DTCC00574864,1693323,16733,CC(C)SC1=CC=CC=C1NCC2=NCCN2.Cl,CC(C)Sc1ccccc1NCC1=NCCN1
1964,CHEMBL553276,P35368,,QBOMVICVWJRPCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,169.82,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,956277,DTCC00574864,1693323,16733,CC(C)SC1=CC=CC=C1NCC2=NCCN2.Cl,CC(C)Sc1ccccc1NCC1=NCCN1
1965,CHEMBL553276,P35368,,QBOMVICVWJRPCM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,29.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,956288,DTCC00574864,1693323,16733,CC(C)SC1=CC=CC=C1NCC2=NCCN2.Cl,CC(C)Sc1ccccc1NCC1=NCCN1
1966,CHEMBL554416,P35368,,BPLCUMGTKWCTIH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,831.76,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,964105,DTCC00574854,140544,16733,CCCS(=O)(=O)C1=CC=CC=C1NCC2=NCCN2.Cl,CCCS(=O)(=O)c1ccccc1NCC1=NCCN1
1967,CHEMBL554416,P35368,,BPLCUMGTKWCTIH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as percent maximal effect for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha1b; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218076.0,DTCT0023207,964116,DTCC00574854,140544,16733,CCCS(=O)(=O)C1=CC=CC=C1NCC2=NCCN2.Cl,CCCS(=O)(=O)c1ccccc1NCC1=NCCN1
1968,CHEMBL554416,P35368,,BPLCUMGTKWCTIH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,PEC5,<,4.0,,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor assayed in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34474.0,DTCT0023207,964111,DTCC00574854,140544,16733,CCCS(=O)(=O)C1=CC=CC=C1NCC2=NCCN2.Cl,CCCS(=O)(=O)c1ccccc1NCC1=NCCN1
1969,CHEMBL55460,P35368,,CAFBNEJZNQABOY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1120093,DTCC00204040,626427,18073,CN(CCNC1=C(C=CC(=C1)Cl)Cl)CCN2C(=O)CC3(CCCC3)CC2=O,CN(CCNc1cc(Cl)ccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O
1970,CHEMBL555146,P35368,,VGSYEFOBFMUWGO-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22313227.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant alpha1B adrenergic receptor,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012.0,55.0,5.0,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818815.0,DTCT0023207,10474259,DTCC00380469,1106159,48153,C[C@@H]1CCCN1CCC2=CC3=C(O2)C=CC(=C3)C(=O)C4=CC=C(C=C4)F,C[C@@H]1CCCN1CCc1cc2cc(C(=O)c3ccc(F)cc3)ccc2o1
1971,CHEMBL55629,P35368,,ALXPTLNJYZORDB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,63.1,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1268947,DTCC00201843,1455522,5563,CC1=CNC(=O)N(C1=O)CC2(CC2)CN3CCN(CC3)C4=CC=CC=C4OCC(F)(F)F,Cc1c[nH]c(=O)n(CC2(CN3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)c1=O
1972,CHEMBL556313,P35368,,NWSVOKGXCYCZTI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,5.88,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1133146,DTCC00203896,593943,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)F)F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1
1973,CHEMBL556313,P35368,,NWSVOKGXCYCZTI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15828846.0,KI,=,54.0,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor,,"Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.",J. Med. Chem.,2005.0,48.0,8.0,"Konkel MJ, Wetzel JM, Cahir M, Craig DA, Noble SA, Gluchowski C",,302652.0,DTCT0023207,1825484,DTCC00203896,584579,19681,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)F)F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1
1974,CHEMBL55645,P35368,,SDHKUGRGWQZRIK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,158.49,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1273385,DTCC00201764,679494,5563,C1CN(CCN1CCCN2C(=O)C(=CNC2=O)CO)C3=C(C=C(C=C3)F)OCC(F)(F)F,O=c1[nH]cc(CO)c(=O)n1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1
1975,CHEMBL55647,P35368,,JRIJKAXXNHPPNJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1105546,DTCC00204240,1046427,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4[N+](=O)[O-],O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2[N+](=O)[O-])CC1
1976,CHEMBL55654,P35368,,RURCUXSXKOFVNM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,26.6,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1121706,DTCC00204028,690960,18073,CC1=C(C=C(C=C1)Cl)N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
1977,CHEMBL55655,P35368,,XUSSJIRIJFBRBH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,812.58,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1125325,DTCC00204029,400698,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)[N+](=O)[O-])Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc([N+](=O)[O-])ccc2Cl)CC1
1978,CHEMBL556782,P35368,,GFGGZTNVJUNZEE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,1995.26,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214253,DTCC00578668,195994,24162,CC1=CC=C(C=C1)C(=O)N2CCN(C(=O)C2)C3=CC=C(C=C3)OC4CCN(CC4)C5CCC5.Cl,Cc1ccc(C(=O)N2CCN(c3ccc(OC4CCN(C5CCC5)CC4)cc3)C(=O)C2)cc1
1979,CHEMBL55695,P35368,,DYZCPAWLFLCJHL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,10.0,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1258254,DTCC00201678,1552448,5563,CC1=CNC(=O)N(C1=O)CCCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,Cc1c[nH]c(=O)n(CCCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O
1980,CHEMBL55790,P35368,,IOLUHLGDTSFFNV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,915.4,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1097595,DTCC00204027,1078907,18073,CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCN(C)C3=C(C=CC(=C3)Cl)Cl,CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCN(C)c1cc(Cl)ccc1Cl
1981,CHEMBL558226,P35368,SC-52491,DHGXYMAJZPNYQQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,IC50,>,10000.0,NM,,,,,,,,,,,,,,Compound was tested for inhibitory activity against adrenergic alpha-1 receptor,,,Bioorg. Med. Chem. Lett.,1997.0,7.0,17.0,,,30084.0,DTCT0023207,1022055,DTCC00022374,1196056,2213,COC1=CC(=C(C=C1C(=O)NC2C3CC4C2CN(C4)C3)Cl)N.Cl,COc1cc(N)c(Cl)cc1C(=O)NC1C2CC3CN(C2)CC31
1982,CHEMBL55882,P35368,,VRQYVXIQZGEPQK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,79.62,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1135628,DTCC00204230,529540,18073,C1CC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
1983,CHEMBL558890,P35368,,RZKGYUBITDXCBT-WEAPTXNRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19719240.0,KI,=,1.41,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.,J. Med. Chem.,2009.0,52.0,15.0,"Giardinà D, Martarelli D, Sagratini G, Angeli P, Ballinari D, Gulini U, Melchiorre C, Poggesi E, Pompei P",,574169.0,DTCT0023207,2880168,DTCC00593959,1567908,34689,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@H]4[C@@H]3CCCC4)C(=O)C5COC6=CC=CC=C6O5)N)OC,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@@H]4CCCC[C@@H]43)nc(N)c2cc1OC
1984,CHEMBL559206,P35368,,WEVNWEYCEGALHH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18052318.0,KI,<,2511.89,NM,,cell_based,,,,,,,,,,,Rat1,Antagonist activity at human recombinant adrenergic alpha 1B receptor expressed in Rat1 cells assessed as inhibition of phenylephrine-induced cellular calcium mobilization,,4-acyl-1-(4-aminoalkoxyphenyl)-2-ketopiperazines as a novel class of non-brain-penetrant histamine H3 receptor antagonists.,J. Med. Chem.,2007.0,50.0,26.0,"Procopiou PA, Ancliff RA, Bamford MJ, Browning C, Connor H, Davies S, Fogden YC, Hodgson ST, Holmes DS, Looker BE, Morriss KM, Parr CA, Pickup EA, Sehmi SS, White GV, Watts CJ, Wilson DM, Woodrow MD",,452852.0,DTCT0023207,2214138,DTCC00581783,811223,24162,C1CCN(CC1)CCCOC2=CC=C(C=C2)N3CCN(CC3=O)C(=O)C4=CC=CC=C4.Cl,O=C(c1ccccc1)N1CCN(c2ccc(OCCCN3CCCCC3)cc2)C(=O)C1
1985,CHEMBL56,P35368,8-OH-DPAT,ASXGJMSKWNBENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,LOG KI,<,6.0,NM,,cell_based,,,,,,,,,,,,The binding affinity was evaluated on cloned human alpha-1B adrenergic receptor expressed in chinese hamster ovary(CHO) cells by using [3H]prazosin as radioligand.,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34622.0,DTCT0023207,1004965,DTCC00135617,1968637,15289,CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O,CCCN(CCC)C1CCc2cccc(O)c2C1
1986,CHEMBL56,P35368,8-OH-DPAT,ASXGJMSKWNBENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10514291.0,KI,<,1000.0,NM,,,,,,,,,,,,,,Displacement of [3H]prazosin from human cloned Alpha-1B adrenergic receptor,,WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for alpha(1)-adrenoreceptor subtypes and 5-HT(1A) receptors.,J. Med. Chem.,1999.0,42.0,20.0,"Bolognesi ML, Budriesi R, Cavalli A, Chiarini A, Gotti R, Leonardi A, Minarini A, Poggesi E, Recanatini M, Rosini M, Tumiatti V, Melchiorre C",,34485.0,DTCT0023207,649230,DTCC00135617,1980887,15434,CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O,CCCN(CCC)C1CCc2cccc(O)c2C1
1987,CHEMBL56,P35368,8-OH-DPAT,ASXGJMSKWNBENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,5975.0,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1530673,DTCC00135617,1979981,16317,CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O,CCCN(CCC)C1CCc2cccc(O)c2C1
1988,CHEMBL56,P35368,8-OH-DPAT,ASXGJMSKWNBENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11728188.0,KI,=,5975.0,NM,,,,,,,,,,,,,,Binding affinity was determined on human cloned alpha-1B adrenergic receptor,,"trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.",J. Med. Chem.,2001.0,44.0,25.0,"Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R",,34339.0,DTCT0023207,1454751,DTCC00135617,1980967,16537,CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O,CCCN(CCC)C1CCc2cccc(O)c2C1
1989,CHEMBL56,P35368,8-OH-DPAT,ASXGJMSKWNBENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,1882.0,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1110944,DTCC00135617,1979606,18073,CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O,CCCN(CCC)C1CCc2cccc(O)c2C1
1990,CHEMBL56,P35368,8-OH-DPAT,ASXGJMSKWNBENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18817363.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human cloned Alpha-1B adrenoceptor expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.",J. Med. Chem.,2008.0,51.0,20.0,"Quaglia W, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Rafaiani G, Carrieri A, Amantini C, Lucciarini R, Santoni G, Poggesi E, Leonardi A",,539781.0,DTCT0023207,2569132,DTCC00135617,1982988,31993,CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O,CCCN(CCC)C1CCc2cccc(O)c2C1
1991,CHEMBL56,P35368,8-OH-DPAT,ASXGJMSKWNBENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20185311.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenergic receptor expressed in CHO cells,,Discovery of a new series of 5-HT1A receptor agonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,6.0,"Franchini S, Prandi A, Sorbi C, Tait A, Baraldi A, Angeli P, Buccioni M, Cilia A, Poggesi E, Fossa P, Brasili L",,615773.0,DTCT0023207,3228666,DTCC00135617,1972539,38187,CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O,CCCN(CCC)C1CCc2cccc(O)c2C1
1992,CHEMBL56,P35368,8-OH-DPAT,ASXGJMSKWNBENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22145629.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human recombinant alpha1B adrenoceptor expressed in CHO cells after 30 mins by liquid scintillation counting,,"Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic a1- and serotonine 5-HT1A receptors.",J. Med. Chem.,2012.0,55.0,1.0,"Prandi A, Franchini S, Manasieva LI, Fossa P, Cichero E, Marucci G, Buccioni M, Cilia A, Pirona L, Brasili L",,800454.0,DTCT0023207,7608874,DTCC00135617,1973938,47207,CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O,CCCN(CCC)C1CCc2cccc(O)c2C1
1993,CHEMBL56,P35368,8-OH-DPAT,ASXGJMSKWNBENU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23252794.0,KI,>,1000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prazosin from human recombinant alpha1B adrenergic receptor expressed in CHO cell membranes after 30 mins,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in a1-adrenergic and 5-HT1A receptor binding sites recognition.",J. Med. Chem.,2013.0,56.0,2.0,"Bonifazi A, Piergentili A, Del Bello F, Farande Y, Giannella M, Pigini M, Amantini C, Nabissi M, Farfariello V, Santoni G, Poggesi E, Leonardi A, Menegon S, Quaglia W",,936572.0,DTCT0023207,11756540,DTCC00135617,1995139,53287,CCCN(CCC)C1CCC2=C(C1)C(=CC=C2)O,CCCN(CCC)C1CCc2cccc(O)c2C1
1994,CHEMBL56150,P35368,,AXWMVVQSGDHICA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1121702,DTCC00203981,1881968,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC(=C(C=C4)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(Cl)c(Cl)c2)CC1
1995,CHEMBL561851,P35368,,NXJYLDGTQWINTD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19719240.0,KI,=,0.9329999999999999,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.,J. Med. Chem.,2009.0,52.0,15.0,"Giardinà D, Martarelli D, Sagratini G, Angeli P, Ballinari D, Gulini U, Melchiorre C, Poggesi E, Pompei P",,574169.0,DTCT0023207,2880170,DTCC00583052,1017945,34689,CN(CCCCCCN(C)C(=O)C1COC2=CC=CC=C2O1)C3=NC4=CC(=C(C=C4C(=N3)N)OC)OC,COc1cc2nc(N(C)CCCCCCN(C)C(=O)C3COc4ccccc4O3)nc(N)c2cc1OC
1996,CHEMBL56248,P35368,,FPRCXYVVQHMAFI-IZVMNLJQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,130.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,641228,DTCC00204611,172529,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@H]2CC[C@@H](C2)N3CCC(CC3)C4=CC=CC=N4)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1
1997,CHEMBL56292,P35368,,QGNJCJCADQNVJR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,7.76,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1122888,DTCC00204246,2076784,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCC(CC3)C4=CC=CC=C4Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCC(c2ccccc2Cl)CC1
1998,CHEMBL56331,P35368,RS-100329,RCOBWVAGWYRNHZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,31.62,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1271171,DTCC01740394,1423663,5563,CC1=CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=CC=CC=C3OCC(F)(F)F,Cc1c[nH]c(=O)n(CCCN2CCN(c3ccccc3OCC(F)(F)F)CC2)c1=O
1999,CHEMBL56375,P35368,,CFECXSNWRXZHNR-QFBILLFUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,251.19,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1257052,DTCC00105154,1649500,5563,C[C@]1([C@@H](NC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F)O)O,C[C@]1(O)C(=O)N(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)C(=O)N[C@H]1O
2000,CHEMBL56403,P35368,,HKVGUNQUKFESHS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1121714,DTCC00204372,1467220,18073,CC1(CC(=O)N(C(=O)C1)CCN2CCN(CC2)C3=CC=CC=C3Cl)C,CC1(C)CC(=O)N(CCN2CCN(c3ccccc3Cl)CC2)C(=O)C1
2001,CHEMBL56438,P35368,,LAZUXKZZDKCHKK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,ACTIVITY,=,0.1,,,,,,,,,,,,,,,Fraction involved in salt bridge interactions with Asp3:11 part of the alpha-1B adrenergic receptor,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34189.0,DTCT0023207,1108223,DTCC00204012,1563982,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
2002,CHEMBL56438,P35368,,LAZUXKZZDKCHKK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,9.9,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1108212,DTCC00204012,1563982,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
2003,CHEMBL56438,P35368,,LAZUXKZZDKCHKK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,PKB,=,5.55,,,,,,,,,,,,,,,Dissociation constant against guinea pig spleen alpha-1B adrenergic receptor in vitro was determined,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34192.0,DTCT0023207,1108217,DTCC00204012,1563982,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
2004,CHEMBL56438,P35368,,LAZUXKZZDKCHKK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,RATIO,=,76.15,,,,,,,,,,,,,,,Selectivity ratio towards alpha-1B adrenergic receptor compared with other receptors,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,226997.0,DTCT0023207,1108219,DTCC00204012,1563982,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
2005,CHEMBL56439,P35368,,LBZWBSVJICGQRV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1102624,DTCC00204013,1849713,18073,CN(CCN1C(=O)CC2(CCCC2)CC1=O)CC(=O)N(C)C3=C(C=CC(=C3)Cl)Cl,CN(CCN1C(=O)CC2(CCCC2)CC1=O)CC(=O)N(C)c1cc(Cl)ccc1Cl
2006,CHEMBL564481,P35368,CYCLODOXAZOSIN,RZKGYUBITDXCBT-ZJWBFHOUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19719240.0,KI,=,0.41700000000000004,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.,J. Med. Chem.,2009.0,52.0,15.0,"Giardinà D, Martarelli D, Sagratini G, Angeli P, Ballinari D, Gulini U, Melchiorre C, Poggesi E, Pompei P",,574169.0,DTCT0023207,2880167,DTCC00586036,1665010,34689,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN([C@@H]4[C@H]3CCCC4)C(=O)C5COC6=CC=CC=C6O5)N)OC,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)[C@H]4CCCC[C@H]43)nc(N)c2cc1OC
2007,CHEMBL56489,P35368,,QPOJVLKZPPBFKN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,158.49,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1282412,DTCC00201837,485839,5563,CC1=CC(=O)N(C(=O)N1)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,Cc1cc(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c(=O)[nH]1
2008,CHEMBL56558,P35368,,JQADWKQLVHNXRA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1102628,DTCC00203945,1914046,18073,CN(C1=C(C=CC(=C1)Cl)Cl)C(=O)CNCCN2C(=O)CC3(CCCC3)CC2=O,CN(C(=O)CNCCN1C(=O)CC2(CCCC2)CC1=O)c1cc(Cl)ccc1Cl
2009,CHEMBL56620,P35368,,PBOALASTYPPBPW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,83.61,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1096150,DTCC00204768,497463,18073,C1CCC2(C1)CC(=O)N(C2=O)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCC2)C(=O)N1CCN1CCN(c2cc(Cl)ccc2Cl)CC1
2010,CHEMBL56804,P35368,,IXXRJDPEMQTXTR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,35.56,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1108227,DTCC00203941,1596410,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4C5CC5,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2C2CC2)CC1
2011,CHEMBL56805,P35368,,KVZHZGYSXAXYRK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1104018,DTCC00203942,497462,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4C(F)(F)F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2C(F)(F)F)CC1
2012,CHEMBL56851,P35368,,LAONLJLGRHVSLN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1131869,DTCC00203897,1467219,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC=C4Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2c(Cl)cccc2Cl)CC1
2013,CHEMBL56863,P35368,,LOSOVXONSYGDJN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,5.01,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1265500,DTCC00201751,1423662,5563,C1CN(CCN1CCCN2C(=O)C3=CC=CC=C3NC2=O)C4=CC=CC=C4OCC(F)(F)F,O=c1[nH]c2ccccc2c(=O)n1CCCN1CCN(c2ccccc2OCC(F)(F)F)CC1
2014,CHEMBL56869,P35368,,ZWLNTIYBKQAWAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,122.03,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1098961,DTCC00204025,1207204,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4Br,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Br)CC1
2015,CHEMBL56878,P35368,,SXINCFMIBHSDBJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1129286,DTCC00204200,367915,18073,CCOC(=O)C1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,CCOC(=O)c1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
2016,CHEMBL56899,P35368,,MQBZNVUMTSNRTI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,47.54,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1110932,DTCC00204699,1596411,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Br)Br,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(Br)ccc2Br)CC1
2017,CHEMBL569270,P35368,,UTPGRZGMQVAYAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,24147864.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human alpha-1B adrenergic receptor by PDSP assay,,Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1).,J. Med. Chem.,2013.0,56.0,22.0,"Xu R, Zanotti-Fregonara P, Zoghbi SS, Gladding RL, Woock AE, Innis RB, Pike VW",,1274794.0,DTCT0023207,12941483,DTCC00606473,1333771,56413,CNC1=NC=NC(=C1)C2=CSC(=N2)N(C)C(=O)C3=CC=C(C=C3)F,CNc1cc(-c2csc(N(C)C(=O)c3ccc(F)cc3)n2)ncn1
2018,CHEMBL56974,P35368,,SOUVKJLYRGDDOT-XJGOYTCSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,14.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,641231,DTCC00204302,949325,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@@H]2CC[C@H](C2)N3CCN(CC3)C4=CC=CC=C4C#N)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@@H]2CC[C@@H](N3CCN(c4ccccc4C#N)CC3)C2)C(=O)N1
2019,CHEMBL57097,P35368,,YKHNMLLSJVJESN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1108231,DTCC00204453,819891,18073,CC(=O)N1CCC2(CC1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(C(C)=O)CC3)CC2=O)CC1
2020,CHEMBL57098,P35368,,DYAIXJSMQOGHAZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1097603,DTCC00204454,2012461,18073,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCNCC4)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCNCC3)CC2=O)CC1
2021,CHEMBL57163,P35368,,FKIGXRKDASCJOU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,2.57,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1580555,DTCC00200226,917410,17389,C1CN(CCN1CCN2C(=O)C3=C(C4=CC=CC=C4N3)NC2=O)C5=CC=CC=C5Cl,O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2Cl)CC1
2022,CHEMBL57168,P35368,,FTBUCOBNSRIEMM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1117194,DTCC00204378,140308,18073,COC1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,COc1ccc(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)cc1
2023,CHEMBL57317,P35368,,OPNJYTBFAIGRFB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,43.35,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1115793,DTCC00204449,593944,18073,CCC1(CC(=O)N(C(=O)C1)CCN2CCN(CC2)C3=C(C=CC(=C3)Cl)Cl)C,CCC1(C)CC(=O)N(CCN2CCN(c3cc(Cl)ccc3Cl)CC2)C(=O)C1
2024,CHEMBL57364,P35368,,ATIJQZLSMDZBIR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,220.52,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1122876,DTCC00204434,1370528,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC(=CC=C4)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cccc(Cl)c2)CC1
2025,CHEMBL57425,P35368,,XAAKCGAPUOGSOP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1115785,DTCC00204500,75621,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=C(C=C4)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(Cl)cc2)CC1
2026,CHEMBL57540,P35368,,NMZPGTCGQWMZBC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,131.95,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1098969,DTCC00204747,1143880,18073,COC1=CC=CC=C1N2CCN(CC2)CCN3C=CC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2C=CC3(CCCC3)CC2=O)CC1
2027,CHEMBL57546,P35368,,YSLMGFFVMWWPSA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1094797,DTCC00204416,497459,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=C(C=C4)F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2)CC1
2028,CHEMBL57546,P35368,,YSLMGFFVMWWPSA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15828846.0,KI,=,255.0,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor,,"Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.",J. Med. Chem.,2005.0,48.0,8.0,"Konkel MJ, Wetzel JM, Cahir M, Craig DA, Noble SA, Gluchowski C",,302652.0,DTCT0023207,1825345,DTCC00204416,488112,19681,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=C(C=C4)F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2)CC1
2029,CHEMBL57593,P35368,,DABSIMIABRDOKT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,86.96,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1109564,DTCC00204379,204448,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2Cl)CC1
2030,CHEMBL57691,P35368,,FPRCXYVVQHMAFI-ISCCLHIJSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10987417.0,KI,=,290.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor stably expressed in LM cells,,"Preparation and evaluation of 1,3-diaminocyclopentane-linked dihydropyrimidinone derivatives as selective alpha1a-receptor antagonists.",Bioorg. Med. Chem. Lett.,2000.0,10.0,17.0,"Barrow JC, Glass KL, Selnick HG, Freidinger RM, Chang RS, O'Malley SS, Woyden C",,34345.0,DTCT0023207,637865,DTCC00204046,2044753,3840,COCC1=C([C@@H](N(C(=O)N1)C(=O)N[C@H]2CC[C@H](C2)N3CCC(CC3)C4=CC=CC=N4)C5=CC(=C(C=C5)F)F)C(=O)OC,COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccn4)CC3)C2)C(=O)N1
2031,CHEMBL57740,P35368,,MWHOAOCIHTURNQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,100.0,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1247790,DTCC00201838,1713461,5563,CC(C)C1=CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,CC(C)c1c[nH]c(=O)n(CCCN2CCN(c3ccc(F)cc3OCC(F)(F)F)CC2)c1=O
2032,CHEMBL57747,P35368,,YIKBIQNMYTVXBG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1120089,DTCC00204270,916710,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC(=C4)C(F)(F)F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cccc(C(F)(F)F)c2)CC1
2033,CHEMBL57797,P35368,,CRMNYGHOWIXDED-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1129295,DTCC00204015,1752990,18073,CN(CCN1C(=O)CC2(CCCC2)CC1=O)CC(=O)NC3=C(C=CC(=C3)Cl)Cl,CN(CCN1C(=O)CC2(CCCC2)CC1=O)CC(=O)Nc1cc(Cl)ccc1Cl
2034,CHEMBL57859,P35368,,FEWRBUTUYATDFG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,54.99,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1117206,DTCC00204296,1402937,18073,COC1=CC=CC=C1N2CCN(CC2)CCN3CCC4(CCCC4)CC3=O,COc1ccccc1N1CCN(CCN2CCC3(CCCC3)CC2=O)CC1
2035,CHEMBL57868,P35368,,GUJILKGAXBCELS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,17.01,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1130495,DTCC00204661,561767,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)Cl)C#N,N#Cc1ccc(Cl)cc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
2036,CHEMBL57882,P35368,,XKCZYCVTPRLLOI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1124076,DTCC00204651,204450,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)C(F)(F)F)F,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(C(F)(F)F)ccc2F)CC1
2037,CHEMBL57999,P35368,,YNIYVMWQXYYOIY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1122880,DTCC00203877,433018,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cccc(Cl)c2Cl)CC1
2038,CHEMBL58105,P35368,,HKSUNNWTUBMNAB-GHTZIAJQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,11.3,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1272571,DTCC00208332,2065244,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=C(S5)C6=CC=CC=C6)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(-c5ccccc5)sc4c3=O)C[C@@H]21
2039,CHEMBL58384,P35368,,BVYRODJRYHZDHU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,447.86,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1134411,DTCC00204658,464498,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=C(C=CC(=C4)I)Cl,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(I)ccc2Cl)CC1
2040,CHEMBL58476,P35368,,DHPRWORIQRWDMF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,119.18,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1101355,DTCC00204593,819892,18073,CC1=CC(=C(C=C1)F)N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,Cc1ccc(F)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1
2041,CHEMBL58585,P35368,,HJYOVHVIYFAHDI-OXJNMPFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,191.0,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1270432,DTCC00208300,323481,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4CC5=CC(=C(C=C5NC4=O)OC)OC,COc1cc2c(cc1OC)NC(=O)N(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)C2
2042,CHEMBL58612,P35368,,RLJXOVFXQJQZMU-HNAYVOBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,29.1,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1266958,DTCC00208401,1649584,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCNC(=O)C4=CC(=C(C=C4N)OC)OC,COc1cc(N)c(C(=O)NCCN2C[C@@H]3CCc4c(OC)cccc4[C@@H]3C2)cc1OC
2043,CHEMBL58862,P35368,,UEDODQFERYKFQS-OXJNMPFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,3.31,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1264704,DTCC00208261,614693,16272,CN1C2=CC(=C(C=C2C(=O)N(C1=O)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC)OC)OC,COc1cc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)n(C)c2cc1OC
2044,CHEMBL589,P35368,ROPINIROLE,UHSKFQJFRQCDBE-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14741149,DTCC00148082,2107640,69012,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,CCCN(CCC)CCc1cccc2c1CC(=O)N2
2045,CHEMBL589,P35368,ROPINIROLE,UHSKFQJFRQCDBE-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14978194.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14741148,DTCC00148082,2107639,69180,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,CCCN(CCC)CCc1cccc2c1CC(=O)N2
2046,CHEMBL58930,P35368,,RQOKWILVQFVGSH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1114678,DTCC00203944,1467221,18073,CN(CCN1C(=O)CC2(CCCC2)CC1=O)CCOC3=CC=CC=C3Cl,CN(CCOc1ccccc1Cl)CCN1C(=O)CC2(CCCC2)CC1=O
2047,CHEMBL58956,P35368,,GWTJWBBBBACSBB-MGPUTAFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,0.66,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1268162,DTCC00208550,1838427,16272,COC1=CC2=C(C=C1)C(=O)N(C(=O)N2)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC,COc1ccc2c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)[nH]c2c1
2048,CHEMBL59033,P35368,,BADSRELYUVTCEO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1102632,DTCC00203943,204449,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCNCCOC3=CC=CC=C3Cl,O=C1CC2(CCCC2)CC(=O)N1CCNCCOc1ccccc1Cl
2049,CHEMBL590615,P35368,,CWYDYWFZPBTTIM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19954972.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Alpha1B adrenoceptor receptor at 10 uM,,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603545.0,DTCT0023207,3163745,DTCC00609878,176896,36082,C1C2C3C4C1C5C2C6C3C4C5(O6)NCCC7=CC(=CC=C7)F,Fc1cccc(CCNC23OC4C5C6CC(C7C6C4C72)C53)c1
2050,CHEMBL59149,P35368,,MIFOAIQVLLADSX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,193.29,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1129290,DTCC00204693,1563983,18073,CC1=CC(=C(C=C1)Cl)N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,Cc1ccc(Cl)c(N2CCN(CCN3C(=O)CC4(CCCC4)CC3=O)CC2)c1
2051,CHEMBL59153,P35368,,UOHTVECYVGDMIO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12749888.0,KI,=,125.89,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of [3H]prazosin binding to CHO-K1 whole cells expressing human cloned Alpha-1B adrenergic receptor,,"Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonists.",Bioorg. Med. Chem. Lett.,2003.0,13.0,11.0,"Lopez FJ, Arias L, Chan R, Clarke DE, Elworthy TR, Ford AP, Guzman A, Jaime-Figueroa S, Jasper JR, Morgans DJ, Padilla F, Perez-Medrano A, Quintero C, Romero M, Sandoval L, Smith SA, Williams TJ, Blue DR",,34616.0,DTCT0023207,1265509,DTCC00201750,1552449,5563,C1CNC(=O)N(C1=O)CCCN2CCN(CC2)C3=C(C=C(C=C3)F)OCC(F)(F)F,O=C1CCNC(=O)N1CCCN1CCN(c2ccc(F)cc2OCC(F)(F)F)CC1
2052,CHEMBL59262,P35368,,IVMAVCHNIRPHMA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,5.38,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1110936,DTCC00204017,787538,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=C(C=CC(=C4)Cl)Cl,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cc(Cl)ccc2Cl)CC1
2053,CHEMBL59315,P35368,,XDLONFWTAWHJIX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1121698,DTCC00203895,335211,18073,C1CCC2(C1)CC(=O)N(C(=O)C2)CCN3CCN(CC3)C4=CC=CC=C4O,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2O)CC1
2054,CHEMBL595449,P35368,,ILPANLYEJQKXKY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19646882.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of Alpha-1B adrenergic receptor,,Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.,Bioorg. Med. Chem.,2009.0,17.0,17.0,"Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S, Wannemacher KM, Howells RD, Welsh WJ",,601701.0,DTCT0023207,3163167,DTCC00612138,1136637,36541,CC(C)(C)C1=CC=C(C=C1)C2=NC(=NN2C3=CC(=CC=C3)O)CN(C)C,CN(C)Cc1nc(-c2ccc(C(C)(C)C)cc2)n(-c2cccc(O)c2)n1
2055,CHEMBL59575,P35368,,WKPITOGUWYLINO-WMZHIEFXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,116.0,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1265860,DTCC00208324,1681740,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4CCC5=CC(=C(C=C5C4)OC)OC,COc1cc2c(cc1OC)CN(CCN1C[C@@H]3CCc4c(OC)cccc4[C@@H]3C1)CC2
2056,CHEMBL59590,P35368,,FJFCVNFWRHPKPL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11459670.0,KI,=,570.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards cloned human Alpha-1B adrenergic receptor,,Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2001.0,11.0,14.0,"DiPardo RM, Patane MA, Newton RC, Price R, Broten TP, Chang RS, Ransom RW, Di Salvo J, Freidinger RM, Bock MG",,34460.0,DTCT0023207,1661431,DTCC00207926,1002510,4355,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)(C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4C)O,Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3C)CC2)c2ccc(C)cc2)cc1
2057,CHEMBL597,P35368,PHENTOLAMINE,MRBDMNSDAVCSSF-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16153828.0,KI,=,47.4,NM,,cell_based,,,,,,,,,,,CHO,Binding affinity towards human alpha-1B adrenergic receptor expressed in Chinese Hamster ovary (CHO) cells,,Bioisosteric phentolamine analogs as potent alpha-adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2005.0,15.0,21.0,"Hong SS, Bavadekar SA, Lee SI, Patil PN, Lalchandani SG, Feller DR, Miller DD",,320869.0,DTCT0023207,1859043,DTCC00148793,1630986,19790,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
2058,CHEMBL597,P35368,PHENTOLAMINE,MRBDMNSDAVCSSF-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26005522.0,IC50,=,10.8,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-Prazosin from human alpha-1B adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,5.0,,,1497771.0,DTCT0023207,14440306,DTCC00148793,1627419,62748,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
2059,CHEMBL597,P35368,PHENTOLAMINE,MRBDMNSDAVCSSF-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,26005522.0,KI,=,4.8,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-Prazosin from human alpha-1B adrenergic receptor transfected in CHO cell membranes after 2 hrs by microplate scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,5.0,,,1497771.0,DTCT0023207,14440351,DTCC00148793,1627419,62748,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1
2060,CHEMBL600053,P35368,,BKYSPAJPVPEZOE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19954972.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Alpha1B adrenoceptor receptor at 10 uM,,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603545.0,DTCT0023207,3163744,DTCC00609877,405425,36082,C1C2C3C4C1C5C2C6C3C4C5(O6)NCC7=CC(=CC=C7)F,Fc1cccc(CNC23OC4C5C6CC(C7C6C4C72)C53)c1
2061,CHEMBL602850,P35368,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19954972.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of Alpha1B adrenoceptor receptor at 10 uM,Not Determined,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603545.0,DTCT0023207,3163743,DTCC00609826,1309981,36082,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1cccc(F)c1
2062,CHEMBL602850,P35368,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11474353,DTCC00609826,1300183,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1cccc(F)c1
2063,CHEMBL602850,P35368,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600213,DTCC00609826,1301031,55935,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1cccc(F)c1
2064,CHEMBL60452,P35368,,IEMRAOUETYELPW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11459670.0,KI,>,2000.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards cloned human Alpha-1B adrenergic receptor,,Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2001.0,11.0,14.0,"DiPardo RM, Patane MA, Newton RC, Price R, Broten TP, Chang RS, Ransom RW, Di Salvo J, Freidinger RM, Bock MG",,34460.0,DTCT0023207,1659109,DTCC00207277,1902700,4355,CC1=CC=C(C=C1)C2(CC(=S)N(C2=O)CCCN3CCC(CC3)(C#N)C4=CC=CC=C4Cl)C5=CC=C(C=C5)C,Cc1ccc(C2(c3ccc(C)cc3)CC(=S)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1
2065,CHEMBL60471,P35368,,YBNNEESMGJJPKH-IFXJQAMLSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,2.71,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1272575,DTCC00208488,64010,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=C(C=C5)Cl)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(Cl)ccc4c3=O)C[C@@H]21
2066,CHEMBL60510,P35368,,CLIPGTAXZKATAJ-LAUBAEHRSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,4.07,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1273759,DTCC00208406,1649583,16272,CC1=CC2=C(C=C1C)NC(=O)N(C2=O)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C)c(C)cc4c3=O)C[C@@H]21
2067,CHEMBL60583,P35368,,WOTQTCOGYGHNIU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,4.97,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1125321,DTCC00204198,335209,18073,CC(C)OC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCCC4)CC3=O,CC(C)Oc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1
2068,CHEMBL60699,P35368,,CSAAHSGMWAZWDZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,=,262.76,NM,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen,,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34190.0,DTCT0023207,1100241,DTCC00204435,1914045,18073,COC1=CC=CC=C1N2CCN(CC2)CCN3C(=O)CC4(CCN(CC4)CC5=CC=CC=C5)CC3=O,COc1ccccc1N1CCN(CCN2C(=O)CC3(CCN(Cc4ccccc4)CC3)CC2=O)CC1
2069,CHEMBL60721,P35368,,YJZIBDJFLKZMFA-WMLDXEAASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,1.28,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1270428,DTCC00208474,1228057,16272,CC1=CSC2=C1NC(=O)N(C2=O)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(C)csc4c3=O)C[C@@H]21
2070,CHEMBL60722,P35368,,ZJHGMJHJDHEYNX-KBXCAEBGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,3.31,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1249324,DTCC00208475,937891,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(NC4=O)N=CC=C5,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ncccc4c3=O)C[C@@H]21
2071,CHEMBL608560,P35368,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19954972.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of Alpha1B adrenoceptor receptor at 10 uM,Not Determined,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603545.0,DTCT0023207,3163742,DTCC00609825,1789660,36082,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1cccc(F)c1
2072,CHEMBL608560,P35368,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to alpha1B adrenergic receptor,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884055.0,DTCT0023207,11474381,DTCC00609825,1780158,51935,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1cccc(F)c1
2073,CHEMBL608560,P35368,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,23981939.0,KI,,,,,,,,,,,,,,,,,Inhibition of adrenergic alpha1B receptor (unknown origin) by PDSP assay,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985432.0,DTCT0023207,12600215,DTCC00609825,1780917,55935,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1cccc(F)c1
2074,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,1.73,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14857841,DTCC00103842,2113520,70115,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2075,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,2.2,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from human clone,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34465.0,DTCT0023207,746145,DTCC00103842,2013364,13167,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2076,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,30.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from hamster clones.,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34313.0,DTCT0023207,746146,DTCC00103842,2013364,13167,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2077,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7752182.0,KI,=,2.6,NM,,,,,,,,,,,,,,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,,Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.,J. Med. Chem.,1995.0,38.0,10.0,"Wetzel JM, Miao SW, Forray C, Borden LA, Branchek TA, Gluchowski C",,34326.0,DTCT0023207,1033247,DTCC00103842,2012181,12993,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2078,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,2.51,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,703419,DTCC00103842,2000029,14595,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2079,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9379432.0,KI,=,2.68,NM,,,,,,,,,,,,,,Binding affinity against human adrenergic receptor subtype Alpha-1B adrenergic receptor using [3H]prazosin as radioligand,,"Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antagonist for the symptomatic treatment of benign prostatic hyperplasia.",J. Med. Chem.,1997.0,40.0,20.0,"Meyer MD, Altenbach RJ, Basha FZ, Carroll WA, Drizin I, Elmore SW, Ehrlich PP, Lebold SA, Tietje K, Sippy KB, Wendt MD, Plata DJ, Plagge F, Buckner SA, Brune ME, Hancock AA, Kerwin JF",,34330.0,DTCT0023207,499508,DTCC00103842,2001290,14344,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2080,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9548811.0,KI,=,1.2,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity utilizing cloned receptor binding assays by using [125 I]HEAT as radioligand to the human Alpha-1B adrenergic receptor,,"4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.",J. Med. Chem.,1998.0,41.0,8.0,"Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG",,34348.0,DTCT0023207,1417878,DTCC00103842,1999945,15108,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2081,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,1.95,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,765620,DTCC00103842,2012952,14735,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2082,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,1.2,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylaminomethyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32897.0,DTCT0023207,898455,DTCC00103842,2012838,2766,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2083,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579840.0,KI,=,1.9,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.,J. Med. Chem.,1999.0,42.0,23.0,"Nagarathnam D, Miao SW, Lagu B, Chiu G, Fang J, Murali Dhar TG, Zhang J, Tyagarajan S, Marzabadi MR, Zhang F, Wong WC, Sun W, Tian D, Wetzel JM, Forray C, Chang RS, Broten TP, Ransom RW, Schorn TW, Chen TB, O'Malley S, Kling P, Schneck K, Bendesky R, Harrell CM",,34457.0,DTCT0023207,730921,DTCC00103842,2001961,15484,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2084,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10579842.0,KI,=,1.9,NM,,,,,,,,,,,,,,In vitro binding affinity against Alpha-1B adrenergic receptor of human liver microsomes.,,Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chains.,J. Med. Chem.,1999.0,42.0,23.0,"Lagu B, Tian D, Nagarathnam D, Marzabadi MR, Wong WC, Miao SW, Zhang F, Sun W, Chiu G, Fang J, Forray C, Chang RS, Ransom RW, Chen TB, O'Malley S, Zhang K, Vyas KP, Gluchowski C",,34459.0,DTCT0023207,1100111,DTCC00103842,2001969,15486,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2085,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11805207.0,KI,=,1.15,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14741435,DTCC00103842,2107718,68867,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2086,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16420037.0,KI,=,2.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14741442,DTCC00103842,2107719,68752,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2087,CHEMBL611,P35368,TERAZOSIN,VCKUSRYTPJJLNI-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,25813897.0,EC50,=,0.5,NM,,,,,,,,,,,,,,Antagonist activity at alpha-1B adrenergic receptor (unknown origin) incubated for 30 mins prior to agonist addition measured after 5 hrs by CCF4-AM staining-based cellular assay,,a-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.,Bioorg. Med. Chem.,2015.0,23.0,9.0,"Zareba P, Dudek M, Lustyk K, Siwek A, Starowicz G, Bednarski M, Nowinski L, Razny K, Sapa J, Malawska B, Kulig K",,1465128.0,DTCT0023207,14064375,DTCC00103842,2030063,61652,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC
2088,CHEMBL61204,P35368,,DPIGTZTZLGWBTO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15055991.0,KI,,,,,,,,,,,,,,,,,Binding affinity constant against alpha-1B adrenergic receptor of guinea pig spleen.,Not Determined,"Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.",J. Med. Chem.,2004.0,47.0,8.0,"Leonardi A, Barlocco D, Montesano F, Cignarella G, Motta G, Testa R, Poggesi E, Seeber M, De Benedetti PG, Fanelli F",,34191.0,DTCT0023207,1104022,DTCC00203872,1078908,18073,COC1=CC=CC=C1OCCNCCN2C(=O)CC3(CCCC3)CC2=O,COc1ccccc1OCCNCCN1C(=O)CC2(CCCC2)CC1=O
2089,CHEMBL61225,P35368,,KPFQUAOOMMHSJZ-MGPUTAFESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,3.76,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1261125,DTCC00208510,841138,16272,COC1=CC2=C(C=C1)NC(=O)N(C2=O)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC,COc1ccc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2c1
2090,CHEMBL61483,P35368,,VMZJRPSZTYTUEY-GHTZIAJQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,0.33,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1264700,DTCC00208533,1358861,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C(=CS5)C6=CC=CC=C6)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(-c5ccccc5)csc4c3=O)C[C@@H]21
2091,CHEMBL61491,P35368,,QYTLWWWPYDZRAG-HNAYVOBHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,1.16,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1280413,DTCC00208943,96404,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=CC=CC=C5NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4ccccc4c3=O)C[C@@H]21
2092,CHEMBL61598,P35368,,CDHRNZXTVNDRBC-HRAATJIYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,0.84,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1273763,DTCC00208681,1713537,16272,CC(=O)NC1=CC2=C(C=C1)C(=O)N(C(=O)N2)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(NC(C)=O)ccc4c3=O)C[C@@H]21
2093,CHEMBL61643,P35368,,QILUJNITRUUHBK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11459670.0,KI,=,1800.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards cloned human Alpha-1B adrenergic receptor,,Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2001.0,11.0,14.0,"DiPardo RM, Patane MA, Newton RC, Price R, Broten TP, Chang RS, Ransom RW, Di Salvo J, Freidinger RM, Bock MG",,34460.0,DTCT0023207,1676262,DTCC00207435,1293488,4355,CC1=CC=C(C=C1)C(C2=CC=C(C=C2)C)(C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=CC=C4)O,Cc1ccc(C(O)(C(=O)NCCCN2CCC(C#N)(c3ccccc3)CC2)c2ccc(C)cc2)cc1
2094,CHEMBL61861,P35368,ORG-24598,VMQXVSNARQMSDL-UNTBIKODSA-M,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11454468.0,KI,<,10000.0,NM,,,,,,,,,,,,,,The compound was tested for the binding affinity towards Alpha-1B adrenergic receptor,,Discovery and SAR of org 24598-a selective glycine uptake inhibitor.,Bioorg. Med. Chem. Lett.,2001.0,11.0,15.0,"Brown A, Carlyle I, Clark J, Hamilton W, Gibson S, McGarry G, McEachen S, Rae D, Thorn S, Walker G",,32303.0,DTCT0023207,957144,DTCC01740655,2033506,4301,[Li+].CN(CC[C@H](C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F)CC(=O)[O-],CN(CC[C@@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1)CC(=O)[O-]
2095,CHEMBL62028,P35368,,JARQYZBFRPHGBC-XJKSGUPXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,0.74,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1279417,DTCC00208534,614692,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=C(S5)OC)NC4=O,COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1
2096,CHEMBL62033,P35368,,AROSMOXZDJFPHJ-OXJNMPFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,1.56,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1275898,DTCC00208494,841139,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=C(C=C(C=C5)C#N)NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cc(C#N)ccc4c3=O)C[C@@H]21
2097,CHEMBL62045,P35368,,LDEQSIYHAXUIBH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11459670.0,KI,=,98.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards cloned human Alpha-1B adrenergic receptor,,Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2001.0,11.0,14.0,"DiPardo RM, Patane MA, Newton RC, Price R, Broten TP, Chang RS, Ransom RW, Di Salvo J, Freidinger RM, Bock MG",,34460.0,DTCT0023207,1655083,DTCC00207280,1902701,4355,CC1=CC=C(C=C1)C2(CC(=O)N(C2=O)CCCN3CCC(CC3)(C#N)C4=CC=CC=C4Cl)C5=CC=C(C=C5)C,Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CCCN3CCC(C#N)(c4ccccc4Cl)CC3)C2=O)cc1
2098,CHEMBL62109,P35368,,CPYTXHMLULQLQU-KBXCAEBGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,9.27,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1273756,DTCC00208535,841137,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=CC(=C(C=C5NC4=O)OC)Cl,COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2cc1Cl
2099,CHEMBL62110,P35368,,HZFDWJNIIKVQER-QFBILLFUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,1.04,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1274831,DTCC00208536,1552534,16272,CC1=C2C(=CC=C1)NC(=O)N(C2=O)CCN3C[C@@H]4CCC5=C([C@@H]4C3)C=CC=C5OC,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4cccc(C)c4c3=O)C[C@@H]21
2100,CHEMBL62206,P35368,,HTYVDYLLKXEKSL-XJKSGUPXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11384242.0,KI,=,12.59,NM,,,,,,,,,,,,,,Binding affinity to hamster alpha-1B adrenergic receptor,,Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia.,J. Med. Chem.,2001.0,44.0,12.0,"Meyer MD, Altenbach RJ, Bai H, Basha FZ, Carroll WA, Kerwin JF, Lebold SA, Lee E, Pratt JK, Sippy KB, Tietje K, Wendt MD, Brune ME, Buckner SA, Hancock AA, Drizin I",,34198.0,DTCT0023207,1268158,DTCC00208495,1552535,16272,COC1=CC=CC2=C1CC[C@@H]3[C@H]2CN(C3)CCN4C(=O)C5=NC=CN=C5NC4=O,COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4nccnc4c3=O)C[C@@H]21
2101,CHEMBL62249,P35368,,GPYSFGFOHARXCT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11459670.0,KI,=,1500.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards cloned human Alpha-1B adrenergic receptor,,Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2001.0,11.0,14.0,"DiPardo RM, Patane MA, Newton RC, Price R, Broten TP, Chang RS, Ransom RW, Di Salvo J, Freidinger RM, Bock MG",,34460.0,DTCT0023207,1666289,DTCC00207279,388783,4355,CC1=CC=C(C=C1)C2(CC(=O)N(C2=O)CC(CN3CCC(CC3)(C#N)C4=CC=CC=C4C)O)C5=CC=C(C=C5)C,Cc1ccc(C2(c3ccc(C)cc3)CC(=O)N(CC(O)CN3CCC(C#N)(c4ccccc4C)CC3)C2=O)cc1
2102,CHEMBL6310,P35368,,SCIRNASYBOGBOO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,14643338.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,Binding of beta-carbolines at 5-HT(2) serotonin receptors.,Bioorg. Med. Chem. Lett.,2003.0,13.0,24.0,"Grella B, Teitler M, Smith C, Herrick-Davis K, Glennon RA",,34337.0,DTCT0023207,1112872,DTCC00132496,2078044,6037,COC1=CC2=C(C=C1)C3=C(N2)CNCC3,COc1ccc2c3c([nH]c2c1)CNCC3
2103,CHEMBL63208,P35368,NORTOPSENTIN C,OWBTWZBJRVBXIC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,170.0,NM,,,,,,,,,,,,,,Compound was tested for its binding affinity towards Rat-1 cells stably expressing hamster Alpha-1b adrenergic receptor by displacing [125I]HEAT (2-beta-(4-hydroxyphenyl)-ethylaminomethyltetralone),,,Bioorg. Med. Chem. Lett.,1996.0,6.0,17.0,,,32894.0,DTCT0023207,1314892,DTCC00216858,906193,1778,C1=CC=C2C(=C1)C(=CN2)C3=NC=C(N3)C4=CNC5=C4C=CC(=C5)Br,Brc1ccc2c(-c3cnc(-c4c[nH]c5ccccc45)[nH]3)c[nH]c2c1
2104,CHEMBL63354,P35368,AMENTOFLAVONE,YUSWMAULDXZHPY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14753807,DTCC00216407,2103540,69275,C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4=C(C=CC(=C4)C5=CC(=O)C6=C(C=C(C=C6O5)O)O)O)O,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12
2105,CHEMBL639,P35368,AZELASTINE,MBUVEWMHONZEQD-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,21381763.0,KI,=,50.12,NM,,,,,,,,,,,,,,Binding affinity to human adrenergic Alpha-1B receptor expressed in rat intact fibroblasts,,The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.,J. Med. Chem.,2011.0,54.0,7.0,"Procopiou PA, Browning C, Buckley JM, Clark KL, Fechner L, Gore PM, Hancock AP, Hodgson ST, Holmes DS, Kranz M, Looker BE, Morriss KM, Parton DL, Russell LJ, Slack RJ, Sollis SL, Vile S, Watts CJ",,741666.0,DTCT0023207,5929138,DTCC00154784,1746909,44212,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1
2106,CHEMBL639,P35368,AZELASTINE,MBUVEWMHONZEQD-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,22985961.0,KI,=,50.12,NM,,,,,,,,,,,,,,Antagonist activity at human adrenergic alpha1B receptor expressed in rat fibroblasts by by plate-based calcium imaging,,Synthesis and pharmacological investigation of azaphthalazinone human histamine H(1) receptor antagonists.,Bioorg. Med. Chem.,2012.0,20.0,20.0,"Procopiou PA, Browning C, Gore PM, Lynn SM, Richards SA, Slack RJ, Sollis SL",,848015.0,DTCT0023207,11345771,DTCC00154784,1747943,50693,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1
2107,CHEMBL66823,P35368,,DXVHHSNKHNZWOK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,=,2569.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1038281,DTCC00220554,2076950,4980,COC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(S3)CN4CCCCC4O,COc1ccccc1N1CCN(Cc2ccc(CN3CCCCC3O)s2)CC1
2108,CHEMBL67552,P35368,,WALJAWMIJWFJHE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,=,482.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1103772,DTCC00222045,744078,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=CC=C5)F,CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1
2109,CHEMBL67648,P35368,,LQTJOPPTSIYEES-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1115593,DTCC00222259,582439,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)N(C)C)O,CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1
2110,CHEMBL67713,P35368,,SEMGFDKQHLCMCA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,=,384.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1035560,DTCC00220379,433170,4980,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=CS3)CN4CCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)cs2)CC1
2111,CHEMBL67932,P35368,,IGPCTLTXCPFDIO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,=,757.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1022217,DTCC00220199,204636,4980,COC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(S3)Br,COc1ccccc1N1CCN(Cc2ccc(Br)s2)CC1
2112,CHEMBL68045,P35368,,WCKATHKWRMKNPK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1126481,DTCC00221914,2033644,15735,COC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=CC=C5)F)O,COc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1
2113,CHEMBL68203,P35368,,URHATDOBWHTBOV-DEOSSOPVSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,1750.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1102345,DTCC00221996,744079,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)C[C@H](CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)OC)O,COc1ccc(N2C(=O)c3ccc(C(=O)NC[C@H](O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1
2114,CHEMBL68241,P35368,,WSVLBNNZDIDXTO-NRFANRHFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,=,592.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1045765,DTCC00220139,1467416,4980,COC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(S3)CN4CCC[C@H]4C(=O)OC,COC(=O)[C@@H]1CCCN1Cc1ccc(CN2CCN(c3ccccc3OC)CC2)s1
2115,CHEMBL68565,P35368,,IDSYRZJPBIXBRS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,=,1639.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1132952,DTCC00222682,1870487,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=CC=C5OC)O,COc1ccccc1N1C(=O)c2ccc(C(=O)NCC(O)CN3CCN(c4ccccc4OC(C)C)CC3)cc2C1=O
2116,CHEMBL68601,P35368,,CBIKMYNJCCYRFA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,=,606.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1101140,DTCC00221929,1100217,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)Cl)O,CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(Cl)cc2)C3=O)CC1
2117,CHEMBL68604,P35368,,CCJMGYBFMJJAIY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1105359,DTCC00222190,2000676,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)O)O,CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1
2118,CHEMBL68699,P35368,,REFOHXNLQXATAB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1129105,DTCC00222278,1261248,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)C(C)(C)C)O,CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(C(C)(C)C)cc2)C3=O)CC1
2119,CHEMBL68746,P35368,,UQMPYAUGLXZWSM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1110721,DTCC00222198,776159,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)[N+](=O)[O-])O,CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc([N+](=O)[O-])cc2)C3=O)CC1
2120,CHEMBL68913,P35368,,ZVZCHVBOZRWHPS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1127713,DTCC00222164,96557,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=C(C(=C5)OC)OC)OC)O,COc1cc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc(OC)c1OC
2121,CHEMBL69143,P35368,,FXVQHGIESKOKTM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1115588,DTCC00222570,1067379,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=CC=C5)O,CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccccc2)C3=O)CC1
2122,CHEMBL69245,P35368,,FSAKTEBFSIPADS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1135435,DTCC00222996,1681886,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=CC=C5)F)OC,COC(CNC(=O)c1ccc2c(c1)C(=O)N(c1cccc(F)c1)C2=O)CN1CCN(c2ccccc2OC(C)C)CC1
2123,CHEMBL69264,P35368,,OTYOCRKXZWOSNV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,=,465.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1125118,DTCC00222711,1552691,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)N(C)C,CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1
2124,CHEMBL69295,P35368,,IQRXOCGLSGCNLE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1114474,DTCC00222995,1934885,15735,CC1=CC=C(C=C1)N2C(=O)C3=C(C2=O)C=C(C=C3)C(=O)NCC(CN4CCN(CC4)C5=CC=CC=C5OC(C)C)O,Cc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1
2125,CHEMBL69339,P35368,,LYKQJJQHRZAFLA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1020981,DTCC00220078,2076949,4980,COC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(S3)CN4CCCCCC4=O,COc1ccccc1N1CCN(Cc2ccc(CN3CCCCCC3=O)s2)CC1
2126,CHEMBL69733,P35368,RS-100235,UVOCSZKGWJOKNN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,501.19,NM,,,,,,,,,,,,,,Compound was evaluated for binding affinity against Alpha-1B adrenergic receptor using radioligand binding assay,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,18.0,,,32302.0,DTCT0023207,768641,DTCC01740815,1753132,1312,COC1=C(C=C(C=C1)CCCN2CCC(CC2)CCC(=O)C3=CC(=C(C4=C3OCCO4)N)Cl)OC,COc1ccc(CCCN2CCC(CCC(=O)c3cc(Cl)c(N)c4c3OCCO4)CC2)cc1OC
2127,CHEMBL69848,P35368,,KSRPSBGXBYSONY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,=,259.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1029639,DTCC00220450,1175164,4980,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=CS3)CN4CCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCC3=O)cs2)CC1
2128,CHEMBL70095,P35368,,AVHKKQNVOUECLU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1118444,DTCC00222197,486074,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=C(C=C5)OC)OC)O,COc1ccc(N2C(=O)c3ccc(C(=O)NCC(O)CN4CCN(c5ccccc5OC(C)C)CC4)cc3C2=O)cc1OC
2129,CHEMBL70178,P35368,,XNTSPXZSNQJDTP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12127524.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from COS cells membranes expressing human Alpha-1B adrenergic receptor,,Novel thiophene derivatives for the treatment of benign prostatic hyperplasia.,Bioorg. Med. Chem. Lett.,2002.0,12.0,16.0,"Khatuya H, Pulito VL, Jolliffe LK, Li X, Murray WV",,34331.0,DTCT0023207,1024664,DTCC00220842,29545,4980,COC1=CC=CC=C1N2CCN(CC2)CC3=CC=C(S3)CN4CCCC4=O,COc1ccccc1N1CCN(Cc2ccc(CN3CCCC3=O)s2)CC1
2130,CHEMBL70326,P35368,,DLSVKFMVCHCZLY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,975297,DTCC00226638,1370746,16733,CS(=O)(=O)C1=C(C=CC(=C1)F)NCC2=NCCN2,CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1
2131,CHEMBL70326,P35368,,DLSVKFMVCHCZLY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,512.86,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,975291,DTCC00226638,1370746,16733,CS(=O)(=O)C1=C(C=CC(=C1)F)NCC2=NCCN2,CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1
2132,CHEMBL70326,P35368,,DLSVKFMVCHCZLY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as percent maximal effect for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha1b; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218076.0,DTCT0023207,975302,DTCC00226638,1370746,16733,CS(=O)(=O)C1=C(C=CC(=C1)F)NCC2=NCCN2,CS(=O)(=O)c1cc(F)ccc1NCC1=NCCN1
2133,CHEMBL70563,P35368,,RNPCNKHTEISXAL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at alpha-1b adrenoceptors assayed in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34477.0,DTCT0023207,965411,DTCC00225692,1370749,16733,CS(=O)(=O)C1=C(C=CC(=C1)Cl)NCC2=NCCN2,CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1
2134,CHEMBL70563,P35368,,RNPCNKHTEISXAL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,645.65,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,965405,DTCC00225692,1370749,16733,CS(=O)(=O)C1=C(C=CC(=C1)Cl)NCC2=NCCN2,CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1
2135,CHEMBL70563,P35368,,RNPCNKHTEISXAL-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34473.0,DTCT0023207,965416,DTCC00225692,1370749,16733,CS(=O)(=O)C1=C(C=CC(=C1)Cl)NCC2=NCCN2,CS(=O)(=O)c1cc(Cl)ccc1NCC1=NCCN1
2136,CHEMBL70634,P35368,,VFLQPKLTPYIDEK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,61.66,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,950899,DTCC00225721,1499833,16733,CS(=O)(=O)C1=C(C=C(C=C1)Cl)NCC2=NCCN2,CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1
2137,CHEMBL70634,P35368,,VFLQPKLTPYIDEK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,2951.21,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,950893,DTCC00225721,1499833,16733,CS(=O)(=O)C1=C(C=C(C=C1)Cl)NCC2=NCCN2,CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1
2138,CHEMBL70634,P35368,,VFLQPKLTPYIDEK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,103.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,950904,DTCC00225721,1499833,16733,CS(=O)(=O)C1=C(C=C(C=C1)Cl)NCC2=NCCN2,CS(=O)(=O)c1ccc(Cl)cc1NCC1=NCCN1
2139,CHEMBL70676,P35368,,YYTGOWDNUUXBGS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,1905.46,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1668645,DTCC00227303,64226,1335,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)I,Ic1c(NC2=NCCN2)ccc2nccnc12
2140,CHEMBL70691,P35368,,NMTCRDZBJDXVCH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,3.63,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,960251,DTCC00226250,981936,16733,COC1=CC(=C(C=C1)SC)NCC2=NCCN2,COc1ccc(SC)c(NCC2=NCCN2)c1
2141,CHEMBL70691,P35368,,NMTCRDZBJDXVCH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,691.83,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,960245,DTCC00226250,981936,16733,COC1=CC(=C(C=C1)SC)NCC2=NCCN2,COc1ccc(SC)c(NCC2=NCCN2)c1
2142,CHEMBL70691,P35368,,NMTCRDZBJDXVCH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,92.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,960256,DTCC00226250,981936,16733,COC1=CC(=C(C=C1)SC)NCC2=NCCN2,COc1ccc(SC)c(NCC2=NCCN2)c1
2143,CHEMBL70692,P35368,,QJUBRJKAGWBYDR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,85.11,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,941924,DTCC00226251,269851,16733,CSC1=C(C=CC=C1F)NCC2=NCCN2,CSc1c(F)cccc1NCC1=NCCN1
2144,CHEMBL70692,P35368,,QJUBRJKAGWBYDR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,239.88,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,941918,DTCC00226251,269851,16733,CSC1=C(C=CC=C1F)NCC2=NCCN2,CSc1c(F)cccc1NCC1=NCCN1
2145,CHEMBL70692,P35368,,QJUBRJKAGWBYDR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,48.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,941929,DTCC00226251,269851,16733,CSC1=C(C=CC=C1F)NCC2=NCCN2,CSc1c(F)cccc1NCC1=NCCN1
2146,CHEMBL707,P35368,DOXAZOSIN,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,0.74,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from human clone,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34465.0,DTCT0023207,732126,DTCC00159683,1980572,13167,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
2147,CHEMBL707,P35368,DOXAZOSIN,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,1.0,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,700045,DTCC00159683,1967377,14595,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
2148,CHEMBL707,P35368,DOXAZOSIN,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16302814.0,KI,=,0.813,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from cloned human ADRA1B expressed in CHO cells,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4-chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation.",J. Med. Chem.,2005.0,48.0,24.0,"Quaglia W, Santoni G, Pigini M, Piergentili A, Gentili F, Buccioni M, Mosca M, Lucciarini R, Amantini C, Nabissi MI, Ballarini P, Poggesi E, Leonardi A, Giannella M",,326681.0,DTCT0023207,1870351,DTCC00159683,1981918,20070,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
2149,CHEMBL707,P35368,DOXAZOSIN,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16420037.0,KI,=,1.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14716137,DTCC00159683,2100354,68752,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
2150,CHEMBL707,P35368,DOXAZOSIN,RUZYUOTYCVRMRZ-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,19719240.0,KI,=,0.813,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Doxazosin-related alpha1-adrenoceptor antagonists with prostate antitumor activity.,J. Med. Chem.,2009.0,52.0,15.0,"Giardinà D, Martarelli D, Sagratini G, Angeli P, Ballinari D, Gulini U, Melchiorre C, Poggesi E, Pompei P",,574169.0,DTCT0023207,2880172,DTCC00159683,1983537,34689,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC
2151,CHEMBL70740,P35368,,WAXAHQBOIDNYSY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,939493,DTCC00225720,1370748,16733,C1CC2=C(C(=CC=C2)NCC3=NCCN3)S(=O)(=O)C1,O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21
2152,CHEMBL70740,P35368,,WAXAHQBOIDNYSY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,2137.96,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,939487,DTCC00225720,1370748,16733,C1CC2=C(C(=CC=C2)NCC3=NCCN3)S(=O)(=O)C1,O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21
2153,CHEMBL70740,P35368,,WAXAHQBOIDNYSY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34473.0,DTCT0023207,939498,DTCC00225720,1370748,16733,C1CC2=C(C(=CC=C2)NCC3=NCCN3)S(=O)(=O)C1,O=S1(=O)CCCc2cccc(NCC3=NCCN3)c21
2154,CHEMBL70751,P35368,,ZHDIISZEXUGDAJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,0.501,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,960267,DTCC00225722,1111864,16733,CSC1=C(C=C(C=C1)Cl)NCC2=NCCN2,CSc1ccc(Cl)cc1NCC1=NCCN1
2155,CHEMBL70751,P35368,,ZHDIISZEXUGDAJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,69.18,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,960261,DTCC00225722,1111864,16733,CSC1=C(C=C(C=C1)Cl)NCC2=NCCN2,CSc1ccc(Cl)cc1NCC1=NCCN1
2156,CHEMBL70751,P35368,,ZHDIISZEXUGDAJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,103.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,960272,DTCC00225722,1111864,16733,CSC1=C(C=C(C=C1)Cl)NCC2=NCCN2,CSc1ccc(Cl)cc1NCC1=NCCN1
2157,CHEMBL70892,P35368,,UBKDEKNQGPCIFQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,=,255.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1103792,DTCC00222649,614861,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CCCNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC=C(C=C5)O,CC(C)Oc1ccccc1N1CCN(CCCNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(O)cc2)C3=O)CC1
2158,CHEMBL709,P35368,ALFUZOSIN,WNMJYKCGWZFFKR-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,2.8,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from human clone,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34465.0,DTCT0023207,749957,DTCC00159931,1564894,13167,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC
2159,CHEMBL709,P35368,ALFUZOSIN,WNMJYKCGWZFFKR-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,7658428.0,KI,=,12.0,NM,,,,,,,,,,,,,,Binding affinity against Alpha-1B adrenergic receptor from hamster clones.,,Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.,J. Med. Chem.,1995.0,38.0,18.0,"Hieble JP, Bondinell WE, Ruffolo RR",,34313.0,DTCT0023207,749958,DTCC00159931,1564894,13167,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC
2160,CHEMBL709,P35368,ALFUZOSIN,WNMJYKCGWZFFKR-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,10.0,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,727933,DTCC00159931,1552010,14595,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC
2161,CHEMBL709,P35368,ALFUZOSIN,WNMJYKCGWZFFKR-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16420037.0,KI,=,10.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14715949,DTCC00159931,2100293,68752,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,COc1cc2nc(N(C)CCCNC(=O)C3CCCO3)nc(N)c2cc1OC
2162,CHEMBL70973,P35368,,ZZCOHDYKTIEHEF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,950883,DTCC00105715,561990,16733,CCS(=O)(=O)C1=CC=CC=C1NCC2=NCCN2,CCS(=O)(=O)c1ccccc1NCC1=NCCN1
2163,CHEMBL70973,P35368,,ZZCOHDYKTIEHEF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,912.01,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,950877,DTCC00105715,561990,16733,CCS(=O)(=O)C1=CC=CC=C1NCC2=NCCN2,CCS(=O)(=O)c1ccccc1NCC1=NCCN1
2164,CHEMBL70973,P35368,,ZZCOHDYKTIEHEF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as percent maximal effect for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha1b; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218076.0,DTCT0023207,950888,DTCC00105715,561990,16733,CCS(=O)(=O)C1=CC=CC=C1NCC2=NCCN2,CCS(=O)(=O)c1ccccc1NCC1=NCCN1
2165,CHEMBL71001,P35368,,WURKOHONKFWQNR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,962805,DTCC00226249,237162,16733,COC1=CC(=C(C=C1)S(=O)(=O)C)NCC2=NCCN2,COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1
2166,CHEMBL71001,P35368,,WURKOHONKFWQNR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,4570.88,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,962799,DTCC00226249,237162,16733,COC1=CC(=C(C=C1)S(=O)(=O)C)NCC2=NCCN2,COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1
2167,CHEMBL71001,P35368,,WURKOHONKFWQNR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34473.0,DTCT0023207,962810,DTCC00226249,237162,16733,COC1=CC(=C(C=C1)S(=O)(=O)C)NCC2=NCCN2,COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1
2168,CHEMBL71001,P35368,,WURKOHONKFWQNR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12419381.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Activation of human alpha-1B adrenergic receptors expressed in rat-1 fibroblasts,,Alpha(1)-adrenoceptor activation: a comparison of 4-(anilinomethyl)imidazoles and 4-(phenoxymethyl)imidazoles to related 2-imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,23.0,"Hodson SJ, Bigham EC, Garrison DT, Gobel MJ, Irving PE, Liacos JA, Navas F, Saussy DL, Sherman BW, Speake JD, Bishop MJ",,32513.0,DTCT0023207,1170429,DTCC00226249,237902,5253,COC1=CC(=C(C=C1)S(=O)(=O)C)NCC2=NCCN2,COc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1
2169,CHEMBL71473,P35368,,YCKRBYBOMGAOET-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,>,2000.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1097341,DTCC00222134,257865,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)C[C@@H](CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=CC=C5)F)O,CC(C)Oc1ccccc1N1CCN(C[C@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(F)c2)C3=O)CC1
2170,CHEMBL71479,P35368,,NIILDWZATWLEEZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,141.25,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,939477,DTCC00225633,237161,16733,CC1=CC(=C(C=C1)S(=O)(=O)C)NCC2=NCCN2,Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1
2171,CHEMBL71479,P35368,,NIILDWZATWLEEZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,3467.37,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,939471,DTCC00225633,237161,16733,CC1=CC(=C(C=C1)S(=O)(=O)C)NCC2=NCCN2,Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1
2172,CHEMBL71479,P35368,,NIILDWZATWLEEZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,91.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,939482,DTCC00225633,237161,16733,CC1=CC(=C(C=C1)S(=O)(=O)C)NCC2=NCCN2,Cc1ccc(S(C)(=O)=O)c(NCC2=NCCN2)c1
2173,CHEMBL715,P35368,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,1000.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329323.0,DTCT0023207,13582467,DTCC00160346,1516359,39761,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
2174,CHEMBL71580,P35368,,MCCWDRVXIBWEIB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,=,605.0,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1116883,DTCC00221897,938013,15735,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC(CNC(=O)C3=CC4=C(C=C3)C(=O)N(C4=O)C5=CC(=CC=C5)Cl)O,CC(C)Oc1ccccc1N1CCN(CC(O)CNC(=O)c2ccc3c(c2)C(=O)N(c2cccc(Cl)c2)C3=O)CC1
2175,CHEMBL716,P35368,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,100.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329323.0,DTCT0023207,13582469,DTCC00160380,1737586,39761,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
2176,CHEMBL72147,P35368,,ICROYPJYNVAMQF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,<,100000.0,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1671276,DTCC00226706,3584,1335,CC1=CN=C2C(=N1)C=CC(=C2Br)NC3=NCCN3,Cc1cnc2c(Br)c(NC3=NCCN3)ccc2n1
2177,CHEMBL72441,P35368,,ZVVQFUFKMNLNCB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,0.41700000000000004,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,966808,DTCC00225661,949545,16733,CC1=CC(=C(C=C1)SC)NCC2=NCCN2,CSc1ccc(C)cc1NCC1=NCCN1
2178,CHEMBL72441,P35368,,ZVVQFUFKMNLNCB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,123.03,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,966802,DTCC00225661,949545,16733,CC1=CC(=C(C=C1)SC)NCC2=NCCN2,CSc1ccc(C)cc1NCC1=NCCN1
2179,CHEMBL72441,P35368,,ZVVQFUFKMNLNCB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,96.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,966813,DTCC00225661,949545,16733,CC1=CC(=C(C=C1)SC)NCC2=NCCN2,CSc1ccc(C)cc1NCC1=NCCN1
2180,CHEMBL72657,P35368,,UNHGFWKSHHCRHF-DQEYMECFSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8667368.0,KI,=,21.08,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor hamster smooth muscle using [3H]prazosin as radioligand,,"Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.",J. Med. Chem.,1996.0,39.0,11.0,"Quaglia W, Pigini M, Tayebati SK, Piergentili A, Giannella M, Leonardi A, Taddei C, Melchiorre C",,34320.0,DTCT0023207,1144518,DTCC00227382,776215,13601,CC1=CC=C(C=C1)[C@H]2[C@@H](OC3=CC=CC=C3O2)CNCCOC4=C(C=CC=C4OC)OC,COc1cccc(OC)c1OCCNC[C@@H]1Oc2ccccc2O[C@H]1c1ccc(C)cc1
2181,CHEMBL72724,P35368,,GBSLCSDIFSTSOZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,6.03,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,962789,DTCC00226099,108085,16733,CSC1=C(C=C(C=C1)C(F)(F)F)NCC2=NCCN2,CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1
2182,CHEMBL72724,P35368,,GBSLCSDIFSTSOZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,2041.74,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,962783,DTCC00226099,108085,16733,CSC1=C(C=C(C=C1)C(F)(F)F)NCC2=NCCN2,CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1
2183,CHEMBL72724,P35368,,GBSLCSDIFSTSOZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,114.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,962794,DTCC00226099,108085,16733,CSC1=C(C=C(C=C1)C(F)(F)F)NCC2=NCCN2,CSc1ccc(C(F)(F)F)cc1NCC1=NCCN1
2184,CHEMBL72753,P35368,,VJQWCCBDYLTRPZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,10471.29,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1647137,DTCC00227367,64227,1335,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Cl,Clc1c(NC2=NCCN2)ccc2nccnc12
2185,CHEMBL72768,P35368,,BCCMUPQZPVRDCD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,=,1.86,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,969250,DTCC00225750,108086,16733,CSC1=C(C=C(C=C1)F)NCC2=NCCN2,CSc1ccc(F)cc1NCC1=NCCN1
2186,CHEMBL72768,P35368,,BCCMUPQZPVRDCD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,40.74,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,969244,DTCC00225750,108086,16733,CSC1=C(C=C(C=C1)F)NCC2=NCCN2,CSc1ccc(F)cc1NCC1=NCCN1
2187,CHEMBL72768,P35368,,BCCMUPQZPVRDCD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,=,92.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34472.0,DTCT0023207,969255,DTCC00225750,108086,16733,CSC1=C(C=C(C=C1)F)NCC2=NCCN2,CSc1ccc(F)cc1NCC1=NCCN1
2188,CHEMBL72958,P35368,NS-49,XYLJNMCMDOOJRW-VIFPVBQESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,"Activation of recombinant human adrenergic, alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway",,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34475.0,DTCT0023207,872867,DTCC00226609,692279,5326,CS(=O)(=O)NC1=CC(=C(C=C1)F)[C@H](CN)O,CS(=O)(=O)Nc1ccc(F)c([C@@H](O)CN)c1
2189,CHEMBL72958,P35368,NS-49,XYLJNMCMDOOJRW-VIFPVBQESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11814822.0,MAX,,,,,,,,,,,,,,,,,Activation of human alpha-1B receptor expressed in rat-1 fibroblasts determined via calcium mobilization through Gq coupled PLC pathway expressed as percent of phenylephrine (40 um) response; No data,No data,alpha(1)-Adrenoceptor agonists: the identification of novel alpha(1A )subtype selective 2'-heteroaryl-2-(phenoxymethyl)imidazolines.,Bioorg. Med. Chem. Lett.,2002.0,12.0,3.0,"Bishop MJ, Barvian KA, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Navas F, Saussy DL, Speake JD",,34469.0,DTCT0023207,872868,DTCC00226609,692279,5326,CS(=O)(=O)NC1=CC(=C(C=C1)F)[C@H](CN)O,CS(=O)(=O)Nc1ccc(F)c([C@@H](O)CN)c1
2190,CHEMBL72958,P35368,NS-49,XYLJNMCMDOOJRW-VIFPVBQESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,953693,DTCC00226609,691181,16733,CS(=O)(=O)NC1=CC(=C(C=C1)F)[C@H](CN)O,CS(=O)(=O)Nc1ccc(F)c([C@@H](O)CN)c1
2191,CHEMBL72958,P35368,NS-49,XYLJNMCMDOOJRW-VIFPVBQESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,11220.18,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,953687,DTCC00226609,691181,16733,CS(=O)(=O)NC1=CC(=C(C=C1)F)[C@H](CN)O,CS(=O)(=O)Nc1ccc(F)c([C@@H](O)CN)c1
2192,CHEMBL72958,P35368,NS-49,XYLJNMCMDOOJRW-VIFPVBQESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34473.0,DTCT0023207,953698,DTCC00226609,691181,16733,CS(=O)(=O)NC1=CC(=C(C=C1)F)[C@H](CN)O,CS(=O)(=O)Nc1ccc(F)c([C@@H](O)CN)c1
2193,CHEMBL72995,P35368,,XBTUHMKOYJCXOJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,<,100000.0,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1645956,DTCC00227174,582498,1335,CC1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,CC1CN=C(Nc2ccc3nccnc3c2Br)N1
2194,CHEMBL73151,P35368,TERGURIDE,JOAHPSVPXZTVEP-YXJHDRRASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,34.67,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14714777,DTCC00228840,2099811,69012,CCN(CC)C(=O)N[C@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)C,CCN(CC)C(=O)N[C@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
2195,CHEMBL73164,P35368,,HBHGSUXQIQVLPX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,141253.75,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1648466,DTCC00227449,647652,1335,C1COC(=N1)NC2=C(C3=NC=CN=C3C=C2)Br,Brc1c(NC2=NCCO2)ccc2nccnc12
2196,CHEMBL73392,P35368,,KSVHJUZGYJOCLG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,60255.96,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1668657,DTCC00227179,291187,1335,C1CSC(=N1)NC2=C(C3=NC=CN=C3C=C2)Br,Brc1c(NC2=NCCS2)ccc2nccnc12
2197,CHEMBL74071,P35368,,XDUYFOWMTMCCEI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,10000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,965396,DTCC00226459,529762,16733,CC(C)S(=O)(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1
2198,CHEMBL74071,P35368,,XDUYFOWMTMCCEI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,1000.0,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,965390,DTCC00226459,529762,16733,CC(C)S(=O)(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1
2199,CHEMBL74071,P35368,,XDUYFOWMTMCCEI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as percent maximal effect for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha1b; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218076.0,DTCT0023207,335363,DTCC00226459,529762,16733,CC(C)S(=O)(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)S(=O)(=O)c1ccccc1NCC1=NCCN1
2200,CHEMBL74114,P35368,,FAINGUBYHMRNKU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,940667,DTCC00225996,1849948,16733,CS(=O)(=O)C1=CC=CC(=C1NCC2=NCCN2)F,CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1
2201,CHEMBL74114,P35368,,FAINGUBYHMRNKU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,380.19,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,940661,DTCC00225996,1849948,16733,CS(=O)(=O)C1=CC=CC(=C1NCC2=NCCN2)F,CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1
2202,CHEMBL74114,P35368,,FAINGUBYHMRNKU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as percent maximal effect for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha1b; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218076.0,DTCT0023207,940672,DTCC00225996,1849948,16733,CS(=O)(=O)C1=CC=CC(=C1NCC2=NCCN2)F,CS(=O)(=O)c1cccc(F)c1NCC1=NCCN1
2203,CHEMBL74283,P35368,,CETMNKCDAHCKRC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,4365.16,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1641244,DTCC00227173,1261294,1335,C1CNC2=C(N1)C=CC(=C2Br)NC3=NCCN3,Brc1c(NC2=NCCN2)ccc2c1NCCN2
2204,CHEMBL74342,P35368,,MIYQUCZRQJRHHG-AOOOYVTPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,104712.85,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1648454,DTCC00226676,679731,1335,C1CC[C@@H]2[C@H](C1)NC(=N2)NC3=C(C4=NC=CN=C4C=C3)Br,Brc1c(NC2=N[C@@H]3CCCC[C@@H]3N2)ccc2nccnc12
2205,CHEMBL74467,P35368,,YYHDOUOUAFMQDK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,100000.0,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,948385,DTCC00225997,594178,16733,CS(=O)(=O)C1=C(C=C(C=C1)F)NCC2=NCCN2,CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1
2206,CHEMBL74467,P35368,,YYHDOUOUAFMQDK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,1318.26,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,948379,DTCC00225997,594178,16733,CS(=O)(=O)C1=C(C=C(C=C1)F)NCC2=NCCN2,CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1
2207,CHEMBL74467,P35368,,YYHDOUOUAFMQDK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as percent maximal effect for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human alpha1b; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,218076.0,DTCT0023207,335087,DTCC00225997,594178,16733,CS(=O)(=O)C1=C(C=C(C=C1)F)NCC2=NCCN2,CS(=O)(=O)c1ccc(F)cc1NCC1=NCCN1
2208,CHEMBL75030,P35368,,FXNNPMSELIMMHU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,407380000000000.0,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor by the displacement of [3H]prazosin,,,Bioorg. Med. Chem. Lett.,1994.0,4.0,19.0,,,34607.0,DTCT0023207,1710803,DTCC00230873,1979905,933,C1CC(C2=CC=CC=C2C1)NC3=NCCO3,c1ccc2c(c1)CCCC2NC1=NCCO1
2209,CHEMBL75201,P35368,,ICFHSWCDTICIIC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,1000000000000.0,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor by the displacement of [3H]prazosin,,,Bioorg. Med. Chem. Lett.,1994.0,4.0,19.0,,,34607.0,DTCT0023207,1693956,DTCC00230757,29774,933,C1COC(=N1)N2CCOCC2,C1COC(N2CCOCC2)=N1
2210,CHEMBL75808,P35368,,BFLQALILHDTZOK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11055359.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards COS cell membrane expressing the human Alpha-1B adrenergic receptor,,Novel heterocycles as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,20.0,"Li X, McCoy KA, Murray WV, Jolliffe L, Pulito V",,34342.0,DTCT0023207,924363,DTCC00235219,2000805,3968,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=NC(=N3)N)CN4CCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nc(N)n2)CC1
2211,CHEMBL761,P35368,NAPHAZOLINE,CNIIGCLFLJGOGP-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,642281,DTCC00167193,108515,4573,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,c1ccc2c(CC3=NCCN3)cccc2c1
2212,CHEMBL761,P35368,NAPHAZOLINE,CNIIGCLFLJGOGP-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1003607,DTCC00167193,97943,5345,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,c1ccc2c(CC3=NCCN3)cccc2c1
2213,CHEMBL76168,P35368,,RAWLZBUZFGOUJJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8667368.0,KI,=,1.58,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor hamster smooth muscle using [3H]prazosin as radioligand,,"Synthesis, absolute configuration, and biological profile of the enantiomers of trans-[2-(2,6-dimethoxyphenoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (mephendioxan), a potent competitive alpha 1A-adrenoreceptor antagonist.",J. Med. Chem.,1996.0,39.0,11.0,"Quaglia W, Pigini M, Tayebati SK, Piergentili A, Giannella M, Leonardi A, Taddei C, Melchiorre C",,34320.0,DTCT0023207,1146959,DTCC00228078,1391731,13601,CC1=CC(=C(C=C1)OC)N2CCN(CC2)CCCNC3=CC(=O)N(C(=O)N3C)C,COc1ccc(C)cc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1
2214,CHEMBL762,P35368,OXYMETAZOLINE,WYWIFABBXFUGLM-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,158.49,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14714471,DTCC00167236,2099646,68596,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
2215,CHEMBL762,P35368,OXYMETAZOLINE,WYWIFABBXFUGLM-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,633381,DTCC00167236,2013075,4573,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
2216,CHEMBL762,P35368,OXYMETAZOLINE,WYWIFABBXFUGLM-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11844675.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,In vitro activation of human Alpha-1B receptor expressed in rat-1 fibroblasts via calcium mobilization through the Gq coupled PLC pathway as functional assay,,2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether series.,Bioorg. Med. Chem. Lett.,2002.0,12.0,4.0,"Navas F, Bishop MJ, Garrison DT, Hodson SJ, Speake JD, Bigham EC, Drewry DH, Saussy DL, Liacos JH, Irving PE, Gobel MJ",,34480.0,DTCT0023207,1010813,DTCC00167236,2002131,5345,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
2217,CHEMBL762,P35368,OXYMETAZOLINE,WYWIFABBXFUGLM-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,EC50,<,25118.86,NM,,,,,,,,,,,,,,Agonist potency at Alpha-1B adrenergic receptor expressed in rat-1 fibroblasts,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34476.0,DTCT0023207,974071,DTCC00167236,2012683,16733,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
2218,CHEMBL762,P35368,OXYMETAZOLINE,WYWIFABBXFUGLM-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,KI,=,831.76,NM,,,,,,,,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34489.0,DTCT0023207,974065,DTCC00167236,2012683,16733,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
2219,CHEMBL762,P35368,OXYMETAZOLINE,WYWIFABBXFUGLM-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12014961.0,MAX,,,,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1B adrenergic receptor; ND is No Data,Not Determined,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,2002.0,45.0,11.0,"Hodson SJ, Bishop MJ, Speake JD, Navas F, Garrison DT, Bigham EC, Saussy DL, Liacos JA, Irving PE, Gobel MJ, Sherman BW",,34473.0,DTCT0023207,973813,DTCC00167236,2012683,16733,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1
2220,CHEMBL76399,P35368,,FASDKYOPVNHBLU-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14714316,DTCC00228542,2099590,69012,CCCNC1CCC2=C(C1)SC(=N2)N,CCCNC1CCc2nc(N)sc2C1
2221,CHEMBL76643,P35368,,JAUBBRVLQJATCN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11055359.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards COS cell membrane expressing the human Alpha-1B adrenergic receptor,,Novel heterocycles as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,20.0,"Li X, McCoy KA, Murray WV, Jolliffe L, Pulito V",,34342.0,DTCT0023207,913988,DTCC00233747,1132472,3968,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NOC(C3)CN4CCCCC4=O,CC(C)Oc1ccccc1N1CCN(CC2=NOC(CN3CCCCC3=O)C2)CC1
2222,CHEMBL76867,P35368,,WEGSBUBJYGWBQE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11055359.0,KI,=,2770.0,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards COS cell membrane expressing the human Alpha-1B adrenergic receptor,,Novel heterocycles as selective alpha1-adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,2000.0,10.0,20.0,"Li X, McCoy KA, Murray WV, Jolliffe L, Pulito V",,34342.0,DTCT0023207,928115,DTCC00234377,1100344,3968,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=NN3C)CN4CCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)nn2C)CC1
2223,CHEMBL77618,P35368,,NRYJUVLALBJESR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,1.44,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1525877,DTCC00236187,1207534,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCCN3CCN(CC3)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1
2224,CHEMBL77618,P35368,,NRYJUVLALBJESR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,8.85,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1525874,DTCC00236187,1207534,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCCN3CCN(CC3)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1
2225,CHEMBL778,P35368,DEXMEDETOMIDINE,CUHVIMMYOGQXCV-NSHDSACASA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,-1.0,EC50,=,364.0,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15029409,DTCC00169175,2113753,70044,CC1=C(C(=CC=C1)[C@H](C)C2=CN=CN2)C,Cc1cccc([C@H](C)c2cnc[nH]2)c1C
2226,CHEMBL77901,P35368,,JTNOVHSABZCNCD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,49.84,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1548349,DTCC00237352,1467589,16317,CC1=NN(C(=O)C(=C1C(=O)C)NCCN2CCN(CC2)C3=CC=CC=C3OC)C,COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1
2227,CHEMBL77901,P35368,,JTNOVHSABZCNCD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,7.3,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1548346,DTCC00237352,1467589,16317,CC1=NN(C(=O)C(=C1C(=O)C)NCCN2CCN(CC2)C3=CC=CC=C3OC)C,COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1
2228,CHEMBL78584,P35368,,JALWBCWMBMTPNJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,258.92,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1543663,DTCC00237019,1144238,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)N3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(c2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1
2229,CHEMBL78584,P35368,,JALWBCWMBMTPNJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,6.59,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1543660,DTCC00237019,1144238,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)N3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(c2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1
2230,CHEMBL78676,P35368,,ZVWUWJMYOLNCLM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,2.01,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1541309,DTCC00237357,1785424,16317,CN1C(=O)C(=CC(=N1)C2=CC=CC=C2)NCCCN3CCN(CC3)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1
2231,CHEMBL78676,P35368,,ZVWUWJMYOLNCLM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,8.7,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,377962,DTCC00237357,1785424,16317,CN1C(=O)C(=CC(=N1)C2=CC=CC=C2)NCCCN3CCN(CC3)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1
2232,CHEMBL78785,P35368,,OKNLSDNUZNHITO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,5.51,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1522626,DTCC00236874,1435263,16317,CN1C(=O)C(=CC(=N1)C2=CC=CC=C2)NCCCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1
2233,CHEMBL78785,P35368,,OKNLSDNUZNHITO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,826.0,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1522623,DTCC00236874,1435263,16317,CN1C(=O)C(=CC(=N1)C2=CC=CC=C2)NCCCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCCNc2cc(-c3ccccc3)nn(C)c2=O)CC1
2234,CHEMBL78874,P35368,,WWXDGSCJMHTQQR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,1.45,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1524818,DTCC00236770,75952,16317,CCC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=CC=CC=C4OC,CCC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2OC)CC1
2235,CHEMBL78874,P35368,,WWXDGSCJMHTQQR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,8.84,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1524815,DTCC00236770,75952,16317,CCC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=CC=CC=C4OC,CCC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1NCCN1CCN(c2ccccc2OC)CC1
2236,CHEMBL79161,P35368,,JJNSORDALXSHNX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,53.39,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1548357,DTCC00236550,949663,16317,CC1=NN(C(=O)C(=C1C(=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC)C,COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1
2237,CHEMBL79161,P35368,,JJNSORDALXSHNX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,7.27,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1548353,DTCC00236550,949663,16317,CC1=NN(C(=O)C(=C1C(=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC)C,COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1
2238,CHEMBL79532,P35368,,YGPKJFYMSVJDNW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873568.0,KI,=,2200.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor was evaluated by cloned receptor binding assay,,Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivity.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Patane MA, DiPardo RM, Price RP, Chang RS, Ransom RW, O'Malley SS, Di Salvo J, Bock MG",,33013.0,DTCT0023207,1129833,DTCC00241948,1552890,2771,COC(=O)C1(CCN(CC1)CCCCN2C(=O)C3=C(S2(=O)=O)C=CC(=C3)Cl)C4=CC=CC=C4,COC(=O)C1(c2ccccc2)CCN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC1
2239,CHEMBL79817,P35368,,ZJEHREFWDSGYHV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1429481,DTCC00238195,1067570,5035,C1CCC(=O)N(CC1)CC2=NOC(=C2)CN3CCN(CC3)C4=CC=CC=C4OC5=CC=CC=C5,O=C1CCCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1
2240,CHEMBL79940,P35368,,OMSACAZYELQJHO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1426947,DTCC00238573,744254,5035,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NC(=CO3)CN4CCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCC3=O)co2)CC1
2241,CHEMBL79990,P35368,,QUFMDMYSYWGKMF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1429491,DTCC00238795,64342,5035,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NC(=CO3)CN4C(=O)C5=CC=CC=C5C4=O,CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)c4ccccc4C3=O)co2)CC1
2242,CHEMBL80036,P35368,,TXCOHHYQPMKABG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1431911,DTCC00238029,1132513,5035,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NC(=CO3)CN4C(=O)CC5(CCCC5)CC4=O,CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3C(=O)CC4(CCCC4)CC3=O)co2)CC1
2243,CHEMBL80109,P35368,,DWRUGEVTFWEDAY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1425764,DTCC00238718,193455,5035,C1CC(=O)N(C1)CC2=NOC(=C2)CN3CCN(CC3)C4=CC=CC=C4OC5=CC=CC=C5,O=C1CCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1
2244,CHEMBL80125,P35368,,NHBSUQDVNVOGGK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,=,3719.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1442200,DTCC00238067,3817,5035,C1CN(CCN1CC2=CC(=NO2)CO)C3=CC=CC=C3OC4=CC=CC=C4,OCc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1
2245,CHEMBL80132,P35368,,COXFKNBPMUTWPD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,33.13,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1528327,DTCC00236551,917091,16317,CC1=NN(C(=O)C(=C1)NCCN2CCN(CC2)C3=CC=CC=C3OC)C,COc1ccccc1N1CCN(CCNc2cc(C)nn(C)c2=O)CC1
2246,CHEMBL80132,P35368,,COXFKNBPMUTWPD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,7.48,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1528174,DTCC00236551,917091,16317,CC1=NN(C(=O)C(=C1)NCCN2CCN(CC2)C3=CC=CC=C3OC)C,COc1ccccc1N1CCN(CCNc2cc(C)nn(C)c2=O)CC1
2247,CHEMBL80260,P35368,,NAYUKRZMBPSGCB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,20.28,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1552222,DTCC00236822,1403265,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1
2248,CHEMBL80260,P35368,,NAYUKRZMBPSGCB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,7.69,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1552219,DTCC00236822,1403265,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1
2249,CHEMBL80458,P35368,,IOWGBMSSVZVFKH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,3.95,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1552216,DTCC00236743,594291,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1
2250,CHEMBL80458,P35368,,IOWGBMSSVZVFKH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,8.4,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1552213,DTCC00236743,594291,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1
2251,CHEMBL80599,P35368,,LPHRVZPLNGRXOZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,8.04,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1523867,DTCC00236708,2045088,16317,CC1=NN(C(=O)C(=C1C(=O)C)NCCCN2CCN(CC2)C3=C(C=CC(=C3)Cl)OC)C,COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1
2252,CHEMBL80599,P35368,,LPHRVZPLNGRXOZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,8.1,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1523864,DTCC00236708,2045088,16317,CC1=NN(C(=O)C(=C1C(=O)C)NCCCN2CCN(CC2)C3=C(C=CC(=C3)Cl)OC)C,COc1ccc(Cl)cc1N1CCN(CCCNc2c(C(C)=O)c(C)nn(C)c2=O)CC1
2253,CHEMBL80641,P35368,,LVCOTAHRPAKKNR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,3.29,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1557237,DTCC00236329,204830,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1
2254,CHEMBL80641,P35368,,LVCOTAHRPAKKNR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,8.48,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1557234,DTCC00236329,204830,16317,CC(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCNc2c(C(C)=O)c(-c3ccccc3)nn(C)c2=O)CC1
2255,CHEMBL80730,P35368,,KSGSACNIXHZDNP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,0.64,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1537672,DTCC00236217,1914423,16317,CC(C)C(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCNc2c(C(=O)C(C)C)c(-c3ccccc3)nn(C)c2=O)CC1
2256,CHEMBL80730,P35368,,KSGSACNIXHZDNP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,9.19,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1537669,DTCC00236217,1914423,16317,CC(C)C(=O)C1=C(C(=O)N(N=C1C2=CC=CC=C2)C)NCCN3CCN(CC3)C4=CC=CC=C4OC,COc1ccccc1N1CCN(CCNc2c(C(=O)C(C)C)c(-c3ccccc3)nn(C)c2=O)CC1
2257,CHEMBL81006,P35368,,MQRCKTYDHDXFKE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,20.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,904321,DTCC00239708,949702,2766,CC1=CC2=C(C=C1)S(=O)(=O)N(C2=O)CCCCN3CCC(CC3)N4C5=CC=CC=C5OC4=O,Cc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O
2258,CHEMBL81093,P35368,,DXYQOKKQRDKQCQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1409911,DTCC00238095,1359185,5035,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=CC(=NO3)CN4CCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2cc(CN3CCCCC3=O)no2)CC1
2259,CHEMBL81173,P35368,,PKNHRPIRHMNNHQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,6.8,NM,,cell_based,,,,,,,,,,,COS-7,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in COS-7 cells,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32895.0,DTCT0023207,922830,DTCC00240354,2012839,2766,CS(=O)(=O)C1=CC2=C(C=C1)C(=O)N(S2(=O)=O)CCCCN3CCC(CC3)N4C5=CC=CC=C5OC4=O,CS(=O)(=O)c1ccc2c(c1)S(=O)(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)C2=O
2260,CHEMBL81486,P35368,,BJGCUGXZSIBUBN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,KI,=,1.76,NM,,,,,,,,,,,,,,Binding affinity towards human cloned alpha-1B-adrenoceptor using [3H]prazosin as radioligand,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216132.0,DTCT0023207,1531935,DTCC00236794,1175346,16317,CN1C(=O)C(=CC(=N1)C2=CC=CC=C2)NCCN3CCN(CC3)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1
2261,CHEMBL81486,P35368,,BJGCUGXZSIBUBN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11448222.0,PK1B,=,8.75,,,,,,,,,,,,,,,Experimental binding affinity for alpha-1B-adrenergic receptor,,Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists.,J. Med. Chem.,2001.0,44.0,15.0,"Barlocco D, Cignarella G, Piaz VD, Giovannoni MP, De Benedetti PG, Fanelli F, Montesano F, Poggesi E, Leonardi A",,216133.0,DTCT0023207,1531932,DTCC00236794,1175346,16317,CN1C(=O)C(=CC(=N1)C2=CC=CC=C2)NCCN3CCN(CC3)C4=C(C=CC(=C4)Cl)OC,COc1ccc(Cl)cc1N1CCN(CCNc2cc(-c3ccccc3)nn(C)c2=O)CC1
2262,CHEMBL81661,P35368,,YEVKDYPUKCQOFQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,=,2205.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1418283,DTCC00238638,1649922,5035,C1CCN(C(=O)C1)CC2=NOC(=C2)CN3CCN(CC3)C4=CC=CC=C4OC5=CC=CC=C5,O=C1CCCCN1Cc1cc(CN2CCN(c3ccccc3Oc3ccccc3)CC2)on1
2263,CHEMBL82056,P35368,,JOAYDGACBFIMIA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,1152.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,900640,DTCC00240367,1079300,2766,CC1=C2C(=CC=C1)OC(=O)N2C3CCN(CC3)CCCCN4C(=O)C5=CC=CC=C5S4(=O)=O,Cc1cccc2oc(=O)n(C3CCN(CCCCN4C(=O)c5ccccc5S4(=O)=O)CC3)c12
2264,CHEMBL82267,P35368,,IPBOROXXRHATRV-IFMALSPDSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873568.0,KI,=,170.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor was evaluated by cloned receptor binding assay,,Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivity.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Patane MA, DiPardo RM, Price RP, Chang RS, Ransom RW, O'Malley SS, Di Salvo J, Bock MG",,33013.0,DTCT0023207,1129830,DTCC00241980,486288,2771,CCOC(=O)[C@@H]1CN(CC[C@@H]1C2=CC=CC=C2)CCCCN3C(=O)C4=C(S3(=O)=O)C=CC(=C4)Cl,CCOC(=O)[C@@H]1CN(CCCCN2C(=O)c3cc(Cl)ccc3S2(=O)=O)CC[C@@H]1c1ccccc1
2265,CHEMBL82480,P35368,,XPNNGWDHSSEEOO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1436003,DTCC00238166,841465,5035,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NC(=CO3)CN4CCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCC3=O)co2)CC1
2266,CHEMBL82877,P35368,,CBACROBVDLICEW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,75.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,919563,DTCC00240004,1817978,2766,C1CN(CCC1N2C3=CC=CC=C3OC2=O)CCCCN4C(=O)C5=C(S4(=O)=O)C=C(C=C5)[N+](=O)[O-],O=C1c2ccc([N+](=O)[O-])cc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1
2267,CHEMBL83041,P35368,,DPYCKGUROJUFMM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,301.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,904316,DTCC00240025,626806,2766,CC1=CC2=C(C=C1)N(C(=O)O2)C3CCN(CC3)CCCCN4C(=O)C5=CC=CC=C5S4(=O)=O,Cc1ccc2c(c1)oc(=O)n2C1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1
2268,CHEMBL83226,P35368,,GSTGFHBCLUCUEI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,133.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,927895,DTCC00240060,1723049,2766,C1CN(CCC1N2C3=CC=CC=C3OC2=O)CCCCN4C(=O)C5=C(S4(=O)=O)C=CC(=C5)[N+](=O)[O-],O=C1c2cc([N+](=O)[O-])ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1
2269,CHEMBL83272,P35368,,GUROZSUTVHXVSF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,7.3,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,899557,DTCC00239788,982056,2766,C1CN(CCC1N2C3=C(C=C(C=C3)F)OC2=O)CCCCN4C(=O)C5=CC=CC=C5S4(=O)=O,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3cc(F)ccc32)CC1
2270,CHEMBL83340,P35368,,VGCCDDCHXNJOMD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,15.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,917330,DTCC00240388,464866,2766,COC1=CC2=C(C=C1)S(=O)(=O)N(C2=O)CCCCN3CCC(CC3)N4C5=CC=CC=C5OC4=O,COc1ccc2c(c1)C(=O)N(CCCCN1CCC(n3c(=O)oc4ccccc43)CC1)S2(=O)=O
2271,CHEMBL83592,P35368,,RVWSEMKVGGVMFS-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873563.0,KI,=,50.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Nerenberg JB, Erb JM, Thompson WJ, Lee HY, Guare JP, Munson PM, Bergman JM, Huff JR, Broten TP, Chang RS, Chen TB, O'Malley S, Schorn TW, Scott AL",,32896.0,DTCT0023207,917335,DTCC00240387,853200,2766,C1CN(CCC1N2C3=CC=CC=C3OC2=O)CCCCN4C(=O)C5=C(S4(=O)=O)C=CC(=C5)F,O=C1c2cc(F)ccc2S(=O)(=O)N1CCCCN1CCC(n2c(=O)oc3ccccc32)CC1
2272,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,0.13,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14857839,DTCC00182516,2113519,70115,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2273,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,=,4.8,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14948500,DTCC00182516,2113864,70168,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2274,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,1.26,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,697557,DTCC00182516,2196,14595,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2275,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,1.26,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,726533,DTCC00182516,2195,14595,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2276,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,100.0,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,726529,DTCC00182516,2197,14595,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2277,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9379432.0,KI,=,0.61,NM,,,,,,,,,,,,,,Binding affinity against human adrenergic receptor subtype Alpha-1B adrenergic receptor using [3H]prazosin as radioligand,,"Synthesis and pharmacological characterization of 3-[2-((3aR,9bR)-cis-6-methoxy-2,3,3a,4,5,9b-hexahydro-1H-benz[e] isoindol-2-yl)ethyl]pyrido-[3',4':4,5]thieno[3,2-d]pyrimidine-2,4 (1H,3H)-dione (A-131701): a uroselective alpha 1A adrenoceptor antagonist for the symptomatic treatment of benign prostatic hyperplasia.",J. Med. Chem.,1997.0,40.0,20.0,"Meyer MD, Altenbach RJ, Basha FZ, Carroll WA, Drizin I, Elmore SW, Ehrlich PP, Lebold SA, Tietje K, Sippy KB, Wendt MD, Plata DJ, Plagge F, Buckner SA, Brune ME, Hancock AA, Kerwin JF",,34330.0,DTCT0023207,476966,DTCC00182516,4652,14344,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2278,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10841797.0,KI,=,1.92,NM,,,,,,,,,,,,,,Binding affinity towards cloned human alpha-1B adrenergic receptor was determined using [125]-HEAT as radioligand,,"Design, synthesis, and structure-activity relationships of phthalimide-phenylpiperazines: a novel series of potent and selective alpha(1)(a)-adrenergic receptor antagonists.",J. Med. Chem.,2000.0,43.0,11.0,"Kuo GH, Prouty C, Murray WV, Pulito V, Jolliffe L, Cheung P, Varga S, Evangelisto M, Wang J",,34335.0,DTCT0023207,1112059,DTCC00182516,3480,15735,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2279,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11805207.0,KI,=,0.6,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14712154,DTCC00182516,2098598,68867,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2280,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17452102.0,KI,=,2.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1B receptor,,(Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,12.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,444277.0,DTCT0023207,2166065,DTCC00182516,43164,23441,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2281,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17517507.0,KI,=,2.0,NM,,,,,,,,,,,,,,Binding affinity to human cloned adrenergic alpha-1b receptor,,(Phenylpiperidinyl)cyclohexylsulfonamides: development of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2007.0,17.0,14.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,438893.0,DTCT0023207,2104154,DTCC00182516,34374,22924,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2282,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,18055202.0,KI,=,2.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human recombinant adrenergic Alpha-1B receptor,,(Phenylpiperazinyl)cyclohexylureas: discovery of alpha1a/1d-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS).,Bioorg. Med. Chem. Lett.,2008.0,18.0,2.0,"Chiu G, Li S, Connolly PJ, Pulito V, Liu J, Middleton SA",,469777.0,DTCT0023207,2295798,DTCC00182516,43923,25739,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2283,CHEMBL836,P35368,TAMSULOSIN,DRHKJLXJIQTDTD-OAHLLOKOSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,20934789.0,KI,=,0.631,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]prazosin from human Alpha-1B adrenoceptor expressed in CHO cells,,Synthesis and a1-adrenoceptor antagonist activity of tamsulosin analogues.,Eur. J. Med. Chem.,2010.0,45.0,12.0,"Sagratini G, Angeli P, Buccioni M, Gulini U, Marucci G, Melchiorre C, Poggesi E, Giardinà D",,693738.0,DTCT0023207,5008432,DTCC00182516,47333,42213,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1
2284,CHEMBL83791,P35368,,LNUAEDPBKADXTB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12161153.0,KI,>,5000.0,NM,,,,,,,,,,,,,,Displacement of [125I]-HEAT from human Alpha-1B adrenergic receptor,,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,2002.0,12.0,17.0,"Khatuya H, Hutchings RH, Kuo GH, Pulito VL, Jolliffe LK, Li X, Murray WV",,34347.0,DTCT0023207,1429486,DTCC00238673,2000854,5035,CC(C)OC1=CC=CC=C1N2CCN(CC2)CC3=NC(=CO3)CN4CCCCCC4=O,CC(C)Oc1ccccc1N1CCN(Cc2nc(CN3CCCCCC3=O)co2)CC1
2285,CHEMBL8412,P35368,IPSAPIRONE,TZJUVVIWVWFLCD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9873568.0,KI,=,220.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor was evaluated by cloned receptor binding assay,,Selective alpha-1a adrenergic receptor antagonists. Effects of pharmacophore regio- and stereochemistry on potency and selectivity.,Bioorg. Med. Chem. Lett.,1998.0,8.0,18.0,"Patane MA, DiPardo RM, Price RP, Chang RS, Ransom RW, O'Malley SS, Di Salvo J, Bock MG",,33013.0,DTCT0023207,1098231,DTCC00135171,1100428,2771,C1CN(CCN1CCCCN2C(=O)C3=CC=CC=C3S2(=O)=O)C4=NC=CC=N4,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1
2286,CHEMBL844,P35368,BRIMONIDINE,XYLJNLCSTIOKRM-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,-1.0,EC50,=,943.0,NM,,cell_based,binding,reporter_gene,,,,,,,,,,,,,,,,,,,,DTCT0023207,15043117,DTCC00183812,2113752,70044,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Brc1c(NC2=NCCN2)ccc2nccnc12
2287,CHEMBL844,P35368,BRIMONIDINE,XYLJNLCSTIOKRM-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,5370.32,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor from cultured LM(tk-) cells using [3H]prazosin ,,,Bioorg. Med. Chem. Lett.,1995.0,5.0,19.0,,,34490.0,DTCT0023207,1647125,DTCC00183812,2033700,1335,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,Brc1c(NC2=NCCN2)ccc2nccnc12
2288,CHEMBL85,P35368,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,3.16,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14711741,DTCC00138594,2098498,68596,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
2289,CHEMBL85,P35368,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,,KI,=,10.0,NM,,,,,,,,,,,,,,Binding affinity to adrenergic alpha1B receptor (unknown origin) by PDSP assay,,,MedChemComm,2012.0,3.0,5.0,,,1329323.0,DTCT0023207,13584565,DTCC00138594,1387256,39761,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
2290,CHEMBL8618,P35368,NAN-190,SJDOMIRMMUGQQK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17254786.0,KI,=,0.96,NM,,cell_based,,,,,,,,,,,CHO,Displacement of [125]HEAT from human adrenergic alpha-1b receptor expressed in CHO cells,,"1-Arylpiperazinyl-4-cyclohexylamine derived isoindole-1,3-diones as potent and selective alpha-1a/1d adrenergic receptor ligands.",Bioorg. Med. Chem. Lett.,2007.0,17.0,6.0,"Li S, Chiu G, Pulito VL, Liu J, Connolly PJ, Middleton SA",,441868.0,DTCT0023207,2162344,DTCC00135647,1787910,23196,COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)C4=CC=CC=C4C3=O,COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1
2291,CHEMBL88272,P35368,RS-17053,XLZHXAXXJVKTFM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9135028.0,KI,=,15.85,NM,,,,,,,,,,,,,,Binding affinity was tested on human Alpha-1B adrenergic receptor,,Pharmacological options in the treatment of benign prostatic hyperplasia.,J. Med. Chem.,1997.0,40.0,9.0,"Kenny B, Ballard S, Blagg J, Fox D",,34608.0,DTCT0023207,713665,DTCC01741639,1967378,14595,CC(C)(CC1=CNC2=C1C=C(C=C2)Cl)NCCOC3=CC=CC=C3OCC4CC4,CC(C)(Cc1c[nH]c2ccc(Cl)cc12)NCCOc1ccccc1OCC1CC1
2292,CHEMBL88272,P35368,RS-17053,XLZHXAXXJVKTFM-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16420037.0,KI,=,16.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14710822,DTCC01741639,2098279,68752,CC(C)(CC1=CNC2=C1C=C(C=C2)Cl)NCCOC3=CC=CC=C3OCC4CC4,CC(C)(Cc1c[nH]c2ccc(Cl)cc12)NCCOc1ccccc1OCC1CC1
2293,CHEMBL88388,P35368,,FOGMNVRCPAJQDZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,380.19,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,759199,DTCC00251561,2045228,14735,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC6=C(C=C5)OCO6)C(=O)C,CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2
2294,CHEMBL88448,P35368,,AHCOOGMIZVMEKD-PKUSAGTQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,239.88,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,732595,DTCC00251562,270109,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)N(C)CCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)N(C)CCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
2295,CHEMBL88628,P35368,,GJSIQLZDGMIVKC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,1778.28,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,742928,DTCC00250951,1305777,14735,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC6=C(C=C5)OCO6)C(=O)NC,CNC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2
2296,CHEMBL89243,P35368,,OUDWCNZTASZGHL-PKUSAGTQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,151.36,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,739192,DTCC00251246,76107,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)C#N)C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc(C#N)cc1
2297,CHEMBL89685,P35368,,SCZDZQFTMOOIDO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,263.03,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,770562,DTCC00251024,1144395,14735,CC1=C(C(C(=C(N1)C)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)C,CC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
2298,CHEMBL89927,P35368,,UYWFSEXEAMKGLC-AREMUKBSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,130.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1344318,DTCC00254681,1850273,15798,CC1=C([C@H](NC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=C(C=C(C=C4)F)C#N,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C
2299,CHEMBL89965,P35368,,PPRGGQATMMRENB-RUZDIDTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,1100.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1333180,DTCC00254056,2012985,15798,CC1=C([C@H](NC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C
2300,CHEMBL90086,P35368,,LKCYPDONQAJLQQ-RUZDIDTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,7.9,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1334405,DTCC00254212,30238,15798,CN1C=C([C@H](NC1=O)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=C(C=C(C=C4)F)C#N,CN1C=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O
2301,CHEMBL90184,P35368,,JMHJPWHXTFNZBY-JOCHJYFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,270.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1323993,DTCC00254964,1914614,15798,C1CN(CCC1C2=CC=C(C=C2)F)CCCNC(=O)C3=C(NC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F)C(F)(F)F,O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1
2302,CHEMBL90210,P35368,,ZMXFHYHEZZYYHG-JOCHJYFZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,1850.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1361736,DTCC00254865,1947250,15798,C1CN(CCC1C2=CC=CC=N2)CCCNC(=O)C3=CNC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F,O=C1NC=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1
2303,CHEMBL90420,P35368,,JNWYRENLYPYLET-AREMUKBSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,20.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34327.0,DTCT0023207,1342791,DTCC00254746,691457,15798,CC1=C([C@H](N(C(=O)N1C)C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C
2304,CHEMBL90421,P35368,,ACXCLVVRXJUJEC-RUZDIDTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,120.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34327.0,DTCT0023207,1347134,DTCC00254747,885618,15798,CC1=C([C@H](NC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C
2305,CHEMBL90453,P35368,,JLIUDRVXSXMEGO-HHHXNRCGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,33.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1360535,DTCC00254784,1403477,15798,CC1=C([C@H](N(C(=O)N1C)C(=O)C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,CC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1
2306,CHEMBL90606,P35368,,CHSVWGZALFVOMB-RUZDIDTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,4.8,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1353886,DTCC00254785,140855,15798,CC1=C([C@H](N(C(=O)N1)C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C(=O)N1
2307,CHEMBL90652,P35368,,ZRWCHZNUZHLTHH-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,290.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1341618,DTCC00254684,2012986,15798,C1CN(CCC1C2=CC=CC=C2C#N)CCCNC(=O)C3=CNC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F,N#Cc1ccccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1
2308,CHEMBL91022,P35368,,KADUIVAIJUZKJS-KDJFERLWSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,13.49,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,753904,DTCC00251706,270111,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)C4=CC=CC=C4,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
2309,CHEMBL91091,P35368,,QCNCXPPJUJSUHJ-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,970.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1352409,DTCC00254834,270167,15798,C1CN(CCC1(C#N)C2=CC=CC=C2C#N)CCCNC(=O)C3=CNC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F,N#Cc1ccccc1C1(C#N)CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1
2310,CHEMBL91125,P35368,,OFCHYNGUGWDBBL-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,235.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1327805,DTCC00254901,76157,15798,COCC1=C([C@H](NC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=CC=N4,COCC1=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1
2311,CHEMBL91179,P35368,,IMUVOXNSMVUHSB-OAQYLSRUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,>,2000.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1336899,DTCC00254902,1532544,15798,C1CN(CCC1C2=CC=CC=N2)CCCNC(=O)C3=C(NC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F)C(F)(F)F,O=C1NC(C(F)(F)F)=C(C(=O)NCCCN2CCC(c3ccccn3)CC2)[C@@H](c2ccc(F)c(F)c2)N1
2312,CHEMBL91403,P35368,,KIKWDDIOTKEEMS-AREMUKBSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,>,2000.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1341605,DTCC00254025,368458,15798,CC1=C([C@H](NC(=O)N1C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=C(C=C(C=C4)F)C#N,CC1=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1C
2313,CHEMBL91405,P35368,,QFAYCLRYZRQACH-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,40.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1347109,DTCC00254989,820435,15798,CC1=C([C@H](NC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1
2314,CHEMBL91415,P35368,,WJRKWJSQVYFSFK-PKUSAGTQSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,223.87,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,747727,DTCC00251251,30149,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC3=C(C=C2)OCO3)C(=O)NCCCN4CCC(CC4)(C5=CC=CC=C5)C6=CC=CC=C6,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2c(c1)OCO2
2315,CHEMBL91550,P35368,,JEZMYAZTGNMODX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,245.47,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,769330,DTCC00251829,1175523,14735,CCC1=C(C(C(=C(N1)CC)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CC)N1
2316,CHEMBL91616,P35368,,LDXAPIWITLZXNM-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,53.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34327.0,DTCT0023207,1333187,DTCC00254745,1338510,15798,CN1C=C([C@H](NC1=O)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=CC=C(C=C4)F,CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC1=O
2317,CHEMBL91956,P35368,,YQTAOHSPORUWMC-WUVHBKSUSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,77.62,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,737796,DTCC00251770,270110,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
2318,CHEMBL92322,P35368,,OBVUZKZJWYCTTA-WQBMDMGNSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9651170.0,KI,=,138.04,NM,,,,,,,,,,,,,,Binding affinity determined by displacement of [3H]prazosin from alpha-1B adrenergic receptor,,Identification of a dihydropyridine as a potent alpha1a adrenoceptor-selective antagonist that inhibits phenylephrine-induced contraction of the human prostate.,J. Med. Chem.,1998.0,41.0,14.0,"Wong WC, Chiu G, Wetzel JM, Marzabadi MR, Nagarathnam D, Wang D, Fang J, Miao SW, Hong X, Forray C, Vaysse PJ, Branchek TA, Gluchowski C, Tang R, Lepor H",,34615.0,DTCT0023207,739200,DTCC00251252,1175522,14735,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC3=CC=CC=C3C=C2)C(=O)NCCCN4CCC(CC4)(C5=CC=CC=C5)C6=CC=CC=C6,COC(=O)C1=C(C)NC(C)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc2ccccc2c1
2319,CHEMBL92328,P35368,,KOEKJPAUBRTOCK-RUZDIDTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,87.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1347118,DTCC00254921,562282,15798,CC1=C([C@H](NC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=C(C=C(C=C4)F)C#N,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1
2320,CHEMBL92951,P35368,,ZIIQDPQNOPXNGU-RUZDIDTESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,41.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1357963,DTCC00254951,1240478,15798,COCC1=C([C@H](NC(=O)N1)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,COCC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)NC(=O)N1
2321,CHEMBL93240,P35368,METITEPINE,RLJFTICUTYVZDG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,0.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14709109,DTCC00260212,2097903,68596,CN1CCN(CC1)C2CC3=CC=CC=C3SC4=C2C=C(C=C4)SC,CSc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2
2322,CHEMBL93523,P35368,,XQOGKBPVGSEDTB-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,700.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1351019,DTCC00255072,1144439,15798,C1CN(CCC1C2=CC=CC=C2C#N)CCCNC(=O)C3=C(NC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F)C(F)(F)F,N#Cc1ccccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1
2323,CHEMBL93623,P35368,,GPVSQYKLAUEUBR-AREMUKBSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,25.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1352416,DTCC00254649,1144438,15798,CC1=C([C@H](N(C(=O)N1C)C(=O)OC)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,COC(=O)N1C(=O)N(C)C(C)=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1
2324,CHEMBL93693,P35368,,JNWYRENLYPYLET-SANMLTNESA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,85.0,NM,,cell_based,,,,,,,,,,,LM,Ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34327.0,DTCT0023207,1342788,DTCC00254472,530055,15798,CC1=C([C@@H](N(C(=O)N1C)C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)C4=CC=C(C=C4)F,CC1=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H](c2ccc(F)c(F)c2)N(C)C(=O)N1C
2325,CHEMBL93843,P35368,,ACUBKRQETGSILZ-AREMUKBSSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,72.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1335610,DTCC00254667,659283,15798,CN1C=C([C@H](N(C1=O)C)C2=CC(=C(C=C2)F)F)C(=O)NCCCN3CCC(CC3)(C#N)C4=C(C=C(C=C4)F)C#N,CN1C=C(C(=O)NCCCN2CCC(C#N)(c3ccc(F)cc3C#N)CC2)[C@@H](c2ccc(F)c(F)c2)N(C)C1=O
2326,CHEMBL94167,P35368,,PCFUZJJFXKXNPC-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,24.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1348327,DTCC00254992,1014536,15798,C1CN(CCC1C2=CC=C(C=C2)F)CCCNC(=O)C3=CNC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F,O=C1NC=C(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccc(F)c(F)c2)N1
2327,CHEMBL94188,P35368,,KFFBTOAYJRDMAT-XMMPIXPASA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,26.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1336892,DTCC00254977,1629521,15798,C1CN(CCC1C2=C(C=C(C=C2)F)C#N)CCCNC(=O)C3=CNC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F,N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=CNC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1
2328,CHEMBL94259,P35368,,PSQXMJPYXNSOJY-HSZRJFAPSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10893308.0,KI,=,200.0,NM,,cell_based,,,,,,,,,,,LM,Evaluated for the ability to displace [125I]- HEAT from human cloned Alpha-1B adrenergic receptor stably expressed in LM cells.,,In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.,J. Med. Chem.,2000.0,43.0,14.0,"Barrow JC, Nantermet PG, Selnick HG, Glass KL, Rittle KE, Gilbert KF, Steele TG, Homnick CF, Freidinger RM, Ransom RW, Kling P, Reiss D, Broten TP, Schorn TW, Chang RS, O'Malley SS, Olah TV, Ellis JD, Barrish A, Kassahun K, Leppert P, Nagarathnam D, Forray C",,34456.0,DTCT0023207,1329182,DTCC00254889,173061,15798,C1CN(CCC1C2=C(C=C(C=C2)F)C#N)CCCNC(=O)C3=C(NC(=O)N[C@@H]3C4=CC(=C(C=C4)F)F)C(F)(F)F,N#Cc1cc(F)ccc1C1CCN(CCCNC(=O)C2=C(C(F)(F)F)NC(=O)N[C@@H]2c2ccc(F)c(F)c2)CC1
2329,CHEMBL94261,P35368,,VCFMMDVFGUQTHR-FQEVSTJZSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10669560.0,LOG KI,,,,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor; ND means no data.,Not Determined,"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).",J. Med. Chem.,2000.0,43.0,3.0,"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR",,32308.0,DTCT0023207,1096075,DTCC00260551,1500540,16008,CC1CCN(CC1)CC[C@@H]2CCCN2S(=O)(=O)C3=CC=CC4=CC=CC=C43,CC1CCN(CC[C@@H]2CCCN2S(=O)(=O)c2cccc3ccccc23)CC1
2330,CHEMBL94984,P35368,,VCFMMDVFGUQTHR-HXUWFJFHSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10669560.0,KI,=,2511.89,NM,,,,,,,,,,,,,,Binding affinity towards Alpha-1B adrenergic receptor,,"A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).",J. Med. Chem.,2000.0,43.0,3.0,"Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR",,32307.0,DTCT0023207,1110871,DTCC00260552,30931,16008,CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)C3=CC=CC4=CC=CC=C43,CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc3ccccc23)CC1
2331,CHEMBL95191,P35368,,KLNIHTYXOOSMBC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,10000000000000.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34620.0,DTCT0023207,1584511,DTCC00264421,1753601,17389,CCC(C)C1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,CCC(C)c1ccc(N2CCN(CCn3c(=O)[nH]c4c([nH]c5ccccc54)c3=O)CC2)cc1
2332,CHEMBL95245,P35368,,SMQKTFWONSPSLZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,316.23,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,627843,DTCC00264564,303316,4573,C1CCN(C1)C(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(c1ccccc1NCC1=NCCN1)N1CCCC1
2333,CHEMBL95245,P35368,,SMQKTFWONSPSLZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,79.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,627844,DTCC00264564,303316,4573,C1CCN(C1)C(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(c1ccccc1NCC1=NCCN1)N1CCCC1
2334,CHEMBL95253,P35368,,KLHZZCXEMHQCHW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,254.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1219896,DTCC00262984,226055,3366,CCC1=C(C(C(=C(N1)COCCN)C(=O)NCC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,CCNC(=O)C1=C(COCCN)NC(CC)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
2335,CHEMBL95263,P35368,,UYAKCQCCXMIWMQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,127.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1224533,DTCC00262789,906739,3366,CCCCCC1=C(C(C(=C(N1)CC)C(=O)NCC)C2=CC=C(C=C2)[N+](=O)[O-])C(=O)NCCCN3CCC(CC3)(C4=CC=CC=C4)C5=CC=CC=C5,CCCCCC1=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCC)=C(CC)N1
2336,CHEMBL95290,P35368,,KCUCPEWBDAFYOT-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,785.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1243861,DTCC00262928,938456,3366,CCC1=C(C(C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)NCC,CCNC(=O)C1=C(CC)NC(COCCN)=C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)C1c1ccc([N+](=O)[O-])cc1
2337,CHEMBL95333,P35368,,CNOGTSVNRSSSOR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,79.43,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,647832,DTCC00264621,1305925,4573,C1CCN(CC1)C(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(c1ccccc1NCC1=NCCN1)N1CCCCC1
2338,CHEMBL95333,P35368,,CNOGTSVNRSSSOR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,106.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,647833,DTCC00264621,1305925,4573,C1CCN(CC1)C(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(c1ccccc1NCC1=NCCN1)N1CCCCC1
2339,CHEMBL95398,P35368,,CBLUHSHTFYFAED-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,79.43,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,623455,DTCC00264527,1629613,4573,CC(C)COC(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)COC(=O)c1ccccc1NCC1=NCCN1
2340,CHEMBL95398,P35368,,CBLUHSHTFYFAED-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,90.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,623456,DTCC00264527,1629613,4573,CC(C)COC(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)COC(=O)c1ccccc1NCC1=NCCN1
2341,CHEMBL95434,P35368,,LWIMUFCQSSEBRN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,269.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1229837,DTCC00262788,712224,3366,CC1=C(C(C(=C(N1)CCCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCN)N1
2342,CHEMBL95523,P35368,,SPDFYEGKQZMPHC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,1.58,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,642285,DTCC00264526,853458,4573,CNC(=O)C1=CC=CC=C1NCC2=NCCN2,CNC(=O)c1ccccc1NCC1=NCCN1
2343,CHEMBL95523,P35368,,SPDFYEGKQZMPHC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,IC50,=,691.83,NM,,,,,,,,,,,,,,Concentration required for 50% inhibition of binding against human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,34483.0,DTCT0023207,642290,DTCC00264526,853458,4573,CNC(=O)C1=CC=CC=C1NCC2=NCCN2,CNC(=O)c1ccccc1NCC1=NCCN1
2344,CHEMBL95523,P35368,,SPDFYEGKQZMPHC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,99.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,642286,DTCC00264526,853458,4573,CNC(=O)C1=CC=CC=C1NCC2=NCCN2,CNC(=O)c1ccccc1NCC1=NCCN1
2345,CHEMBL95548,P35368,,HSZTUDYUKZUFKK-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,17.9,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1225904,DTCC00262951,356793,3366,CC1=C(C(C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)C3=CC=CC=C3)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)CC2)=C(COCCN)N1
2346,CHEMBL95565,P35368,,NEIUXSPLTUKXGW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,12.59,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,627837,DTCC00263487,1850399,4573,CC(C)CNC(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)CNC(=O)c1ccccc1NCC1=NCCN1
2347,CHEMBL95565,P35368,,NEIUXSPLTUKXGW-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,90.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,627838,DTCC00263487,1850399,4573,CC(C)CNC(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)CNC(=O)c1ccccc1NCC1=NCCN1
2348,CHEMBL95578,P35368,,GHMHLQOFXXKCPZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,447.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1216502,DTCC00262931,1903323,3366,CCC1=C(C(C(=C(N1)COCCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCCN)N1
2349,CHEMBL95605,P35368,,GZCGXJIAJHDKLC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,7762.47,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1572519,DTCC00265182,1338607,17389,C1CN2C(CN1CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O)COC6=CC=CC=C62,O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN2c3ccccc3OCC2C1
2350,CHEMBL95736,P35368,,CWRGETLEMMGBDH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,181.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1215348,DTCC00262547,1742288,3366,CC1=C(C(C(=C(N1)CCCN)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCN)N1
2351,CHEMBL95986,P35368,,PDCJPFURXZYCSG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,100000.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1576428,DTCC00264548,140964,17389,CC(C)C1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5S4)NC3=O,CC(C)c1ccc(N2CCN(CCn3c(=O)[nH]c4c(sc5ccccc54)c3=O)CC2)cc1
2352,CHEMBL96467,P35368,SNAP-7915,DTYAFBJXWWLRMA-QMHKHESXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10956183.0,KI,=,119.0,NM,,,,,,,,,,,,,,"Binding affinity towards Alpha1B human adrenergic receptors, using [125I]HEAT as radioligand.",,De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailability.,J. Med. Chem.,2000.0,43.0,15.0,"Lagu B, Tian D, Jeon Y, Li C, Wetzel JM, Nagarathnam D, Shen Q, Forray C, Chang RS, Broten TP, Ransom RW, Chan TB, O'Malley SS, Schorn TW, Rodrigues AD, Kassahun K, Pettibone DJ, Freidinger RO, Gluchowski C",,34334.0,DTCT0023207,691191,DTCC01741790,808855,15807,C[C@H]1[C@@H](N(C(=O)O1)C(=O)NCCCN2CCC(CC2)C3=CC=C(C=C3)F)C4=CC(=C(C=C4)F)F,C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1
2353,CHEMBL96467,P35368,SNAP-7915,DTYAFBJXWWLRMA-QMHKHESXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10956183.0,KI,=,121.0,NM,,,,,,,,,,,,,,"Binding affinity towards Alpha1B dog adrenergic receptors, using [125I]HEAT as radioligand.",,De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailability.,J. Med. Chem.,2000.0,43.0,15.0,"Lagu B, Tian D, Jeon Y, Li C, Wetzel JM, Nagarathnam D, Shen Q, Forray C, Chang RS, Broten TP, Ransom RW, Chan TB, O'Malley SS, Schorn TW, Rodrigues AD, Kassahun K, Pettibone DJ, Freidinger RO, Gluchowski C",,34188.0,DTCT0023207,691194,DTCC01741790,808855,15807,C[C@H]1[C@@H](N(C(=O)O1)C(=O)NCCCN2CCC(CC2)C3=CC=C(C=C3)F)C4=CC(=C(C=C4)F)F,C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1
2354,CHEMBL96467,P35368,SNAP-7915,DTYAFBJXWWLRMA-QMHKHESXSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11133073.0,KI,=,119.0,NM,,,,,,,,,,,,,,Tested for binding affinity against recombinant human Alpha-1B adrenergic receptor using [125I]HEAT in competition binding assay,,Determination of the relative and absolute stereochemistry of a potent and alpha1A-selective adrenoceptor antagonist.,Bioorg. Med. Chem. Lett.,2000.0,10.0,24.0,"Lagu B, Wetzel JM, Forray C, Patane MA, Bock MG",,34463.0,DTCT0023207,668280,DTCC01741790,820423,4034,C[C@H]1[C@@H](N(C(=O)O1)C(=O)NCCCN2CCC(CC2)C3=CC=C(C=C3)F)C4=CC(=C(C=C4)F)F,C[C@@H]1OC(=O)N(C(=O)NCCCN2CCC(c3ccc(F)cc3)CC2)[C@H]1c1ccc(F)c(F)c1
2355,CHEMBL96988,P35368,,KJYJPEXJENXWRY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,627832,DTCC00263407,1144541,4573,C1CC(C1)NC(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(NC1CCC1)c1ccccc1NCC1=NCCN1
2356,CHEMBL96988,P35368,,KJYJPEXJENXWRY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,,,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,627833,DTCC00263407,1144541,4573,C1CC(C1)NC(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(NC1CCC1)c1ccccc1NCC1=NCCN1
2357,CHEMBL97044,P35368,,RGGYMFBJVPVXKH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,251.19,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,622410,DTCC00263408,917395,4573,C1CC1NC(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(NC1CC1)c1ccccc1NCC1=NCCN1
2358,CHEMBL97044,P35368,,RGGYMFBJVPVXKH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,IC50,=,2238.72,NM,,,,,,,,,,,,,,Concentration required for 50% inhibition of binding against human Alpha-1B adrenergic receptor,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,34483.0,DTCT0023207,622414,DTCC00263408,917395,4573,C1CC1NC(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(NC1CC1)c1ccccc1NCC1=NCCN1
2359,CHEMBL97044,P35368,,RGGYMFBJVPVXKH-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,50.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,622411,DTCC00263408,917395,4573,C1CC1NC(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(NC1CC1)c1ccccc1NCC1=NCCN1
2360,CHEMBL97698,P35368,,XBRXTUGRUXGBPX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,8917649.0,KI,=,0.589,NM,,,,,,,,,,,,,,Compound was tested for binding affinity against cloned Alpha-1B adrenergic receptor from hamster smooth muscle using radioligand ([3H]prazosin) binding assay,,"Synthesis and biological profile of the enantiomers of [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-cis-octahydroquinoxalin- 1-yl]furan-2-ylmethanone (cyclazosin), a potent competitive alpha 1B- adrenoceptor antagonist.",J. Med. Chem.,1996.0,39.0,23.0,"Giardinà D, Crucianelli M, Romanelli R, Leonardi A, Poggesi E, Melchiorre C",,34317.0,DTCT0023207,1425903,DTCC00261807,1436254,13894,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(C4C3CCCC4)C(=O)C5=CC=CO5)N)OC,COc1cc2nc(N3CCN(C(=O)c4ccco4)C4CCCCC43)nc(N)c2cc1OC
2361,CHEMBL97859,P35368,,ASOZEEQINAQAHV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,625692,DTCC00264668,1693746,4573,CCC(C)OC(=O)C1=CC=CC=C1NCC2=NCCN2,CCC(C)OC(=O)c1ccccc1NCC1=NCCN1
2362,CHEMBL98016,P35368,,ZTVXUJSEZMDLLE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,125.89,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,650190,DTCC00264131,1240600,4573,CC(C)NC(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)NC(=O)c1ccccc1NCC1=NCCN1
2363,CHEMBL98016,P35368,,ZTVXUJSEZMDLLE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,95.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,650191,DTCC00264131,1240600,4573,CC(C)NC(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)NC(=O)c1ccccc1NCC1=NCCN1
2364,CHEMBL98038,P35368,,RLFPVKPYWHWRJC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,38681.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1245076,DTCC00263333,324106,3366,CC1=C(C(C(=C(N1)COCCN)C(=O)NCCCN2CCC(CC2)(CN(C)C)C3=CC=CC=C3)C4=CC=C(C=C4)[N+](=O)[O-])C(=O)N,CC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(CN(C)C)(c3ccccc3)CC2)=C(COCCN)N1
2365,CHEMBL98063,P35368,,OVMVWTGSJYRVPV-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,98.3,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1B adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,34329.0,DTCT0023207,1223460,DTCC00262602,1618016,3366,CCC1=C(C(C(=C(N1)COCCN=[N+]=[N-])C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(COCCN=[N+]=[N-])N1
2366,CHEMBL98167,P35368,,YFZDJBNVNRXEMA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,1294.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,503716,DTCC00266965,938516,3405,C1CN(CCC12CC(=O)C3=CC=CC=C3O2)CCC4=CC=CC=N4,O=C1CC2(CCN(CCc3ccccn3)CC2)Oc2ccccc21
2367,CHEMBL98168,P35368,,AROUGQIPMYQUEE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,137.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,512286,DTCC00266966,1553160,3405,C1CN(CCC12CC3=CC=CC=C3C(=O)O2)CCC4=CC=CC5=CC=CC=C54,O=C1OC2(CCN(CCc3cccc4ccccc34)CC2)Cc2ccccc21
2368,CHEMBL98241,P35368,SNAP-8719,WCWNYVYNQAPOOX-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11354357.0,KI,=,165.0,NM,,,,,,,,,,,,,,Binding affinity towards human Alpha-1B adrenergic receptor,,Two novel and potent 3-[(o-methoxyphenyl)piperazinylethyl]-5-phenylthien.,Bioorg. Med. Chem. Lett.,2001.0,11.0,9.0,"Carroll WA, Sippy KB, Esbenshade TA, Buckner SA, Hancock AA, Meyer MD",,34336.0,DTCT0023207,729494,DTCC01741844,207408,4794,C[C@H](CN1CCN(CC1)C2=CC(=C(C=C2F)F)F)N3C(=O)CC4(CCCC4)CC3=O,C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O
2369,CHEMBL98241,P35368,SNAP-8719,WCWNYVYNQAPOOX-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,191.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34333.0,DTCT0023207,1579226,DTCC01741844,205151,17389,C[C@H](CN1CCN(CC1)C2=CC(=C(C=C2F)F)F)N3C(=O)CC4(CCCC4)CC3=O,C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O
2370,CHEMBL98241,P35368,SNAP-8719,WCWNYVYNQAPOOX-OAHLLOKOSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15828846.0,KI,=,165.0,NM,,,,,,,,,,,,,,Binding affinity for human Alpha-1B adrenergic receptor,,"Synthesis and structure-activity relationship of fluoro analogues of 8-{2-[4-(4-methoxyphenyl)piperazin-1yl]ethyl}-8-azaspiro[4.5]decane-7,9-dione as selective alpha(1d)-adrenergic receptor antagonists.",J. Med. Chem.,2005.0,48.0,8.0,"Konkel MJ, Wetzel JM, Cahir M, Craig DA, Noble SA, Gluchowski C",,302652.0,DTCT0023207,1825496,DTCC01741844,195265,19681,C[C@H](CN1CCN(CC1)C2=CC(=C(C=C2F)F)F)N3C(=O)CC4(CCCC4)CC3=O,C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O
2371,CHEMBL98243,P35368,,BZZFDOAWNMBVEQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,63.1,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,637852,DTCC00264529,335899,4573,CC(C)(C)OC(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)(C)OC(=O)c1ccccc1NCC1=NCCN1
2372,CHEMBL98243,P35368,,BZZFDOAWNMBVEQ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,81.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,637853,DTCC00264529,335899,4573,CC(C)(C)OC(=O)C1=CC=CC=C1NCC2=NCCN2,CC(C)(C)OC(=O)c1ccccc1NCC1=NCCN1
2373,CHEMBL98413,P35368,,GAWCPJXNKBSMOF-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,LOG KI,<,6.0,NM,,cell_based,,,,,,,,,,,,The binding affinity was evaluated on cloned human Alpha-1B adrenergic receptor expressed in chinese hamster ovary(CHO) cells by using [3H]prazosin as radioligand.,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34621.0,DTCT0023207,989150,DTCC00268464,808965,15289,COC1=C(C(=CC=C1)OC)OCCNCC2C(SC3=CC=CC=C3C2=O)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1C(=O)c2ccccc2SC1c1ccccc1
2374,CHEMBL98430,P35368,,MRBDOYSYHLKZAG-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,221.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,509775,DTCC00267609,1326716,3405,CC1=C(C2=CC=CC=C2N1)CCN3CCC4(CC3)CC(=O)C5=C(O4)C=C(C=C5)NS(=O)(=O)C,Cc1[nH]c2ccccc2c1CCN1CCC2(CC1)CC(=O)c1ccc(NS(C)(=O)=O)cc1O2
2375,CHEMBL98769,P35368,,GBDMPVCOGLRHJI-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,635654,DTCC00264667,1371171,4573,CCCN(CC)C(=O)C1=CC=CC=C1NCC2=NCCN2,CCCN(CC)C(=O)c1ccccc1NCC1=NCCN1
2376,CHEMBL98807,P35368,,LFGYMZUBIQPQKO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,162.18,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1584508,DTCC00264894,1207800,17389,COC1=CC=CC=C1N2CCN(CC2)CCCN3C=NC4=C(C3=O)NC5=CC=CC=C54,COc1ccccc1N1CCN(CCCn2cnc3c([nH]c4ccccc43)c2=O)CC1
2377,CHEMBL98912,P35368,,KNUUIOPRZQVRMC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,<,10000.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1594626,DTCC00264547,270295,17389,CC(C)C1=CC=C(C=C1)N2CCN(CC2)CCN3C=NC4=C(C3=O)NC5=CC=CC=C54,CC(C)c1ccc(N2CCN(CCn3cnc4c([nH]c5ccccc54)c3=O)CC2)cc1
2378,CHEMBL98921,P35368,,JGDIYDHZAMLQDC-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,<,5011.87,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,634607,DTCC00264590,1532642,4573,C1CCC(CC1)OC(=O)C2=CC=CC=C2NCC3=NCCN3,O=C(OC1CCCCC1)c1ccccc1NCC1=NCCN1
2379,CHEMBL99142,P35368,,PTZPHMWEBRURCP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,20.89,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1577750,DTCC00264803,853469,17389,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=CC=C4OC)NC5=CC=CC=C52,COc1ccccc1N1CCN(CCn2c(C)nc3c([nH]c4ccccc43)c2=O)CC1
2380,CHEMBL99142,P35368,,PTZPHMWEBRURCP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,17027264.0,KI,=,20.89,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]BE2254 from human cloned adrenergic alpha 1B receptor expressed in HEK293 cells,,"New pyrimido[5,4-b]indoles and [1]benzothieno[3,2-d]pyrimidines: high affinity ligands for the alpha(1)-adrenoceptor subtypes.",Bioorg. Med. Chem. Lett.,2006.0,16.0,24.0,"Romeo G, Materia L, Marucci G, Modica M, Pittalà V, Salerno L, Siracusa MA, Buccioni M, Angeli P, Minneman KP",,425083.0,DTCT0023207,2017520,DTCC00264803,843762,21852,CC1=NC2=C(C(=O)N1CCN3CCN(CC3)C4=CC=CC=C4OC)NC5=CC=CC=C52,COc1ccccc1N1CCN(CCn2c(C)nc3c([nH]c4ccccc43)c2=O)CC1
2381,CHEMBL99362,P35368,,LQGPNFSDWYQHAY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,199.53,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,635645,DTCC00264525,885719,4573,CCNC(=O)C1=CC=CC=C1NCC2=NCCN2,CCNC(=O)c1ccccc1NCC1=NCCN1
2382,CHEMBL99362,P35368,,LQGPNFSDWYQHAY-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,64.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,635646,DTCC00264525,885719,4573,CCNC(=O)C1=CC=CC=C1NCC2=NCCN2,CCNC(=O)c1ccccc1NCC1=NCCN1
2383,CHEMBL99363,P35368,,YHWHUPMNMMTFKN-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,<,10000.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1568591,DTCC00265180,1338606,17389,CC1=NC2=C(C(=O)N1CCN3CCN4C(C3)COC5=CC=CC=C54)NC6=CC=CC=C62,Cc1nc2c([nH]c3ccccc32)c(=O)n1CCN1CCN2c3ccccc3OCC2C1
2384,CHEMBL99397,P35368,,LBAHCBYHXKEZKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,1e+27,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34620.0,DTCT0023207,1597322,DTCC00265027,1723297,17389,C1CCC(CC1)C2=CC=C(C=C2)N3CCN(CC3)CCN4C(=O)C5=C(C6=CC=CC=C6N5)NC4=O,O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccc(C3CCCCC3)cc2)CC1
2385,CHEMBL99489,P35368,,PUAAUDBUJSSOLX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,LOG KI,=,6.84,NM,,cell_based,,,,,,,,,,,,The binding affinity was evaluated on cloned human alpha-1B adrenergic receptor expressed in chinese hamster ovary(CHO) cells by using [3H]prazosin as radioligand.,,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34622.0,DTCT0023207,996643,DTCC00268465,64673,15289,COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3C2=O)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1C(=O)c2ccccc2OC1c1ccccc1
2386,CHEMBL99489,P35368,,PUAAUDBUJSSOLX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10425105.0,PKB,=,6.05,,,,,,,,,,,,,,,Antagonist affinity was expressed as apparent pKb at alpha-1B adrenergic receptor on isolated Guinea pig spleen (Alpha-1B adrenergic receptor),,"Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.",J. Med. Chem.,1999.0,42.0,15.0,"Quaglia W, Pigini M, Piergentili A, Giannella M, Marucci G, Poggesi E, Leonardi A, Melchiorre C",,34194.0,DTCT0023207,996650,DTCC00268465,64673,15289,COC1=C(C(=CC=C1)OC)OCCNCC2C(OC3=CC=CC=C3C2=O)C4=CC=CC=C4,COc1cccc(OC)c1OCCNCC1C(=O)c2ccccc2OC1c1ccccc1
2387,CHEMBL99559,P35368,,PGTTUJMHQDYCRX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,EC50,=,25.12,NM,,,,,,,,,,,,,,Potency against cloned human alpha 1B adrenoceptor expressed in rat-1 fibroblasts.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30099.0,DTCT0023207,637846,DTCC00264676,1693747,4573,CCCCOC(=O)C1=CC=CC=C1NCC2=NCCN2,CCCCOC(=O)c1ccccc1NCC1=NCCN1
2388,CHEMBL99559,P35368,,PGTTUJMHQDYCRX-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11597419.0,MAX,=,63.0,%,,,,,,,,,,,,,,Efficacy against alpha 1B-adrenoceptor in human expressed as phenylephrine response at the dose of 40 uM.,,2-(Anilinomethyl)imidazolines as alpha(1)-adrenoceptor agonists: the identification of alpha(1A) subtype selective 2'-carboxylic acid esters and amides.,Bioorg. Med. Chem. Lett.,2001.0,11.0,21.0,"Bishop MJ, Berman J, Bigham EC, Garrison DT, Gobel MJ, Hodson SJ, Irving PE, Liacos JA, Minick DJ, Navas F, Saussy DL, Speake JD",,30098.0,DTCT0023207,637847,DTCC00264676,1693747,4573,CCCCOC(=O)C1=CC=CC=C1NCC2=NCCN2,CCCCOC(=O)c1ccccc1NCC1=NCCN1
2389,CHEMBL99614,P35368,,KWGFRDRXXIKKIO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10021947.0,KI,=,149.0,NM,,cell_based,,,,,,,,,,,LM,Displacement of [125I]HEAT from human Alpha-1B adrenergic receptor expressed in LM cells,,"4-Oxospiro[benzopyran-2,4'-piperidines] as selective alpha 1a-adrenergic receptor antagonists.",Bioorg. Med. Chem. Lett.,1999.0,9.0,2.0,"Nerenberg JB, Erb JM, Bergman JM, O'Malley S, Chang RS, Scott AL, Broten TP, Bock MG",,34325.0,DTCT0023207,507459,DTCC00267421,2001165,3405,CS(=O)(=O)NC1=CC2=C(C=C1)C(=O)CC3(O2)CCN(CC3)CCC4=CC=CC5=CC=CC=C54,CS(=O)(=O)Nc1ccc2c(c1)OC1(CCN(CCc3cccc4ccccc34)CC1)CC2=O
2390,CHEMBL99761,P35368,,NLRALOPNDFSYJZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,2.88,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1575127,DTCC00264488,1240612,17389,COC1=CC=CC=C1C2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5N4)NC3=O,COc1ccccc1C1CCN(CCn2c(=O)[nH]c3c([nH]c4ccccc43)c2=O)CC1
2391,CHEMBL99864,P35368,,CPNQDPLKZHXMSB-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10522703.0,KI,=,347.0,NM,,,,,,,,,,,,,,Binding affinity against human Alpha-1b adrenergic receptor,,Design and synthesis of novel dihydropyridine alpha-1a antagonists.,Bioorg. Med. Chem. Lett.,1999.0,9.0,19.0,"Marzabadi MR, Hong X, Nagarathnam D, Miao SW, Chiu G, Wong WC, Wetzel JM, Fang J, Forray C, Chen TB, O'Malley SS, Chang RS, Gluchowski C",,33012.0,DTCT0023207,1234636,DTCC00263328,1935316,3366,CCC1=C(C(C(=C(N1)CCCCOC)C(=O)NCCCN2CCC(CC2)(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC=C(C=C5)[N+](=O)[O-])C(=O)N,CCC1=C(C(N)=O)C(c2ccc([N+](=O)[O-])cc2)C(C(=O)NCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)=C(CCCCOC)N1
2392,CHEMBL99879,P35368,,GBFNGIUKBXQBKO-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,11.75,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1594629,DTCC00264749,853468,17389,C1CN(CCN1CCN2C(=O)C3=C(C4=CC=CC=C4N3)NC2=O)C5=CC=CC=C5O,O=c1[nH]c2c([nH]c3ccccc32)c(=O)n1CCN1CCN(c2ccccc2O)CC1
2393,CHEMBL99979,P35368,,PFAQKUQPCOULOJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,=,27.54,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1583212,DTCC00264433,1914741,17389,CCC1=NC2=C(C(=O)N1CCCN3CCN(CC3)C4=CC=CC=C4OC)NC5=CC=CC=C52,CCc1nc2c([nH]c3ccccc32)c(=O)n1CCCN1CCN(c2ccccc2OC)CC1
2394,CHEMBL99994,P35368,,ZJDZLOMQPUVIDD-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12825930.0,KI,<,10000.0,NM,,,,,,,,,,,,,,In vitro binding affinity at human Alpha-1B adrenergic receptor.,,"New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.",J. Med. Chem.,2003.0,46.0,14.0,"Romeo G, Materia L, Manetti F, Cagnotto A, Mennini T, Nicoletti F, Botta M, Russo F, Minneman KP",,34606.0,DTCT0023207,1583215,DTCC00264689,303327,17389,CC(C)(C)C1=CC=C(C=C1)N2CCN(CC2)CCN3C=NC4=C(C3=O)NC5=CC=CC=C54,CC(C)(C)c1ccc(N2CCN(CCn3cnc4c([nH]c5ccccc54)c3=O)CC2)cc1
2395,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,-1.0,KI,=,6637.0,NM,,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15059899,DTCC01744004,2113367,70044,,
2396,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,-1.0,KI,=,7211.0,NM,,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15059897,DTCC01744004,2113367,70044,,
2397,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,-1.0,KI,>,14700.0,NM,,,binding,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15058330,DTCC01744004,2113367,70044,,
2398,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,12.65,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14857838,DTCC01744004,2113518,70115,,
2399,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,14.15,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14857850,DTCC01744004,2113518,70115,,
2400,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,15.5,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14857851,DTCC01744004,2113518,70115,,
2401,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,42.1,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14857836,DTCC01744004,2113518,70115,,
2402,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,104.8,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14857857,DTCC01744004,2113518,70115,,
2403,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,461.1,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14858603,DTCC01744004,2113518,70115,,
2404,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,514.8,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14857858,DTCC01744004,2113518,70115,,
2405,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,598.6,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14857844,DTCC01744004,2113518,70115,,
2406,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27658792.0,EC50,=,608.4,NM,,cell_based,,,,luminescence,,,,,,,,,,,,,,,,,,DTCT0023207,14857837,DTCC01744004,2113518,70115,,
2407,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,=,7928.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15071092,DTCC01744004,2113723,70168,,
2408,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,=,9170.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15071094,DTCC01744004,2113723,70168,,
2409,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15043341,DTCC01744004,2113723,70168,,
2410,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15043342,DTCC01744004,2113723,70168,,
2411,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15071091,DTCC01744004,2113723,70168,,
2412,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15071093,DTCC01744004,2113723,70168,,
2413,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15071095,DTCC01744004,2113723,70168,,
2414,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15071096,DTCC01744004,2113723,70168,,
2415,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15071097,DTCC01744004,2113723,70168,,
2416,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15071098,DTCC01744004,2113723,70168,,
2417,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15071099,DTCC01744004,2113723,70168,,
2418,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27709945.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,15079038,DTCC01744004,2113723,70168,,
2419,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27839919.0,KI,>,10000.0,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14849206,DTCC01744004,2113386,70060,,
2420,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,27839919.0,KI,>,10000.0,NM,,cell_based,binding,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14849208,DTCC01744004,2113386,70060,,
2421,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,316.23,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14756069,DTCC01744004,2110165,68596,,
2422,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11082457.0,KI,=,316.2278,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14748268,DTCC01744004,2109583,69438,,
2423,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11805207.0,KI,=,25.12,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14732727,DTCC01744004,2104738,68867,,
2424,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12065700.0,KI,=,446.68,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14756075,DTCC01744004,2110831,69360,,
2425,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14746978,DTCC01744004,2109188,69275,,
2426,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14751433,DTCC01744004,2109188,69275,,
2427,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12388666.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14754045,DTCC01744004,2110038,69012,,
2428,,P35368,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14751418,DTCC01744004,2110075,69159,,
2429,,P35368,ACMC-20B84V,XSOUHEXVEOQRKJ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,10611634.0,KI,=,1000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14745464,DTCC01746021,2108972,69195,,
2430,,P35368,D-HOMOCYSTEIC ACID,VBOQYPQEPHKASR-GSVOUGTGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14755113,DTCC01745877,2104421,69159,,
2431,,P35368,D-HOMOCYSTEINE SULFINIC ACID,PDNJLMZEGXHSCU-GSVOUGTGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14758603,DTCC01746621,2110340,69159,,
2432,,P35368,D-HOMOCYSTEINE THIOLACTONE,KIWQWJKWBHZMDT-GSVOUGTGSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14751372,DTCC01746491,2110074,69159,,
2433,,P35368,DL-HOMOCYSTEIC ACID,VBOQYPQEPHKASR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14755149,DTCC01745876,2104415,69159,,
2434,,P35368,MDL 100907,HXTGXYRHXAGCFP-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15999145.0,KI,=,424.7,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14752687,DTCC01745097,2109914,69464,,
2435,,P35368,REC 15/3079,HVMKWKIPLGPYAR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,11714892.0,KI,=,105.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14750475,DTCC01746388,2109907,69813,,
2436,,P35368,REC 15/3079,HVMKWKIPLGPYAR-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15951403.0,KI,=,104.71,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14750469,DTCC01746388,2109908,69226,,
2437,,P35368,REC 27/0074,QQLBAAQRZXVWPZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15951403.0,KI,=,1.02,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14753642,DTCC01745728,2103395,69226,,
2438,,P35368,REC 27/0224,IRNNHEZQBOQPHZ-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,15951403.0,KI,=,645.65,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14753125,DTCC01746641,2110369,69226,,
2439,,P35368,SURECN8097715,UVEKKXRFQCNLQE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,2.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14754839,DTCC01744028,2110637,68596,,
2440,,P35368,SURECN8097715,UVEKKXRFQCNLQE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,9653897.0,KI,=,3.16,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14754841,DTCC01744028,2110637,68596,,
2441,,P35368,SURECN8097715,UVEKKXRFQCNLQE-UHFFFAOYSA-N,0,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,GPCR,,,16420037.0,KI,=,2.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023207,14754840,DTCC01744028,2110636,68752,,
